# Reaction Data Report

**Generated:** 2025-08-30 15:13:35
**Source Folder:** C:/Git-ChemRobox/Scifinder-Data-process/dataset/Amide formation/2021-2024
**Total Reactions:** 1000

## Summary

**Total Reactions:** 1000

**Reaction Types:**
  - Other: 1000 (100.0%)

**Yield Statistics:**
  - Reactions with yield data: 1000/1000
  - Average yield: 88.4%

**Data Quality Notes:**
  - CAS number validation and correction enabled
  - Compound name/CAS mismatches are automatically flagged
  - Manual corrections applied for known common compounds
  - Look for ⚠️ warnings in individual reactions for data quality issues

# Individual Reactions

## Reaction 31-117-CAS-22288687

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 35.0°C
  - Time: 0.75 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COc1ccc(C(=CC(=O)O)Cc2ccccc2)cc1.CCCN`
  - Products: `CCCNC(=O)CC(=Cc1ccccc1)c1ccc(OC)cc1`

**Reference:**
  - **Title:** Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents
  - **Authors:** Imran Ahamad, Mohd.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(11), 127138.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127138](https://doi.org/10.1016/j.bmcl.2020.127138)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-117-CAS-22288687
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 30 min, 0 °C
1.2|15 min, 0 °C; 35 °C
Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis
By: Yu, Wei-Chieh; et al
Journal of Medicinal Chemistry (2023), 66(15), 10528-10557.
10.1021/acs.jmedchem.3c00644
```

---

## Reaction 31-170-CAS-23304717

**Type:** Other

**Reagents:**
  - KOH (CAS: 1310-58-3) - Role: BASE
  - Potassium hydroxide - Role: UNK

**Solvents:**
  - DMSO (CAS: 67-68-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 125.0°C
  - Time: 21.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `Nc1cc(F)ccc1C(=O)O.CC(=O)O.N=CN.CN(C)CCCO`
  - Products: `CN(C)CCCOc1ccc2c(=O)nc[nH]c2c1`

**Reference:**
  - **Title:** Development of a Robust Scale-Up Synthetic Route for BPR1K871: A Clinical Candidate for the Treatment of Acute Myeloid Leukemia and Solid Tumors
  - **Authors:** Reddy, Julakanti Satyanarayana; et al
  - **Citation:** Organic Process Research & Development (2021), 25(4), 817-830.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.0c00515](https://doi.org/10.1021/acs.oprd.0c00515)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-170-CAS-23304717
1.1|Solvents: Dimethyl sulfoxide; rt; 4 h, rt → 120 °C
1.2|1 h, 120 °C
1.3|Reagents: Potassium hydroxide; 16 h, 125 °C
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
By: Breidenbach, Julian; et al
Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
10.1021/acs.jmedchem.4c00053
```

---

## Reaction 31-356-CAS-22071800

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 30.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)CO.Cl.C(=NC1CCCCC1)=NC1CCCCC1.O=C(O)/C=C/c1ccc(F)cc1`
  - Products: `COC(=O)[C@H](CO)NC(=O)/C=C/c1ccc(F)cc1.COC(=O)[C@H](COC(=O)/C=C/c1ccc(F)cc1)NC(=O)/C=C/c1ccc(F)cc1.O=C(/C=C/c1ccc(F)cc1)OC(=NC1CCCCC1)NC1CCCCC1`

**Reference:**
  - **Title:** Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine
  - **Authors:** Aguirre-Renteria, Saul A.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127074](https://doi.org/10.1016/j.bmcl.2020.127074)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-356-CAS-22071800
1.1|Reagents: Triethylamine
Solvents: Dichloromethane; 2 h, 40 °C; 0.5 h, 40 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 30 min, 40 °C; 2 h, 40 °C; 24 h, rt; 1 h, 5 °C
Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease
By: Kilpelainen, Tommi P.; et al
Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.
10.1021/acs.jmedchem.3c00235
```

---

## Reaction 31-356-CAS-22071801

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 30.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)CO.Cl.COc1ccc(/C=C/C(=O)O)cc1`
  - Products: `COC(=O)[C@H](CO)NC(=O)/C=C/c1ccc(OC)cc1.COC(=O)[C@H](COC(=O)/C=C/c1ccc(OC)cc1)NC(=O)/C=C/c1ccc(OC)cc1`

**Reference:**
  - **Title:** Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine
  - **Authors:** Aguirre-Renteria, Saul A.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127074](https://doi.org/10.1016/j.bmcl.2020.127074)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-356-CAS-22071801
1.1|Reagents: Triethylamine
Solvents: Dichloromethane; 2 h, 40 °C; 0.5 h, 40 °C
1.2|Reagents: Dicyclohexylcarbodiimide
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 30 min, 40 °C; 2 h, 40 °C; 24 h, rt; 1 h, 5 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-356-CAS-22071802

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 30.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)CO.Cl.C(=NC1CCCCC1)=NC1CCCCC1.Cc1ccc(/C=C/C(=O)O)cc1`
  - Products: `Cc1ccc(/C=C/C(=O)OC(=NC2CCCCC2)NC2CCCCC2)cc1.COC(=O)[C@H](CO)NC(=O)/C=C/c1ccc(C)cc1.COC(=O)[C@H](COC(=O)/C=C/c1ccc(C)cc1)NC(=O)/C=C/c1ccc(C)cc1`

**Reference:**
  - **Title:** Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine
  - **Authors:** Aguirre-Renteria, Saul A.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127074](https://doi.org/10.1016/j.bmcl.2020.127074)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-356-CAS-22071802
1.1|Reagents: Triethylamine
Solvents: Dichloromethane; 2 h, 40 °C; 0.5 h, 40 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 30 min, 40 °C; 2 h, 40 °C; 24 h, rt; 1 h, 5 °C
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Discovery of Nanomolar DCAF1 Small Molecule Ligands
By: Li, Alice Shi Ming; et al
Journal of Medicinal Chemistry (2023), 66(7), 5041-5060.
10.1021/acs.jmedchem.2c02132
```

---

## Reaction 31-363-CAS-23416807

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - MeOH (CAS: 67-56-1) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)cc1.CC(C)(C)OC(=O)NCCCCCC(=O)O`
  - Products: `Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCNC(=O)OC(C)(C)C)C(C)(C)C)cc1`

**Reference:**
  - **Title:** Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers
  - **Authors:** Cao, Chaoguo; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(19), 11012-11033.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00821](https://doi.org/10.1021/acs.jmedchem.0c00821)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-363-CAS-23416807
1.1|Reagents: Hydrochloric acid
Solvents: Methanol, Dichloromethane, 1,4-Dioxane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; rt → 0 °C; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease
By: Liu, Longbin; et al
Journal of Medicinal Chemistry (2023), 66(18), 13205-13246.
10.1021/acs.jmedchem.3c01173
```

---

## Reaction 31-367-CAS-21533229

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 10.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC(=O)CCC(=O)O.CC(C)c1cc(C(=O)N2Cc3ccc(N)cc3C2)c(OCc2ccccc2)cc1OCc1ccccc1`
  - Products: `COC(=O)CCC(=O)Nc1ccc2c(c1)CN(C(=O)c1cc(C(C)C)c(OCc3ccccc3)cc1OCc1ccccc1)C2`

**Reference:**
  - **Title:** Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo
  - **Authors:** Ojha, Ritu; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 190, 112086pp..
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112086](https://doi.org/10.1016/j.ejmech.2020.112086)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-21533229
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 5 h, rt; 5 h, rt
1.2|Reagents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1
By: Zhou, Qilong; et al
European Journal of Medicinal Chemistry (2022), 244, 114830.
10.1016/j.ejmech.2022.114830
```

---

## Reaction 31-367-CAS-21607012

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 6.5 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(=O)O.Cn1cc(Nc2cc(-c3cccc(N)c3)ncn2)cn1`
  - Products: `Cn1cc(Nc2cc(-c3cccc(NC(=O)CNC(=O)OC(C)(C)C)c3)ncn2)cn1`

**Reference:**
  - **Title:** Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors
  - **Authors:** Shu, Lei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 191, 112148pp..
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112148](https://doi.org/10.1016/j.ejmech.2020.112148)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-21607012
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 30 min, 0 °C
1.2|6 h, 0 °C → rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Synthesis Optimization, Scale-Up, and Catalyst Screening Efforts toward the MGAT2 Clinical Candidate, BMS-963272
By: Kempson, James; et al
Organic Process Research & Development (2022), 26(4), 1327-1335.
10.1021/acs.oprd.2c00036
```

---

## Reaction 31-367-CAS-21607035

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `N#CCC(=O)O.Cn1cc(Nc2cc(-c3cccc(N)c3)ncn2)cn1`
  - Products: `Cn1cc(Nc2cc(-c3cccc(NC(=O)CC#N)c3)ncn2)cn1`

**Reference:**
  - **Title:** Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors
  - **Authors:** Shu, Lei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 191, 112148pp..
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112148](https://doi.org/10.1016/j.ejmech.2020.112148)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-367-CAS-21607035
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; 0 °C; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-367-CAS-21717118

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 3.167 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2oc(=O)ccc2c1.COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1`
  - Products: `COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2ccc3oc(=O)ccc3c2)cc1`

**Reference:**
  - **Title:** Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 186, 111900.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2019.111900](https://doi.org/10.1016/j.ejmech.2019.111900)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-367-CAS-21717118
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 10 min, 0 °C; 1 h, rt
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, rt
Double bond geometry shown
Relative stereochemistry shown
Relative stereochemistry shown
Double bond geometry shown
Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors
By: Kong, Deyu; et al
Journal of Medicinal Chemistry (2024), 67(7), 5866-5882.
10.1021/acs.jmedchem.4c00148
```

---

## Reaction 31-367-CAS-21782635

**Type:** Other

**Reagents:**
  - Py (CAS: 110-86-1) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -10.0°C
  - Time: 16.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `C=C[C@@H](C)C(=O)O.C=CC[C@H](NC(=O)OC(C)(C)C)c1cc(-c2ccc(NC(=O)OC)cc2N)ccn1`
  - Products: `C=CC[C@H](NC(=O)OC(C)(C)C)c1cc(-c2ccc(NC(=O)OC)cc2NC(=O)[C@H](C)C=C)ccn1`

**Reference:**
  - **Title:** Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups
  - **Authors:** Corte, James R.; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(2), 784-803.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b01768](https://doi.org/10.1021/acs.jmedchem.9b01768)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-367-CAS-21782635
1.1|Reagents: Pyridine, Propylphosphonic anhydride
Solvents: Ethyl acetate; -10 °C; -10 °C → rt; overnight, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Structure-guided design and optimization of covalent VHL-targeted sulfonyl fluoride PROTACs
By: Shah, Rishi R.; et al
Journal of Medicinal Chemistry (2024), 67(6), 4641-4654.
10.1021/acs.jmedchem.3c02123
```

---

## Reaction 31-367-CAS-21822005

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `Cc1ccccc1NC(=O)C=CC(=O)O.NC1Cc2ccccc2NC1=O`
  - Products: `Cc1ccccc1NC(=O)C=CC(=O)NC1Cc2ccccc2NC1=O`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-21822005
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Discovery of a potent dual inhibitor of wild-type and mutant respiratory syncytial virus fusion proteins through the modulation of atropisomer interconversion properties
By: Yamaguchi-Sasaki, Toru; et al
Bioorganic & Medicinal Chemistry (2020), 28(24), 115818.
10.1016/j.bmc.2020.115818
```

---

## Reaction 31-367-CAS-21822006

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.25 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `Cc1cccc(NC(=O)C=CC(=O)O)c1.NC1Cc2ccccc2NC1=O`
  - Products: `Cc1cccc(NC(=O)C=CC(=O)NC2Cc3ccccc3NC2=O)c1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-367-CAS-21822006
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-367-CAS-21822007

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `Cc1ccc(NC(=O)C=CC(=O)O)cc1.NC1Cc2ccccc2NC1=O`
  - Products: `Cc1ccc(NC(=O)C=CC(=O)NC2Cc3ccccc3NC2=O)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-21822007
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis
By: Hopkins, Brian T.; et al
Journal of Medicinal Chemistry (2022), 65(2), 1206-1224.
10.1021/acs.jmedchem.1c00926
```

---

## Reaction 31-367-CAS-21822008

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `COc1ccccc1NC(=O)C=CC(=O)O.NC1Cc2ccccc2NC1=O`
  - Products: `COc1ccccc1NC(=O)C=CC(=O)NC1Cc2ccccc2NC1=O`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-367-CAS-21822008
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-367-CAS-21822009

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.25 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `COc1ccc(NC(=O)C=CC(=O)O)cc1.NC1Cc2ccccc2NC1=O`
  - Products: `COc1ccc(NC(=O)C=CC(=O)NC2Cc3ccccc3NC2=O)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-367-CAS-21822009
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-367-CAS-21822010

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.25 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)C=CC(=O)Nc1ccccc1[N+](=O)[O-].NC1Cc2ccccc2NC1=O`
  - Products: `O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccccc1[N+](=O)[O-]`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-367-CAS-21822010
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-367-CAS-21822011

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -3.0°C
  - Time: 0.25 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)C=CC(=O)Nc1cccc([N+](=O)[O-])c1.NC1Cc2ccccc2NC1=O`
  - Products: `O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1cccc([N+](=O)[O-])c1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-367-CAS-21822011
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Discovery of Selective Dopamine Receptor Ligands Derived from (-)-Stepholidine via C-3 Alkoxylation and C-3/C-9 Dialkoxylation
By: Namballa, Hari K.; et al
Journal of Medicinal Chemistry (2023), 66(14), 10060-10079.
10.1021/acs.jmedchem.3c00976
```

---

## Reaction 31-367-CAS-21822012

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)C=CC(=O)Nc1ccc([N+](=O)[O-])cc1.NC1Cc2ccccc2NC1=O`
  - Products: `O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccc([N+](=O)[O-])cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-367-CAS-21822012
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors
By: Wiedemeyer, Simon J. A.; et al
ChemMedChem (2023), 18(6), e202200632.
10.1002/cmdc.202200632
```

---

## Reaction 31-367-CAS-21822013

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)C=CC(=O)Nc1ccccc1Cl.NC1Cc2ccccc2NC1=O`
  - Products: `O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccccc1Cl`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-367-CAS-21822013
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
By: Fang, Wei; et al
Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
10.1021/acs.jmedchem.3c02063
```

---

## Reaction 31-367-CAS-21822014

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.25 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)C=CC(=O)Nc1ccc(Cl)cc1.NC1Cc2ccccc2NC1=O`
  - Products: `O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccc(Cl)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-21822014
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-367-CAS-21822015

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.25 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)C=CC(=O)Nc1ccccc1Br.NC1Cc2ccccc2NC1=O`
  - Products: `O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccccc1Br`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-367-CAS-21822015
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-367-CAS-21822016

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)C=CC(=O)Nc1cccc(Br)c1.NC1Cc2ccccc2NC1=O`
  - Products: `O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1cccc(Br)c1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-367-CAS-21822016
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale
By: McCoy, Michael A.; et al
Journal of Medicinal Chemistry (2022), 65(10), 7246-7261.
10.1021/acs.jmedchem.2c00228
```

---

## Reaction 31-367-CAS-21822017

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)C=CC(=O)Nc1ccc(Br)cc1.NC1Cc2ccccc2NC1=O`
  - Products: `O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccc(Br)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-367-CAS-21822017
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
By: Tormaehlen, Niklas M.; et al
Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
10.1021/acs.jmedchem.0c01773
```

---

## Reaction 31-367-CAS-21822018

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)C=CC(=O)Nc1ccccc1F.NC1Cc2ccccc2NC1=O`
  - Products: `O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccccc1F`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-367-CAS-21822018
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-367-CAS-21822019

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)C=CC(=O)Nc1ccc(F)cc1.NC1Cc2ccccc2NC1=O`
  - Products: `O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccc(F)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-21822019
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors
By: Zhang, Hao; et al
Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.
10.1021/acs.jmedchem.2c00611
```

---

## Reaction 31-367-CAS-21822021

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)C=CC(=O)Nc1ccccc1.NC1Cc2ccccc2NC1=O`
  - Products: `O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccccc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-367-CAS-21822021
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease
By: Zhou, Jianhui; et al
Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.
10.1021/acs.jmedchem.4c00159
```

---

## Reaction 31-367-CAS-21822022

**Type:** Other

**Full Catalytic System:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Catalyst Core:**
  - I2 (CAS: 7553-56-2) - Role: OXIDANT
  - P(OEt)3 (CAS: 122-52-1) - Role: REDUCTANT

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)C=CC(=O)Nc1cccc2ccccc12.NC1Cc2ccccc2NC1=O`
  - Products: `O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1cccc2ccccc12`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
  - **Authors:** Li, Baihui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 195, 112278.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112278](https://doi.org/10.1016/j.ejmech.2020.112278)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-367-CAS-21822022
1.1|Reagents: Triethylamine
Catalysts: Triethyl phosphite, Iodine
Solvents: Dichloromethane; 15 min, cooled
1.2|cooled; rt
Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease
By: Zhou, Jianhui; et al
Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.
10.1021/acs.jmedchem.4c00159
```

---

## Reaction 31-367-CAS-21894967

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 10.0°C
  - Time: 1.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)Nc1nc(/C(=N/OC2(C(=O)OC(c3ccccc3)c3ccccc3)CC2)C(=O)O)cs1.COc1nc(Cl)nc(OC)n1.N[C@@H]1C(=O)N[C@@H]1CN1CCOC1=O`
  - Products: `COc1nc(OC)nc(Oc2nc(OC)nc(OC)n2)n1.CC(C)(C)OC(=O)Nc1nc(/C(=N/OC2(C(=O)OC(c3ccccc3)c3ccccc3)CC2)C(=O)N[C@@H]2C(=O)N[C@@H]2CN2CCOC2=O)cs1.CC(C)(C)OC(=O)Nc1nc(/C(=N/OC2(C(=O)OC(c3ccccc3)c3ccccc3)CC2)C(=O)N[C@@H]2C(=O)N[C@@H]2CN2C(=O)OCC2O)cs1`

**Reference:**
  - **Title:** Process Development for the Synthesis of a Monobactam Antibiotic-LYS228
  - **Authors:** Fei, Zhongbo; et al
  - **Citation:** Organic Process Research & Development (2020), 24(3), 363-370.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.9b00330](https://doi.org/10.1021/acs.oprd.9b00330)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-367-CAS-21894967
1.1|Reagents: 4-Methylmorpholine
Solvents: Dimethylformamide; rt; rt → 0 °C
1.2|< 10 °C; 1 h, 0 - 5 °C
1.3|Solvents: Dimethylformamide, Water
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities
By: Sun, Lin; et al
Journal of Medicinal Chemistry (2020), 63(9), 4790-4810.
10.1021/acs.jmedchem.0c00015
```

---

## Reaction 31-367-CAS-21911742

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 7.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(=O)O.COc1ccc(N(C)C(=O)[C@@H](N)Cc2ccccc2)cc1`
  - Products: `COc1ccc(N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)OC(C)(C)C)cc1`

**Reference:**
  - **Title:** Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities
  - **Authors:** Sun, Lin; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(9), 4790-4810.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00015](https://doi.org/10.1021/acs.jmedchem.0c00015)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-21911742
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 1 h, 0 °C
1.2|Reagents: Diisopropylethylamine; 0 °C; 6 h, rt
Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands
By: Andreasson, Maans; et al
Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.
10.1021/acs.jmedchem.3c02127
```

---

## Reaction 31-367-CAS-21945245

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `O=C(O)c1cc(Br)c(Br)s1.CC(C)(C)OC(=O)N1CCC(CN)CC1`
  - Products: `CC(C)(C)OC(=O)N1CCC(CNC(=O)c2cc(Br)c(Br)s2)CC1`

**Reference:**
  - **Title:** Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP
  - **Authors:** Wu, Fangrui; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(9), 4716-4731.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b02164](https://doi.org/10.1021/acs.jmedchem.9b02164)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-367-CAS-21945245
1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 0 °C; 1 h, rt
1.2|Reagents: Sodium bicarbonate
Solvents: Water; rt
Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase
By: Russ, Nadine; et al
Journal of Medicinal Chemistry (2021), 64(19), 14358-14376.
10.1021/acs.jmedchem.1c00845
```

---

## Reaction 31-367-CAS-21974278

**Type:** Other

**Reagents:**
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 14.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `O=C(O)Cc1ccc([N+](=O)[O-])cc1Br.NCCc1ccccc1`
  - Products: `O=C(Cc1ccc([N+](=O)[O-])cc1Br)NCCc1ccccc1`

**Reference:**
  - **Title:** Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity
  - **Authors:** Karki, Anupam; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127053](https://doi.org/10.1016/j.bmcl.2020.127053)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-367-CAS-21974278
1.1|Reagents: 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Tetrahydrofuran; 30 min, rt
1.2|Solvents: Tetrahydrofuran; 30 min, rt; 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
By: Behring, Lydia; et al
Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
10.1021/acs.jmedchem.2c01360
```

---

## Reaction 31-367-CAS-21974286

**Type:** Other

**Reagents:**
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 14.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `O=C(O)Cc1ccc([N+](=O)[O-])cc1Br.COc1cc(CCN)ccc1OCc1ccccc1`
  - Products: `COc1cc(CCNC(=O)Cc2ccc([N+](=O)[O-])cc2Br)ccc1OCc1ccccc1`

**Reference:**
  - **Title:** Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity
  - **Authors:** Karki, Anupam; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127053](https://doi.org/10.1016/j.bmcl.2020.127053)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-367-CAS-21974286
1.1|Reagents: 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Tetrahydrofuran; 30 min, rt
1.2|Solvents: Tetrahydrofuran; 30 min, rt; 12 h, rt
Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety
By: Pandrala, Mallesh; et al
Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.
10.1021/acs.jmedchem.1c01853
```

---

## Reaction 31-367-CAS-21978534

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)O.NCC1(CC(=O)OCc2ccccc2)CCCCC1.O=C(O)C(F)(F)F`
  - Products: `CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)NCC1(CC(=O)OCc2ccccc2)CCCCC1`

**Reference:**
  - **Title:** Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors
  - **Authors:** Meena, Chhuttan L.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127039](https://doi.org/10.1016/j.bmcl.2020.127039)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-367-CAS-21978534
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity
By: Yamada, Yousuke; et al
Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.
10.1021/acs.jmedchem.0c01215
```

---

## Reaction 31-367-CAS-21978535

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)O.CC(C)(N)C(=O)OCc1ccccc1.O=C(O)C(F)(F)F`
  - Products: `CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)NC(C)(C)C(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors
  - **Authors:** Meena, Chhuttan L.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127039](https://doi.org/10.1016/j.bmcl.2020.127039)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-367-CAS-21978535
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide
By: Guryanov, Ivan; et al
Organic Process Research & Development (2021), 25(7), 1598-1611.
10.1021/acs.oprd.1c00021
```

---

## Reaction 31-367-CAS-21978536

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)O.NC1(C(=O)OCc2ccccc2)CCCCC1.O=C(O)C(F)(F)F`
  - Products: `CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)NC1(C(=O)OCc2ccccc2)CCCCC1`

**Reference:**
  - **Title:** Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors
  - **Authors:** Meena, Chhuttan L.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127039](https://doi.org/10.1016/j.bmcl.2020.127039)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-367-CAS-21978536
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 16 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-367-CAS-21978537

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)O.COc1c(N)cccc1C(=O)OCc1ccccc1.O=C(O)C(F)(F)F`
  - Products: `COc1c(NC(=O)[C@@H](Cc2ccccc2)NC(=O)OC(C)(C)C)cccc1C(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors
  - **Authors:** Meena, Chhuttan L.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127039](https://doi.org/10.1016/j.bmcl.2020.127039)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-367-CAS-21978537
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-367-CAS-22020035

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Na2CO3 (CAS: 497-19-8) - Role: UNK (Registry: BASE)
  - Sodium carbonate - Role: UNK

**Solvents:**
  - Xylene (CAS: 1330-20-7) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 100.0°C
  - Time: 7.5 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `O=C(O)c1cccc([N+](=O)[O-])c1F.Nc1ccc(C(F)(C(F)(F)F)C(F)(F)F)cc1C(F)(F)F`
  - Products: `O=C(Nc1ccc(C(F)(C(F)(F)F)C(F)(F)F)cc1C(F)(F)F)c1cccc([N+](=O)[O-])c1F`

**Reference:**
  - **Title:** Development of an efficient synthetic process for broflanilide
  - **Authors:** Luo, Chunyan; et al
  - **Citation:** Organic Process Research & Development (2020), 24(6), 1024-1031.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.0c00028](https://doi.org/10.1021/acs.oprd.0c00028)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-367-CAS-22020035
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide
Solvents: Xylene; 25 °C; 2 h, reflux
1.2|Solvents: Xylene; 5 h, 100 °C
1.3|Reagents: Sodium carbonate
Solvents: Water; 100 °C; 30 min, 80 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors
By: Zhang, Hao; et al
Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.
10.1021/acs.jmedchem.2c00611
```

---

## Reaction 31-367-CAS-22020083

**Type:** Other

**Reagents:**
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - N-Methylmorpholine (CAS: 109-02-4) - Role: AMIDE_BASE
  - 4-Methylmorpholine

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O.CC(C)C[C@H](N)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C.O=C(O)C(F)(F)F`
  - Products: `CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C`

**Reference:**
  - **Title:** Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma
  - **Authors:** Zhou, Yi; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b02161](https://doi.org/10.1021/acs.jmedchem.9b02161)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-367-CAS-22020083
1.1|Reagents: O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide, 4-Methylmorpholine; 0 °C; 16 h, rt
Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance
By: He, Siyu; et al
ACS Medicinal Chemistry Letters (2022), 13(8), 1286-1294.
10.1021/acsmedchemlett.2c00175
```

---

## Reaction 31-367-CAS-22020084

**Type:** Other

**Reagents:**
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - N-Methylmorpholine (CAS: 109-02-4) - Role: AMIDE_BASE
  - 4-Methylmorpholine

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.CC(C)C[C@H](N)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C.O=C(O)C(F)(F)F`
  - Products: `CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C`

**Reference:**
  - **Title:** Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma
  - **Authors:** Zhou, Yi; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b02161](https://doi.org/10.1021/acs.jmedchem.9b02161)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-22020084
1.1|Reagents: O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide, 4-Methylmorpholine; 0 °C; 16 h, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-367-CAS-22020120

**Type:** Other

**Reagents:**
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - N-Methylmorpholine (CAS: 109-02-4) - Role: AMIDE_BASE
  - 4-Methylmorpholine

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(=O)O.CC(C)C[C@H](N)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C.O=C(O)C(F)(F)F`
  - Products: `CC(C)C[C@H](NC(=O)CNC(=O)OC(C)(C)C)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C`

**Reference:**
  - **Title:** Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma
  - **Authors:** Zhou, Yi; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b02161](https://doi.org/10.1021/acs.jmedchem.9b02161)

**Original Text:**
```
Steps: 1, Yield: 89-99%
CAS Reaction Number: 31-367-CAS-22020120
1.1|Reagents: O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide, 4-Methylmorpholine; 0 °C; 16 h, rt
Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma
By: Wang, Xueyuan; et al
European Journal of Medicinal Chemistry (2023), 250, 115187.
10.1016/j.ejmech.2023.115187
```

---

## Reaction 31-367-CAS-22303119

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 20.25 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)CCCc1cccs1.Nc1ccc(C(F)(F)F)cc1`
  - Products: `O=C(CCCc1cccs1)Nc1ccc(C(F)(F)F)cc1`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of aryl piperazines with potential as antidiabetic agents via the stimulation of glucose uptake and inhibition of NADH:ubiquinone oxidoreductase
  - **Authors:** Devine, R.; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 202, 112416.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112416](https://doi.org/10.1016/j.ejmech.2020.112416)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-367-CAS-22303119
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 15 min, rt
1.2|Solvents: Dichloromethane; 20 h, rt
Absolute stereochemistry shown,
Rotation (+)
Double bond geometry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine
By: Aguirre-Renteria, Saul A.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.
10.1016/j.bmcl.2020.127074
```

---

## Reaction 31-367-CAS-22370048

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 19.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1F.Nc1ccc([N+](=O)[O-])cc1O`
  - Products: `O=C(Nc1ccc([N+](=O)[O-])cc1O)c1ccccc1F`

**Reference:**
  - **Title:** Pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one derivatives as CDK8 inhibitors
  - **Authors:** Martinez-Gonzalez, Sonia; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 201, 112443.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112443](https://doi.org/10.1016/j.ejmech.2020.112443)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-367-CAS-22370048
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 3 h, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Tetrahydrofuran; 0 °C; overnight, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 7, rt
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
By: Hiesinger, Kerstin; et al
Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.
10.1021/acs.jmedchem.0c00561
```

---

## Reaction 31-367-CAS-22401841

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.5 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)c1cc(=O)c2c(OCc3ccc(Br)cc3)cccc2o1.COC(=O)[C@@H](N)Cc1ccccc1.Cl`
  - Products: `COC(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(=O)c2c(OCc3ccc(Br)cc3)cccc2o1`

**Reference:**
  - **Title:** Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2
  - **Authors:** Roussel, Emile; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 202, 112503.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112503](https://doi.org/10.1016/j.ejmech.2020.112503)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-367-CAS-22401841
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide; 30 min, rt
1.2|Solvents: Dimethylformamide; 12 - 24 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; acidified, rt
Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization
By: Zirimwabagabo, Jean-Olivier; et al
Journal of Medicinal Chemistry (2021), 64(6), 3299-3319.
10.1021/acs.jmedchem.0c02191
```

---

## Reaction 31-367-CAS-22401842

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.5 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)c1cc(=O)c2c(OCc3ccc(Br)cc3)cccc2o1.COC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.Cl`
  - Products: `COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(=O)c2c(OCc3ccc(Br)cc3)cccc2o1`

**Reference:**
  - **Title:** Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2
  - **Authors:** Roussel, Emile; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 202, 112503.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112503](https://doi.org/10.1016/j.ejmech.2020.112503)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-367-CAS-22401842
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide; 30 min, rt
1.2|Solvents: Dimethylformamide; 12 - 24 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; acidified, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2
By: Roussel, Emile; et al
European Journal of Medicinal Chemistry (2020), 202, 112503.
10.1016/j.ejmech.2020.112503
```

---

## Reaction 31-367-CAS-22401843

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.5 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1cc(=O)c2c(OCc3ccc(Br)cc3)cccc2o1.COC(=O)[C@H](N)Cc1c[nH]c2ccccc12.Cl`
  - Products: `COC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(=O)c2c(OCc3ccc(Br)cc3)cccc2o1`

**Reference:**
  - **Title:** Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2
  - **Authors:** Roussel, Emile; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 202, 112503.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112503](https://doi.org/10.1016/j.ejmech.2020.112503)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-367-CAS-22401843
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide; 30 min, rt
1.2|Solvents: Dimethylformamide; 12 - 24 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; acidified, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown
Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide
By: Guryanov, Ivan; et al
Organic Process Research & Development (2021), 25(7), 1598-1611.
10.1021/acs.oprd.1c00021
```

---

## Reaction 31-367-CAS-22470947

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 3.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `C[C@@H](C(=O)N[C@H](C(=O)N1C[C@@H](N)C[C@H]1C(=O)Nc1c(F)cccc1F)C(C)(C)C)N(C)C(=O)OC(C)(C)C.CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(CC(=O)NCCOCCOCCOCCC(=O)O)CC4)cn3)nc2n(C2CCCC2)c1=O`
  - Products: `CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(CC(=O)NCCOCCOCCOCCC(=O)N[C@H]5C[C@@H](C(=O)Nc6c(F)cccc6F)N(C(=O)[C@@H](NC(=O)[C@H](C)N(C)C(=O)OC(C)(C)C)C(C)(C)C)C5)CC4)cn3)nc2n(C2CCCC2)c1=O`

**Reference:**
  - **Title:** Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs
  - **Authors:** Anderson, Niall A.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127106.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127106](https://doi.org/10.1016/j.bmcl.2020.127106)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-367-CAS-22470947
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, 0 °C; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
By: Gillis, Eric P.; et al
Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
10.1021/acs.jmedchem.2c01732
```

---

## Reaction 31-367-CAS-22486109

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 20.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `NS(=O)(=O)c1ccc(-n2nc(C(=O)O)cc2-c2ccccc2)cc1.NC1CCCCC1`
  - Products: `NS(=O)(=O)c1ccc(-n2nc(C(=O)NC3CCCCC3)cc2-c2ccccc2)cc1`

**Reference:**
  - **Title:** Discovery of novel urea-diarylpyrazole hybrids as dual COX-2/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks
  - **Authors:** Abdelazeem, Ahmed H.; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 205, 112662.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112662](https://doi.org/10.1016/j.ejmech.2020.112662)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-22486109
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 3 h, reflux
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; overnight, rt
Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
By: Sheppard, George S.; et al
Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.
10.1021/acs.jmedchem.0c00628
```

---

## Reaction 31-367-CAS-22493175

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.083 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CC(C)Cc1nc(Br)sc1C(=O)O.NCc1ccc(F)cc1`
  - Products: `CC(C)Cc1nc(Br)sc1C(=O)NCc1ccc(F)cc1`

**Reference:**
  - **Title:** Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors
  - **Authors:** Jia, Haiyong; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 202, 112495.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112495](https://doi.org/10.1016/j.ejmech.2020.112495)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-367-CAS-22493175
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 5 min, rt
1.2|Reagents: Diisopropylethylamine; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity
By: Ikeda, Zenichi; et al
Journal of Medicinal Chemistry (2022), 65(12), 8456-8477.
10.1021/acs.jmedchem.2c00463
```

---

## Reaction 31-367-CAS-22513054

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 45.0°C
  - Time: 3.5 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CN.COc1ccc(Br)c(F)c1CC(=O)O`
  - Products: `CNC(=O)Cc1c(OC)ccc(Br)c1F`

**Reference:**
  - **Title:** Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process
  - **Authors:** Smith, Daniel; et al
  - **Citation:** Organic Process Research & Development (2020), 24(6), 1157-1163.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.0c00198](https://doi.org/10.1021/acs.oprd.0c00198)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-367-CAS-22513054
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide, Tetrahydrofuran; rt; rt → 45 °C; 2 h, rt
1.2|Reagents: Water; 30 min, rt; 1 h, rt
Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site
By: Lin, Songwen; et al
Journal of Medicinal Chemistry (2022), 65(24), 16372-16391.
10.1021/acs.jmedchem.2c01208
```

---

## Reaction 31-367-CAS-22513060

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - NMP (CAS: 872-50-4) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `Cl.NC1(c2ncccn2)CC1.CNC(=O)c1c(-c2ccc(F)cc2)oc2ccc(-c3cc(C(=O)O)ccc3C)c(F)c12`
  - Products: `CNC(=O)c1c(-c2ccc(F)cc2)oc2ccc(-c3cc(C(=O)NC4(c5ncccn5)CC4)ccc3C)c(F)c12`

**Reference:**
  - **Title:** Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process
  - **Authors:** Smith, Daniel; et al
  - **Citation:** Organic Process Research & Development (2020), 24(6), 1157-1163.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.0c00198](https://doi.org/10.1021/acs.oprd.0c00198)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-22513060
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: N-Methyl-2-pyrrolidone; rt; 3 h, rt
1.2|Reagents: Water; 10 min, rt
Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
By: Pal, Kavita; et al
European Journal of Medicinal Chemistry (2023), 248, 115055.
10.1016/j.ejmech.2022.115055
```

---

## Reaction 31-367-CAS-22568847

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(Nc1ccccc1C(=O)O)OCc1ccccc1.CC(C)(C)OC(=O)NC1CC1c1ccc(N)cc1`
  - Products: `CC(C)(C)OC(=O)NC1CC1c1ccc(NC(=O)c2ccccc2NC(=O)OCc2ccccc2)cc1`

**Reference:**
  - **Title:** Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation
  - **Authors:** Fioravanti, Rossella; et al
  - **Citation:** ChemMedChem (2020), 15(7), 643-658.
  - **DOI:** [https://doi.org/10.1002/cmdc.201900730](https://doi.org/10.1002/cmdc.201900730)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-22568847
1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 1 h, rt
1.2|Reagents: Water; rt
Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects
By: Nepali, Kunal; et al
European Journal of Medicinal Chemistry (2023), 248, 115054.
10.1016/j.ejmech.2022.115054
```

---

## Reaction 31-367-CAS-22568850

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NC1CC1c1ccc(N)cc1.O=C(Nc1cc(-c2ccccc2)ccc1C(=O)O)OCc1ccccc1`
  - Products: `CC(C)(C)OC(=O)NC1CC1c1ccc(NC(=O)c2ccc(-c3ccccc3)cc2NC(=O)OCc2ccccc2)cc1`

**Reference:**
  - **Title:** Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation
  - **Authors:** Fioravanti, Rossella; et al
  - **Citation:** ChemMedChem (2020), 15(7), 643-658.
  - **DOI:** [https://doi.org/10.1002/cmdc.201900730](https://doi.org/10.1002/cmdc.201900730)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-367-CAS-22568850
1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 1 h, rt
1.2|Reagents: Water; rt
Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists
By: Shan, Bin; et al
Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.
10.1021/acs.jmedchem.2c01714
```

---

## Reaction 31-367-CAS-22615131

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)Cc1ccccc1.CC(C)(C)OC(=O)CCSc1nnc(N)s1`
  - Products: `CC(C)(C)OC(=O)CCSc1nnc(NC(=O)Cc2ccccc2)s1`

**Reference:**
  - **Title:** Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker
  - **Authors:** Duvall, Bridget; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2020), 28(20), 115698.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2020.115698](https://doi.org/10.1016/j.bmc.2020.115698)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-367-CAS-22615131
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; overnight, 0 °C → rt
Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer
By: Sharma, Horrick; et al
European Journal of Medicinal Chemistry (2024), 275, 116598.
10.1016/j.ejmech.2024.116598
```

---

## Reaction 31-367-CAS-22629929

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 8.5 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1cccnc1.Nc1nc(-c2ccncc2)cs1`
  - Products: `O=C(Nc1nc(-c2ccncc2)cs1)c1cccnc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of 4-aryl-5-aminoalkyl-thiazole-2-amines derivatives as ROCK II inhibitors
  - **Authors:** Ma, Shuchao; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2020), 28(19), 115683.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2020.115683](https://doi.org/10.1016/j.bmc.2020.115683)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-22629929
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 30 min, rt
1.2|Solvents: Dichloromethane; 8 h, rt
Double bond geometry shown
Double bond geometry shown
Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers
By: Braconi, Laura; et al
European Journal of Medicinal Chemistry (2023), 259, 115716.
10.1016/j.ejmech.2023.115716
```

---

## Reaction 31-367-CAS-22631808

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - Tetramethylchloroformamidinium hexafluorophosphate (CAS: 330645-87-9) - Role: UNK (Registry: ACTIVATOR)
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `CC(C)CN.CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N(NC(=O)OC(C)(C)C)[C@H](Cc1ccccc1)C(=O)O`
  - Products: `CC(C)CNC(=O)[C@@H](Cc1ccccc1)N(NC(=O)OC(C)(C)C)C(=O)[C@H](CC(C)C)NC(=O)OCC1c2ccccc2-c2ccccc21`

**Reference:**
  - **Title:** Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S
  - **Authors:** Rathman, Benjamin M.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127283](https://doi.org/10.1016/j.bmcl.2020.127283)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-367-CAS-22631808
1.1|Reagents: 4-Methylmorpholine, 1-[Bis(dimethylamino)methylene]-5-chloro-1H-benzotriazolium 3-oxide hexafluorophosphate(1-) (1:1)
Solvents: Dimethylformamide; 1 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2023), 246, 114981.
10.1016/j.ejmech.2022.114981
```

---

## Reaction 31-367-CAS-22631809

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - Tetramethylchloroformamidinium hexafluorophosphate (CAS: 330645-87-9) - Role: UNK (Registry: ACTIVATOR)
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CC(C)CN.CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N(NC(=O)OC(C)(C)C)[C@H](Cc1ccccc1)C(=O)O`
  - Products: `CC(C)CNC(=O)[C@H](Cc1ccccc1)N(NC(=O)OC(C)(C)C)C(=O)[C@H](CC(C)C)NC(=O)OCC1c2ccccc2-c2ccccc21`

**Reference:**
  - **Title:** Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S
  - **Authors:** Rathman, Benjamin M.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127283](https://doi.org/10.1016/j.bmcl.2020.127283)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-22631809
1.1|Reagents: 4-Methylmorpholine, 1-[Bis(dimethylamino)methylene]-5-chloro-1H-benzotriazolium 3-oxide hexafluorophosphate(1-) (1:1)
Solvents: Dimethylformamide; 1 h, rt
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor
By: Wang, Le; et al
ACS Medicinal Chemistry Letters (2020), 11(10), 1829-1836.
10.1021/acsmedchemlett.9b00568
```

---

## Reaction 31-367-CAS-22706647

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: WORKUP (Registry: BASE)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 0.167 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)c1cnccn1.C#CCN`
  - Products: `C#CCNC(=O)c1cnccn1`

**Reference:**
  - **Title:** The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles
  - **Authors:** Reddyrajula, Rajkumar; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2019.126846](https://doi.org/10.1016/j.bmcl.2019.126846)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-367-CAS-22706647
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0 °C; 10 min, rt
1.2|Reagents: Triethylamine
Solvents: Dimethylformamide; rt
1.3|Reagents: Water; 0 °C
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
By: Li, Bing-yan; et al
Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.
10.1021/acs.jmedchem.3c02407
```

---

## Reaction 31-367-CAS-22706648

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: WORKUP (Registry: BASE)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 0.167 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)c1cccnc1.C#CCN`
  - Products: `C#CCNC(=O)c1cccnc1`

**Reference:**
  - **Title:** The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles
  - **Authors:** Reddyrajula, Rajkumar; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2019.126846](https://doi.org/10.1016/j.bmcl.2019.126846)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-367-CAS-22706648
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0 °C; 10 min, rt
1.2|Reagents: Triethylamine
Solvents: Dimethylformamide; rt
1.3|Reagents: Water; 0 °C
The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles
By: Reddyrajula, Rajkumar; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.
10.1016/j.bmcl.2019.126846
```

---

## Reaction 31-367-CAS-22706649

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: WORKUP (Registry: BASE)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 0.167 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1.C#CCN`
  - Products: `C#CCNC(=O)c1ccccc1`

**Reference:**
  - **Title:** The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles
  - **Authors:** Reddyrajula, Rajkumar; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2019.126846](https://doi.org/10.1016/j.bmcl.2019.126846)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-367-CAS-22706649
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0 °C; 10 min, rt
1.2|Reagents: Triethylamine
Solvents: Dimethylformamide; rt
1.3|Reagents: Water; 0 °C
Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation
By: Bayrak, Alp; et al
Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.
10.1021/acs.jmedchem.2c01198
```

---

## Reaction 31-367-CAS-22721830

**Type:** Other

**Reagents:**
  - EDC (CAS: 1892-57-5) - Role: BASE (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.083 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `Cc1cc(=O)oc2cc(NC(=O)[C@@H](N)CCCCNC(=O)OCC3c4ccccc4-c4ccccc43)ccc12.O=C(O)C(F)(F)F.CC(=O)N[C@@H](CCC(=O)NC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(=O)O`
  - Products: `CC(=O)N[C@@H](CCC(=O)NC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CCCCNC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)Nc1ccc2c(C)cc(=O)oc2c1.O=C(O)C(F)(F)F`

**Reference:**
  - **Title:** Dethioacylation by Sirtuins 1-3: Considerations for Drug Design Using Mechanism-Based Sirtuin Inhibition
  - **Authors:** Rajabi, Nima; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2020), 11(10), 1886-1892.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.9b00580](https://doi.org/10.1021/acsmedchemlett.9b00580)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-22721830
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine
Solvents: Dimethylformamide, Dichloromethane; 5 min, 0 °C; 3 h, rt
Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa
By: Wang, Yuan-Yuan; et al
Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.
10.1021/acs.jmedchem.2c02044
```

---

## Reaction 31-367-CAS-22759240

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 18.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2ncccc2c1.COc1cccc2nc(Nc3cccc(N)c3)ccc12`
  - Products: `COc1cccc2nc(Nc3cccc(NC(=O)c4ccc5ncccc5c4)c3)ccc12`

**Reference:**
  - **Title:** 2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAFV600E/C-RAF kinase inhibitory effects: Design, synthesis, in-vitro cell-based and oncogenic kinase assessments
  - **Authors:** El-Damasy, Ashraf K.; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 208, 112756.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112756](https://doi.org/10.1016/j.ejmech.2020.112756)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-22759240
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2.5 - 18 h, 70 - 80 °C
1.2|Reagents: Water
Absolute stereochemistry shown
Absolute stereochemistry shown
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity
By: Yamada, Yousuke; et al
Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.
10.1021/acs.jmedchem.0c01215
```

---

## Reaction 31-367-CAS-22782720

**Type:** Other

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CCCCCCOC(C)c1c(C)c2cc3nc(c(CC(=O)O)c4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CC)c(C)c4C(=O)O)[C@@H](CCC(=O)O)[C@@H]3C.CC(C)(C)OC(=O)C[C@H](N)C(=O)OC(C)(C)C.Cl`
  - Products: `CCCCCCOC(C)c1c(C)c2cc3nc(c(CC(=O)N[C@@H](CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C)c4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CC)c(C)c4C(=O)O)[C@@H](CCC(=O)O)[C@@H]3C`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 131-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives as potent photosensitizers for photodynamic therapy
  - **Authors:** Zhang, Xing-Jie; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 207, 112715.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112715](https://doi.org/10.1016/j.ejmech.2020.112715)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-367-CAS-22782720
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 4 h, rt
1.2|Reagents: Diisopropylethylamine; 8 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Optimization of mTOR Inhibitors Using Property-Based Drug Design and Free-Wilson Analysis for Improved In Vivo Efficacy
By: Murphy, Sean T.; et al
ACS Medicinal Chemistry Letters (2023), 14(11), 1544-1550.
10.1021/acsmedchemlett.3c00351
```

---

## Reaction 31-367-CAS-22827989

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: BASE (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)C(CO)c1ccccc1.NCc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1.O=C(O)C(F)(F)F`
  - Products: `O=C(NCc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1)C(CO)c1ccccc1`

**Reference:**
  - **Title:** Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans
  - **Authors:** Binjubair, Faizah A.; et al
  - **Citation:** ChemMedChem (2020), 15(14), 1294-1309.
  - **DOI:** [https://doi.org/10.1002/cmdc.202000250](https://doi.org/10.1002/cmdc.202000250)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-367-CAS-22827989
1.1|Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole
Solvents: Ethyl acetate; 30 min, 0 °C
1.2|Reagents: Triethylamine
Solvents: Ethyl acetate; 30 min, rt; overnight, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity
By: Ikeda, Zenichi; et al
Journal of Medicinal Chemistry (2022), 65(12), 8456-8477.
10.1021/acs.jmedchem.2c00463
```

---

## Reaction 31-367-CAS-22829000

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: BASE (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)C(CO)c1ccccc1.COc1ccc(S(=O)(=O)Nc2ccc(CN)cc2)cc1.O=C(O)C(F)(F)F`
  - Products: `COc1ccc(S(=O)(=O)Nc2ccc(CNC(=O)C(CO)c3ccccc3)cc2)cc1`

**Reference:**
  - **Title:** Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans
  - **Authors:** Binjubair, Faizah A.; et al
  - **Citation:** ChemMedChem (2020), 15(14), 1294-1309.
  - **DOI:** [https://doi.org/10.1002/cmdc.202000250](https://doi.org/10.1002/cmdc.202000250)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-367-CAS-22829000
1.1|Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole
Solvents: Ethyl acetate; 30 min, 0 °C
1.2|Reagents: Triethylamine
Solvents: Ethyl acetate; 30 min, rt; overnight, rt
Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
By: Fang, Wei; et al
Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
10.1021/acs.jmedchem.3c02063
```

---

## Reaction 31-367-CAS-22856831

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 23.0°C
  - Time: 2.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `CC(=O)O[C@H]1C[C@]2(C)[C@H]3CC[C@@H]4[C@H]5[C@H](C(C)=O)CC[C@]5(C(=O)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C(C)(C)[C@H]1OC(C)=O.NCc1ccccc1`
  - Products: `CC(=O)O[C@H]1C[C@]2(C)[C@H]3CC[C@@H]4[C@H]5[C@H](C(C)=O)CC[C@]5(C(=O)NCc5ccccc5)CC[C@@]4(C)[C@]3(C)CC[C@H]2C(C)(C)[C@H]1OC(C)=O`

**Reference:**
  - **Title:** Betulinic acid derived amides are highly cytotoxic, apoptotic and selective
  - **Authors:** Hoenke, Sophie; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 207, 112815.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112815](https://doi.org/10.1016/j.ejmech.2020.112815)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-367-CAS-22856831
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 1 h, 23 °C
1.2|Solvents: Dichloromethane; 1 h, 23 °C
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown
Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei
By: Scheuplein, Nicolas J.; et al
Journal of Medicinal Chemistry (2023), 66(13), 8876-8895.
10.1021/acs.jmedchem.3c00458
```

---

## Reaction 31-367-CAS-22861646

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.167 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CCC1(CC)O[C@H]2[C@H](OC[C@@H](NC(=O)OCC3c4ccccc4-c4ccccc43)C(=O)O)O[C@H](CN=[N+]=[N-])[C@H]2O1.CC1(C)O[C@@H]2[C@H](O1)[C@@H](CN)O[C@H]2n1ccc(=O)[nH]c1=O`
  - Products: `CCC1(CC)O[C@H]2[C@H](OC[C@@H](NC(=O)OCC3c4ccccc4-c4ccccc43)C(=O)NC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(C)(C)O[C@@H]43)O[C@H](CN=[N+]=[N-])[C@H]2O1`

**Reference:**
  - **Title:** Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores
  - **Authors:** Patel, Bhautikkumar; et al
  - **Citation:** ChemMedChem (2020), 15(15), 1429-1438.
  - **DOI:** [https://doi.org/10.1002/cmdc.202000033](https://doi.org/10.1002/cmdc.202000033)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-367-CAS-22861646
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 10 min, rt
1.2|overnight, rt
Absolute stereochemistry shown
Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen
By: Hekking, Koen F. W.; et al
Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.
10.1021/acs.jmedchem.3c02206
```

---

## Reaction 31-367-CAS-22862660

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.167 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `CCC1(CC)O[C@H]2[C@H](OC[C@H](NC(=O)OCC3c4ccccc4-c4ccccc43)C(=O)O)O[C@H](CN=[N+]=[N-])[C@H]2O1.CC1(C)O[C@@H]2[C@H](O1)[C@@H](CN)O[C@H]2n1ccc(=O)[nH]c1=O`
  - Products: `CCC1(CC)O[C@H]2[C@H](OC[C@H](NC(=O)OCC3c4ccccc4-c4ccccc43)C(=O)NC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(C)(C)O[C@@H]43)O[C@H](CN=[N+]=[N-])[C@H]2O1`

**Reference:**
  - **Title:** Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores
  - **Authors:** Patel, Bhautikkumar; et al
  - **Citation:** ChemMedChem (2020), 15(15), 1429-1438.
  - **DOI:** [https://doi.org/10.1002/cmdc.202000033](https://doi.org/10.1002/cmdc.202000033)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-367-CAS-22862660
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 10 min, rt
1.2|overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores
By: Patel, Bhautikkumar; et al
ChemMedChem (2020), 15(15), 1429-1438.
10.1002/cmdc.202000033
```

---

## Reaction 31-367-CAS-22866626

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 5.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)c1cccnc1.CN(C)c1ccc([N+](=O)[O-])cc1N`
  - Products: `CN(C)c1ccc([N+](=O)[O-])cc1NC(=O)c1cccnc1`

**Reference:**
  - **Title:** Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction injury
  - **Authors:** Pang, Haiying; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 197, 112314.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112314](https://doi.org/10.1016/j.ejmech.2020.112314)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-367-CAS-22866626
1.1|Reagents: Thionyl chloride; rt; 4 h, reflux
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 1 h, rt
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis
By: Mohamed, Abdelrahman; et al
Journal of Medicinal Chemistry (2022), 65(17), 11726-11744.
10.1021/acs.jmedchem.2c00589
```

---

## Reaction 31-367-CAS-22988979

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.533 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CC[C@H](N(Cc2ccccc2)Cc2ccccc2)[C@@H](C(=O)O)C1.NC1CCCCC1`
  - Products: `CC(C)(C)OC(=O)N1CC[C@H](N(Cc2ccccc2)Cc2ccccc2)[C@@H](C(=O)NC2CCCCC2)C1`

**Reference:**
  - **Title:** GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins
  - **Authors:** Watson, Robert J.; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(17), 9045-9069.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00614](https://doi.org/10.1021/acs.jmedchem.0c00614)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-367-CAS-22988979
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 min, rt
1.2|0.5 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Pyrazolidinone-based peptidomimetic SARS-CoV-2 Mpro inhibitors
By: Jelisejevs, Daniels; et al
Bioorganic & Medicinal Chemistry Letters (2023), 96, 129530.
10.1016/j.bmcl.2023.129530
```

---

## Reaction 31-367-CAS-23040320

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)Cc1c[nH]c2ccccc12.COc1ccc(CCN)cc1OC`
  - Products: `COc1ccc(CCNC(=O)Cc2c[nH]c3ccccc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-367-CAS-23040320
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
1.2|3 h, rt
Relative stereochemistry shown
Relative stereochemistry shown
Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality
By: Chen, Yuanguang; et al
Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.
10.1021/acs.jmedchem.3c02006
```

---

## Reaction 31-367-CAS-23040326

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(CCN)cc1OC.Cn1cc(CC(=O)O)c2ccccc21`
  - Products: `COc1ccc(CCNC(=O)Cc2cn(C)c3ccccc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23040326
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Relative stereochemistry shown
Relative stereochemistry shown
Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma
By: Weiss, Matthew M.; et al
Journal of Medicinal Chemistry (2024), 67(13), 10548-10566.
10.1021/acs.jmedchem.3c01823
```

---

## Reaction 31-367-CAS-23040400

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(CCN)cc1OC.O=C(O)Cc1c[nH]c2ccc(Br)cc12`
  - Products: `COc1ccc(CCNC(=O)Cc2c[nH]c3ccc(Br)cc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23040400
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-367-CAS-23040590

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(CCN)cc1OC.COc1ccc2[nH]cc(CC(=O)O)c2c1`
  - Products: `COc1ccc2[nH]cc(CC(=O)NCCc3ccc(OC)c(OC)c3)c2c1`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23040590
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-367-CAS-23040801

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(CCN)cc1OC.Cc1ccc2[nH]cc(CC(=O)O)c2c1`
  - Products: `COc1ccc(CCNC(=O)Cc2c[nH]c3ccc(C)cc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23040801
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease
By: Zhou, Jianhui; et al
Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.
10.1021/acs.jmedchem.4c00159
```

---

## Reaction 31-367-CAS-23040945

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(CCN)cc1OC.O=C(O)Cc1c[nH]c2cc(Cl)ccc12`
  - Products: `COc1ccc(CCNC(=O)Cc2c[nH]c3cc(Cl)ccc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23040945
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics
By: Garsi, Jean-Baptiste; et al
ACS Medicinal Chemistry Letters (2022), 13(6), 949-954.
10.1021/acsmedchemlett.2c00094
```

---

## Reaction 31-367-CAS-23040954

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)Cc1c[nH]c2cccc(Cl)c12.CCOc1ccc(CCN)cc1OC`
  - Products: `CCOc1ccc(CCNC(=O)Cc2c[nH]c3cccc(Cl)c23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23040954
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-367-CAS-23041098

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(CCN)cc1OC.O=C(O)Cc1c[nH]c2c(Cl)cccc12`
  - Products: `COc1ccc(CCNC(=O)Cc2c[nH]c3c(Cl)cccc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23041098
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
By: Novotna, Katerina; et al
Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
10.1021/acs.jmedchem.3c01681
```

---

## Reaction 31-367-CAS-23041868

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)Cc1c[nH]c2cc(Cl)ccc12.CCOc1ccc(CCN)cc1OC`
  - Products: `CCOc1ccc(CCNC(=O)Cc2c[nH]c3cc(Cl)ccc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23041868
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-367-CAS-23042059

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)Cc1ccccc1.COc1ccc(CCN)cc1OC`
  - Products: `COc1ccc(CCNC(=O)Cc2ccccc2)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23042059
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process
By: Smith, Daniel; et al
Organic Process Research & Development (2020), 24(6), 1157-1163.
10.1021/acs.oprd.0c00198
```

---

## Reaction 31-367-CAS-23042848

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 6.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(CCN)cc1OC.O=C(O)Cc1ccsc1`
  - Products: `COc1ccc(CCNC(=O)Cc2ccsc2)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23042848
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one derivatives as CDK8 inhibitors
By: Martinez-Gonzalez, Sonia; et al
European Journal of Medicinal Chemistry (2020), 201, 112443.
10.1016/j.ejmech.2020.112443
```

---

## Reaction 31-367-CAS-23043310

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `Cn1cc(CC(=O)O)c2ccccc21.CCOc1ccc(CCN)cc1OC`
  - Products: `CCOc1ccc(CCNC(=O)Cc2cn(C)c3ccccc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23043310
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists
By: Shan, Bin; et al
Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.
10.1021/acs.jmedchem.2c01714
```

---

## Reaction 31-367-CAS-23044787

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)Cc1c[nH]c2c(Cl)cccc12.CCOc1ccc(CCN)cc1OC`
  - Products: `CCOc1ccc(CCNC(=O)Cc2c[nH]c3c(Cl)cccc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23044787
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
CRBN ligand expansion for hematopoietic prostaglandin D2 synthase (H-PGDS) targeting PROTAC design and their in vitro ADME profiles
By: Osawa, Hinata; et al
Bioorganic & Medicinal Chemistry (2023), 84, 117259.
10.1016/j.bmc.2023.117259
```

---

## Reaction 31-367-CAS-23044991

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(CCN)cc1OC.O=C(O)Cc1cc2ccccc2[nH]1`
  - Products: `COc1ccc(CCNC(=O)Cc2cc3ccccc3[nH]2)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23044991
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice
By: Zareba, Paula; et al
European Journal of Medicinal Chemistry (2020), 188, 111920.
10.1016/j.ejmech.2019.111920
```

---

## Reaction 31-367-CAS-23045015

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `Cc1ccc2[nH]cc(CC(=O)O)c2c1.CCOc1ccc(CCN)cc1OC`
  - Products: `CCOc1ccc(CCNC(=O)Cc2c[nH]c3ccc(C)cc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23045015
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Discovery of novel urea-diarylpyrazole hybrids as dual COX-2/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks
By: Abdelazeem, Ahmed H.; et al
European Journal of Medicinal Chemistry (2020), 205, 112662.
10.1016/j.ejmech.2020.112662
```

---

## Reaction 31-367-CAS-23045625

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc2[nH]cc(CC(=O)O)c2c1.CCOc1ccc(CCN)cc1OC`
  - Products: `CCOc1ccc(CCNC(=O)Cc2c[nH]c3ccc(OC)cc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23045625
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
By: Jung, Sascha; et al
Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
10.1021/acs.jmedchem.1c01002
```

---

## Reaction 31-367-CAS-23045691

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(CCN)cc1OC.COc1ccc2[nH]c(C)c(CC(=O)O)c2c1`
  - Products: `COc1ccc2[nH]c(C)c(CC(=O)NCCc3ccc(OC)c(OC)c3)c2c1`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23045691
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-367-CAS-23045819

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `CCOc1ccc(CCN)cc1OC.O=C(O)Cc1c[nH]c2ccc(Br)cc12`
  - Products: `CCOc1ccc(CCNC(=O)Cc2c[nH]c3ccc(Br)cc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23045819
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
By: Jung, Sascha; et al
Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
10.1021/acs.jmedchem.1c01002
```

---

## Reaction 31-367-CAS-23046042

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(CCN)cc1OC.O=C(O)Cc1c[nH]c2cccc(Cl)c12`
  - Products: `COc1ccc(CCNC(=O)Cc2c[nH]c3cccc(Cl)c23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23046042
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-367-CAS-23046121

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc2[nH]c(C)c(CC(=O)O)c2c1.CCOc1ccc(CCN)cc1OC`
  - Products: `CCOc1ccc(CCNC(=O)Cc2c(C)[nH]c3ccc(OC)cc23)cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
  - **Authors:** Zhang, Rui; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 211, 113004.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.113004](https://doi.org/10.1016/j.ejmech.2020.113004)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23046121
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
By: Jung, Sascha; et al
Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
10.1021/acs.jmedchem.1c01002
```

---

## Reaction 31-367-CAS-23182426

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 23.5 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `Nc1ccc(Cl)c(F)c1.CC(C)(C)OC(=O)N1CCC[C@H](C(=O)O)C1`
  - Products: `CC(C)(C)OC(=O)N1CCC[C@H](C(=O)Nc2ccc(Cl)c(F)c2)C1`

**Reference:**
  - **Title:** Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity
  - **Authors:** Grenier, Melissa C.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2020), 11(3), 371-378.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.9b00445](https://doi.org/10.1021/acsmedchemlett.9b00445)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-23182426
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 22 h, rt
1.2|Reagents: Water; 30 min, rt
Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
By: Sheppard, George S.; et al
Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.
10.1021/acs.jmedchem.0c00628
```

---

## Reaction 31-367-CAS-23230949

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 6.5 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `C=C1CC[C@H]2[C@@](C)(CC[C@@H](O)[C@@]2(C)C(=O)O)[C@@H]1/C=C/C1=CCOC1=O.NCc1ccccc1`
  - Products: `C=C1CC[C@H]2[C@@](C)(CC[C@@H](O)[C@@]2(C)C(=O)NCc2ccccc2)[C@@H]1/C=C/C1=CCOC1=O`

**Reference:**
  - **Title:** Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo
  - **Authors:** Zhang, Songxuan; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 213, 113185.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113185](https://doi.org/10.1016/j.ejmech.2021.113185)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-23230949
1.1|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 15 min, rt
1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 15 min, rt
1.3|6 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2
By: Grifagni, Deborah; et al
ACS Medicinal Chemistry Letters (2024), 15(2), 250-257.
10.1021/acsmedchemlett.3c00498
```

---

## Reaction 31-367-CAS-23231473

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMAc (CAS: 127-19-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)CCCC[C@@H]1CCSS1.COC(=O)/C(O)=C/C(=O)c1ccc(N)cc1`
  - Products: `COC(=O)/C(O)=C/C(=O)c1ccc(NC(=O)CCCC[C@H]2CCSS2)cc1`

**Reference:**
  - **Title:** Inhibition of Human Immunodeficiency Virus-1 Integrase by β-Diketo Acid Coated Gold Nanoparticles
  - **Authors:** Sanna, Vanna; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2020), 11(5), 857-861.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.9b00648](https://doi.org/10.1021/acsmedchemlett.9b00648)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-367-CAS-23231473
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylacetamide; 1 h, rt
1.2|3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors
By: Zhang, Hao; et al
Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.
10.1021/acs.jmedchem.2c00611
```

---

## Reaction 31-367-CAS-23309934

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 6.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)O.COC(=O)[C@@H](N)CC1CCCCC1.Cl`
  - Products: `COC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C`

**Reference:**
  - **Title:** A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors
  - **Authors:** Yang, Kai S.; et al
  - **Citation:** ChemMedChem (2021), 16(6), 942-948.
  - **DOI:** [https://doi.org/10.1002/cmdc.202000924](https://doi.org/10.1002/cmdc.202000924)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-367-CAS-23309934
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; 6 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors
By: Zhu, Junjie; et al
European Journal of Medicinal Chemistry (2023), 259, 115666.
10.1016/j.ejmech.2023.115666
```

---

## Reaction 31-367-CAS-23310372

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 6.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `C[C@@H](OC(C)(C)C)[C@H](NC(=O)OCc1ccccc1)C(=O)O.COC(=O)[C@@H](N)CC1CCCCC1.Cl`
  - Products: `COC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)[C@@H](C)OC(C)(C)C`

**Reference:**
  - **Title:** A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors
  - **Authors:** Yang, Kai S.; et al
  - **Citation:** ChemMedChem (2021), 16(6), 942-948.
  - **DOI:** [https://doi.org/10.1002/cmdc.202000924](https://doi.org/10.1002/cmdc.202000924)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-367-CAS-23310372
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; 6 h, rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-367-CAS-23337821

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: WORKUP (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMAc (CAS: 127-19-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `Nc1cccnc1.O=C(O)c1ccc(CNC(=O)c2ccc(F)cc2)cc1`
  - Products: `O=C(NCc1ccc(C(=O)Nc2cccnc2)cc1)c1ccc(F)cc1`

**Reference:**
  - **Title:** A new chemotype with promise against Trypanosoma cruzi
  - **Authors:** Wang, Xiaofang; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2019.126778](https://doi.org/10.1016/j.bmcl.2019.126778)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-367-CAS-23337821
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylacetamide; 24 h, rt
1.2|Reagents: Water; rt
Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
By: Fang, Wei; et al
Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
10.1021/acs.jmedchem.3c02063
```

---

## Reaction 31-367-CAS-23338306

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: WORKUP (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMAc (CAS: 127-19-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `Cc1ccc(N)c(C)n1.O=C(O)c1ccc(CNS(=O)(=O)c2ccc(F)cc2)cc1`
  - Products: `Cc1ccc(NC(=O)c2ccc(CNS(=O)(=O)c3ccc(F)cc3)cc2)c(C)n1`

**Reference:**
  - **Title:** A new chemotype with promise against Trypanosoma cruzi
  - **Authors:** Wang, Xiaofang; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2019.126778](https://doi.org/10.1016/j.bmcl.2019.126778)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-367-CAS-23338306
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylacetamide; 24 h, rt
1.2|Reagents: Water; rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders
By: Li, Huajie; et al
ACS Medicinal Chemistry Letters (2024), 15(5), 631-639.
10.1021/acsmedchemlett.4c00029
```

---

## Reaction 31-367-CAS-23338374

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: WORKUP (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMAc (CAS: 127-19-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `Nc1cccnc1.O=C(O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(F)cc2)CC1`
  - Products: `O=C(Nc1cccnc1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(F)cc2)CC1`

**Reference:**
  - **Title:** A new chemotype with promise against Trypanosoma cruzi
  - **Authors:** Wang, Xiaofang; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2019.126778](https://doi.org/10.1016/j.bmcl.2019.126778)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-367-CAS-23338374
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylacetamide; 24 h, rt
1.2|Reagents: Water; rt
A new chemotype with promise against Trypanosoma cruzi
By: Wang, Xiaofang; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.
10.1016/j.bmcl.2019.126778
```

---

## Reaction 31-367-CAS-23338923

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: WORKUP (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMAc (CAS: 127-19-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Cc1ccc(N)cn1.O=C(O)c1ccc(CNS(=O)(=O)c2ccc(F)cc2)cc1`
  - Products: `Cc1ccc(NC(=O)c2ccc(CNS(=O)(=O)c3ccc(F)cc3)cc2)cn1`

**Reference:**
  - **Title:** A new chemotype with promise against Trypanosoma cruzi
  - **Authors:** Wang, Xiaofang; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2019.126778](https://doi.org/10.1016/j.bmcl.2019.126778)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-367-CAS-23338923
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylacetamide; 24 h, rt
1.2|Reagents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity
By: Yamada, Yousuke; et al
Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.
10.1021/acs.jmedchem.0c01215
```

---

## Reaction 31-367-CAS-23349010

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `Nc1ccc(F)cc1.CC(C(=O)O)C12CC(NC(=O)OC(C)(C)C)(C1)C2`
  - Products: `CC(C(=O)Nc1ccc(F)cc1)C12CC(NC(=O)OC(C)(C)C)(C1)C2`

**Reference:**
  - **Title:** Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors
  - **Authors:** Pu, Qinglin; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2020), 11(8), 1548-1554.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.0c00195](https://doi.org/10.1021/acsmedchemlett.0c00195)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-367-CAS-23349010
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation
By: Bayrak, Alp; et al
Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.
10.1021/acs.jmedchem.2c01198
```

---

## Reaction 31-367-CAS-23361600

**Type:** Other

**Reagents:**
  - DMAP (CAS: 1122-58-3) - Role: BASE (Registry: LIGAND)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 4-(Dimethylamino)pyridine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - Chloroform (CAS: 67-66-3) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 12.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CC(C)(C)c1ccc(C(=O)O)cc1.COC(=O)c1ccc(Cn2ccc3ccc(N)cc32)cc1`
  - Products: `COC(=O)c1ccc(Cn2ccc3ccc(NC(=O)c4ccc(C(C)(C)C)cc4)cc32)cc1`

**Reference:**
  - **Title:** Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast
  - **Authors:** Schierle, Simone; et al
  - **Citation:** ChemMedChem (2020), 15(1), 50-67.
  - **DOI:** [https://doi.org/10.1002/cmdc.201900576](https://doi.org/10.1002/cmdc.201900576)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-367-CAS-23361600
1.1|Reagents: 4-(Dimethylamino)pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Chloroform; 12 h, 50 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (+)
Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity
By: Grenier, Melissa C.; et al
ACS Medicinal Chemistry Letters (2020), 11(3), 371-378.
10.1021/acsmedchemlett.9b00445
```

---

## Reaction 31-367-CAS-23413494

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1C[C@H](O)C[C@H]1C(=O)O.Cc1ncsc1-c1ccc(CN)cc1`
  - Products: `Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)OC(C)(C)C)cc1`

**Reference:**
  - **Title:** Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers
  - **Authors:** Cao, Chaoguo; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(19), 11012-11033.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00821](https://doi.org/10.1021/acs.jmedchem.0c00821)

**Original Text:**
```
Steps: 1, Yield: 83-90%
CAS Reaction Number: 31-367-CAS-23413494
1.1|Solvents: Dimethylformamide; rt → 0 °C
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 2 h, rt
Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma
By: Tu, Yalin; et al
Journal of Medicinal Chemistry (2021), 64(14), 10167-10184.
10.1021/acs.jmedchem.1c00460
```

---

## Reaction 31-367-CAS-23439616

**Type:** Other

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - MeOH (CAS: 67-56-1) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 22.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)CCCCCN1C(=O)C=CC1=O.COc1cc2c(cc1OCCCOc1cc3c(cc1OC)C(=O)N1C=C(c4ccc(N5CCN(C)CC5)cc4)C[C@H]1C=N3)N=C[C@@H]1CC(c3ccc(NC(=O)[C@@H](C)NC(=O)[C@@H](N)C(C)C)cc3)=CN1C2=O`
  - Products: `COc1cc2c(cc1OCCCOc1cc3c(cc1OC)C(=O)N1C=C(c4ccc(N5CCN(C)CC5)cc4)C[C@H]1C=N3)N=C[C@@H]1CC(c3ccc(NC(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)CCCCCN4C(=O)C=CC4=O)C(C)C)cc3)=CN1C2=O`

**Reference:**
  - **Title:** Early Development, Scale-Up, and Reverse-Phase Purification of a Highly Potent Pyrrolobenzodiazepine Dimer, SG3259, for Use in Antibody-Drug Conjugates
  - **Authors:** Holte, Dane; et al
  - **Citation:** Organic Process Research & Development (2021), 25(4), 799-809.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.0c00497](https://doi.org/10.1021/acs.oprd.0c00497)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-367-CAS-23439616
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Methanol, Dichloromethane; 22 h, rt
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension
By: Vakalopoulos, Alexandros; et al
Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.
10.1021/acs.jmedchem.2c02082
```

---

## Reaction 31-367-CAS-23500779

**Type:** Other

**Reagents:**
  - Megestrol acetate (CAS: 595-33-5) - Role: UNK
  - BOP (CAS: 56602-33-6) - Role: UNK (Registry: ACTIVATOR)
  - BOP reagent - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.25 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `Cc1ccc(C(=O)O)cc1.COC(=O)c1cc(N)cc(Br)c1`
  - Products: `COC(=O)c1cc(Br)cc(NC(=O)c2ccc(C)cc2)c1`

**Reference:**
  - **Title:** Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y14R antagonists with potential high efficiency against acute gouty arthritis
  - **Authors:** Lu, Ran; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 216, 113313.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113313](https://doi.org/10.1016/j.ejmech.2021.113313)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-367-CAS-23500779
1.1|Reagents: Megestrol acetate, BOP reagent
Solvents: Dichloromethane; 15 min, rt
1.2|overnight, rt
Double bond geometry shown
Double bond geometry shown
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
By: Zhang, Kuojun; et al
Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
10.1021/acs.jmedchem.2c00077
```

---

## Reaction 31-367-CAS-23513655

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Br)cn1.CC(C)(C)OC(=O)NC1=N[C@](C)(c2cccc(N)c2)CO[C@@]1(C)C(F)(F)F`
  - Products: `CC(C)(C)OC(=O)NC1=N[C@](C)(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CO[C@@]1(C)C(F)(F)F`

**Reference:**
  - **Title:** Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360
  - **Authors:** Rueeger, Heinrich; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02143](https://doi.org/10.1021/acs.jmedchem.0c02143)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-367-CAS-23513655
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 2 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis and biological evaluation of novel 131-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives as potent photosensitizers for photodynamic therapy
By: Zhang, Xing-Jie; et al
European Journal of Medicinal Chemistry (2020), 207, 112715.
10.1016/j.ejmech.2020.112715
```

---

## Reaction 31-367-CAS-23514679

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Br)cn1.CC(C)(C)OC(=O)NC1=N[C@](C)(c2cc(N)ccc2F)CO[C@@]1(C)C(F)(F)F`
  - Products: `CC(C)(C)OC(=O)NC1=N[C@](C)(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@]1(C)C(F)(F)F`

**Reference:**
  - **Title:** Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360
  - **Authors:** Rueeger, Heinrich; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02143](https://doi.org/10.1021/acs.jmedchem.0c02143)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-367-CAS-23514679
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 2 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension
By: Vakalopoulos, Alexandros; et al
Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.
10.1021/acs.jmedchem.2c02082
```

---

## Reaction 31-367-CAS-23515650

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 44.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `COc1cccc(C(=O)O)c1OC.CCOC(CN)OCC`
  - Products: `CCOC(CNC(=O)c1cccc(OC)c1OC)OCC`

**Reference:**
  - **Title:** The total synthesis of berberine and selected analogues, and their evaluation as amyloid beta aggregation inhibitors
  - **Authors:** Tajiri, Misato; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 215, 113289.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113289](https://doi.org/10.1016/j.ejmech.2021.113289)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-367-CAS-23515650
1.1|Reagents: Thionyl chloride
Solvents: Dichloromethane; -80 °C; 20 h, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Tetrahydrofuran; 24 h, 0 °C
Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes
By: Saint-Dizier, Francois; et al
Journal of Medicinal Chemistry (2023), 66(4), 2622-2645.
10.1021/acs.jmedchem.2c01591
```

---

## Reaction 31-367-CAS-23517437

**Type:** Other

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 16.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NC1=N[C@](C)(c2cc(N)ccc2F)CO[C@@]1(C)C(F)(F)F.Cc1cc(C#N)cnc1C(=O)O`
  - Products: `Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(NC(=O)OC(C)(C)C)=N2)c1`

**Reference:**
  - **Title:** Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360
  - **Authors:** Rueeger, Heinrich; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02143](https://doi.org/10.1021/acs.jmedchem.0c02143)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-367-CAS-23517437
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt
Solvents: Dimethylformamide; 0 - 5 °C; overnight, 20 °C
Double bond geometry shown
Double bond geometry shown
Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
By: Tang, Sheng; et al
European Journal of Medicinal Chemistry (2024), 263, 115939.
10.1016/j.ejmech.2023.115939
```

---

## Reaction 31-367-CAS-23575722

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.25 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `Cc1nc(-c2ccc(I)cc2)sc1-c1cc(C(=O)O)n[nH]1.NC1CCCCC1`
  - Products: `Cc1nc(-c2ccc(I)cc2)sc1-c1cc(C(=O)NC2CCCCC2)n[nH]1`

**Reference:**
  - **Title:** Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity
  - **Authors:** Patel, Bhautikkumar; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2021.127853](https://doi.org/10.1016/j.bmcl.2021.127853)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-367-CAS-23575722
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 min, rt
1.2|8 - 16 h, rt
Development of an efficient synthetic process for broflanilide
By: Luo, Chunyan; et al
Organic Process Research & Development (2020), 24(6), 1024-1031.
10.1021/acs.oprd.0c00028
```

---

## Reaction 31-367-CAS-23580267

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.25 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `Cc1nc(-c2ccc(I)cc2)sc1-c1cc(C(=O)O)n[nH]1.Nc1ccccc1`
  - Products: `Cc1nc(-c2ccc(I)cc2)sc1-c1cc(C(=O)Nc2ccccc2)n[nH]1`

**Reference:**
  - **Title:** Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity
  - **Authors:** Patel, Bhautikkumar; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2021.127853](https://doi.org/10.1016/j.bmcl.2021.127853)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-367-CAS-23580267
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 min, rt
1.2|8 - 16 h, rt
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast
By: Schierle, Simone; et al
ChemMedChem (2020), 15(1), 50-67.
10.1002/cmdc.201900576
```

---

## Reaction 31-367-CAS-23620855

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - Isopropanol (CAS: 67-63-0) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 21.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(OC(F)F)cn1.C[C@H]1C[C@H]2CSC(NC(=O)c3ccccc3)=N[C@@]2(c2nc(N)cs2)CO1`
  - Products: `C[C@H]1C[C@H]2CSC(NC(=O)c3ccccc3)=N[C@@]2(c2nc(NC(=O)c3ccc(OC(F)F)cn3)cs2)CO1`

**Reference:**
  - **Title:** Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor-Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors
  - **Authors:** Li, Bryan; et al
  - **Citation:** Organic Process Research & Development (2021), 25(6), 1440-1453.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00126](https://doi.org/10.1021/acs.oprd.1c00126)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-367-CAS-23620855
1.1|Reagents: Triethylamine, Propylphosphonic anhydride
Solvents: Ethyl acetate; < 5 °C; 5 °C → 25 °C; 12 h, 25 °C; 25 °C → 15 °C
1.2|Reagents: Hydrochloric acid
Solvents: Isopropanol, Water; 3 h, 0 - 10 °C; 6 h, 0 - 10 °C
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-367-CAS-23643185

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 3.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(C(F)(F)F)cc1.Nc1cccc(Br)c1`
  - Products: `O=C(Nc1cccc(Br)c1)c1ccc(C(F)(F)F)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of 1H-indazole derivatives as novel ASK1 inhibitors
  - **Authors:** Hou, Shaohua; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 220, 113482.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113482](https://doi.org/10.1016/j.ejmech.2021.113482)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-367-CAS-23643185
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Tetrahydrofuran; 0 °C; 1 h, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Tetrahydrofuran; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
By: Fuchs, Natalie; et al
ChemMedChem (2023), 18(15), e202300160.
10.1002/cmdc.202300160
```

---

## Reaction 31-367-CAS-23663323

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@H](CCCCNC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CCOC(=O)c1csc([C@@H](N)C(C)C)n1.O=C(O)C(F)(F)F`
  - Products: `CCOC(=O)c1csc([C@@H](NC(=O)[C@@H](CCCCNC(=O)OCC2c3ccccc3-c3ccccc32)NC(=O)OC(C)(C)C)C(C)C)n1`

**Reference:**
  - **Title:** Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins
  - **Authors:** Sindhikara, Dan; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(20), 12100-12115.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01500](https://doi.org/10.1021/acs.jmedchem.0c01500)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-367-CAS-23663323
1.1|Reagents: Diisopropylethylamine, HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 3 h, rt
Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs
By: Maucort, Chloe; et al
Journal of Medicinal Chemistry (2023), 66(15), 10639-10657.
10.1021/acs.jmedchem.3c00797
```

---

## Reaction 31-367-CAS-23663728

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CC(C)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)OC(C)(C)C)c1nc(C(=O)O)cs1`
  - Products: `CC(C)[C@@H]1NC(=O)[C@H](NC(=O)OC(C)(C)C)CCCCNC(=O)c2csc1n2`

**Reference:**
  - **Title:** Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins
  - **Authors:** Sindhikara, Dan; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(20), 12100-12115.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01500](https://doi.org/10.1021/acs.jmedchem.0c01500)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-367-CAS-23663728
1.1|Reagents: Diisopropylethylamine, HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide, Dichloromethane; overnight, rt
Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis
By: Betzemeier, Bodo; et al
European Journal of Medicinal Chemistry (2024), 265, 116038.
10.1016/j.ejmech.2023.116038
```

---

## Reaction 31-367-CAS-23696722

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 5.0°C
  - Time: 5.5 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `Cl.NCc1csc(-c2ccc(Cl)cc2)n1.CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)O)C2`
  - Products: `CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)NCc1csc(-c3ccc(Cl)cc3)n1)C2`

**Reference:**
  - **Title:** Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold
  - **Authors:** Huang, Danling; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2021.128006](https://doi.org/10.1016/j.bmcl.2021.128006)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-367-CAS-23696722
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 30 min, 0 - 5 °C; 5 h, rt
New Broad-Spectrum Antibiotics Containing a Pyrrolobenzodiazepine Ring with Activity against Multidrug-Resistant Gram-Negative Bacteria
By: Picconi, Pietro; et al
Journal of Medicinal Chemistry (2020), 63(13), 6941-6958.
10.1021/acs.jmedchem.0c00328
```

---

## Reaction 31-367-CAS-23698808

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 5.0°C
  - Time: 5.5 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)O)C2.Cc1ccc(-c2nc(CN)cs2)cc1.Cl`
  - Products: `Cc1ccc(-c2nc(CNC(=O)CCC(=O)O[C@@H]3C[C@@H]4CC[C@@]3(C)C4(C)C)cs2)cc1`

**Reference:**
  - **Title:** Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold
  - **Authors:** Huang, Danling; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2021.128006](https://doi.org/10.1016/j.bmcl.2021.128006)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-367-CAS-23698808
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 30 min, 0 - 5 °C; 5 h, rt
Relative stereochemistry shown
Relative stereochemistry shown
Novel selective agents for the degradation of AR/AR-V7 to treat advanced prostate cancer
By: Yang, Yifei; et al
European Journal of Medicinal Chemistry (2024), 271, 116400.
10.1016/j.ejmech.2024.116400
```

---

## Reaction 31-367-CAS-23701150

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 5.0°C
  - Time: 5.5 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)O)C2.Cl.NCc1csc(-c2ccc(F)cc2)n1`
  - Products: `CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)NCc1csc(-c3ccc(F)cc3)n1)C2`

**Reference:**
  - **Title:** Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold
  - **Authors:** Huang, Danling; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2021.128006](https://doi.org/10.1016/j.bmcl.2021.128006)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-367-CAS-23701150
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 30 min, 0 - 5 °C; 5 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold
By: Huang, Danling; et al
Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.
10.1016/j.bmcl.2021.128006
```

---

## Reaction 31-367-CAS-23701514

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 5.0°C
  - Time: 5.5 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Cl.NCc1csc(-c2ccccc2)n1.CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)O)C2`
  - Products: `CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)NCc1csc(-c3ccccc3)n1)C2`

**Reference:**
  - **Title:** Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold
  - **Authors:** Huang, Danling; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2021.128006](https://doi.org/10.1016/j.bmcl.2021.128006)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-367-CAS-23701514
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 30 min, 0 - 5 °C; 5 h, rt
Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2
By: Zhang, Yi; et al
Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.
10.1021/acs.jmedchem.3c00504
```

---

## Reaction 31-367-CAS-23747861

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 20.167 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(=O)O.Cc1ccc(CNC(=O)C(CCN)N(C)CCC=C2c3ccccc3CCc3ccccc32)cc1`
  - Products: `CC(=O)NCCC(C(=O)NCc1ccc(C)cc1)N(C)CCC=C1c2ccccc2CCc2ccccc21`

**Reference:**
  - **Title:** Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity
  - **Authors:** Zareba, Paula; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 221, 113512.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113512](https://doi.org/10.1016/j.ejmech.2021.113512)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-367-CAS-23747861
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 10 min, 0 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors
By: Yang, Kai S.; et al
ChemMedChem (2021), 16(6), 942-948.
10.1002/cmdc.202000924
```

---

## Reaction 31-367-CAS-23747921

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 20.167 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CC(=O)O.CN(CCC=C1c2ccccc2CCc2ccccc21)C(CCN)C(=O)NCc1ccc(Cl)cc1`
  - Products: `CC(=O)NCCC(C(=O)NCc1ccc(Cl)cc1)N(C)CCC=C1c2ccccc2CCc2ccccc21`

**Reference:**
  - **Title:** Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity
  - **Authors:** Zareba, Paula; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 221, 113512.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113512](https://doi.org/10.1016/j.ejmech.2021.113512)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-367-CAS-23747921
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 10 min, 0 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt
Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity
By: Zareba, Paula; et al
European Journal of Medicinal Chemistry (2021), 221, 113512.
10.1016/j.ejmech.2021.113512
```

---

## Reaction 31-367-CAS-23748721

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 20.167 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CC(=O)O.CN(CCC=C1c2ccccc2CCc2ccccc21)C(CCN)C(=O)NCc1ccccc1`
  - Products: `CC(=O)NCCC(C(=O)NCc1ccccc1)N(C)CCC=C1c2ccccc2CCc2ccccc21`

**Reference:**
  - **Title:** Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity
  - **Authors:** Zareba, Paula; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 221, 113512.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113512](https://doi.org/10.1016/j.ejmech.2021.113512)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-367-CAS-23748721
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 10 min, 0 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt
Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors
By: Huang, Daowei; et al
European Journal of Medicinal Chemistry (2021), 223, 113648.
10.1016/j.ejmech.2021.113648
```

---

## Reaction 31-367-CAS-23749117

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 20.167 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `CC(=O)O.CN(CCC=C1c2ccccc2CCc2ccccc21)C(CCN)C(=O)NCc1ccc(F)cc1`
  - Products: `CC(=O)NCCC(C(=O)NCc1ccc(F)cc1)N(C)CCC=C1c2ccccc2CCc2ccccc21`

**Reference:**
  - **Title:** Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity
  - **Authors:** Zareba, Paula; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 221, 113512.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113512](https://doi.org/10.1016/j.ejmech.2021.113512)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-367-CAS-23749117
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 10 min, 0 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt
Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity
By: Patel, Bhautikkumar; et al
Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853.
10.1016/j.bmcl.2021.127853
```

---

## Reaction 31-367-CAS-23749889

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 23.167 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CC(=O)O.CN(CCC=C1c2ccccc2CCc2ccccc21)C(CCN)C(=O)NCc1ccccc1Cl`
  - Products: `CC(=O)NCCC(C(=O)NCc1ccccc1Cl)N(C)CCC=C1c2ccccc2CCc2ccccc21`

**Reference:**
  - **Title:** Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity
  - **Authors:** Zareba, Paula; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 221, 113512.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113512](https://doi.org/10.1016/j.ejmech.2021.113512)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-367-CAS-23749889
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 10 min, 0 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt
Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors
By: Li, Peng; et al
European Journal of Medicinal Chemistry (2021), 216, 113291.
10.1016/j.ejmech.2021.113291
```

---

## Reaction 31-367-CAS-23753109

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - Py (CAS: 110-86-1) - Role: BASE

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 20.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)c1[nH]ccc(=O)c1OCc1ccccc1.C[C@@H](N)C(F)(F)F`
  - Products: `C[C@@H](NC(=O)c1[nH]ccc(=O)c1OCc1ccccc1)C(F)(F)F`

**Reference:**
  - **Title:** Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the influenza cap-dependent endonuclease inhibitor
  - **Authors:** Taoda, Yoshiyuki; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(22), 127547.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127547](https://doi.org/10.1016/j.bmcl.2020.127547)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-367-CAS-23753109
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Pyridine; 20 h, rt
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity
By: Zhang, Sicheng; et al
ACS Medicinal Chemistry Letters (2021), 12(4), 572-578.
10.1021/acsmedchemlett.0c00571
```

---

## Reaction 31-367-CAS-23761770

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `CCOC(CN)OCC.CC(C)(C)OC(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)O`
  - Products: `CCOC(CNC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C)OCC`

**Reference:**
  - **Title:** Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis
  - **Authors:** Koralewski, Robert; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(24), 15527-15540.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01179](https://doi.org/10.1021/acs.jmedchem.0c01179)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-367-CAS-23761770
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 3 h, rt
DNA-Encoded Library Hit Confirmation: Bridging the Gap Between On-DNA and Off-DNA Chemistry
By: Xia, Bing; et al
ACS Medicinal Chemistry Letters (2021), 12(7), 1166-1172.
10.1021/acsmedchemlett.1c00156
```

---

## Reaction 31-367-CAS-23762561

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `CC(C)(C)OC[C@H](Br)C(=O)O.N[C@H](CO)Cc1ccc(Cl)cc1`
  - Products: `CC(C)(C)OC[C@@H](Br)C(=O)N[C@H](CO)Cc1ccc(Cl)cc1`

**Reference:**
  - **Title:** Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis
  - **Authors:** Koralewski, Robert; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(24), 15527-15540.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01179](https://doi.org/10.1021/acs.jmedchem.0c01179)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-367-CAS-23762561
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; overnight, rt
A “Two-Birds-One-Stone” Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region
By: Wang, Chao; et al
Journal of Medicinal Chemistry (2021), 64(15), 11460-11471.
10.1021/acs.jmedchem.1c00781
```

---

## Reaction 31-367-CAS-23762826

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - NMP (CAS: 872-50-4) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Yield: 80%

**SMILES:**
  - Reactants: `Cl.NCC(O)C(F)(F)F.Nc1cc(Br)cnc1C(=O)O`
  - Products: `Nc1cc(Br)cnc1C(=O)NCC(O)C(F)(F)F`

**Reference:**
  - **Title:** Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis
  - **Authors:** Van der Plas, Steven E.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(1), 343-353.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01796](https://doi.org/10.1021/acs.jmedchem.0c01796)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-23762826
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: N-Methyl-2-pyrrolidone; rt
Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer
By: Sharma, Horrick; et al
European Journal of Medicinal Chemistry (2024), 275, 116598.
10.1016/j.ejmech.2024.116598
```

---

## Reaction 31-367-CAS-23860462

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `O=C(O)CNC(=O)OCc1ccccc1.COC(=O)CN.Cl`
  - Products: `COC(=O)CNC(=O)CNC(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6
  - **Authors:** Osko, Jeremy D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(1), 295-308.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b01540](https://doi.org/10.1021/acs.jmedchem.9b01540)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-367-CAS-23860462
1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride
Solvents: Dichloromethane; 0 °C; 1 h, 0 °C
1.2|Reagents: Water; cooled
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria
By: de Lera Ruiz, Manuel; et al
ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.
10.1021/acsmedchemlett.2c00355
```

---

## Reaction 31-367-CAS-23881400

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `NCc1ccco1.CC1(C)C(=O)N(Cc2ccccc2F)c2cc(C(=O)O)ccc21`
  - Products: `CC1(C)C(=O)N(Cc2ccccc2F)c2cc(C(=O)NCc3ccco3)ccc21`

**Reference:**
  - **Title:** The discovery of potent small molecule activators of human STING
  - **Authors:** Pryde, David C.; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 209, 112869.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112869](https://doi.org/10.1016/j.ejmech.2020.112869)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-23881400
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; rt; 2 h, rt
Relative stereochemistry shown
Relative stereochemistry shown
Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2020), 186, 111900.
10.1016/j.ejmech.2019.111900
```

---

## Reaction 31-367-CAS-23896427

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.333 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1ccc(Cl)cc1.Cc1nccc2c1[nH]c1ccc(OCCN)cc12`
  - Products: `Cc1nccc2c1[nH]c1ccc(OCCNC(=O)/C=C/c3ccc(Cl)cc3)cc12`

**Reference:**
  - **Title:** Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action
  - **Authors:** Marinovic, Marina; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 224, 113687.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113687](https://doi.org/10.1016/j.ejmech.2021.113687)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-367-CAS-23896427
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 20 min, rt
1.2|1 h, rt
Double bond geometry shown
Double bond geometry shown
Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action
By: Marinovic, Marina; et al
European Journal of Medicinal Chemistry (2021), 224, 113687.
10.1016/j.ejmech.2021.113687
```

---

## Reaction 31-367-CAS-23896526

**Type:** Other

**Reagents:**
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: BASE (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 14.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)C(Br)CCN1C(=O)c2ccccc2C1=O.NCc1ccc(F)cc1`
  - Products: `O=C(NCc1ccc(F)cc1)C(Br)CCN1C(=O)c2ccccc2C1=O`

**Reference:**
  - **Title:** Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice
  - **Authors:** Zareba, Paula; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 188, 111920.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2019.111920](https://doi.org/10.1016/j.ejmech.2019.111920)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-367-CAS-23896526
1.1|Reagents: Propylphosphonic anhydride
Solvents: Dichloromethane, Ethyl acetate; 2 h, 0 °C
1.2|Reagents: Triethylamine; 12 h, rt
Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice
By: Zareba, Paula; et al
European Journal of Medicinal Chemistry (2020), 188, 111920.
10.1016/j.ejmech.2019.111920
```

---

## Reaction 31-367-CAS-23896755

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.333 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1ccc(F)cc1.Cc1nccc2c1[nH]c1ccc(OCCN)cc12`
  - Products: `Cc1nccc2c1[nH]c1ccc(OCCNC(=O)/C=C/c3ccc(F)cc3)cc12`

**Reference:**
  - **Title:** Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action
  - **Authors:** Marinovic, Marina; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 224, 113687.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113687](https://doi.org/10.1016/j.ejmech.2021.113687)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-367-CAS-23896755
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 20 min, rt
1.2|1 h, rt
Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors
By: Deng, Wuqing; et al
ACS Medicinal Chemistry Letters (2021), 12(4), 647-652.
10.1021/acsmedchemlett.1c00052
```

---

## Reaction 31-367-CAS-23897128

**Type:** Other

**Reagents:**
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: BASE (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 14.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)C(Br)CCN1C(=O)c2ccccc2C1=O.NCc1ccc(Cl)cc1`
  - Products: `O=C(NCc1ccc(Cl)cc1)C(Br)CCN1C(=O)c2ccccc2C1=O`

**Reference:**
  - **Title:** Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice
  - **Authors:** Zareba, Paula; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 188, 111920.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2019.111920](https://doi.org/10.1016/j.ejmech.2019.111920)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-367-CAS-23897128
1.1|Reagents: Propylphosphonic anhydride
Solvents: Dichloromethane, Ethyl acetate; 2 h, 0 °C
1.2|Reagents: Triethylamine; 12 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer
By: Zhu, Di; et al
Journal of Medicinal Chemistry (2024), 67(10), 7973-7994.
10.1021/acs.jmedchem.4c00030
```

---

## Reaction 31-367-CAS-23899050

**Type:** Other

**Reagents:**
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)c1cnc(Cl)cn1.COC[C@]12C[C@H]1[C@@](C)(c1cc(N)cc(F)c1F)N=C(N)S2`
  - Products: `COC[C@]12C[C@H]1[C@@](C)(c1cc(NC(=O)c3cnc(Cl)cn3)cc(F)c1F)N=C(N)S2`

**Reference:**
  - **Title:** Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2
  - **Authors:** Pettus, Liping H.; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(5), 2263-2281.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b01034](https://doi.org/10.1021/acs.jmedchem.9b01034)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-367-CAS-23899050
1.1|Reagents: Propylphosphonic anhydride
Solvents: Dichloromethane, Ethyl acetate; rt; overnight, rt
Double bond geometry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Double bond geometry shown
Economical and Practical Process Development for a Novel Multitarget Tyrosine Kinase Inhibitor Vorolanib
By: Xiu, Xiaomeng; et al
Organic Process Research & Development (2024), 28(2), 492-499.
10.1021/acs.oprd.3c00311
```

---

## Reaction 31-367-CAS-23901334

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - Chloroform (CAS: 67-66-3) - Role: SOLVENT
  - MeCN (CAS: 75-05-8) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.25 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N(COCC[Si](C)(C)C)C1=N[C@](C)(c2cccc(F)c2F)[C@@H]2C[C@]2(C(=O)O)S1.CN`
  - Products: `CNC(=O)[C@]12C[C@H]1[C@@](C)(c1cccc(F)c1F)N=C(N(COCC[Si](C)(C)C)C(=O)OC(C)(C)C)S2`

**Reference:**
  - **Title:** Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2
  - **Authors:** Pettus, Liping H.; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(5), 2263-2281.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b01034](https://doi.org/10.1021/acs.jmedchem.9b01034)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-367-CAS-23901334
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Chloroform, Acetonitrile; 45 min, rt
1.2|Solvents: Tetrahydrofuran; 30 min, rt
Tumor-microenvironmental-response Bi-functional molecules for efficient imaging and anti-tumor activity therapy
By: Wang, Jin; et al
European Journal of Medicinal Chemistry (2022), 230, 114120.
10.1016/j.ejmech.2022.114120
```

---

## Reaction 31-367-CAS-23922679

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 48.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.O=C(O)CCC(CCC(=O)O)(CCC(=O)O)[N+](=O)[O-]`
  - Products: `COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCC(CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC)(CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC)[N+](=O)[O-]`

**Reference:**
  - **Title:** Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors
  - **Authors:** Martinez-Gualda, Belen; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(1), 349-368.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b01737](https://doi.org/10.1021/acs.jmedchem.9b01737)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-367-CAS-23922679
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 48 h, 30 °C
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-367-CAS-23923283

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 48.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.O=C(O)CCOCC(COCCC(=O)O)(COCCC(=O)O)COCCC(=O)O`
  - Products: `COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCOCC(COCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC)(COCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC)COCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC`

**Reference:**
  - **Title:** Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors
  - **Authors:** Martinez-Gualda, Belen; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(1), 349-368.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b01737](https://doi.org/10.1021/acs.jmedchem.9b01737)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-367-CAS-23923283
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 48 h, 30 °C
Relative stereochemistry shown
Relative stereochemistry shown
Discovery and SAR of JTE-151: A Novel RORγ Inhibitor for Clinical Development
By: Maeba, Takaki; et al
Journal of Medicinal Chemistry (2024), 67(2), 952-970.
10.1021/acs.jmedchem.3c01933
```

---

## Reaction 31-367-CAS-23963694

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.083 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2nc(-c3cccc(F)c3)cn2c1.CC(C)(O)[C@@H]1CC[C@@H](N)CO1`
  - Products: `CC(C)(O)[C@H]1CC[C@H](NC(=O)c2ccc3nc(-c4cccc(F)c4)cn3c2)CO1`

**Reference:**
  - **Title:** A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors
  - **Authors:** Schulte, Christie A.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2021), 47, 128113.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2021.128113](https://doi.org/10.1016/j.bmcl.2021.128113)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-367-CAS-23963694
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 5 min, rt; overnight, rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-367-CAS-24091261

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Dimethyl carbonate (CAS: 616-38-6) - Role: UNK
  - NaOH (CAS: 1310-73-2) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - 1,1′-Carbonyldiimidazole - Role: UNK
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - EtOH (CAS: 64-17-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 22.067 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `C[C@@H]1CCO[C@H]2Cn3cc(C(=O)O)c(=O)c(O)c3C(=O)N12.NCc1ccc(F)cc1F`
  - Products: `C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12.[Na]`

**Reference:**
  - **Title:** Six-Step Gram-Scale Synthesis of the Human Immunodeficiency Virus Integrase Inhibitor Dolutegravir Sodium
  - **Authors:** Dietz, Jule-Philipp; et al
  - **Citation:** Organic Process Research & Development (2021), 25(8), 1898-1910.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00139](https://doi.org/10.1021/acs.oprd.1c00139)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-367-CAS-24091261
1.1|Reagents: 1,1′-Carbonyldiimidazole, Dimethyl carbonate; 2 h, rt → 80 °C; 80 °C → rt
1.2|< 2 min, rt; 2 h, rt
1.3|Reagents: Sodium hydroxide
Solvents: Dichloromethane, Water; 18 h, rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 1 - 2, 0 °C
1.5|Reagents: Sodium hydroxide
Solvents: Ethanol; 2 min, rt → reflux
Relative stereochemistry shown
Relative stereochemistry shown
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy
By: Bumpers, Quinn A.; et al
Journal of Medicinal Chemistry (2024), 67(16), 14466-14477.
10.1021/acs.jmedchem.4c01232
```

---

## Reaction 31-367-CAS-24132213

**Type:** Other

**Reagents:**
  - N,N-Diisopropylcarbodiimide (CAS: 693-13-0) - Role: BASE (Registry: N'-DIISOPROPYLCARBODIIMIDE)
  - N-Hydroxysuccinimide (CAS: 6066-82-6) - Role: NUC (Registry: AMIDE_ADDITIVE)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Copper sulfate (CAS: 7758-98-7) - Role: UNK
  - Ethylenediaminetetraacetic acid (CAS: 60-00-4) - Role: UNK
  - Diisopropylcarbodiimide - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - Me2CO (CAS: 67-64-1) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 82.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)C(=O)OC(C)(C)C.Cl.NCCCC[C@H](N)C(=O)O`
  - Products: `CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@H](N)C(=O)O)C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide
  - **Authors:** Guryanov, Ivan; et al
  - **Citation:** Organic Process Research & Development (2021), 25(7), 1598-1611.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00021](https://doi.org/10.1021/acs.oprd.1c00021)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-367-CAS-24132213
1.1|Reagents: Diisopropylcarbodiimide, N-Hydroxysuccinimide
Solvents: Acetone; 1 h, rt
1.2|Reagents: Sodium bicarbonate, Copper sulfate
Solvents: Water; 1 h, rt; overnight, rt; 2 d, rt
1.3|Reagents: Ethylenediaminetetraacetic acid
Solvents: Water; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-367-CAS-24133668

**Type:** Other

**Reagents:**
  - N,N-Diisopropylcarbodiimide (CAS: 693-13-0) - Role: BASE (Registry: N'-DIISOPROPYLCARBODIIMIDE)
  - N-Hydroxysuccinimide (CAS: 6066-82-6) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylcarbodiimide - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 32.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)O.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)O`
  - Products: `CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide
  - **Authors:** Guryanov, Ivan; et al
  - **Citation:** Organic Process Research & Development (2021), 25(7), 1598-1611.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00021](https://doi.org/10.1021/acs.oprd.1c00021)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-367-CAS-24133668
1.1|Reagents: Diisopropylcarbodiimide, N-Hydroxysuccinimide
Solvents: Acetonitrile, Dichloromethane; overnight, rt
1.2|Reagents: Diisopropylethylamine; overnight, rt
Structure-Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT
By: Wannowius, Marie; et al
Journal of Medicinal Chemistry (2024), 67(21), 19342-19364.
10.1021/acs.jmedchem.4c01743
```

---

## Reaction 31-614-CAS-23925515

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.5 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `Cc1c(N)cccc1Br.O=C(O)Cc1cc(Cl)ccn1`
  - Products: `Cc1c(Br)cccc1NC(=O)Cc1cc(Cl)ccn1`

**Reference:**
  - **Title:** Driving Potency with Rotationally Stable Atropisomers: Discovery of Pyridopyrimidinedione-Carbazole Inhibitors of BTK
  - **Authors:** Srivastava, Anurag S.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2020), 11(11), 2195-2203.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.0c00335](https://doi.org/10.1021/acsmedchemlett.0c00335)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-23925515
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 90 min, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties
By: Tsuji, Kohei; et al
Journal of Medicinal Chemistry (2023), 66(19), 13516-13529.
10.1021/acs.jmedchem.3c00777
```

---

## Reaction 31-614-CAS-23938496

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 5.0°C
  - Time: 15.083 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `O=C(O)CCCCCNC(=O)OCc1ccccc1.CC(C)[C@H]1CC[C@@H](N2CCC(n3cc(CN)c4ccccc43)CC2)CC1.Cl`
  - Products: `CC(C)[C@H]1CC[C@@H](N2CCC(n3cc(CNC(=O)CCCCCNC(=O)OCc4ccccc4)c4ccccc43)CC2)CC1`

**Reference:**
  - **Title:** Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson’s Disease Models
  - **Authors:** Kamakolanu, Uma Gayathri; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(5), 2688-2704.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b02134](https://doi.org/10.1021/acs.jmedchem.9b02134)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-23938496
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 2 h, 5 °C
1.2|Solvents: Dichloromethane; 1 h, 5 °C; 5 °C → rt; 12 h, rt
1.3|Reagents: Sodium bicarbonate
Solvents: Water; 5 min, rt
Relative stereochemistry shown
Relative stereochemistry shown
Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer
By: Xiang, Weiguo; et al
Journal of Medicinal Chemistry (2021), 64(18), 13487-13509.
10.1021/acs.jmedchem.1c00900
```

---

## Reaction 31-614-CAS-23938870

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - BOP (CAS: 56602-33-6) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - BOP reagent - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 25.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CCCCCCOc1ccc(C(=O)O)cc1.COC(=O)[C@@H](N)C(C)C.Cl`
  - Products: `CCCCCCOc1ccc(C(=O)N[C@H](C(=O)OC)C(C)C)cc1`

**Reference:**
  - **Title:** A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities
  - **Authors:** Peiretti, Franck; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(21), 13124-13139.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01555](https://doi.org/10.1021/acs.jmedchem.0c01555)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-23938870
1.1|Reagents: Diisopropylethylamine, BOP reagent
Solvents: Dichloromethane; 24 h, 20 °C
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors
By: Rullo, Mariagrazia; et al
European Journal of Medicinal Chemistry (2023), 255, 115352.
10.1016/j.ejmech.2023.115352
```

---

## Reaction 31-614-CAS-23939232

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.083 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(-c2ccccc2)cc1.COC(=O)[C@@H](N)CCNC(=O)OC(C)(C)C.Cl`
  - Products: `COC(=O)[C@H](CCNC(=O)OC(C)(C)C)NC(=O)c1ccc(-c2ccccc2)cc1`

**Reference:**
  - **Title:** Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity
  - **Authors:** Yamada, Yousuke; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01215](https://doi.org/10.1021/acs.jmedchem.0c01215)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-23939232
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 5 min, rt; 16 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis
By: Koralewski, Robert; et al
Journal of Medicinal Chemistry (2020), 63(24), 15527-15540.
10.1021/acs.jmedchem.0c01179
```

---

## Reaction 31-614-CAS-23939242

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `Nc1cccc(OC(F)(F)F)c1.CSCC[C@@H](NC(=O)OC(C)(C)C)C(=O)O`
  - Products: `CSCC[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1cccc(OC(F)(F)F)c1`

**Reference:**
  - **Title:** Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity
  - **Authors:** Yamada, Yousuke; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01215](https://doi.org/10.1021/acs.jmedchem.0c01215)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-23939242
1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Targeting Vancomycin-Resistant Enterococci (VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid-Peptide Conjugates
By: Saini, Varsha; et al
Journal of Medicinal Chemistry (2022), 65(22), 15312-15326.
10.1021/acs.jmedchem.2c01293
```

---

## Reaction 31-614-CAS-23939243

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `Nc1cccc(OC(F)(F)F)c1.CC(C)(C)OC(=O)NC[C@@H](NC(=O)OCc1ccccc1)C(=O)O`
  - Products: `CC(C)(C)OC(=O)NC[C@@H](NC(=O)OCc1ccccc1)C(=O)Nc1cccc(OC(F)(F)F)c1`

**Reference:**
  - **Title:** Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity
  - **Authors:** Yamada, Yousuke; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01215](https://doi.org/10.1021/acs.jmedchem.0c01215)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-23939243
1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 3 h, rt
Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model
By: He, Feng; et al
Journal of Medicinal Chemistry (2021), 64(7), 3794-3812.
10.1021/acs.jmedchem.0c01940
```

---

## Reaction 31-614-CAS-23939255

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `Nc1cccc(OC(F)(F)F)c1.CC(C)(C)OC(=O)N[C@H](CC(=O)OCc1ccccc1)C(=O)O`
  - Products: `CC(C)(C)OC(=O)N[C@H](CC(=O)OCc1ccccc1)C(=O)Nc1cccc(OC(F)(F)F)c1`

**Reference:**
  - **Title:** Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity
  - **Authors:** Yamada, Yousuke; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01215](https://doi.org/10.1021/acs.jmedchem.0c01215)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-23939255
1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Practical Synthesis of Chiral 3-(Hydroxyiminomethyl)adipic Acid, a Key Intermediate of the ROR-γ Inhibitor JTE-151, via Crystallization-Induced Dynamic Resolution
By: Takiguchi, Hiromu; et al
Organic Process Research & Development (2023), 27(12), 2355-2364.
10.1021/acs.oprd.3c00320
```

---

## Reaction 31-614-CAS-24003995

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 15.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `CN(CC(=O)O)C(=O)OC(C)(C)C.COC(=O)c1cc(F)ccc1OCCN`
  - Products: `COC(=O)c1cc(F)ccc1OCCNC(=O)CN(C)C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Discovery of a potent dual inhibitor of wild-type and mutant respiratory syncytial virus fusion proteins through the modulation of atropisomer interconversion properties
  - **Authors:** Yamaguchi-Sasaki, Toru; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2020), 28(24), 115818.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2020.115818](https://doi.org/10.1016/j.bmc.2020.115818)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-24003995
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
N-Alkyl Carbamoylimidazoles as Versatile Synthons for the Synthesis of Urea-Based PSMA Inhibitors
By: Gade, Narendar Reddy; et al
ACS Medicinal Chemistry Letters (2023), 14(7), 943-948.
10.1021/acsmedchemlett.3c00087
```

---

## Reaction 31-614-CAS-24031232

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 9.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `Nc1ccccc1.O=C(O)CCC(=O)c1ccc(F)cc1`
  - Products: `O=C(CCC(=O)c1ccc(F)cc1)Nc1ccccc1`

**Reference:**
  - **Title:** Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections
  - **Authors:** Chen, Wei-Chia; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(3), 1313-1327.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b01779](https://doi.org/10.1021/acs.jmedchem.9b01779)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-24031232
1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Tetrahydrofuran; 8 h, rt
On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System
By: Fang, Zhengqi; et al
Organic Process Research & Development (2024), 28(8), 3143-3151.
10.1021/acs.oprd.4c00043
```

---

## Reaction 31-614-CAS-24100902

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `COC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1N.O=C(O)c1cc(-c2ccc(F)cc2F)on1`
  - Products: `COC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1NC(=O)c1cc(-c2ccc(F)cc2F)on1`

**Reference:**
  - **Title:** Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239
  - **Authors:** Richard-Bildstein, Sylvia; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(24), 15864-15882.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01588](https://doi.org/10.1021/acs.jmedchem.0c01588)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-24100902
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-24100916

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `Cl.NC1(c2ncccn2)CC1.CC(C)(C)OC(=O)N1CC[C@H](NC(=O)c2cc(-c3ccc(F)cc3F)on2)[C@@H](C(=O)O)C1`
  - Products: `CC(C)(C)OC(=O)N1CC[C@H](NC(=O)c2cc(-c3ccc(F)cc3F)on2)[C@@H](C(=O)NC2(c3ncccn3)CC2)C1`

**Reference:**
  - **Title:** Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239
  - **Authors:** Richard-Bildstein, Sylvia; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(24), 15864-15882.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01588](https://doi.org/10.1021/acs.jmedchem.0c01588)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-24100916
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 4 h, rt
Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
By: Tang, Sheng; et al
European Journal of Medicinal Chemistry (2024), 263, 115939.
10.1016/j.ejmech.2023.115939
```

---

## Reaction 31-614-CAS-24120096

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Ammonia (CAS: 7664-41-7) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `CCOC(=O)C[C@@H](Cc1ccc(Br)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)CCC(=O)O`
  - Products: `CCOC(=O)C[C@@H](Cc1ccc(Br)cc1)NC(=O)CCC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors
  - **Authors:** Kawanami, Toshio; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2020), 11(2), 188-194.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.9b00578](https://doi.org/10.1021/acsmedchemlett.9b00578)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-24120096
1.1|Reagents: Hydrochloric acid
Solvents: 1,4-Dioxane; 1 h, rt
1.2|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt
Solvents: Dimethylformamide; 2 h, rt
1.3|Reagents: Ammonia
Solvents: Water
Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents
By: Amblard, Franck; et al
Bioorganic & Medicinal Chemistry (2021), 31, 115952.
10.1016/j.bmc.2020.115952
```

---

## Reaction 31-614-CAS-24126939

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Ac2O (CAS: 108-24-7) - Role: UNK (Registry: SOLVENT)
  - Piperidine (CAS: 110-89-4) - Role: UNK (Registry: BASE)
  - N,N-Diisopropylcarbodiimide (CAS: 693-13-0) - Role: UNK (Registry: N'-DIISOPROPYLCARBODIIMIDE)
  - Ethyl 2-cyano-2-(hydroxyimino)acetate (CAS: 3849-21-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - Diisopropylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - MeOH (CAS: 67-56-1) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 10.0°C
  - Time: 14.333 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)CNC(=O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CC(C)(C)Oc1ccc(C[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)cc1.CC(C)(C)OC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CC(C)[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CC(C)(C)OC(=O)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O`
  - Products: `CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(OC(C)(C)C)cc1)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)OC(C)(C)C)NC(=O)OCC1c2ccccc2-c2ccccc21)C(C)C)C(=O)N[C@@H](CCC(=O)OC(C)(C)C)C(=O)NCC(=O)O`

**Reference:**
  - **Title:** Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide
  - **Authors:** Guryanov, Ivan; et al
  - **Citation:** Organic Process Research & Development (2021), 25(7), 1598-1611.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00021](https://doi.org/10.1021/acs.oprd.1c00021)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-24126939
1.1|Reagents: Diisopropylethylamine
Solvents: Dichloromethane; 1 h, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Methanol, Dichloromethane; 15 min, rt
1.3|Reagents: Acetic anhydride, Diisopropylethylamine
Solvents: Dichloromethane; 15 min, rt
1.4|Reagents: Piperidine
Solvents: Dimethylformamide; 20 min, rt
1.5|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt
1.6|Reagents: Piperidine
Solvents: Dimethylformamide; 20 min, rt
1.7|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt
1.8|Reagents: Piperidine
Solvents: Dimethylformamide; 20 min, rt
1.9|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt
1.10|Reagents: Piperidine
Solvents: Dimethylformamide; 20 min, rt
1.11|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt
1.12|Reagents: Piperidine
Solvents: Dimethylformamide; 20 min, rt
1.13|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt
1.14|Reagents: Piperidine
Solvents: Dimethylformamide; 20 min, rt
1.15|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt
1.16|Reagents: Piperidine
Solvents: Dimethylformamide; 20 min, rt
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)
By: Shi, Yan; et al
Journal of Medicinal Chemistry (2022), 65(5), 4291-4317.
10.1021/acs.jmedchem.1c02110
```

---

## Reaction 31-614-CAS-24126943

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Ac2O (CAS: 108-24-7) - Role: UNK (Registry: SOLVENT)
  - Piperidine (CAS: 110-89-4) - Role: UNK (Registry: BASE)
  - N,N-Diisopropylcarbodiimide (CAS: 693-13-0) - Role: UNK (Registry: N'-DIISOPROPYLCARBODIIMIDE)
  - Ethyl 2-cyano-2-(hydroxyimino)acetate (CAS: 3849-21-6) - Role: UNK
  - i-PrOH (CAS: 920-66-1) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - Diisopropylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - MeOH (CAS: 67-56-1) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 20.883 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `O=C(O)COCCOCCNC(=O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C`
  - Products: `CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide
  - **Authors:** Guryanov, Ivan; et al
  - **Citation:** Organic Process Research & Development (2021), 25(7), 1598-1611.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00021](https://doi.org/10.1021/acs.oprd.1c00021)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-24126943
1.1|Reagents: Diisopropylethylamine
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Acetic anhydride, Diisopropylethylamine
Solvents: Methanol, Dichloromethane; rt
1.3|Reagents: Piperidine
Solvents: Dimethylformamide; rt
1.4|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 3 min, rt; 90 min, rt
1.5|Reagents: Piperidine
Solvents: Dimethylformamide; 20 min, rt
1.6|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate
Solvents: Dimethylformamide; overnight, rt
1.7|Reagents: Acetic anhydride
Solvents: Dimethylformamide; rt
1.8|Reagents: 1,1,1,3,3,3-Hexafluoro-2-propanol
Solvents: Dichloromethane; 60 min, rt
Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality
By: Chen, Yuanguang; et al
Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.
10.1021/acs.jmedchem.3c02006
```

---

## Reaction 31-614-CAS-24128601

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 6.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.NCCN`
  - Products: `C=C(C)[C@@H]1CC[C@]2(C(=O)NCCN)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12`

**Reference:**
  - **Title:** Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum
  - **Authors:** Kraft, Oliver; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 209, 112920.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112920](https://doi.org/10.1016/j.ejmech.2020.112920)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-24128601
1.1|Reagents: Oxalyl chloride
Solvents: Dimethylformamide, Dichloromethane; 4 h, 0 °C → 25 °C
1.2|Solvents: Dichloromethane; 2 h, 0 °C → rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19
By: Allais, Christophe; et al
Organic Process Research & Development (2023), 27(12), 2223-2239.
10.1021/acs.oprd.2c00375
```

---

## Reaction 31-614-CAS-24132347

**Type:** Other

**Reagents:**
  - N,N-Diisopropylcarbodiimide (CAS: 693-13-0) - Role: BASE (Registry: N'-DIISOPROPYLCARBODIIMIDE)
  - N-Hydroxysuccinimide (CAS: 6066-82-6) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylcarbodiimide - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 32.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CCCCCCCCCCCCCCCC(=O)O.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)O`
  - Products: `CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide
  - **Authors:** Guryanov, Ivan; et al
  - **Citation:** Organic Process Research & Development (2021), 25(7), 1598-1611.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00021](https://doi.org/10.1021/acs.oprd.1c00021)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-24132347
1.1|Reagents: Diisopropylcarbodiimide, N-Hydroxysuccinimide
Solvents: Acetonitrile, Dichloromethane; overnight, rt
1.2|Reagents: Diisopropylethylamine; overnight, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
By: Wang, Xu; et al
Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.
10.1021/acs.jmedchem.4c02009
```

---

## Reaction 31-614-CAS-24176908

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC(=O)c1ccccc1CSC[C@@H](NC(=O)OC(C)(C)C)C(=O)N(C)C.CC(C)(C)OC(=O)NCC(=O)O`
  - Products: `COC(=O)c1ccccc1CSC[C@@H](NC(=O)CNC(=O)OC(C)(C)C)C(=O)N(C)C`

**Reference:**
  - **Title:** Mining Natural Products for Macrocycles to Drug Difficult Targets
  - **Authors:** Begnini, Fabio; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(2), 1054-1072.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01569](https://doi.org/10.1021/acs.jmedchem.0c01569)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-24176908
1.1|Reagents: Hydrochloric acid
Solvents: 1,4-Dioxane; 1 h, rt
1.2|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 2 h, rt
Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
By: Fang, Wei; et al
Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
10.1021/acs.jmedchem.3c02063
```

---

## Reaction 31-614-CAS-24250402

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `Cl.N[C@@H]1[C@H]2COC[C@@H]12.CNC(=O)c1cc(C(=O)O)cc2c1O[C@H](CF)[C@H]2c1ccccc1`
  - Products: `CNC(=O)c1cc(C(=O)N[C@H]2[C@@H]3COC[C@@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1`

**Reference:**
  - **Title:** GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family
  - **Authors:** Preston, Alex; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2020), 11(8), 1581-1587.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.0c00247](https://doi.org/10.1021/acsmedchemlett.0c00247)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-24250402
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 16 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown
Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins
By: Sindhikara, Dan; et al
Journal of Medicinal Chemistry (2020), 63(20), 12100-12115.
10.1021/acs.jmedchem.0c01500
```

---

## Reaction 31-614-CAS-24281822

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)CO.CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O`
  - Products: `COC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Synthesis and Biological Evaluation of CF3Se-Substituted α-Amino Acid Derivatives
  - **Authors:** Han, Zhou-Zhou; et al
  - **Citation:** ChemMedChem (2021), 16(20), 3177-3180.
  - **DOI:** [https://doi.org/10.1002/cmdc.202100451](https://doi.org/10.1002/cmdc.202100451)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-24281822
1.1|Reagents: Triethylamine, Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 1 h, 0 °C; 12 h, 0 °C → rt
1.2|Reagents: Hydrochloric acid
Solvents: Water; pH 2 - 3, rt
Development and in-vitro Profiling of Dual FXR/LTA4H Modulators
By: Schierle, Simone; et al
ChemMedChem (2021), 16(15), 2366-2374.
10.1002/cmdc.202100118
```

---

## Reaction 31-614-CAS-24304120

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - DBU (CAS: 6674-22-2) - Role: UNK (Registry: BASE)
  - 1,1′-Carbonyldiimidazole - Role: UNK
  - 1,8-Diazabicyclo[5.4.0]undec-7-ene - Role: UNK

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 13.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCc2cccc(C(=O)O)c2C1.Nc1nc2ccccc2s1`
  - Products: `CC(C)(C)OC(=O)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1`

**Reference:**
  - **Title:** Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor
  - **Authors:** Wang, Le; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2020), 11(10), 1829-1836.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.9b00568](https://doi.org/10.1021/acsmedchemlett.9b00568)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-24304120
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Acetonitrile; 30 min, 25 °C
1.2|Reagents: 1,8-Diazabicyclo[5.4.0]undec-7-ene; 30 min, 25 °C
1.3|12 h, 60 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities
By: Wang, Juan; et al
European Journal of Medicinal Chemistry (2021), 215, 113267.
10.1016/j.ejmech.2021.113267
```

---

## Reaction 31-614-CAS-24357848

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `Cl.NCCCl.Cc1cc[nH]c1C(=O)O`
  - Products: `Cc1cc[nH]c1C(=O)NCCCl`

**Reference:**
  - **Title:** Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors
  - **Authors:** Li, Zizhou; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(8), 3956-3975.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b01784](https://doi.org/10.1021/acs.jmedchem.9b01784)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-24357848
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 2 h, rt
Insights into Fast Amide Couplings in Aqueous Nanomicelles
By: Sharma, Sudripet; et al
Organic Process Research & Development (2021), 25(8), 1960-1965.
10.1021/acs.oprd.1c00203
```

---

## Reaction 31-614-CAS-24358051

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `Cn1cc(Br)c2cc(C(=O)O)[nH]c2c1=O.CC(C)(C)N`
  - Products: `Cn1cc(Br)c2cc(C(=O)NC(C)(C)C)[nH]c2c1=O`

**Reference:**
  - **Title:** Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
  - **Authors:** Sheppard, George S.; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00628](https://doi.org/10.1021/acs.jmedchem.0c00628)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-24358051
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 3 h, rt
1.2|Solvents: Tetrahydrofuran; 1 h, rt
Function-oriented synthesis of Imidazo[1,2-a]pyrazine and Imidazo[1,2-b]pyridazine derivatives as potent PI3K/mTOR dual inhibitors
By: Li, Chuchu; et al
European Journal of Medicinal Chemistry (2023), 247, 115030.
10.1016/j.ejmech.2022.115030
```

---

## Reaction 31-614-CAS-24358052

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `Cn1cc(Br)c2cc(C(=O)O)[nH]c2c1=O.CN`
  - Products: `CNC(=O)c1cc2c(Br)cn(C)c(=O)c2[nH]1`

**Reference:**
  - **Title:** Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
  - **Authors:** Sheppard, George S.; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00628](https://doi.org/10.1021/acs.jmedchem.0c00628)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-24358052
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 2 h, rt
1.2|Solvents: Dimethylformamide, Tetrahydrofuran; 2 h, rt
Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
By: Narayanan, Dilip; et al
Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.
10.1021/acs.jmedchem.2c00830
```

---

## Reaction 31-614-CAS-24358057

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMSO (CAS: 67-68-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.083 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `Cn1cc(Br)c2cc(C(=O)O)[nH]c2c1=O.NC1CC1`
  - Products: `Cn1cc(Br)c2cc(C(=O)NC3CC3)[nH]c2c1=O`

**Reference:**
  - **Title:** Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
  - **Authors:** Sheppard, George S.; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00628](https://doi.org/10.1021/acs.jmedchem.0c00628)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-24358057
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethyl sulfoxide; 5 min, rt
1.2|overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-24358105

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CCS(=O)(=O)c1ccc(F)c(-c2cn(C)c(=O)c3[nH]c(C(=O)O)cc23)c1.CCN`
  - Products: `CCNC(=O)c1cc2c(-c3cc(S(=O)(=O)CC)ccc3F)cn(C)c(=O)c2[nH]1`

**Reference:**
  - **Title:** Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
  - **Authors:** Sheppard, George S.; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00628](https://doi.org/10.1021/acs.jmedchem.0c00628)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-24358105
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 2 h, rt
1.2|Solvents: Dimethylformamide, Tetrahydrofuran; 2 h, rt
1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
By: Chen, Bei; et al
Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.
10.1021/acs.jmedchem.3c01326
```

---

## Reaction 31-614-CAS-24358150

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Hexane (CAS: 110-54-3) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 25.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `Cc1cccc(C)c1Oc1ccc(C(=O)O)cc1Br.CCN.Cl`
  - Products: `CCNC(=O)c1ccc(Oc2c(C)cccc2C)c(Br)c1`

**Reference:**
  - **Title:** Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
  - **Authors:** Sheppard, George S.; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00628](https://doi.org/10.1021/acs.jmedchem.0c00628)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-24358150
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane, Hexane; rt; 1 h, rt
1.2|24 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
By: Fuchs, Natalie; et al
ChemMedChem (2023), 18(15), e202300160.
10.1002/cmdc.202300160
```

---

## Reaction 31-614-CAS-24359763

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)c1cc(Br)c(Br)o1.C#CCN`
  - Products: `C#CCNC(=O)c1cc(Br)c(Br)o1`

**Reference:**
  - **Title:** From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase
  - **Authors:** Juillet, Charlotte; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(2), 1197-1219.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02064](https://doi.org/10.1021/acs.jmedchem.0c02064)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-24359763
1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride
Solvents: Ethyl acetate; rt; 1 d, rt
1.2|Reagents: Water; rt
Boronic Acid: A Novel Pharmacophore Targeting Src Homology 2 (SH2) Domain of STAT3
By: Deng, Lin; et al
Journal of Medicinal Chemistry (2022), 65(19), 13094-13111.
10.1021/acs.jmedchem.2c00940
```

---

## Reaction 31-614-CAS-24359775

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 28.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `C#CCN.O=C(O)c1cc(Br)c(Br)s1`
  - Products: `C#CCNC(=O)c1cc(Br)c(Br)s1`

**Reference:**
  - **Title:** From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase
  - **Authors:** Juillet, Charlotte; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(2), 1197-1219.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02064](https://doi.org/10.1021/acs.jmedchem.0c02064)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-24359775
1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride
Solvents: Ethyl acetate; rt; 1 d, rt
1.2|Reagents: Water; rt
Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease
By: Li, Feng; et al
Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.
10.1021/acs.jmedchem.0c01544
```

---

## Reaction 31-614-CAS-24398148

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.167 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `Nc1ccc(Br)cc1C(=O)O.CCN`
  - Products: `CCNC(=O)c1cc(Br)ccc1N`

**Reference:**
  - **Title:** Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels
  - **Authors:** Fernandez, Ariadna; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00416](https://doi.org/10.1021/acsmedchemlett.1c00416)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-24398148
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 10 min, 0 °C
1.2|Solvents: Tetrahydrofuran; 0 °C; overnight, rt
Discovery of aromatic 2-(3-(methylcarbamoyl) guanidino)-N-aylacetamides as highly potent chitinase inhibitors
By: Zhao, Zhixiang; et al
Bioorganic & Medicinal Chemistry (2023), 80, 117172.
10.1016/j.bmc.2023.117172
```

---

## Reaction 31-614-CAS-24398168

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `CCC[C@H](O)C(=O)O.CCNC(=O)c1cc(Br)ccc1N`
  - Products: `CCC[C@H](O)C(=O)Nc1ccc(Br)cc1C(=O)NCC`

**Reference:**
  - **Title:** Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels
  - **Authors:** Fernandez, Ariadna; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00416](https://doi.org/10.1021/acsmedchemlett.1c00416)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-24398168
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors
By: Pu, Qinglin; et al
ACS Medicinal Chemistry Letters (2020), 11(8), 1548-1554.
10.1021/acsmedchemlett.0c00195
```

---

## Reaction 31-614-CAS-24414244

**Type:** Other

**Reagents:**
  - DIPA (CAS: 108-18-9) - Role: NUC (Registry: BASE)
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 20.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(I)c1.NCCC(c1ccccc1)c1ccc(OC(F)(F)F)cc1`
  - Products: `O=C(NCCC(c1ccccc1)c1ccc(OC(F)(F)F)cc1)c1cccc(I)c1`

**Reference:**
  - **Title:** Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
  - **Authors:** Hiesinger, Kerstin; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00561](https://doi.org/10.1021/acs.jmedchem.0c00561)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-24414244
1.1|Reagents: Diisopropylamine, PyBOP
Solvents: Tetrahydrofuran; 16 - 20 h, rt
Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones
By: Ryan, Michael C.; et al
ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.
10.1021/acsmedchemlett.1c00539
```

---

## Reaction 31-614-CAS-24414246

**Type:** Other

**Reagents:**
  - DIPA (CAS: 108-18-9) - Role: NUC (Registry: BASE)
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 1.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(I)c1.NCCC(c1ccccc1)c1ccc(Cl)c(Cl)c1`
  - Products: `O=C(NCCC(c1ccccc1)c1ccc(Cl)c(Cl)c1)c1cccc(I)c1`

**Reference:**
  - **Title:** Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
  - **Authors:** Hiesinger, Kerstin; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00561](https://doi.org/10.1021/acs.jmedchem.0c00561)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-24414246
1.1|Reagents: Diisopropylamine, PyBOP
Solvents: Tetrahydrofuran; 1 h, 60 °C
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis
By: Houstecka, Radka; et al
Journal of Medicinal Chemistry (2020), 63(4), 1576-1596.
10.1021/acs.jmedchem.9b01351
```

---

## Reaction 31-614-CAS-24414253

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 1.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(I)c1.NCCC(c1ccccc1)c1ccc(S(N)(=O)=O)cc1`
  - Products: `NS(=O)(=O)c1ccc(C(CCNC(=O)c2cccc(I)c2)c2ccccc2)cc1`

**Reference:**
  - **Title:** Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
  - **Authors:** Hiesinger, Kerstin; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00561](https://doi.org/10.1021/acs.jmedchem.0c00561)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-24414253
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; rt; 1 h, 60 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic
By: Shurtleff, Valerie W.; et al
Journal of Medicinal Chemistry (2024), 67(5), 3935-3958.
10.1021/acs.jmedchem.3c02248
```

---

## Reaction 31-614-CAS-24414256

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 1.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(I)c1.NCCC(c1ccc(F)cc1)c1ccc(OC(F)(F)F)cc1`
  - Products: `O=C(NCCC(c1ccc(F)cc1)c1ccc(OC(F)(F)F)cc1)c1cccc(I)c1`

**Reference:**
  - **Title:** Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
  - **Authors:** Hiesinger, Kerstin; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00561](https://doi.org/10.1021/acs.jmedchem.0c00561)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-24414256
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; rt; 1 h, 60 °C
Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis
By: Sarkar, Dipayan; et al
Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.
10.1021/acs.jmedchem.3c01431
```

---

## Reaction 31-614-CAS-24414263

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(I)c1.NCCC(c1ccc(F)cc1)c1ccc(F)cc1`
  - Products: `O=C(NCCC(c1ccc(F)cc1)c1ccc(F)cc1)c1cccc(I)c1`

**Reference:**
  - **Title:** Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
  - **Authors:** Hiesinger, Kerstin; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00561](https://doi.org/10.1021/acs.jmedchem.0c00561)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-24414263
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; rt; 18 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors
By: Gao, Dingding; et al
European Journal of Medicinal Chemistry (2021), 216, 113333.
10.1016/j.ejmech.2021.113333
```

---

## Reaction 31-614-CAS-24414274

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `Cc1ccc2[nH]c(C(=O)O)cc2c1.COC(=O)[C@H]1CN(S(=O)(=O)c2ccccc2)CC[C@@H]1N.Cl`
  - Products: `COC(=O)[C@H]1CN(S(=O)(=O)c2ccccc2)CC[C@@H]1NC(=O)c1cc2cc(C)ccc2[nH]1`

**Reference:**
  - **Title:** Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists
  - **Authors:** Cooper, Martin; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00828](https://doi.org/10.1021/acs.jmedchem.0c00828)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-24414274
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach
By: Iannelli, Giulia; et al
Journal of Medicinal Chemistry (2022), 65(17), 11574-11606.
10.1021/acs.jmedchem.2c00252
```

---

## Reaction 31-614-CAS-24414277

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(I)c1.NCCN(c1ccccc1)c1ccccc1`
  - Products: `O=C(NCCN(c1ccccc1)c1ccccc1)c1cccc(I)c1`

**Reference:**
  - **Title:** Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
  - **Authors:** Hiesinger, Kerstin; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00561](https://doi.org/10.1021/acs.jmedchem.0c00561)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-24414277
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; rt; 24 h, rt
Novel estrogen receptor β/histone deacetylase dual-targeted near-infrared fluorescent probes as theranostic agents for imaging and treatment of prostate cancer
By: He, Pei; et al
European Journal of Medicinal Chemistry (2024), 268, 116236.
10.1016/j.ejmech.2024.116236
```

---

## Reaction 31-614-CAS-24414281

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.5 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Cc1ccc2[nH]c(C(=O)O)cc2c1.CCOC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1N`
  - Products: `CCOC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1NC(=O)c1cc2cc(C)ccc2[nH]1`

**Reference:**
  - **Title:** Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists
  - **Authors:** Cooper, Martin; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00828](https://doi.org/10.1021/acs.jmedchem.0c00828)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-24414281
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Acetonitrile; 30 min, rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-24414310

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - 4-Methylmorpholine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Cc1ccc2[nH]c(C(=O)O)cc2c1.COC(=O)[C@H]1CN(C(=O)OC(C)(C)C)C[C@@H]1N.Cl`
  - Products: `COC(=O)[C@H]1CN(C(=O)OC(C)(C)C)C[C@@H]1NC(=O)c1cc2cc(C)ccc2[nH]1`

**Reference:**
  - **Title:** Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists
  - **Authors:** Cooper, Martin; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00828](https://doi.org/10.1021/acs.jmedchem.0c00828)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-24414310
1.1|Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization
By: Zirimwabagabo, Jean-Olivier; et al
Journal of Medicinal Chemistry (2021), 64(6), 3299-3319.
10.1021/acs.jmedchem.0c02191
```

---

## Reaction 31-614-CAS-24494512

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 23.0°C
  - Time: 22.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(-c2ccc(Cl)cc2)c1.COC(=O)c1ccccc1N`
  - Products: `COC(=O)c1ccccc1NC(=O)c1cccc(-c2ccc(Cl)cc2)c1`

**Reference:**
  - **Title:** Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure
  - **Authors:** Velcicky, Juraj; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(17), 9856-9875.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01020](https://doi.org/10.1021/acs.jmedchem.0c01020)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-24494512
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 2 h, 23 °C
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 20 h, 23 °C
1.3|Reagents: Sodium bicarbonate
Solvents: Water
Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis
By: Sarkar, Dipayan; et al
Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.
10.1021/acs.jmedchem.3c01431
```

---

## Reaction 31-614-CAS-24495739

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)C(F)(F)c1ccc(Cl)cc1.NCc1ccc2c(c1)CN(C1CCC(=O)NC1=O)C2=O`
  - Products: `O=C1CCC(N2Cc3cc(CNC(=O)C(F)(F)c4ccc(Cl)cc4)ccc3C2=O)C(=O)N1`

**Reference:**
  - **Title:** CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia
  - **Authors:** Hansen, Joshua D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(4), 1835-1843.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01489](https://doi.org/10.1021/acs.jmedchem.0c01489)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-24495739
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 24 h, 25 °C
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-24533574

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.5 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `O=C(O)c1ccoc1.COC(=O)[C@@H](N)CC(C)C.Cl`
  - Products: `COC(=O)[C@H](CC(C)C)NC(=O)c1ccoc1`

**Reference:**
  - **Title:** Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide
  - **Authors:** Sampaio-Dias, Ivo E.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00252](https://doi.org/10.1021/acs.jmedchem.1c00252)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-24533574
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 30 min, rt
1.2|1 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (-)
Insights into Fast Amide Couplings in Aqueous Nanomicelles
By: Sharma, Sudripet; et al
Organic Process Research & Development (2021), 25(8), 1960-1965.
10.1021/acs.oprd.1c00203
```

---

## Reaction 31-614-CAS-24554462

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.5 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5[C@@H](C)[C@H](C)CC[C@]5(C(=O)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C.Br.NCCBr`
  - Products: `CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5[C@@H](C)[C@H](C)CC[C@]5(C(=O)NCCBr)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C`

**Reference:**
  - **Title:** Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors
  - **Authors:** Wei, Huiqiang; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 227, 113918.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113918](https://doi.org/10.1016/j.ejmech.2021.113918)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-24554462
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0.5 h, 0 °C; 0 °C; overnight, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency
By: Guzelj, Samo; et al
ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.
10.1021/acsmedchemlett.2c00121
```

---

## Reaction 31-614-CAS-24558277

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.5 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(=O)c1ccc(C(=O)O)cc1.COC(=O)CCCCN.Cl`
  - Products: `COC(=O)CCCCNC(=O)c1ccc(C(C)=O)cc1`

**Reference:**
  - **Title:** HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells
  - **Authors:** Liang, Tao; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01454](https://doi.org/10.1021/acs.jmedchem.0c01454)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-24558277
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 30 min, rt
1.2|overnight, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Serendipitous Discovery of Leucine and Methionine Depletion Agents during the Search for Polyamine Transport Inhibitors
By: Massaro, Chelsea; et al
Journal of Medicinal Chemistry (2020), 63(6), 2814-2832.
10.1021/acs.jmedchem.9b00568
```

---

## Reaction 31-614-CAS-24558288

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.5 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `CC(=O)c1ccc(C(=O)O)cc1.COC(=O)CCCCCCN.Cl`
  - Products: `COC(=O)CCCCCCNC(=O)c1ccc(C(C)=O)cc1`

**Reference:**
  - **Title:** HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells
  - **Authors:** Liang, Tao; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01454](https://doi.org/10.1021/acs.jmedchem.0c01454)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-24558288
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 30 min, rt
1.2|overnight, rt
Absolute stereochemistry shown,
Rotation (+)
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Double bond geometry shown
Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine
By: Aguirre-Renteria, Saul A.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.
10.1016/j.bmcl.2020.127074
```

---

## Reaction 31-614-CAS-24558300

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.5 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `CC(=O)c1ccc(C(=O)O)cc1.COC(=O)c1ccc(CN)cc1.Cl`
  - Products: `COC(=O)c1ccc(CNC(=O)c2ccc(C(C)=O)cc2)cc1`

**Reference:**
  - **Title:** HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells
  - **Authors:** Liang, Tao; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01454](https://doi.org/10.1021/acs.jmedchem.0c01454)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-24558300
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 30 min, rt
1.2|overnight, rt
Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors
By: Balestri, Lorenzo Jacopo Ilic; et al
ACS Medicinal Chemistry Letters (2023), 14(4), 417-424.
10.1021/acsmedchemlett.2c00472
```

---

## Reaction 31-614-CAS-24719960

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `Cc1cc(F)c(C(=O)O)cc1Br.CC(C)(C)CCCN.Cl`
  - Products: `Cc1cc(F)c(C(=O)NCCCC(C)(C)C)cc1Br`

**Reference:**
  - **Title:** Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor
  - **Authors:** Huestis, Malcolm P.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2021), 12(5), 791-797.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00063](https://doi.org/10.1021/acsmedchemlett.1c00063)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-24719960
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Double bond geometry shown
Double bond geometry shown
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
By: Zhang, Kuojun; et al
Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
10.1021/acs.jmedchem.2c00077
```

---

## Reaction 31-614-CAS-24719966

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CC(C)(C#N)c1cccc(C(=O)O)c1.Cc1cc(F)c(N)cc1Br`
  - Products: `Cc1cc(F)c(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Br`

**Reference:**
  - **Title:** Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor
  - **Authors:** Huestis, Malcolm P.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2021), 12(5), 791-797.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00063](https://doi.org/10.1021/acsmedchemlett.1c00063)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-24719966
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C → rt; 17 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels
By: Fernandez, Ariadna; et al
ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809.
10.1021/acsmedchemlett.1c00416
```

---

## Reaction 31-614-CAS-24775907

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.5 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `O=C(O)c1ccoc1.COC(=O)[C@@H](N)C(C)C.Cl`
  - Products: `COC(=O)[C@@H](NC(=O)c1ccoc1)C(C)C`

**Reference:**
  - **Title:** Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide
  - **Authors:** Sampaio-Dias, Ivo E.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00252](https://doi.org/10.1021/acs.jmedchem.1c00252)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-24775907
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 30 min, rt
1.2|1 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer
By: Xu, Zhongren; et al
Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.
10.1021/acs.jmedchem.3c00063
```

---

## Reaction 31-614-CAS-24775908

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.5 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CC(C)[C@H](NC(=O)c1ccoc1)C(=O)O.COC(=O)[C@H](C)N.Cl`
  - Products: `COC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)c1ccoc1)C(C)C`

**Reference:**
  - **Title:** Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide
  - **Authors:** Sampaio-Dias, Ivo E.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00252](https://doi.org/10.1021/acs.jmedchem.1c00252)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-24775908
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 30 min, rt
1.2|1 h, rt
Double bond geometry shown
Double bond geometry shown
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
By: Zhang, Kuojun; et al
Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
10.1021/acs.jmedchem.2c00077
```

---

## Reaction 31-614-CAS-24775917

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.5 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CC(C)[C@H](NC(=O)c1ccoc1)C(=O)O.COC(=O)CN.Cl`
  - Products: `COC(=O)CNC(=O)[C@@H](NC(=O)c1ccoc1)C(C)C`

**Reference:**
  - **Title:** Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide
  - **Authors:** Sampaio-Dias, Ivo E.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00252](https://doi.org/10.1021/acs.jmedchem.1c00252)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-24775917
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 30 min, rt
1.2|1 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability
By: Meta, Mergim; et al
ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.
10.1021/acsmedchemlett.4c00050
```

---

## Reaction 31-614-CAS-24782806

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 65.0°C
  - Time: 16.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `Nc1ccc(F)c(F)c1.Cn1cccc1C(=O)O`
  - Products: `Cn1cccc1C(=O)Nc1ccc(F)c(F)c1`

**Reference:**
  - **Title:** Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents
  - **Authors:** Amblard, Franck; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 31, 115952.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2020.115952](https://doi.org/10.1016/j.bmc.2020.115952)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-24782806
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; rt; overnight, 65 °C
1.2|Reagents: Ammonium chloride
Solvents: Water
Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker
By: Duvall, Bridget; et al
Bioorganic & Medicinal Chemistry (2020), 28(20), 115698.
10.1016/j.bmc.2020.115698
```

---

## Reaction 31-614-CAS-24782811

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Ammonium chloride (CAS: 12125-02-9) - Role: WORKUP
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `C#CCN.Cn1cc(C(=O)C(=O)O)cc1C(=O)Nc1ccc(F)c(F)c1`
  - Products: `C#CCNC(=O)C(=O)c1cc(C(=O)Nc2ccc(F)c(F)c2)n(C)c1`

**Reference:**
  - **Title:** Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents
  - **Authors:** Amblard, Franck; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 31, 115952.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2020.115952](https://doi.org/10.1016/j.bmc.2020.115952)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-24782811
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide, Dichloromethane; 1 - 2 h, rt
1.2|Reagents: Ammonium chloride
Solvents: Water; rt
Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents
By: Amblard, Franck; et al
Bioorganic & Medicinal Chemistry (2021), 31, 115952.
10.1016/j.bmc.2020.115952
```

---

## Reaction 31-614-CAS-24782812

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Ammonium chloride (CAS: 12125-02-9) - Role: WORKUP
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `C=CCN.Cn1cc(C(=O)C(=O)O)cc1C(=O)Nc1ccc(F)c(F)c1`
  - Products: `C=CCNC(=O)C(=O)c1cc(C(=O)Nc2ccc(F)c(F)c2)n(C)c1`

**Reference:**
  - **Title:** Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents
  - **Authors:** Amblard, Franck; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 31, 115952.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2020.115952](https://doi.org/10.1016/j.bmc.2020.115952)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-24782812
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide, Dichloromethane; 1 - 2 h, rt
1.2|Reagents: Ammonium chloride
Solvents: Water; rt
Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction
By: Christie, Louisa A.; et al
Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.
10.1021/acs.jmedchem.3c00630
```

---

## Reaction 31-614-CAS-24782813

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Ammonium chloride (CAS: 12125-02-9) - Role: WORKUP
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `NCc1ccccc1.Cn1cc(C(=O)C(=O)O)cc1C(=O)Nc1ccc(F)c(F)c1`
  - Products: `Cn1cc(C(=O)C(=O)NCc2ccccc2)cc1C(=O)Nc1ccc(F)c(F)c1`

**Reference:**
  - **Title:** Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents
  - **Authors:** Amblard, Franck; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 31, 115952.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2020.115952](https://doi.org/10.1016/j.bmc.2020.115952)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-24782813
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide, Dichloromethane; 1 - 2 h, rt
1.2|Reagents: Ammonium chloride
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-614-CAS-24782838

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Ammonium chloride (CAS: 12125-02-9) - Role: WORKUP
  - NaOH (CAS: 1310-73-2) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - 1,1′-Carbonyldiimidazole - Role: UNK
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - MeOH (CAS: 67-56-1) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `C#CCN.CCOC(=O)c1c(C)c(C(=O)C(=O)O)c(C)n1C`
  - Products: `C#CCNC(=O)C(=O)c1c(C)c(C(=O)O)n(C)c1C`

**Reference:**
  - **Title:** Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents
  - **Authors:** Amblard, Franck; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 31, 115952.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2020.115952](https://doi.org/10.1016/j.bmc.2020.115952)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-24782838
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide, Dichloromethane; 2 h, rt
1.2|Reagents: Ammonium chloride
Solvents: Water; rt
1.3|Reagents: Sodium hydroxide
Solvents: Methanol, Tetrahydrofuran, Water; overnight, rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 1, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies
By: Rahman, Toufiqur Md; et al
Journal of Medicinal Chemistry (2021), 64(16), 12397-12413.
10.1021/acs.jmedchem.1c01075
```

---

## Reaction 31-614-CAS-24840905

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 4-Methylmorpholine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CC1(C)O[C@@H]2[C@H](O1)[C@@H](CSCCN)O[C@H]2n1cnc2c(N)ncnc21.CC(C)(C)OC(=O)N1Cc2ccccc2CC1C(=O)O`
  - Products: `CC(C)(C)OC(=O)N1Cc2ccccc2CC1C(=O)NCCSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@@H]2OC(C)(C)O[C@@H]21`

**Reference:**
  - **Title:** Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1
  - **Authors:** Lu, Jian; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(22), 13878-13898.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01475](https://doi.org/10.1021/acs.jmedchem.0c01475)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-24840905
1.1|Reagents: 4-Methylmorpholine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide, Water; 0 °C → rt; 12 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer’s Disease
By: Machauer, Rainer; et al
Journal of Medicinal Chemistry (2021), 64(20), 15262-15279.
10.1021/acs.jmedchem.1c01300
```

---

## Reaction 31-614-CAS-24891371

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.167 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCN(c2c(N)cnc3cc(Br)c(Cl)cc23)C(C(=O)O)C1`
  - Products: `CC(C)(C)OC(=O)N1CCN2c3c(cnc4cc(Br)c(Cl)cc34)NC(=O)C2C1`

**Reference:**
  - **Title:** Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C
  - **Authors:** Kettle, Jason G.; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(9), 4468-4483.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b01720](https://doi.org/10.1021/acs.jmedchem.9b01720)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-24891371
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; 10 min, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites
By: Belouin, Audrey; et al
Bioorganic & Medicinal Chemistry (2024), 98, 117553.
10.1016/j.bmc.2023.117553
```

---

## Reaction 31-614-CAS-24900179

**Type:** Other

**Full Catalytic System:**
  - Poly(oxy-1,2-ethanediyl) (CAS: 2135447-74-2)

**Catalyst Core:**
  - Poly(oxy-1,2-ethanediyl) (CAS: 2135447-74-2)

**Reagents:**
  - Py (CAS: 110-86-1) - Role: BASE
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 0.583 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Cc1cc(C)cc(N)c1.O=C(O)Cc1ccc(O)cc1`
  - Products: `Cc1cc(C)cc(NC(=O)Cc2ccc(O)cc2)c1`

**Reference:**
  - **Title:** Insights into Fast Amide Couplings in Aqueous Nanomicelles
  - **Authors:** Sharma, Sudripet; et al
  - **Citation:** Organic Process Research & Development (2021), 25(8), 1960-1965.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00203](https://doi.org/10.1021/acs.oprd.1c00203)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-24900179
1.1|Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide
Catalysts: Poly(oxy-1,2-ethanediyl), α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-
Solvents: Water; 35 min, 60 °C
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
By: Behring, Lydia; et al
Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
10.1021/acs.jmedchem.2c01360
```

---

## Reaction 31-614-CAS-24942483

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: WORKUP (Registry: ACID)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - MeOH (CAS: 67-56-1) - Role: SOLVENT
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.5 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CN(C)C(=O)c1cc(-c2ccc(NC(=O)OC(C)(C)C)cc2)cn1C.Cn1cc(NC(=O)OC(C)(C)C)cc1C(=O)O`
  - Products: `CN(C)C(=O)c1cc(-c2ccc(NC(=O)c3cc(NC(=O)OC(C)(C)C)cn3C)cc2)cn1C`

**Reference:**
  - **Title:** New Broad-Spectrum Antibiotics Containing a Pyrrolobenzodiazepine Ring with Activity against Multidrug-Resistant Gram-Negative Bacteria
  - **Authors:** Picconi, Pietro; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(13), 6941-6958.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00328](https://doi.org/10.1021/acs.jmedchem.0c00328)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-24942483
1.1|Reagents: Hydrochloric acid
Solvents: Methanol, 1,4-Dioxane; 2 h, rt
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 30 min, rt; overnight, rt
1.3|Reagents: Water; rt
The discovery of potent small molecule activators of human STING
By: Pryde, David C.; et al
European Journal of Medicinal Chemistry (2021), 209, 112869.
10.1016/j.ejmech.2020.112869
```

---

## Reaction 31-614-CAS-24985530

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate (CAS: 1075198-30-9) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(=O)O.CNc1ccccc1N`
  - Products: `CNc1ccccc1NC(=O)CNC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Virtual Screening Approach to Identifying a Novel and Tractable Series of Pseudomonas aeruginosa Elastase Inhibitors
  - **Authors:** Leiris, Simon; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2021), 12(2), 217-227.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.0c00554](https://doi.org/10.1021/acsmedchemlett.0c00554)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-24985530
1.1|Reagents: Diisopropylethylamine, N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate
Solvents: Dichloromethane; 2 h, rt
Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones
By: Ryan, Michael C.; et al
ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.
10.1021/acsmedchemlett.1c00539
```

---

## Reaction 31-614-CAS-25082100

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `N#CCC(=O)O.COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3N)nc2)c1Cl`
  - Products: `COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC(=O)CC#N)nc2)c1Cl`

**Reference:**
  - **Title:** Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors
  - **Authors:** Deng, Wuqing; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2021), 12(4), 647-652.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00052](https://doi.org/10.1021/acsmedchemlett.1c00052)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-25082100
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Demonstrating Ligandability of the LC3A and LC3B Adapter Interface
By: Hartmann, Markus; et al
Journal of Medicinal Chemistry (2021), 64(7), 3720-3746.
10.1021/acs.jmedchem.0c01564
```

---

## Reaction 31-614-CAS-25082446

**Type:** Other

**Reagents:**
  - HOAt (CAS: 39968-33-7) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 8.25 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(=O)O.COc1ccc([C@H](C)N)cc1`
  - Products: `COc1ccc([C@H](C)NC(=O)CNC(=O)OC(C)(C)C)cc1`

**Reference:**
  - **Title:** Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors
  - **Authors:** Gao, Dingding; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 216, 113333.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113333](https://doi.org/10.1016/j.ejmech.2021.113333)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-25082446
1.1|Reagents: HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; 15 min, 0 °C
1.2|Reagents: Diisopropylethylamine; 8 h, rt
Rhodium(III)-Picolinamide Complexes Act as Anticancer and Antimetastasis Agents via Inducing Apoptosis and Autophagy
By: Gu, Yun-Qiong; et al
Journal of Medicinal Chemistry (2023), 66(14), 9592-9606.
10.1021/acs.jmedchem.3c00318
```

---

## Reaction 31-614-CAS-25109422

**Type:** Other

**Reagents:**
  - N,N-Dimethylaniline (CAS: 121-69-7) - Role: NUC
  - Phosphorus oxychloride (CAS: 10025-87-3) - Role: BASE
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - PhMe (CAS: 108-88-3) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 95.0°C
  - Time: 2.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `Nc1cc(Cl)ccc1Nc1ccc(F)cc1C(=O)O`
  - Products: `O=C1Nc2cc(Cl)ccc2Nc2ccc(F)cc21`

**Reference:**
  - **Title:** Identification of 2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepine with clozapine-like mixed activities at muscarinic acetylcholine, dopamine, and serotonin receptors
  - **Authors:** Watanabe, Hitoshi; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2021), 40, 127911.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2021.127911](https://doi.org/10.1016/j.bmcl.2021.127911)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-25109422
1.1|Reagents: N,N-Dimethylaniline, Phosphorus oxychloride
Solvents: Toluene; 2 h, 95 °C
1.2|Solvents: Water; 0 °C
1.3|Reagents: Sodium bicarbonate
Solvents: Water; neutralized, 0 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations
By: Thomson, Clare; et al
Journal of Medicinal Chemistry (2024), 67(11), 8988-9027.
10.1021/acs.jmedchem.4c00227
```

---

## Reaction 31-614-CAS-25136532

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - NaOH (CAS: 1310-73-2) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 21.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CC(C)CCc1cccc(C(=O)O)c1.Cl.Nc1c(O)c2ccc([N+](=O)[O-])cc2oc1=O`
  - Products: `CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc([N+](=O)[O-])cc3oc2=O)c1`

**Reference:**
  - **Title:** Demonstrating Ligandability of the LC3A and LC3B Adapter Interface
  - **Authors:** Hartmann, Markus; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(7), 3720-3746.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01564](https://doi.org/10.1021/acs.jmedchem.0c01564)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-25136532
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 16 h, rt
1.2|Reagents: Sodium hydroxide
Solvents: Water; 5 h, rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-25838983

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 180.0°C
  - Time: 14.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `NC=O.Nc1cc(F)ccc1C(=O)O`
  - Products: `O=c1nc[nH]c2cc(F)ccc12`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists
  - **Authors:** Bae, Inhwan; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2021), 34, 127676.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127676](https://doi.org/10.1016/j.bmcl.2020.127676)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-25838983
1.1|Catalysts: Dimethylformamide; rt → 180 °C; 14 h, 180 °C
Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR
By: Grossman, Scott; et al
European Journal of Medicinal Chemistry (2020), 208, 112778.
10.1016/j.ejmech.2020.112778
```

---

## Reaction 31-614-CAS-25849249

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `Nc1ccc2c(c1)CC1(C2)C(=O)Nc2ncccc21.CC(C)(C)C(=O)N(CC(=O)O)Cc1ccccc1Br`
  - Products: `CC(C)(C)C(=O)N(CC(=O)Nc1ccc2c(c1)CC1(C2)C(=O)Nc2ncccc21)Cc1ccccc1Br`

**Reference:**
  - **Title:** Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization
  - **Authors:** Zirimwabagabo, Jean-Olivier; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(6), 3299-3319.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02191](https://doi.org/10.1021/acs.jmedchem.0c02191)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-25849249
1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt
Solvents: Dimethylformamide; 18 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1
By: Ryu, SeongShick; et al
Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.
10.1021/acs.jmedchem.1c01359
```

---

## Reaction 31-614-CAS-25849341

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(=O)O.Nc1ccc2c(c1)CC1(C2)C(=O)Nc2ncccc21`
  - Products: `CC(C)(C)OC(=O)NCC(=O)Nc1ccc2c(c1)CC1(C2)C(=O)Nc2ncccc21`

**Reference:**
  - **Title:** Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization
  - **Authors:** Zirimwabagabo, Jean-Olivier; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(6), 3299-3319.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02191](https://doi.org/10.1021/acs.jmedchem.0c02191)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-25849341
1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt
Solvents: Dimethylformamide; 18 h, rt
1.2|Reagents: Sodium bicarbonate
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases
By: Andrews, Mark D.; et al
Journal of Medicinal Chemistry (2022), 65(13), 8828-8842.
10.1021/acs.jmedchem.2c00422
```

---

## Reaction 31-614-CAS-25849885

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.017 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `Cn1cc(-c2cc(C(=O)O)ccc2OCc2ccccc2)nn1.CCN`
  - Products: `CCNC(=O)c1ccc(OCc2ccccc2)c(-c2cn(C)nn2)c1`

**Reference:**
  - **Title:** Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors
  - **Authors:** Aylott, Helen E.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(6), 3249-3281.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02156](https://doi.org/10.1021/acs.jmedchem.0c02156)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-25849885
1.1|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 10 s
1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 1 min
1.3|Solvents: Tetrahydrofuran; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-26205271

**Type:** Other

**Reaction Conditions:**
  - Temperature: 135.0°C
  - Time: 7.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `NC=O.Nc1ccc(Br)cc1C(=O)O`
  - Products: `O=c1nc[nH]c2ccc(Br)cc12`

**Reference:**
  - **Title:** Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition
  - **Authors:** Fan, Chengcheng; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 190, 112108pp..
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112108](https://doi.org/10.1016/j.ejmech.2020.112108)

**Original Text:**
```
Steps: 1, Yield: 88-95%
CAS Reaction Number: 31-614-CAS-26205271
1.1|4 h, 130 - 135 °C
Design, synthesis, and biological evaluation of novel 6-(pyridin-3-yl) quinazolin-4(3H)-one derivatives as potential anticancer agents via PI3K inhibition
By: Yang, Huarong; et al
Bioorganic & Medicinal Chemistry (2021), 46, 116346.
10.1016/j.bmc.2021.116346
```

---

## Reaction 31-614-CAS-26768391

**Type:** Other

**Solvents:**
  - AcOH (CAS: 64-19-7) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 120.0°C
  - Time: 4.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CC(=O)O.N=CN.Nc1ccc(Br)cc1C(=O)O`
  - Products: `O=c1nc[nH]c2ccc(Br)cc12`

**Reference:**
  - **Title:** Discovery of novel quinazoline derivatives as potent PI3Kδ inhibitors with high selectivity
  - **Authors:** Teng, Yu; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 208, 112865.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112865](https://doi.org/10.1016/j.ejmech.2020.112865)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-26768391
1.1|Solvents: Acetic acid; 4 h, 120 °C
Double bond geometry shown
Double bond geometry shown
In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole
By: Zhao, Ya-Dong; et al
Bioorganic & Medicinal Chemistry Letters (2024), 105, 129752.
10.1016/j.bmcl.2024.129752
```

---

## Reaction 31-614-CAS-27641723

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1C[C@H](O)C[C@H]1C(=O)O.Cc1ncsc1-c1ccc(CN)cc1`
  - Products: `Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)OC(C)(C)C)cc1`

**Reference:**
  - **Title:** Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma
  - **Authors:** Tu, Yalin; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(14), 10167-10184.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00460](https://doi.org/10.1021/acs.jmedchem.1c00460)

**Original Text:**
```
Steps: 1, Yield: 83-90%
CAS Reaction Number: 31-614-CAS-27641723
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; 2 h, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
By: Breidenbach, Julian; et al
Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
10.1021/acs.jmedchem.4c00053
```

---

## Reaction 31-614-CAS-28202897

**Type:** Other

**Reaction Conditions:**
  - Temperature: 150.0°C
  - Time: 12.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `NC=O.Nc1cc(Br)ccc1C(=O)O`
  - Products: `O=c1nc[nH]c2cc(Br)ccc12`

**Reference:**
  - **Title:** Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors
  - **Authors:** Li, Peng; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 216, 113291.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113291](https://doi.org/10.1016/j.ejmech.2021.113291)

**Original Text:**
```
Steps: 1, Yield: 87-89%
CAS Reaction Number: 31-614-CAS-28202897
1.1|12 h, 150 °C
Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy
By: Meng, Yangyang; et al
Journal of Medicinal Chemistry (2023), 66(17), 11815-11830.
10.1021/acs.jmedchem.3c00264
```

---

## Reaction 31-614-CAS-29435452

**Type:** Other

**Full Catalytic System:**
  - Poly(oxy-1,2-ethanediyl) (CAS: 2135447-74-2)

**Catalyst Core:**
  - Poly(oxy-1,2-ethanediyl) (CAS: 2135447-74-2)

**Reagents:**
  - Py (CAS: 110-86-1) - Role: BASE
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 0.25 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1.COC(=O)[C@@H](N)Cc1ccccc1.Cl`
  - Products: `COC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1`

**Reference:**
  - **Title:** Insights into Fast Amide Couplings in Aqueous Nanomicelles
  - **Authors:** Sharma, Sudripet; et al
  - **Citation:** Organic Process Research & Development (2021), 25(8), 1960-1965.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00203](https://doi.org/10.1021/acs.oprd.1c00203)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-29435452
1.1|Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide
Catalysts: Poly(oxy-1,2-ethanediyl), α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-
Solvents: Water; 15 min, 60 °C
Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis
By: Sarkar, Dipayan; et al
Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.
10.1021/acs.jmedchem.3c01431
```

---

## Reaction 31-614-CAS-29435453

**Type:** Other

**Full Catalytic System:**
  - Poly(oxy-1,2-ethanediyl) (CAS: 2135447-74-2)

**Catalyst Core:**
  - Poly(oxy-1,2-ethanediyl) (CAS: 2135447-74-2)

**Reagents:**
  - Py (CAS: 110-86-1) - Role: BASE
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 0.417 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `Nc1ccccc1.CC(C)[C@@H](NC(=O)OCc1ccccc1)C(=O)O`
  - Products: `CC(C)[C@@H](NC(=O)OCc1ccccc1)C(=O)Nc1ccccc1`

**Reference:**
  - **Title:** Insights into Fast Amide Couplings in Aqueous Nanomicelles
  - **Authors:** Sharma, Sudripet; et al
  - **Citation:** Organic Process Research & Development (2021), 25(8), 1960-1965.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00203](https://doi.org/10.1021/acs.oprd.1c00203)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-29435453
1.1|Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide
Catalysts: Poly(oxy-1,2-ethanediyl), α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-
Solvents: Water; 25 min, 60 °C
Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors
By: Huang, Daowei; et al
European Journal of Medicinal Chemistry (2021), 223, 113648.
10.1016/j.ejmech.2021.113648
```

---

## Reaction 31-614-CAS-29435454

**Type:** Other

**Full Catalytic System:**
  - Poly(oxy-1,2-ethanediyl) (CAS: 2135447-74-2)

**Catalyst Core:**
  - Poly(oxy-1,2-ethanediyl) (CAS: 2135447-74-2)

**Reagents:**
  - Py (CAS: 110-86-1) - Role: BASE
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 0.583 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `Cc1cc(C)cc(N)c1.CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)O`
  - Products: `Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2C(=O)OC(C)(C)C)c1`

**Reference:**
  - **Title:** Insights into Fast Amide Couplings in Aqueous Nanomicelles
  - **Authors:** Sharma, Sudripet; et al
  - **Citation:** Organic Process Research & Development (2021), 25(8), 1960-1965.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00203](https://doi.org/10.1021/acs.oprd.1c00203)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-29435454
1.1|Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide
Catalysts: Poly(oxy-1,2-ethanediyl), α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-
Solvents: Water; 35 min, 60 °C
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21
By: Goericke, Fabian; et al
Journal of Medicinal Chemistry (2023), 66(5), 3431-3447.
10.1021/acs.jmedchem.2c01933
```

---

## Reaction 31-614-CAS-31159913

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Yield: 96%

**SMILES:**
  - Reactants: `Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1.COCCS(=O)(=O)c1ccc2c(c1)CN(C(=O)OC(C)(C)C)C2C(=O)O`
  - Products: `COCCS(=O)(=O)c1ccc2c(c1)CN(C(=O)OC(C)(C)C)C2C(=O)Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1`

**Reference:**
  - **Title:** AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2
  - **Authors:** Narjes, Frank; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(18), 13807-13829.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01197](https://doi.org/10.1021/acs.jmedchem.1c01197)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-31159913
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-31159925

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1.N#CC1(CS(=O)(=O)c2ccc3c(c2)CN(C(=O)OCC2c4ccccc4-c4ccccc42)C3C(=O)O)CC1`
  - Products: `N#CC1(CS(=O)(=O)c2ccc3c(c2)CN(C(=O)OCC2c4ccccc4-c4ccccc42)C3C(=O)Nc2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1`

**Reference:**
  - **Title:** AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2
  - **Authors:** Narjes, Frank; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(18), 13807-13829.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01197](https://doi.org/10.1021/acs.jmedchem.1c01197)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-31159925
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors
By: Ma, Chunhua; et al
Journal of Medicinal Chemistry (2021), 64(21), 16242-16270.
10.1021/acs.jmedchem.1c01559
```

---

## Reaction 31-614-CAS-31168962

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.5 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `Cc1cc2cc(Br)cc(C(=O)O)c2o1.CN`
  - Products: `CNC(=O)c1cc(Br)cc2cc(C)oc12`

**Reference:**
  - **Title:** Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow
  - **Authors:** Alder, Catherine M.; et al
  - **Citation:** Organic Process Research & Development (2022), 26(2), 365-379.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00422](https://doi.org/10.1021/acs.oprd.1c00422)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-31168962
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0 °C; 2 h, 0 °C; 2 h, 0 °C
1.2|Reagents: Diisopropylethylamine
Solvents: Dichloromethane, Tetrahydrofuran; 30 min, 0 °C
Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways
By: Kandasamy, Pachamuthu; et al
Journal of Medicinal Chemistry (2023), 66(4), 2506-2523.
10.1021/acs.jmedchem.2c01337
```

---

## Reaction 31-614-CAS-31168985

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `Cl.N[C@@H]1[C@H]2COC[C@@H]12.CNC(=O)c1cc(C(=O)O)cc2c1O[C@H](CF)[C@H]2c1ccccc1`
  - Products: `CNC(=O)c1cc(C(=O)N[C@H]2[C@@H]3COC[C@@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1`

**Reference:**
  - **Title:** Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow
  - **Authors:** Alder, Catherine M.; et al
  - **Citation:** Organic Process Research & Development (2022), 26(2), 365-379.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00422](https://doi.org/10.1021/acs.oprd.1c00422)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31168985
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 16 h, rt
Absolute stereochemistry shown
Relative stereochemistry shown
Absolute stereochemistry shown
GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family
By: Preston, Alex; et al
ACS Medicinal Chemistry Letters (2020), 11(8), 1581-1587.
10.1021/acsmedchemlett.0c00247
```

---

## Reaction 31-614-CAS-31186582

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `COc1cc(F)cc([C@H](N)CO)c1.Cl.COc1cc(Nc2ncc(Cl)c(-c3ccc4c(c3)C(=O)N([C@H](C)C(=O)O)C4)n2)ccn1`
  - Products: `COc1cc(F)cc([C@@H](CO)NC(=O)[C@@H](C)N2Cc3ccc(-c4nc(Nc5ccnc(OC)c5)ncc4Cl)cc3C2=O)c1`

**Reference:**
  - **Title:** Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2
  - **Authors:** Heightman, Tom D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12286-12303.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00905](https://doi.org/10.1021/acs.jmedchem.1c00905)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-31186582
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide; 1 h, rt
Absolute stereochemistry shown
Relative stereochemistry shown
Absolute stereochemistry shown
Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists
By: Granberg, Kenneth L.; et al
Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.
10.1021/acs.jmedchem.3c02183
```

---

## Reaction 31-614-CAS-31186652

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.083 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `Cc1cc(C(=O)O)cn(C)c1=O.NCC(c1ccccc1)c1ccccc1`
  - Products: `Cc1cc(C(=O)NCC(c2ccccc2)c2ccccc2)cn(C)c1=O`

**Reference:**
  - **Title:** Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit
  - **Authors:** Rianjongdee, Francesco; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(15), 10806-10833.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00412](https://doi.org/10.1021/acs.jmedchem.1c00412)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-31186652
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 5 min, rt
1.2|1 h, rt
Development and in-vitro Profiling of Dual FXR/LTA4H Modulators
By: Schierle, Simone; et al
ChemMedChem (2021), 16(15), 2366-2374.
10.1002/cmdc.202100118
```

---

## Reaction 31-614-CAS-31187992

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: WORKUP (Registry: SOLVENT)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 3.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.Cl.NCCc1c[nH]c2ccccc12`
  - Products: `O=C(NCCc1c[nH]c2ccccc12)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2`

**Reference:**
  - **Title:** Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
  - **Authors:** Tormaehlen, Niklas M.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01773](https://doi.org/10.1021/acs.jmedchem.0c01773)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-31187992
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide; 2 h, 50 °C
1.2|1 h, 50 °C
1.3|Reagents: Water
Absolute stereochemistry shown
Absolute stereochemistry shown
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders
By: Turdi, Huji; et al
Journal of Medicinal Chemistry (2021), 64(19), 14773-14792.
10.1021/acs.jmedchem.1c01356
```

---

## Reaction 31-614-CAS-31187995

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: WORKUP (Registry: SOLVENT)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 4.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.NCCC(N)=O`
  - Products: `NC(=O)CCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2`

**Reference:**
  - **Title:** Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
  - **Authors:** Tormaehlen, Niklas M.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01773](https://doi.org/10.1021/acs.jmedchem.0c01773)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-31187995
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide; 2 h, 50 °C
1.2|1 h, 50 °C
1.3|Reagents: Water
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-614-CAS-31188001

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: WORKUP (Registry: SOLVENT)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 3.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.Nc1ccccc1`
  - Products: `O=C(Nc1ccccc1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2`

**Reference:**
  - **Title:** Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
  - **Authors:** Tormaehlen, Niklas M.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01773](https://doi.org/10.1021/acs.jmedchem.0c01773)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-31188001
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide; 2 h, 50 °C
1.2|1 h, 50 °C
1.3|Reagents: Water
Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma
By: Morelli, Maria Beatrice; et al
Journal of Medicinal Chemistry (2024), 67(11), 9662-9685.
10.1021/acs.jmedchem.4c00821
```

---

## Reaction 31-614-CAS-31188010

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: WORKUP (Registry: SOLVENT)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 3.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.COC(=O)CCN.Cl`
  - Products: `COC(=O)CCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2`

**Reference:**
  - **Title:** Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
  - **Authors:** Tormaehlen, Niklas M.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01773](https://doi.org/10.1021/acs.jmedchem.0c01773)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-31188010
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide; 2 h, 50 °C
1.2|1 h, 50 °C
1.3|Reagents: Water
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors
By: Wiedemeyer, Simon J. A.; et al
ChemMedChem (2023), 18(6), e202200632.
10.1002/cmdc.202200632
```

---

## Reaction 31-614-CAS-31188011

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: WORKUP (Registry: SOLVENT)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 4.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.COC(=O)CCCN.Cl`
  - Products: `COC(=O)CCCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2`

**Reference:**
  - **Title:** Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
  - **Authors:** Tormaehlen, Niklas M.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01773](https://doi.org/10.1021/acs.jmedchem.0c01773)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-31188011
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide; 2 h, 50 °C
1.2|1 h, 50 °C
1.3|Reagents: Water
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-614-CAS-31188013

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: WORKUP (Registry: SOLVENT)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 3.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.COC(=O)CC[C@H](N)C(=O)OC.Cl`
  - Products: `COC(=O)CC[C@H](NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2)C(=O)OC`

**Reference:**
  - **Title:** Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
  - **Authors:** Tormaehlen, Niklas M.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01773](https://doi.org/10.1021/acs.jmedchem.0c01773)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-31188013
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide; 2 h, 50 °C
1.2|1 h, 50 °C
1.3|Reagents: Water
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups
By: Corte, James R.; et al
Journal of Medicinal Chemistry (2020), 63(2), 784-803.
10.1021/acs.jmedchem.9b01768
```

---

## Reaction 31-614-CAS-31188014

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: WORKUP (Registry: SOLVENT)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 3.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.COC(=O)C(N)Cc1ccccc1.Cl`
  - Products: `COC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2`

**Reference:**
  - **Title:** Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
  - **Authors:** Tormaehlen, Niklas M.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01773](https://doi.org/10.1021/acs.jmedchem.0c01773)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-31188014
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide; 2 h, 50 °C
1.2|1 h, 50 °C
1.3|Reagents: Water
Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation
By: Fioravanti, Rossella; et al
ChemMedChem (2020), 15(7), 643-658.
10.1002/cmdc.201900730
```

---

## Reaction 31-614-CAS-31188036

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: WORKUP (Registry: SOLVENT)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 3.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `Nc1ccccc1Nc1ccc2c(c1)CCc1ccc(C(=O)O)cc1C2=O.COC(=O)CCN`
  - Products: `COC(=O)CCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3N)cc1CC2`

**Reference:**
  - **Title:** Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
  - **Authors:** Tormaehlen, Niklas M.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01773](https://doi.org/10.1021/acs.jmedchem.0c01773)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-31188036
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide; 2 h, 50 °C
1.2|1 h, 50 °C
1.3|Reagents: Water
Design and synthesis of novel cereblon binders for use in targeted protein degradation
By: Norris, Stephen; et al
Journal of Medicinal Chemistry (2023), 66(23), 16388-16409.
10.1021/acs.jmedchem.3c01848
```

---

## Reaction 31-614-CAS-31188048

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: WORKUP (Registry: SOLVENT)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 3.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3[N+](=O)[O-])cc1CC2.CN`
  - Products: `CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3[N+](=O)[O-])cc1CC2`

**Reference:**
  - **Title:** Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
  - **Authors:** Tormaehlen, Niklas M.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01773](https://doi.org/10.1021/acs.jmedchem.0c01773)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-31188048
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide; 2 h, 50 °C
1.2|Solvents: Tetrahydrofuran; 1 h, 50 °C
1.3|Reagents: Water
Efficacy, Mechanism, and Structure-Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis
By: Zhou, Zi-ying; et al
Journal of Medicinal Chemistry (2023), 66(3), 1742-1760.
10.1021/acs.jmedchem.2c01377
```

---

## Reaction 31-614-CAS-31188278

**Type:** Other

**Reagents:**
  - 1-Chloro-N,N-2-trimethylpropenylamine (CAS: 26189-59-3) - Role: NUC
  - Py (CAS: 110-86-1) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 73.5 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H]1CCC[C@H](C(=O)O)C1.Nc1cc(Br)ccn1`
  - Products: `CC(C)(C)OC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(Br)ccn2)C1`

**Reference:**
  - **Title:** Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies
  - **Authors:** Barlaam, Bernard; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(24), 15564-15590.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01754](https://doi.org/10.1021/acs.jmedchem.0c01754)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-31188278
1.1|Reagents: 1-Chloro-N,N-2-trimethylpropenylamine
Solvents: Dichloromethane; 1.5 h, 0 °C
1.2|Reagents: Pyridine
Solvents: Dichloromethane; 0 °C → rt; 72 h, rt
Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
By: Tormaehlen, Niklas M.; et al
Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
10.1021/acs.jmedchem.0c01773
```

---

## Reaction 31-614-CAS-31188286

**Type:** Other

**Reagents:**
  - 1-Chloro-N,N-2-trimethylpropenylamine (CAS: 26189-59-3) - Role: NUC
  - Py (CAS: 110-86-1) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.5 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H]1CCC[C@H](C(=O)O)C1.Nc1cc(Br)c(Cl)cn1`
  - Products: `CC(C)(C)OC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(Br)c(Cl)cn2)C1`

**Reference:**
  - **Title:** Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies
  - **Authors:** Barlaam, Bernard; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(24), 15564-15590.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01754](https://doi.org/10.1021/acs.jmedchem.0c01754)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-31188286
1.1|Reagents: 1-Chloro-N,N-2-trimethylpropenylamine
Solvents: Dichloromethane; 0 °C; 1.5 h, rt
1.2|Reagents: Pyridine; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Development of small molecule-drug conjugates based on derivatives of natural proteasome inhibitors that exhibit selectivity for PSMA-expressing cancer cells
By: Obara, Takahiro; et al
Bioorganic & Medicinal Chemistry (2024), 108, 117773.
10.1016/j.bmc.2024.117773
```

---

## Reaction 31-614-CAS-31375482

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Py (CAS: 110-86-1) - Role: WORKUP (Registry: BASE)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK

**Solvents:**
  - Chloroform (CAS: 67-66-3) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 75.0°C
  - Time: 17.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)O)c1.Cl.Nc1sc2c(c1C(=O)c1cnn(-c3ccc(Cl)cc3)c1)CCCC2`
  - Products: `CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)Nc2sc3c(c2C(=O)c2cnn(-c4ccc(Cl)cc4)c2)CCCC3)c1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors
  - **Authors:** Ushiki, Yasunobu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.128572](https://doi.org/10.1016/j.bmcl.2022.128572)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-31375482
1.1|Reagents: Thionyl chloride
Solvents: Chloroform; 1 h, 75 °C
1.2|Reagents: Pyridine
Solvents: Chloroform; overnight, rt
1.3|Reagents: Ammonium chloride
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
By: Granberg, Kenneth L.; et al
Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.
10.1021/acs.jmedchem.3c02184
```

---

## Reaction 31-614-CAS-31375486

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Py (CAS: 110-86-1) - Role: WORKUP (Registry: BASE)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK

**Solvents:**
  - Chloroform (CAS: 67-66-3) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 75.0°C
  - Time: 18.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)O)c1.Cl.CC(=O)N1CCc2c(sc(N)c2C(=O)c2cnn(-c3ccc(Cl)cc3)c2)C1`
  - Products: `CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)Nc2sc3c(c2C(=O)c2cnn(-c4ccc(Cl)cc4)c2)CCN(C(C)=O)C3)c1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors
  - **Authors:** Ushiki, Yasunobu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.128572](https://doi.org/10.1016/j.bmcl.2022.128572)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-31375486
1.1|Reagents: Thionyl chloride
Solvents: Chloroform; 1 h, 75 °C
1.2|Reagents: Pyridine
Solvents: Chloroform; overnight, rt
1.3|Reagents: Ammonium chloride
Solvents: Water; rt
Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors
By: Ushiki, Yasunobu; et al
Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.
10.1016/j.bmcl.2022.128572
```

---

## Reaction 31-614-CAS-31375489

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Py (CAS: 110-86-1) - Role: WORKUP (Registry: BASE)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK

**Solvents:**
  - Chloroform (CAS: 67-66-3) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 75.0°C
  - Time: 17.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)O)c1.Cl.CS(=O)(=O)N1CCc2c(sc(N)c2C(=O)c2cnn(-c3ccc(Cl)cc3)c2)C1`
  - Products: `CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)Nc2sc3c(c2C(=O)c2cnn(-c4ccc(Cl)cc4)c2)CCN(S(C)(=O)=O)C3)c1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors
  - **Authors:** Ushiki, Yasunobu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.128572](https://doi.org/10.1016/j.bmcl.2022.128572)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-31375489
1.1|Reagents: Thionyl chloride
Solvents: Chloroform; 1 h, 75 °C
1.2|Reagents: Pyridine
Solvents: Chloroform; overnight, rt
1.3|Reagents: Ammonium chloride
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2
By: Heightman, Tom D.; et al
Journal of Medicinal Chemistry (2021), 64(16), 12286-12303.
10.1021/acs.jmedchem.1c00905
```

---

## Reaction 31-614-CAS-31375495

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Py (CAS: 110-86-1) - Role: WORKUP (Registry: BASE)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK

**Solvents:**
  - Chloroform (CAS: 67-66-3) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 75.0°C
  - Time: 17.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)O)c1.Cl.Nc1sc2c(c1C(=O)c1cnn(-c3ccc(Cl)cc3)c1)CCN(C1CC1)C2`
  - Products: `CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)Nc2sc3c(c2C(=O)c2cnn(-c4ccc(Cl)cc4)c2)CCN(C2CC2)C3)c1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors
  - **Authors:** Ushiki, Yasunobu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.128572](https://doi.org/10.1016/j.bmcl.2022.128572)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-31375495
1.1|Reagents: Thionyl chloride
Solvents: Chloroform; 1 h, 75 °C
1.2|Reagents: Pyridine
Solvents: Chloroform; overnight, rt
1.3|Reagents: Ammonium chloride
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate
By: Critcher, Douglas J.; et al
Organic Process Research & Development (2024), 28(7), 2646-2658.
10.1021/acs.oprd.4c00049
```

---

## Reaction 31-614-CAS-31381010

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `COC[C@H](NC(=O)OC(C)(C)C)C(=O)O.COC(=O)[C@@H](N)CSC.Cl`
  - Products: `COC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](CSC)C(=O)OC`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-31381010
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis
By: Sarkar, Dipayan; et al
Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.
10.1021/acs.jmedchem.3c01431
```

---

## Reaction 31-614-CAS-31382127

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 5.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `COC(=O)c1ccc(CN)cc1.Cl.CC(C)(C)OC(=O)NC1CCC(C(=O)O)CC1`
  - Products: `COC(=O)c1ccc(CNC(=O)C2CCC(NC(=O)OC(C)(C)C)CC2)cc1`

**Reference:**
  - **Title:** Discovery of soluble epoxide hydrolase inhibitors through DNA-encoded library technology (ELT)
  - **Authors:** Ding, Yun; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 41, 116216.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116216](https://doi.org/10.1016/j.bmc.2021.116216)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-31382127
1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 2 h, 0 °C; 3 h, rt
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
By: Hiesinger, Kerstin; et al
Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.
10.1021/acs.jmedchem.0c00561
```

---

## Reaction 31-614-CAS-31442449

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - THF (CAS: 96-47-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 16.5 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1ccncc1.Nc1ccccc1`
  - Products: `O=C(Nc1ccccc1)c1ccncc1`

**Reference:**
  - **Title:** Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase
  - **Authors:** Bagal, Sharan K.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(23), 17146-17183.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01161](https://doi.org/10.1021/acs.jmedchem.1c01161)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-31442449
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: 2-Methyltetrahydrofuran; 25 °C; 30 min, 60 °C; 16 h, 60 °C
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
By: Li, Bing-yan; et al
Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.
10.1021/acs.jmedchem.3c02407
```

---

## Reaction 31-614-CAS-31446392

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)O.N[C@@H](Cc1ccc(O)cc1)C(=O)OCc1ccccc1`
  - Products: `CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer’s Disease
  - **Authors:** Lee, Min Jae; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(15), 10934-10950.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00291](https://doi.org/10.1021/acs.jmedchem.1c00291)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-31446392
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction
By: Si, Ru; et al
European Journal of Medicinal Chemistry (2023), 257, 115497.
10.1016/j.ejmech.2023.115497
```

---

## Reaction 31-614-CAS-31490957

**Type:** Other

**Reagents:**
  - DMAP (CAS: 1122-58-3) - Role: BASE (Registry: LIGAND)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 4-(Dimethylamino)pyridine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - Chloroform (CAS: 67-66-3) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 12.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `Nc1cccc([N+](=O)[O-])c1.O=C(O)c1ccc(OCCCc2ccccc2)cc1`
  - Products: `O=C(Nc1cccc([N+](=O)[O-])c1)c1ccc(OCCCc2ccccc2)cc1`

**Reference:**
  - **Title:** Development and in-vitro Profiling of Dual FXR/LTA4H Modulators
  - **Authors:** Schierle, Simone; et al
  - **Citation:** ChemMedChem (2021), 16(15), 2366-2374.
  - **DOI:** [https://doi.org/10.1002/cmdc.202100118](https://doi.org/10.1002/cmdc.202100118)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31490957
1.1|Reagents: 4-(Dimethylamino)pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Chloroform, Dimethylformamide; 12 h, 50 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-31490959

**Type:** Other

**Reagents:**
  - DMAP (CAS: 1122-58-3) - Role: BASE (Registry: LIGAND)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 4-(Dimethylamino)pyridine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - Chloroform (CAS: 67-66-3) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 12.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CCOC(=O)c1ccc(N)cc1.O=C(O)c1ccc(OCCCc2ccccc2)cc1`
  - Products: `CCOC(=O)c1ccc(NC(=O)c2ccc(OCCCc3ccccc3)cc2)cc1`

**Reference:**
  - **Title:** Development and in-vitro Profiling of Dual FXR/LTA4H Modulators
  - **Authors:** Schierle, Simone; et al
  - **Citation:** ChemMedChem (2021), 16(15), 2366-2374.
  - **DOI:** [https://doi.org/10.1002/cmdc.202100118](https://doi.org/10.1002/cmdc.202100118)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31490959
1.1|Reagents: 4-(Dimethylamino)pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Chloroform, Dimethylformamide; 12 h, 50 °C
Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents
By: Amblard, Franck; et al
Bioorganic & Medicinal Chemistry (2021), 31, 115952.
10.1016/j.bmc.2020.115952
```

---

## Reaction 31-614-CAS-31495546

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - NaOH (CAS: 1310-73-2) - Role: UNK (Registry: BASE)
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - 1,3-Dimethyl-2-imidazolidinone (CAS: 80-73-9)
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 1.5 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)c1cnc(C(F)F)cn1.C[C@H]1OC[C@]2(c3cc(N)ccc3F)N=C(N)SC[C@H]12`
  - Products: `C[C@H]1OC[C@]2(c3cc(NC(=O)c4cnc(C(F)F)cn4)ccc3F)N=C(N)SC[C@H]12`

**Reference:**
  - **Title:** Synthesis of BACE1 Inhibitors E2609/E2071 via Oxime-Olefin Cycloaddition Following Process Risk Mitigation Strategy
  - **Authors:** Kim, Dae-Shik; et al
  - **Citation:** Organic Process Research & Development (2022), 26(3), 804-816.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00223](https://doi.org/10.1021/acs.oprd.1c00223)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-31495546
1.1|Reagents: Thionyl chloride
Solvents: 1,3-Dimethyl-2-imidazolidinone, Water; < 10 °C; 4 - 10 °C; 10 °C → 0 °C; < 5 °C; 0.5 h, 15 - 20 °C
1.2|Reagents: Sodium hydroxide
Solvents: Water; > pH 10, < 30 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors
By: Ma, Chunhua; et al
Journal of Medicinal Chemistry (2021), 64(21), 16242-16270.
10.1021/acs.jmedchem.1c01559
```

---

## Reaction 31-614-CAS-31497669

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -20.0°C
  - Time: 12.5 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1ccccc1.COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](N)Cc1ccccc1.Cl`
  - Products: `COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)/C=C/c1ccccc1`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2
  - **Authors:** Dai, Wenhao; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02258](https://doi.org/10.1021/acs.jmedchem.0c02258)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31497669
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 30 min, -20 °C
1.2|Reagents: Diisopropylethylamine; -20 °C; 12 h, -20 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-614-CAS-31497680

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -20.0°C
  - Time: 12.5 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O.COC(=O)[C@@H](N)C[C@@H]1CCNC1=O.Cl`
  - Products: `COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2
  - **Authors:** Dai, Wenhao; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02258](https://doi.org/10.1021/acs.jmedchem.0c02258)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-31497680
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 30 min, -20 °C
1.2|Reagents: Diisopropylethylamine; -20 °C; 12 h, -20 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain
By: Hartz, Richard A.; et al
Journal of Medicinal Chemistry (2021), 64(15), 11090-11128.
10.1021/acs.jmedchem.1c00472
```

---

## Reaction 31-614-CAS-31497747

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -20.0°C
  - Time: 12.5 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O.COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](N)Cc1ccccc1.Cl`
  - Products: `COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2
  - **Authors:** Dai, Wenhao; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02258](https://doi.org/10.1021/acs.jmedchem.0c02258)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-31497747
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 30 min, -20 °C
1.2|Reagents: Diisopropylethylamine; -20 °C; 12 h, -20 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer
By: Sun, Li-ping; et al
Journal of Medicinal Chemistry (2023), 66(21), 14700-14715.
10.1021/acs.jmedchem.3c01210
```

---

## Reaction 31-614-CAS-31510779

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `N#CCN.COc1ccc(-c2ccc(C(=O)N(CC(=O)O)Cc3ccccc3)cc2)cc1`
  - Products: `COc1ccc(-c2ccc(C(=O)N(CC(=O)NCC#N)Cc3ccccc3)cc2)cc1`

**Reference:**
  - **Title:** Nitrile-based peptoids as cysteine protease inhibitors
  - **Authors:** Alves, Luana; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 41, 116211.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116211](https://doi.org/10.1016/j.bmc.2021.116211)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-31510779
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; 16 h, rt
Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing
By: Li, Derun; et al
Journal of Medicinal Chemistry (2022), 65(8), 6001-6016.
10.1021/acs.jmedchem.1c01670
```

---

## Reaction 31-614-CAS-31510782

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `N#CC1(N)CC1.COc1ccc(-c2ccc(C(=O)N(CC(=O)O)Cc3ccccc3)cc2)cc1`
  - Products: `COc1ccc(-c2ccc(C(=O)N(CC(=O)NC3(C#N)CC3)Cc3ccccc3)cc2)cc1`

**Reference:**
  - **Title:** Nitrile-based peptoids as cysteine protease inhibitors
  - **Authors:** Alves, Luana; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 41, 116211.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116211](https://doi.org/10.1016/j.bmc.2021.116211)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-31510782
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; 16 h, rt
Design, synthesis, and in vitro protective effect evaluation of α-carboline derivatives against H2O2-induced cardiomyocyte injury
By: Zhang, Rong-Hong; et al
European Journal of Medicinal Chemistry (2022), 238, 114469.
10.1016/j.ejmech.2022.114469
```

---

## Reaction 31-614-CAS-31542322

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 23.0°C
  - Time: 2.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Cl)cc1C(F)(F)F.C[C@H](N)C1CC1`
  - Products: `C[C@H](NC(=O)c1ccc(Cl)cc1C(F)(F)F)C1CC1`

**Reference:**
  - **Title:** Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)
  - **Authors:** Mata, Guillaume; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(2), 1418-1444.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01153](https://doi.org/10.1021/acs.jmedchem.1c01153)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31542322
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, 23 °C
1.2|Reagents: Ammonium chloride
Solvents: Water
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo
By: Abram, Michal; et al
Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.
10.1021/acs.jmedchem.2c00534
```

---

## Reaction 31-614-CAS-31542523

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Sodium chloride (CAS: 7647-14-5) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 5.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `Nc1ccccn1.CCOC(=O)c1nc([C@@H]2CCCN2C(=O)OC(C)(C)C)[nH]c1-c1ccc(C(=O)O)cc1`
  - Products: `CCOC(=O)c1nc([C@@H]2CCCN2C(=O)OC(C)(C)C)[nH]c1-c1ccc(C(=O)Nc2ccccn2)cc1`

**Reference:**
  - **Title:** Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors
  - **Authors:** Ma, Chunhua; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(21), 16242-16270.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01559](https://doi.org/10.1021/acs.jmedchem.1c01559)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-31542523
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 4 h, 80 °C
1.2|Reagents: Sodium chloride
Solvents: Water
Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors
By: Ushiki, Yasunobu; et al
Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.
10.1016/j.bmcl.2022.128572
```

---

## Reaction 31-614-CAS-31542534

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Sodium chloride (CAS: 7647-14-5) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 4.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CCc1ccnc(N)c1.CCOC(=O)c1nc([C@@H]2CCCCN2C(=O)OC(C)(C)C)[nH]c1-c1ccc(C(=O)O)cc1`
  - Products: `CCOC(=O)c1nc([C@@H]2CCCCN2C(=O)OC(C)(C)C)[nH]c1-c1ccc(C(=O)Nc2cc(CC)ccn2)cc1`

**Reference:**
  - **Title:** Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors
  - **Authors:** Ma, Chunhua; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(21), 16242-16270.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01559](https://doi.org/10.1021/acs.jmedchem.1c01559)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-31542534
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 4 h, 80 °C; 80 °C → rt
1.2|Reagents: Sodium chloride
Solvents: Water; rt
Relative stereochemistry shown
Relative stereochemistry shown
Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360
By: Rueeger, Heinrich; et al
Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.
10.1021/acs.jmedchem.0c02143
```

---

## Reaction 31-614-CAS-31542881

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 72.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Cl)cc1.CC(C)(N)C1C2CC(O[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)CC21`
  - Products: `CC(C)(NC(=O)c1ccc(Cl)cc1)C1C2CC(O[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)CC21`

**Reference:**
  - **Title:** Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme
  - **Authors:** Hamilton, Matthew M.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(15), 11302-11329.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00679](https://doi.org/10.1021/acs.jmedchem.1c00679)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-31542881
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; 3 d, rt
Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis
By: Zhao, Hongyi; et al
Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.
10.1021/acs.jmedchem.2c00718
```

---

## Reaction 31-614-CAS-31545310

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)c1cc(Cl)ccc1Cl.COC[C@H](N)C(=O)N[C@@H](CSC)C(=O)OC.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)c1cc(Cl)ccc1Cl)C(=O)N[C@@H](CSC)C(=O)OC`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545310
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Double bond geometry shown
Double bond geometry shown
Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors
By: Feng, Zi-Qiang; et al
European Journal of Medicinal Chemistry (2024), 266, 116113.
10.1016/j.ejmech.2023.116113
```

---

## Reaction 31-614-CAS-31545313

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)c1cc(Cl)ccc1Cl.COC[C@H](NC(=O)[C@@H](N)CSC)C(=O)OC.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(Cl)ccc1Cl)C(=O)OC`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545313
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown
Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1
By: Ryu, SeongShick; et al
Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.
10.1021/acs.jmedchem.1c01359
```

---

## Reaction 31-614-CAS-31545319

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)c1cnccn1.COC[C@H](N)C(=O)N[C@@H](CSC)C(=O)OC.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)c1cnccn1)C(=O)N[C@@H](CSC)C(=O)OC`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545319
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo[1,2-a]quinoxaline Core
By: Garcia-Marin, Javier; et al
ChemMedChem (2021), 16(18), 2895-2906.
10.1002/cmdc.202100338
```

---

## Reaction 31-614-CAS-31545320

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)c1cc(Cl)ccc1Cl.COC(=O)[C@H](CSC)NC(=O)[C@@H](N)CSC.O=C(O)C(F)(F)F`
  - Products: `COC(=O)[C@H](CSC)NC(=O)[C@H](CSC)NC(=O)c1cc(Cl)ccc1Cl`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545320
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
By: Fang, Wei; et al
Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
10.1021/acs.jmedchem.3c02063
```

---

## Reaction 31-614-CAS-31545322

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)c1cnccn1.COC[C@H](NC(=O)[C@@H](N)CSC)C(=O)OC.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cnccn1)C(=O)OC`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545322
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide
By: Guryanov, Ivan; et al
Organic Process Research & Development (2021), 25(7), 1598-1611.
10.1021/acs.oprd.1c00021
```

---

## Reaction 31-614-CAS-31545324

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)c1cnccn1.COC(=O)[C@H](CSC)NC(=O)[C@@H](N)CSC.O=C(O)C(F)(F)F`
  - Products: `COC(=O)[C@H](CSC)NC(=O)[C@H](CSC)NC(=O)c1cnccn1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545324
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-31545325

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `Cc1cc(C(=O)O)no1.COC[C@H](NC(=O)[C@@H](N)CSC)C(=O)OC.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1)C(=O)OC`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545325
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-31545329

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `Cc1cc(C(=O)O)no1.COC[C@H](N)C(=O)N[C@@H](CSC)C(=O)OC.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)c1cc(C)on1)C(=O)N[C@@H](CSC)C(=O)OC`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545329
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
By: Guzelj, Samo; et al
Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.
10.1021/acs.jmedchem.2c00808
```

---

## Reaction 31-614-CAS-31545333

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `Cc1cc(C(=O)O)no1.COC[C@H](NC(=O)CN)C(=O)OC.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)CNC(=O)c1cc(C)on1)C(=O)OC`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545333
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-31545336

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `Cc1cc(C(=O)O)no1.COC(=O)[C@H](CSC)NC(=O)[C@@H](N)CSC.O=C(O)C(F)(F)F`
  - Products: `COC(=O)[C@H](CSC)NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545336
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
A Mitochondria-Targeted Phenylbutyric Acid Prodrug Confers Drastically Improved Anticancer Activities
By: Huang, Ding; et al
Journal of Medicinal Chemistry (2022), 65(14), 9955-9973.
10.1021/acs.jmedchem.2c00640
```

---

## Reaction 31-614-CAS-31545339

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 8.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `Cc1cc(C(=O)O)no1.COC[C@H](N)C(=O)NCC(=O)OC.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)OC`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545339
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors
By: Rullo, Mariagrazia; et al
European Journal of Medicinal Chemistry (2023), 255, 115352.
10.1016/j.ejmech.2023.115352
```

---

## Reaction 31-614-CAS-31545344

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `Cc1ncc(C(=O)O)s1.COC(=O)[C@H](CSC)NC(=O)[C@@H](N)CSC.O=C(O)C(F)(F)F`
  - Products: `COC(=O)[C@H](CSC)NC(=O)[C@H](CSC)NC(=O)c1cnc(C)s1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545344
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy
By: Chuang, Chihyuan; et al
Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.
10.1021/acs.jmedchem.1c01290
```

---

## Reaction 31-614-CAS-31545345

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `Cc1cc(C(=O)O)no1.COC(=O)CNC(=O)[C@@H](N)CSC.O=C(O)C(F)(F)F`
  - Products: `COC(=O)CNC(=O)[C@H](CSC)NC(=O)c1cc(C)on1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545345
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Double bond geometry shown
Double bond geometry shown
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
By: Zhang, Kuojun; et al
Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
10.1021/acs.jmedchem.2c00077
```

---

## Reaction 31-614-CAS-31545348

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 8.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `Cc1ncc(C(=O)O)s1.COC(=O)CNC(=O)[C@@H](N)CSC.O=C(O)C(F)(F)F`
  - Products: `COC(=O)CNC(=O)[C@H](CSC)NC(=O)c1cnc(C)s1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31545348
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors
By: Rullo, Mariagrazia; et al
European Journal of Medicinal Chemistry (2023), 255, 115352.
10.1016/j.ejmech.2023.115352
```

---

## Reaction 31-614-CAS-31545365

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(Cl)ccc1Cl)C(=O)O.C[C@]1(C(=O)[C@@H](N)Cc2ccccc2)CO1.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(Cl)ccc1Cl)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31545365
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-31545371

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CSC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)O.CC(C)C[C@H](N)C(=O)[C@@]1(C)CO1.O=C(O)C(F)(F)F`
  - Products: `CSC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31545371
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer
By: Sharma, Horrick; et al
European Journal of Medicinal Chemistry (2024), 275, 116598.
10.1016/j.ejmech.2024.116598
```

---

## Reaction 31-614-CAS-31545372

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)O.CC(C)C[C@H](N)C(=O)[C@@]1(C)CO1.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31545372
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR
By: Grossman, Scott; et al
European Journal of Medicinal Chemistry (2020), 208, 112778.
10.1016/j.ejmech.2020.112778
```

---

## Reaction 31-614-CAS-31545373

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CSC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1)C(=O)O.C[C@]1(C(=O)[C@@H](N)Cc2ccccc2)CO1.O=C(O)C(F)(F)F`
  - Products: `CSC[C@H](NC(=O)c1cc(C)on1)C(=O)N[C@@H](CSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31545373
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Absolute stereochemistry shown
Relative stereochemistry shown
Absolute stereochemistry shown
The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure
By: Cadilla, Rodolfo; et al
Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.
10.1016/j.bmc.2020.115791
```

---

## Reaction 31-614-CAS-31545374

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)O.C[C@]1(C(=O)[C@@H](N)Cc2ccccc2)CO1.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-31545374
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia
By: Ali, Imran; et al
European Journal of Medicinal Chemistry (2024), 265, 116052.
10.1016/j.ejmech.2023.116052
```

---

## Reaction 31-614-CAS-31545377

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CSC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cnc(C)s1)C(=O)O.C[C@]1(C(=O)[C@@H](N)Cc2ccccc2)CO1.O=C(O)C(F)(F)F`
  - Products: `CSC[C@H](NC(=O)c1cnc(C)s1)C(=O)N[C@@H](CSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31545377
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold
By: Huang, Danling; et al
Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.
10.1016/j.bmcl.2021.128006
```

---

## Reaction 31-614-CAS-31545380

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1)C(=O)O.CC(C)C[C@H](N)C(=O)[C@@]1(C)CO1.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31545380
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-31545381

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC[C@H](NC(=O)c1cnccn1)C(=O)N[C@@H](CSC)C(=O)O.CC(C)C[C@H](N)C(=O)[C@@]1(C)CO1.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)c1cnccn1)C(=O)N[C@@H](CSC)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31545381
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction
By: Wang, Yu; et al
European Journal of Medicinal Chemistry (2022), 229, 113998.
10.1016/j.ejmech.2021.113998
```

---

## Reaction 31-614-CAS-31545383

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1)C(=O)O.C[C@]1(C(=O)[C@@H](N)Cc2ccccc2)CO1.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31545383
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S
By: Rathman, Benjamin M.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283.
10.1016/j.bmcl.2020.127283
```

---

## Reaction 31-614-CAS-31545386

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC[C@H](NC(=O)CNC(=O)c1cc(C)on1)C(=O)O.CC(C)C[C@H](N)C(=O)[C@@]1(C)CO1.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)CNC(=O)c1cc(C)on1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31545386
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of Osteoarthritis
By: Bendele, Alison M.; et al
European Journal of Medicinal Chemistry (2021), 224, 113666.
10.1016/j.ejmech.2021.113666
```

---

## Reaction 31-614-CAS-31545392

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 7.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC[C@H](NC(=O)CNC(=O)c1cc(C)on1)C(=O)O.C[C@]1(C(=O)[C@@H](N)Cc2ccccc2)CO1.O=C(O)C(F)(F)F`
  - Products: `COC[C@H](NC(=O)CNC(=O)c1cc(C)on1)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1`

**Reference:**
  - **Title:** Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
  - **Authors:** Zhang, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 40, 116182.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116182](https://doi.org/10.1016/j.bmc.2021.116182)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31545392
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -5 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C
1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt
Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors
By: Shu, Lei; et al
European Journal of Medicinal Chemistry (2020), 191, 112148pp..
10.1016/j.ejmech.2020.112148
```

---

## Reaction 31-614-CAS-31556145

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Reaction Conditions:**
  - Time: 5.5 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)CC12CC3CC(CC(C3)C1)C2.NCCCCO`
  - Products: `O=C(CC12CC3CC(CC(C3)C1)C2)NCCCCO`

**Reference:**
  - **Title:** Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway
  - **Authors:** Rastelli, Ettore J.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2021.128167](https://doi.org/10.1016/j.bmcl.2021.128167)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-31556145
1.1|Reagents: Thionyl chloride; 1.5 h, reflux
1.2|Reagents: Triethylamine; 0 °C → rt; 4 h, rt
Absolute stereochemistry shown
Selective Recognition of c-KIT 1 G-Quadruplex by Structural Tuning of Heteroaromatic Scaffolds and Side Chains
By: Fatma, Khushnood; et al
ACS Medicinal Chemistry Letters (2024), 15(3), 388-395.
10.1021/acsmedchemlett.3c00537
```

---

## Reaction 31-614-CAS-31556160

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Reaction Conditions:**
  - Time: 13.5 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)CC12CC3CC(CC(C3)C1)C2.CC(C)(C)OC(=O)NCCCN`
  - Products: `CC(C)(C)OC(=O)NCCCNC(=O)CC12CC3CC(CC(C3)C1)C2`

**Reference:**
  - **Title:** Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway
  - **Authors:** Rastelli, Ettore J.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2021.128167](https://doi.org/10.1016/j.bmcl.2021.128167)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-31556160
1.1|Reagents: Thionyl chloride; 1.5 h, rt → reflux; reflux → rt
1.2|Reagents: Triethylamine; 0 °C → rt; 12 h, rt
On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System
By: Fang, Zhengqi; et al
Organic Process Research & Development (2024), 28(8), 3143-3151.
10.1021/acs.oprd.4c00043
```

---

## Reaction 31-614-CAS-31556162

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Reaction Conditions:**
  - Temperature: 11.0°C
  - Time: 13.5 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)CC12CC3CC(CC(C3)C1)C2.CC(C)(C)OC(=O)NCCOCCOCCN`
  - Products: `CC(C)(C)OC(=O)NCCOCCOCCNC(=O)CC12CC3CC(CC(C3)C1)C2`

**Reference:**
  - **Title:** Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway
  - **Authors:** Rastelli, Ettore J.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2021.128167](https://doi.org/10.1016/j.bmcl.2021.128167)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-31556162
1.1|Reagents: Thionyl chloride; 1.5 h, rt → reflux; reflux → rt
1.2|Reagents: Triethylamine; 0 °C → rt; 12 h, rt
[11C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins
By: Liu, Longbin; et al
Journal of Medicinal Chemistry (2021), 64(16), 12003-12021.
10.1021/acs.jmedchem.1c00667
```

---

## Reaction 31-614-CAS-31592225

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `O=C(O)[C@@H]1CCCN1C(=O)OCc1ccccc1.COC(=O)[C@@H](N)CCSC.Cl`
  - Products: `COC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1
  - **Authors:** Ryu, SeongShick; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01359](https://doi.org/10.1021/acs.jmedchem.1c01359)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-31592225
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.2|Reagents: Water
Solvents: Ethyl acetate; rt
Copyright © 2025 American Chemical Society (ACS). All Rights Reserved.
```

---

## Reaction 31-614-CAS-31592226

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC(C)(C)C)[C@@H](C)O.CC(C)(C)OC(=O)N[C@@H](COCc1ccccc1)C(=O)O`
  - Products: `COC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)OC(C)(C)C)[C@@H](C)O`

**Reference:**
  - **Title:** Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1
  - **Authors:** Ryu, SeongShick; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01359](https://doi.org/10.1021/acs.jmedchem.1c01359)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-31592226
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 0 °C; 3 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.3|Reagents: Water
Solvents: Ethyl acetate; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2
By: Pettus, Liping H.; et al
Journal of Medicinal Chemistry (2020), 63(5), 2263-2281.
10.1021/acs.jmedchem.9b01034
```

---

## Reaction 31-614-CAS-31592253

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `C=CCOC(=O)[C@@H](NC(=O)OC(C)(C)C)[C@@H](C)O.CC(C)(C)OC(=O)N[C@@H](COCc1ccccc1)C(=O)O`
  - Products: `C=CCOC(=O)[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)OC(C)(C)C)[C@@H](C)O`

**Reference:**
  - **Title:** Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1
  - **Authors:** Ryu, SeongShick; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01359](https://doi.org/10.1021/acs.jmedchem.1c01359)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-31592253
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 0 °C; 3 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.3|Reagents: Water
Solvents: Ethyl acetate; rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-31592256

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `C=CCOC(=O)[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)OC(C)(C)C)[C@@H](C)O.CC(C)(C)OC(=O)CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O`
  - Products: `C=CCOC(=O)[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)OCC1c2ccccc2-c2ccccc21)[C@@H](C)O`

**Reference:**
  - **Title:** Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1
  - **Authors:** Ryu, SeongShick; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01359](https://doi.org/10.1021/acs.jmedchem.1c01359)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-31592256
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 0 °C; 3 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.3|Reagents: Water
Solvents: Ethyl acetate; rt
Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders
By: Roehrig, Susanne; et al
Journal of Medicinal Chemistry (2023), 66(17), 12203-12224.
10.1021/acs.jmedchem.3c00795
```

---

## Reaction 31-614-CAS-31592277

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `COC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)OC(C)(C)C)[C@@H](C)O.CC(C)(C)OC(=O)N[C@@H](CCC(N)=O)C(=O)O`
  - Products: `COC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)OC(C)(C)C)[C@@H](C)O`

**Reference:**
  - **Title:** Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1
  - **Authors:** Ryu, SeongShick; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01359](https://doi.org/10.1021/acs.jmedchem.1c01359)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-31592277
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 0 °C; 3 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.3|Reagents: Water
Solvents: Ethyl acetate; rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
By: Jung, Sascha; et al
Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
10.1021/acs.jmedchem.1c01002
```

---

## Reaction 31-614-CAS-31592699

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `CSc1ncc(C(=O)O)c(NC2CCCC2)n1.NCCCN1CCCC1=O`
  - Products: `CSc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1`

**Reference:**
  - **Title:** Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase
  - **Authors:** Russ, Nadine; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(19), 14358-14376.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00845](https://doi.org/10.1021/acs.jmedchem.1c00845)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-31592699
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.2|4 h, rt
Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity
By: Zareba, Paula; et al
European Journal of Medicinal Chemistry (2021), 221, 113512.
10.1016/j.ejmech.2021.113512
```

---

## Reaction 31-614-CAS-31592708

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CSc1ncc(C(=O)O)c(NC2CCCC2)n1.NCCCN1CCOC1=O`
  - Products: `CSc1ncc(C(=O)NCCCN2CCOC2=O)c(NC2CCCC2)n1`

**Reference:**
  - **Title:** Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase
  - **Authors:** Russ, Nadine; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(19), 14358-14376.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00845](https://doi.org/10.1021/acs.jmedchem.1c00845)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-31592708
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.2|4 h, rt
Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity
By: Zareba, Paula; et al
European Journal of Medicinal Chemistry (2021), 221, 113512.
10.1016/j.ejmech.2021.113512
```

---

## Reaction 31-614-CAS-31593444

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.25 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O.Cl.N[C@H](/C=C(/F)S(=O)(=O)Oc1ccccc1)CCc1ccccc1`
  - Products: `CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](/C=C(/F)S(=O)(=O)Oc1ccccc1)CCc1ccccc1`

**Reference:**
  - **Title:** Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
  - **Authors:** Jung, Sascha; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01002](https://doi.org/10.1021/acs.jmedchem.1c01002)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-31593444
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 0 °C; 15 min, 0 °C
1.2|Solvents: Dichloromethane; 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-31593448

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.25 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O.Cl.N[C@H](/C=C(\F)S(=O)(=O)Cc1ccccc1)CCc1ccccc1`
  - Products: `CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](/C=C(\F)S(=O)(=O)Cc1ccccc1)CCc1ccccc1`

**Reference:**
  - **Title:** Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
  - **Authors:** Jung, Sascha; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01002](https://doi.org/10.1021/acs.jmedchem.1c01002)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-31593448
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 0 °C; 15 min, 0 °C
1.2|Solvents: Dichloromethane; 12 h, rt
NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer
By: Xu, Zhongren; et al
Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.
10.1021/acs.jmedchem.3c00063
```

---

## Reaction 31-614-CAS-31593451

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.25 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `Cc1ccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)cc1.Cl.N[C@H](/C=C(\F)S(=O)(=O)Oc1ccccc1)CCc1ccccc1`
  - Products: `Cc1ccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](/C=C(\F)S(=O)(=O)Oc2ccccc2)CCc2ccccc2)cc1`

**Reference:**
  - **Title:** Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
  - **Authors:** Jung, Sascha; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01002](https://doi.org/10.1021/acs.jmedchem.1c01002)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-31593451
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 0 °C; 15 min, 0 °C
1.2|Solvents: Dichloromethane; 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Stereoinvertive Deoxyamination of trans-2-Aminocyclohexanol Using Bose-Mitsunobu Azidation and Staudinger Reaction for the Stereoselective Synthesis of Edoxaban
By: Ochiai, Hidenori; et al
Organic Process Research & Development (2023), 27(8), 1517-1532.
10.1021/acs.oprd.3c00189
```

---

## Reaction 31-614-CAS-31593468

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.25 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1cc(F)cc(F)c1.Cc1ccc(C[C@H](N)C(=O)N[C@H](/C=C(\F)S(=O)(=O)Oc2ccccc2)CCc2ccccc2)cc1.Cl`
  - Products: `Cc1ccc(C[C@H](NC(=O)c2cc(F)cc(F)c2)C(=O)N[C@H](/C=C(\F)S(=O)(=O)Oc2ccccc2)CCc2ccccc2)cc1`

**Reference:**
  - **Title:** Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
  - **Authors:** Jung, Sascha; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01002](https://doi.org/10.1021/acs.jmedchem.1c01002)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-31593468
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 15 min, 0 °C
1.2|12 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-614-CAS-31593473

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.25 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(N[C@@H](Cc1ccccc1)C(=O)O)c1ccncc1.Cl.N[C@H](/C=C(\F)S(=O)(=O)Cc1ccccc1)CCc1ccccc1`
  - Products: `O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@H](/C=C(\F)S(=O)(=O)Cc1ccccc1)CCc1ccccc1)c1ccncc1`

**Reference:**
  - **Title:** Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
  - **Authors:** Jung, Sascha; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01002](https://doi.org/10.1021/acs.jmedchem.1c01002)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-31593473
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine
Solvents: Dimethylformamide; 15 min, 0 °C
1.2|12 h, rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-31593480

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.25 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1cc(F)cc(F)c1.Cc1ccc(C[C@H](N)C(=O)N[C@H](/C=C(\F)S(=O)(=O)Cc2ccccc2)CCc2ccccc2)cc1.Cl`
  - Products: `Cc1ccc(C[C@H](NC(=O)c2cc(F)cc(F)c2)C(=O)N[C@H](/C=C(\F)S(=O)(=O)Cc2ccccc2)CCc2ccccc2)cc1`

**Reference:**
  - **Title:** Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
  - **Authors:** Jung, Sascha; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01002](https://doi.org/10.1021/acs.jmedchem.1c01002)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-31593480
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 15 min, 0 °C
1.2|12 h, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2
By: Dai, Wenhao; et al
Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.
10.1021/acs.jmedchem.0c02258
```

---

## Reaction 31-614-CAS-31593490

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.25 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1cc(F)cc(F)c1.Cl.N[C@@H](Cc1ccccc1)C(=O)N[C@H](/C=C(\F)S(=O)(=O)c1ccccc1)CCc1ccccc1`
  - Products: `O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@H](/C=C(\F)S(=O)(=O)c1ccccc1)CCc1ccccc1)c1cc(F)cc(F)c1`

**Reference:**
  - **Title:** Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
  - **Authors:** Jung, Sascha; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01002](https://doi.org/10.1021/acs.jmedchem.1c01002)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-31593490
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 15 min, 0 °C
1.2|12 h, rt
Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine
By: Jiang, Xueyang; et al
European Journal of Medicinal Chemistry (2021), 223, 113663.
10.1016/j.ejmech.2021.113663
```

---

## Reaction 31-614-CAS-31593492

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.25 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)c1ccncc1.Cc1ccc(C[C@H](N)C(=O)N[C@H](/C=C(\F)S(=O)(=O)c2ccccc2)CCc2ccccc2)cc1.Cl`
  - Products: `Cc1ccc(C[C@H](NC(=O)c2ccncc2)C(=O)N[C@H](/C=C(\F)S(=O)(=O)c2ccccc2)CCc2ccccc2)cc1`

**Reference:**
  - **Title:** Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
  - **Authors:** Jung, Sascha; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01002](https://doi.org/10.1021/acs.jmedchem.1c01002)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-31593492
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 15 min, 0 °C
1.2|12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma
By: Zhou, Yi; et al
Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.
10.1021/acs.jmedchem.9b02161
```

---

## Reaction 31-614-CAS-31593501

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.25 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)OCCO2.Cc1cccc(C[C@H](N)C(=O)N[C@H](/C=C(\F)S(=O)(=O)c2ccccc2)CCc2ccccc2)c1.Cl`
  - Products: `Cc1cccc(C[C@H](NC(=O)c2ccc3c(c2)OCCO3)C(=O)N[C@H](/C=C(\F)S(=O)(=O)c2ccccc2)CCc2ccccc2)c1`

**Reference:**
  - **Title:** Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
  - **Authors:** Jung, Sascha; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01002](https://doi.org/10.1021/acs.jmedchem.1c01002)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-31593501
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 15 min, 0 °C
1.2|12 h, rt
Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
By: Pal, Kavita; et al
European Journal of Medicinal Chemistry (2023), 248, 115055.
10.1016/j.ejmech.2022.115055
```

---

## Reaction 31-614-CAS-31605939

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `COc1cc(-c2cccc(Cl)c2)cnc1C(=O)O.COC(=O)CN.Cl`
  - Products: `COC(=O)CNC(=O)c1ncc(-c2cccc(Cl)c2)cc1OC`

**Reference:**
  - **Title:** Development of a Robust and Scalable Process for the Large-Scale Preparation of Vadadustat
  - **Authors:** Lin, Biyue; et al
  - **Citation:** Organic Process Research & Development (2021), 25(4), 960-968.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00004](https://doi.org/10.1021/acs.oprd.1c00004)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-31605939
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dichloromethane; 2 h, rt
1.2|1 h, rt
1.3|Solvents: Water; 2 h, rt
Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d]pyrimidine derivatives
By: Guo, Wen-Ge; et al
Bioorganic & Medicinal Chemistry Letters (2022), 76, 129020.
10.1016/j.bmcl.2022.129020
```

---

## Reaction 31-614-CAS-31626786

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COc1cccc(N)c1.Nc1ccc([N+](=O)[O-])cc1C(=O)O`
  - Products: `COc1cccc(NC(=O)c2cc([N+](=O)[O-])ccc2N)c1`

**Reference:**
  - **Title:** Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones
  - **Authors:** Ryan, Michael C.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00539](https://doi.org/10.1021/acsmedchemlett.1c00539)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31626786
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 17 h, rt
Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors
By: Trinh, Phuc N. H.; et al
Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.
10.1021/acs.jmedchem.0c02169
```

---

## Reaction 31-614-CAS-31626791

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `Nc1ccc(F)cc1.Nc1ccc([N+](=O)[O-])cc1C(=O)O`
  - Products: `Nc1ccc([N+](=O)[O-])cc1C(=O)Nc1ccc(F)cc1`

**Reference:**
  - **Title:** Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones
  - **Authors:** Ryan, Michael C.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00539](https://doi.org/10.1021/acsmedchemlett.1c00539)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31626791
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 17 h, rt
Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27
By: Pillaiyar, Thanigaimalai; et al
European Journal of Medicinal Chemistry (2021), 225, 113777.
10.1016/j.ejmech.2021.113777
```

---

## Reaction 31-614-CAS-31626793

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `COc1ccc(N)cc1.N#Cc1ccc(N)c(C(=O)O)c1`
  - Products: `COc1ccc(NC(=O)c2cc(C#N)ccc2N)cc1F`

**Reference:**
  - **Title:** Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones
  - **Authors:** Ryan, Michael C.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00539](https://doi.org/10.1021/acsmedchemlett.1c00539)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-31626793
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 17 h, rt
The total synthesis of berberine and selected analogues, and their evaluation as amyloid beta aggregation inhibitors
By: Tajiri, Misato; et al
European Journal of Medicinal Chemistry (2021), 215, 113289.
10.1016/j.ejmech.2021.113289
```

---

## Reaction 31-614-CAS-31626798

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `Nc1ccccc1.Nc1ccc([N+](=O)[O-])cc1C(=O)O`
  - Products: `Nc1ccc([N+](=O)[O-])cc1C(=O)Nc1ccccc1`

**Reference:**
  - **Title:** Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones
  - **Authors:** Ryan, Michael C.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00539](https://doi.org/10.1021/acsmedchemlett.1c00539)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31626798
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 17 h, rt
Design, synthesis, and biological evaluation of aryl piperazines with potential as antidiabetic agents via the stimulation of glucose uptake and inhibition of NADH:ubiquinone oxidoreductase
By: Devine, R.; et al
European Journal of Medicinal Chemistry (2020), 202, 112416.
10.1016/j.ejmech.2020.112416
```

---

## Reaction 31-614-CAS-31626803

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `Nc1ccccc1.Nc1cc([N+](=O)[O-])ccc1C(=O)O`
  - Products: `Nc1cc([N+](=O)[O-])ccc1C(=O)Nc1ccccc1`

**Reference:**
  - **Title:** Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones
  - **Authors:** Ryan, Michael C.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00539](https://doi.org/10.1021/acsmedchemlett.1c00539)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-31626803
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 17 h, rt
Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancer
By: Fratta, Simone; et al
European Journal of Medicinal Chemistry (2023), 250, 115170.
10.1016/j.ejmech.2023.115170
```

---

## Reaction 31-614-CAS-31632725

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1.CN1CCOC[C@H]1C(=O)O`
  - Products: `COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2COCCN2C)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-31632725
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-614-CAS-31632729

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1.CN1CCOC[C@H]1C(=O)O`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1COCCN1C)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-31632729
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Relative stereochemistry shown
Relative stereochemistry shown
Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists
By: Cooper, Martin; et al
Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.
10.1021/acs.jmedchem.0c00828
```

---

## Reaction 31-614-CAS-31632730

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(N)cc1.CC(C)(C)OC(=O)N1CCOC[C@H]1C(=O)O`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1COCCN1C(=O)OC(C)(C)C)S(=O)(=O)c1ccc(N)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-31632730
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Design, synthesis and biological evaluation of nitric oxide-releasing 5-cyano-6-phenyl-2, 4-disubstituted pyrimidine derivatives
By: Chi, Lingling; et al
Bioorganic & Medicinal Chemistry Letters (2023), 92, 129389.
10.1016/j.bmcl.2023.129389
```

---

## Reaction 31-614-CAS-31632733

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(O)cc1.CN1CCOC[C@H]1C(=O)O`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1COCCN1C)S(=O)(=O)c1ccc(O)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-31632733
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands
By: Shaik, Anver Basha; et al
Journal of Medicinal Chemistry (2021), 64(20), 15313-15333.
10.1021/acs.jmedchem.1c01353
```

---

## Reaction 31-614-CAS-31632736

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1.CC(C)(C)OC(=O)N1CCOC[C@H]1C(=O)O`
  - Products: `COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2COCCN2C(=O)OC(C)(C)C)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-31632736
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design
By: Krieger, Johannes; et al
ChemMedChem (2023), 18(8), e202200615.
10.1002/cmdc.202200615
```

---

## Reaction 31-614-CAS-31632737

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCOC[C@H]1C(=O)O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(S(C)(=O)=O)cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1COCCN1C(=O)OC(C)(C)C)S(=O)(=O)c1ccc(S(C)(=O)=O)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-31632737
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers
By: Cao, Chaoguo; et al
Journal of Medicinal Chemistry (2020), 63(19), 11012-11033.
10.1021/acs.jmedchem.0c00821
```

---

## Reaction 31-614-CAS-31632739

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCOC[C@H]1C(=O)O.CNc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1`
  - Products: `CNc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2COCCN2C(=O)OC(C)(C)C)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-31632739
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-614-CAS-31632745

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1.CC(C)(C)OC(=O)N1CCO[C@@H](C(=O)O)C1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CCO1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31632745
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase
By: Stachura, Damian L.; et al
ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.
10.1021/acsmedchemlett.2c00505
```

---

## Reaction 31-614-CAS-31632749

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(O)cc1.CC(C)(C)OC(=O)N1CCO[C@@H](C(=O)O)C1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CCO1)S(=O)(=O)c1ccc(O)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-31632749
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant
By: Zhou, Huiyu; et al
European Journal of Medicinal Chemistry (2023), 255, 115389.
10.1016/j.ejmech.2023.115389
```

---

## Reaction 31-614-CAS-31632751

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(N)cc1.CC(C)(C)OC(=O)N1CCO[C@@H](C(=O)O)C1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CCO1)S(=O)(=O)c1ccc(N)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-31632751
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125
By: Caroff, Eva; et al
Journal of Medicinal Chemistry (2022), 65(16), 10918-10933.
10.1021/acs.jmedchem.2c00676
```

---

## Reaction 31-614-CAS-31632756

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCO[C@@H](C(=O)O)C1.CNc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1`
  - Products: `CNc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@H]2CN(C(=O)OC(C)(C)C)CCO2)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-31632756
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Double bond geometry shown
Double bond geometry shown
Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines
By: Marinovic, Marina; et al
Bioorganic & Medicinal Chemistry (2023), 94, 117468.
10.1016/j.bmc.2023.117468
```

---

## Reaction 31-614-CAS-31632768

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)CN1CCS(=O)(=O)CC1.COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1`
  - Products: `COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CN2CCS(=O)(=O)CC2)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-31632768
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (+)
Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors
By: Meena, Chhuttan L.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.
10.1016/j.bmcl.2020.127039
```

---

## Reaction 31-614-CAS-31632771

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)CN1CCS(=O)(=O)CC1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(O)cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CN1CCS(=O)(=O)CC1)S(=O)(=O)c1ccc(O)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-31632771
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency
By: Guzelj, Samo; et al
ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.
10.1021/acsmedchemlett.2c00121
```

---

## Reaction 31-614-CAS-31632772

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)CN1CCS(=O)(=O)CC1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CN1CCS(=O)(=O)CC1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 233, 114251.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114251](https://doi.org/10.1016/j.ejmech.2022.114251)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-31632772
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
By: Jung, Sascha; et al
Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
10.1021/acs.jmedchem.1c01002
```

---

## Reaction 31-614-CAS-31649924

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - NaOH (CAS: 1310-73-2) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 19.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `Nc1ccc(C(=O)O)c(F)c1.CN1CCC(N)CC1`
  - Products: `CN1CCC(NC(=O)c2ccc(N)cc2F)CC1`

**Reference:**
  - **Title:** Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors
  - **Authors:** Karim, Rezaul Md; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(21), 15772-15786.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01096](https://doi.org/10.1021/acs.jmedchem.1c01096)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-31649924
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 30 min, rt
1.2|18 h, rt
1.3|Reagents: Sodium hydroxide
Solvents: Water; 30 min, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)
By: Mata, Guillaume; et al
Journal of Medicinal Chemistry (2022), 65(2), 1418-1444.
10.1021/acs.jmedchem.1c01153
```

---

## Reaction 31-614-CAS-31657448

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 40.25 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `Cc1cc(Cl)ccc1-c1ccc(C(=O)O)cc1.Cc1ccc(N2CCN(C)CC2)c2c1CC[C@H](N)C2`
  - Products: `Cc1cc(Cl)ccc1-c1ccc(C(=O)N[C@H]2CCc3c(C)ccc(N4CCN(C)CC4)c3C2)cc1`

**Reference:**
  - **Title:** Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis
  - **Authors:** Sutherland, Hamish S.; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 229, 114059.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.114059](https://doi.org/10.1016/j.ejmech.2021.114059)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-31657448
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, rt
1.2|40 h, rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-31670168

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -20.0°C
  - Time: 15.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Nc1ccccc1NC1CC1.CC(C)(C)OC(=O)N[C@@H](CC1CCN(C(=O)OCc2ccccc2)CC1)C(=O)O`
  - Products: `CC(C)(C)OC(=O)N[C@@H](CC1CCN(C(=O)OCc2ccccc2)CC1)C(=O)Nc1ccccc1NC1CC1`

**Reference:**
  - **Title:** Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum
  - **Authors:** Teno, Naoki; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2021), 12(3), 420-425.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.0c00640](https://doi.org/10.1021/acsmedchemlett.0c00640)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-31670168
1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt
Solvents: Dimethylformamide; -20 °C; 15 h, rt
1.2|Reagents: Sodium bicarbonate
Solvents: Water; rt
Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus
By: Liu, Yonghua; et al
European Journal of Medicinal Chemistry (2022), 228, 114033.
10.1016/j.ejmech.2021.114033
```

---

## Reaction 31-614-CAS-31670880

**Type:** Other

**Reaction Conditions:**
  - Temperature: 150.0°C
  - Time: 10.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `NC=O.Nc1c(Br)cccc1C(=O)O`
  - Products: `O=c1nc[nH]c2c(Br)cccc12`

**Reference:**
  - **Title:** Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction
  - **Authors:** Wang, Yu; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 229, 113998.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113998](https://doi.org/10.1016/j.ejmech.2021.113998)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-31670880
1.1|6 h, 150 °C
Discovery of Novel 5,6-Dihydro-4H-pyrido[2,3,4-de]quinazoline Irreversible Inhibitors Targeting Both Wild-Type and A775_G776insYVMA Mutated HER2 Kinases
By: Yang, Leifu; et al
Journal of Medicinal Chemistry (2024), 67(7), 5662-5682.
10.1021/acs.jmedchem.3c02302
```

---

## Reaction 31-614-CAS-31683636

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 16.5 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `O=C(O)Cc1nnn[nH]1.Cc1ccc(C(=O)C[C@](N)(c2ccc(OCCCC(F)(F)F)cc2)C(F)(F)F)cc1`
  - Products: `Cc1ccc(C(=O)C[C@](NC(=O)Cc2nnn[nH]2)(c2ccc(OCCCC(F)(F)F)cc2)C(F)(F)F)cc1`

**Reference:**
  - **Title:** Synthesis Optimization, Scale-Up, and Catalyst Screening Efforts toward the MGAT2 Clinical Candidate, BMS-963272
  - **Authors:** Kempson, James; et al
  - **Citation:** Organic Process Research & Development (2022), 26(4), 1327-1335.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.2c00036](https://doi.org/10.1021/acs.oprd.2c00036)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-31683636
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Tetrahydrofuran; 30 min, 0 °C; 16 h, 40 °C
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Pentacyclic triterpene-amino acid derivatives induced apoptosis and autophagy in tumor cells, affected the JNK and PI3K/AKT/mTOR pathway
By: Zhang, Li-qiong; et al
Bioorganic & Medicinal Chemistry (2023), 94, 117478.
10.1016/j.bmc.2023.117478
```

---

## Reaction 31-614-CAS-31702269

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CCOC(=O)CCCCN.Cl.C[C@@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(=O)O`
  - Products: `CCOC(=O)CCCCNC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma
  - **Authors:** Rango, Enrico; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 223, 113653.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113653](https://doi.org/10.1016/j.ejmech.2021.113653)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-31702269
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-614-CAS-31702986

**Type:** Other

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Nc1ccc(O)cc1.O=C(O)C1(C(=O)Nc2ccc(F)cc2)CC1`
  - Products: `O=C(Nc1ccc(O)cc1)C1(C(=O)Nc2ccc(F)cc2)CC1`

**Reference:**
  - **Title:** Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors
  - **Authors:** Huang, Daowei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 223, 113648.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113648](https://doi.org/10.1016/j.ejmech.2021.113648)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-31702986
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 2 h, rt
1.2|Reagents: Hydrochloric acid
Solvents: Water; pH 5, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities
By: Peiretti, Franck; et al
Journal of Medicinal Chemistry (2020), 63(21), 13124-13139.
10.1021/acs.jmedchem.0c01555
```

---

## Reaction 31-614-CAS-31703026

**Type:** Other

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1Nc1ccc(F)cc1.Nc1ccc(O)cc1`
  - Products: `O=C(Nc1ccc(O)cc1)c1ccccc1Nc1ccc(F)cc1`

**Reference:**
  - **Title:** Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors
  - **Authors:** Huang, Daowei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 223, 113648.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113648](https://doi.org/10.1016/j.ejmech.2021.113648)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-31703026
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 4 h, rt
Dual inhibition of Mycobacterium tuberculosis and the host TGFBR1 by an anilinoquinazoline
By: Nandakumar, Meganathan; et al
Journal of Medicinal Chemistry (2023), 66(21), 14724-14734.
10.1021/acs.jmedchem.3c01273
```

---

## Reaction 31-614-CAS-31703028

**Type:** Other

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `Nc1ccc(Oc2ccnc(Cl)c2)cc1.O=C(O)C1(C(=O)Nc2ccc(F)cc2)CC1`
  - Products: `O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc(Cl)c3)cc2)CC1`

**Reference:**
  - **Title:** Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors
  - **Authors:** Huang, Daowei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 223, 113648.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113648](https://doi.org/10.1016/j.ejmech.2021.113648)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-31703028
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 4 h, rt
Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
By: Tormaehlen, Niklas M.; et al
Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
10.1021/acs.jmedchem.0c01773
```

---

## Reaction 31-614-CAS-31703039

**Type:** Other

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `Cc1c(C(=O)O)c(=O)n(-c2ccccc2)n1C.Nc1ccc(O)cc1`
  - Products: `Cc1c(C(=O)Nc2ccc(O)cc2)c(=O)n(-c2ccccc2)n1C`

**Reference:**
  - **Title:** Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors
  - **Authors:** Huang, Daowei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 223, 113648.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113648](https://doi.org/10.1016/j.ejmech.2021.113648)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-31703039
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 4 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury
By: Cui, Yingjun; et al
Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.
10.1021/acs.jmedchem.1c01583
```

---

## Reaction 31-614-CAS-31703041

**Type:** Other

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `Nc1ccc(F)cc1.O=C(O)c1ccccc1Nc1ccc(O)cc1`
  - Products: `O=C(Nc1ccc(F)cc1)c1ccccc1Nc1ccc(O)cc1`

**Reference:**
  - **Title:** Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors
  - **Authors:** Huang, Daowei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 223, 113648.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113648](https://doi.org/10.1016/j.ejmech.2021.113648)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-31703041
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 4 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Insights into Fast Amide Couplings in Aqueous Nanomicelles
By: Sharma, Sudripet; et al
Organic Process Research & Development (2021), 25(8), 1960-1965.
10.1021/acs.oprd.1c00203
```

---

## Reaction 31-614-CAS-31713170

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)C(Cl)=C(Cl)Cl.CCNC(=O)c1cnn(-c2ccc(N)cc2)c1C(F)(F)F`
  - Products: `CCNC(=O)c1cnn(-c2ccc(NC(=O)C(Cl)=C(Cl)Cl)cc2)c1C(F)(F)F`

**Reference:**
  - **Title:** Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity
  - **Authors:** Zhang, Sicheng; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2021), 12(4), 572-578.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.0c00571](https://doi.org/10.1021/acsmedchemlett.0c00571)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-31713170
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 4 h, rt → reflux
1.2|Solvents: Tetrahydrofuran; 12 h, rt
Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors
By: Kim, Namkyoung; et al
European Journal of Medicinal Chemistry (2023), 259, 115635.
10.1016/j.ejmech.2023.115635
```

---

## Reaction 31-614-CAS-31751498

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)c1n[nH]c2ccc(Br)cc12.CC(C)(C)OC(=O)N1CCC(CN)CC1`
  - Products: `CC(C)(C)OC(=O)N1CCC(CNC(=O)c2n[nH]c3ccc(Br)cc23)CC1`

**Reference:**
  - **Title:** Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine
  - **Authors:** Jiang, Xueyang; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 223, 113663.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113663](https://doi.org/10.1016/j.ejmech.2021.113663)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-31751498
1.1|Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole
Solvents: Dimethylformamide; 24 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown
A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors
By: Yang, Kai S.; et al
ChemMedChem (2021), 16(6), 942-948.
10.1002/cmdc.202000924
```

---

## Reaction 31-614-CAS-31751503

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCC(CC(=O)O)CC1.Nc1n[nH]c2cc(Br)ccc12`
  - Products: `CC(C)(C)OC(=O)N1CCC(CC(=O)Nc2n[nH]c3cc(Br)ccc23)CC1`

**Reference:**
  - **Title:** Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine
  - **Authors:** Jiang, Xueyang; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 223, 113663.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113663](https://doi.org/10.1016/j.ejmech.2021.113663)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-31751503
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP
Solvents: Dimethylformamide; 12 h, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
By: Breidenbach, Julian; et al
Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
10.1021/acs.jmedchem.4c00053
```

---

## Reaction 31-614-CAS-31769035

**Type:** Other

**Reagents:**
  - 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (CAS: 3945-69-5) - Role: UNK

**Solvents:**
  - MeOH (CAS: 67-56-1) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.083 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `N#Cc1ccc(C(=O)O)nc1.CC(C)(C)OC(=O)NC1=N[C@](C)(c2cc(N)ccc2F)Cn2c(C#N)cnc21`
  - Products: `CC(C)(C)OC(=O)NC1=N[C@](C)(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2c(C#N)cnc21`

**Reference:**
  - **Title:** A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo
  - **Authors:** Peschiulli, Aldo; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(1), 76-83.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00445](https://doi.org/10.1021/acsmedchemlett.1c00445)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-31769035
1.1|Reagents: 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
Solvents: Methanol; 5 min, rt; rt → 0 °C
1.2|Solvents: Methanol; 0 °C → rt; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Optimization of Drug-Linker to Enable Long-term Storage of Antibody-Drug Conjugate for Subcutaneous Dosing
By: Hobson, Adrian D.; et al
Journal of Medicinal Chemistry (2023), 66(13), 9161-9173.
10.1021/acs.jmedchem.3c00794
```

---

## Reaction 31-614-CAS-31806452

**Type:** Other

**Reagents:**
  - HOAt (CAS: 39968-33-7) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - HATU (CAS: 148893-10-1) - Role: NUC (Registry: ACTIVATOR)
  - N-Methylmorpholine (CAS: 109-02-4) - Role: UNK (Registry: AMIDE_BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 48.017 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `Cc1cc(CNC(=O)c2cc(C(=O)O)ncn2)ccc1F.Cl.[2H]C([2H])(N)c1ccc(C(=O)OC)cc1`
  - Products: `[2H]C([2H])(NC(=O)c1cc(C(=O)NCc2ccc(C(=O)OC)cc2)ncn1)c1ccc(F)c(C)c1`

**Reference:**
  - **Title:** Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of Osteoarthritis
  - **Authors:** Bendele, Alison M.; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 224, 113666.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113666](https://doi.org/10.1016/j.ejmech.2021.113666)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-31806452
1.1|Reagents: HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; > 1 min, rt
1.2|Reagents: 4-Methylmorpholine; 48 h, rt
Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis
By: Li, Na; et al
Journal of Medicinal Chemistry (2023), 66(19), 13428-13451.
10.1021/acs.jmedchem.3c00696
```

---

## Reaction 31-614-CAS-31808459

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `Cl.NC1CCCCc2cc(Br)ccc21.CC(C)(C)c1nnc(C(=O)O)o1.[K]`
  - Products: `CC(C)(C)c1nnc(C(=O)NC2CCCCc3cc(Br)ccc32)o1`

**Reference:**
  - **Title:** Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis
  - **Authors:** Hopkins, Brian T.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(2), 1206-1224.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00926](https://doi.org/10.1021/acs.jmedchem.1c00926)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31808459
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 4 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies
By: Barlaam, Bernard; et al
Journal of Medicinal Chemistry (2020), 63(24), 15564-15590.
10.1021/acs.jmedchem.0c01754
```

---

## Reaction 31-614-CAS-31809349

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `NC1CCC1.COc1cccc(OC)c1-c1cc(C(=O)N[C@@H](CCN2CCCCC2)CC(=O)O)nn1C1CCCC1.Cl`
  - Products: `COc1cccc(OC)c1-c1cc(C(=O)N[C@@H](CCN2CCCCC2)CC(=O)NC2CCC2)nn1C1CCCC1.Cl`

**Reference:**
  - **Title:** Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice
  - **Authors:** Narayanan, Sanju; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(6), 3006-3025.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01448](https://doi.org/10.1021/acs.jmedchem.0c01448)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-31809349
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Acetonitrile; 4 h, rt
1.2|Reagents: Sodium bicarbonate
Solvents: Water; rt
PROTACs Targeting MLKL Protect Cells from Necroptosis
By: Rathje, Oliver H.; et al
Journal of Medicinal Chemistry (2023), 66(16), 11216-11236.
10.1021/acs.jmedchem.3c00665
```

---

## Reaction 31-614-CAS-31814271

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - MeOH (CAS: 67-56-1) - Role: UNK (Registry: SOLVENT)
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK
  - 4-Methylmorpholine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 45.0°C
  - Time: 19.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `C=C[C@@H]1C[C@]1(N)C(=O)NS(=O)(=O)C1(C)CC1.Cl.CC(C)Oc1ccc(-c2nc(O[C@@H]3C[C@@H](C(=O)O)N(C(=O)OC(C)(C)C)C3)c3oc4ccccc4c3n2)cc1`
  - Products: `C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2nc(-c3ccc(OC(C)C)cc3)nc3c2oc2ccccc23)CN1)C(=O)NS(=O)(=O)C1(C)CC1.Cl`

**Reference:**
  - **Title:** Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor, Furaprevir
  - **Authors:** Zhang, Weihong; et al
  - **Citation:** Organic Process Research & Development (2022), 26(4), 1078-1093.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00315](https://doi.org/10.1021/acs.oprd.1c00315)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-31814271
1.1|Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; < 10 °C; 3 h, < 10 °C
1.2|Reagents: Methanol, Thionyl chloride
Solvents: Tetrahydrofuran; < 40 °C; 16 h, 45 °C
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores
By: Patel, Bhautikkumar; et al
ChemMedChem (2020), 15(15), 1429-1438.
10.1002/cmdc.202000033
```

---

## Reaction 31-614-CAS-31824047

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.25 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `COC(=O)[C@H](N)Cc1ccc(O)cc1.CC(C)(C)OC(=O)NCC(=O)O`
  - Products: `COC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
  - **Authors:** Falkenstein, Markus; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 50, 116462.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116462](https://doi.org/10.1016/j.bmc.2021.116462)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-31824047
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 min, rt
1.2|16 h, rt
Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors
By: Jia, Haiyong; et al
European Journal of Medicinal Chemistry (2020), 202, 112495.
10.1016/j.ejmech.2020.112495
```

---

## Reaction 31-614-CAS-31824053

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.25 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)Cc1ccc(O)cc1.CC(C)(C)OC(=O)NCC(=O)O`
  - Products: `COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
  - **Authors:** Falkenstein, Markus; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 50, 116462.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116462](https://doi.org/10.1016/j.bmc.2021.116462)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-31824053
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 min, rt
1.2|16 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
By: Falkenstein, Markus; et al
Bioorganic & Medicinal Chemistry (2021), 50, 116462.
10.1016/j.bmc.2021.116462
```

---

## Reaction 31-614-CAS-31824054

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.25 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)Cc1ccc(O)cc1.CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O`
  - Products: `COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C`

**Reference:**
  - **Title:** Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
  - **Authors:** Falkenstein, Markus; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 50, 116462.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116462](https://doi.org/10.1016/j.bmc.2021.116462)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-31824054
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 min, rt
1.2|16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease
By: Kilpelainen, Tommi P.; et al
Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.
10.1021/acs.jmedchem.3c00235
```

---

## Reaction 31-614-CAS-31824055

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.25 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)Cc1ccc(O)cc1.CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O`
  - Products: `COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
  - **Authors:** Falkenstein, Markus; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 50, 116462.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116462](https://doi.org/10.1016/j.bmc.2021.116462)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-31824055
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 min, rt
1.2|16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-31828433

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 5.0°C
  - Time: 16.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `NCCc1ccccc1.O=C(O)c1c[nH]nc1-c1ccc(Cl)c(Cl)c1`
  - Products: `O=C(NCCc1ccccc1)c1c[nH]nc1-c1ccc(Cl)c(Cl)c1`

**Reference:**
  - **Title:** Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors
  - **Authors:** Sturbaut, Manon; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 226, 113835.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113835](https://doi.org/10.1016/j.ejmech.2021.113835)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-31828433
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; rt → 5 °C; overnight, 5 °C
Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor
By: Liu, Haixia; et al
European Journal of Medicinal Chemistry (2022), 244, 114810.
10.1016/j.ejmech.2022.114810
```

---

## Reaction 31-614-CAS-31857598

**Type:** Other

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `Nc1ccccc1N.O=CC(=O)O`
  - Products: `O=c1cnc2ccccc2[nH]1`

**Reference:**
  - **Title:** A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo[1,2-a]quinoxaline Core
  - **Authors:** Garcia-Marin, Javier; et al
  - **Citation:** ChemMedChem (2021), 16(18), 2895-2906.
  - **DOI:** [https://doi.org/10.1002/cmdc.202100338](https://doi.org/10.1002/cmdc.202100338)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-31857598
1.1|Solvents: Water; 2 h, reflux
Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors
By: Huang, Daowei; et al
European Journal of Medicinal Chemistry (2021), 223, 113648.
10.1016/j.ejmech.2021.113648
```

---

## Reaction 31-614-CAS-31901528

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 7.417 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O.COC(=O)CCCCCCCCCCCN`
  - Products: `COC(=O)CCCCCCCCCCCNC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C`

**Reference:**
  - **Title:** Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis
  - **Authors:** Houstecka, Radka; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(4), 1576-1596.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b01351](https://doi.org/10.1021/acs.jmedchem.9b01351)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-31901528
1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dimethylformamide; 25 min, rt
1.2|Solvents: Dimethylformamide; 6 h, rt
Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors
By: Huang, Daowei; et al
European Journal of Medicinal Chemistry (2021), 223, 113648.
10.1016/j.ejmech.2021.113648
```

---

## Reaction 31-614-CAS-31901530

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 8.417 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](Cc1cccnc1)C(=O)O.COC(=O)CCCCCCCCCCCN`
  - Products: `COC(=O)CCCCCCCCCCCNC(=O)[C@H](Cc1cccnc1)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis
  - **Authors:** Houstecka, Radka; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(4), 1576-1596.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b01351](https://doi.org/10.1021/acs.jmedchem.9b01351)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-31901530
1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dimethylformamide; 25 min, rt
1.2|Solvents: Dimethylformamide; 6 h, rt
Synthesis and in vitro biological evaluation of 3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective inhibitors and PARP-1 DNA trappers
By: Ren, Junkang; et al
Bioorganic & Medicinal Chemistry Letters (2022), 78, 129046.
10.1016/j.bmcl.2022.129046
```

---

## Reaction 31-614-CAS-31909255

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 9.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CCCCCCCC/C=C\CCCCCCCC(=O)O.Nc1cc2cccnc2c2ncccc12`
  - Products: `CCCCCCCC/C=C\CCCCCCCC(=O)Nc1cc2cccnc2c2ncccc12`

**Reference:**
  - **Title:** Development of photoactivable phenanthroline-based manganese(I) CO-Releasing molecules (PhotoCORMs) active against ESKAPE bacteria and bacterial biofilms
  - **Authors:** Toscani, Anita; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 213, 113172.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113172](https://doi.org/10.1016/j.ejmech.2021.113172)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-31909255
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide; 3 h, reflux
1.2|Solvents: Dichloromethane; rt
1.3|Reagents: Triethylamine; 6 h, rt
Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells
By: Elsocht, Mathias; et al
Bioorganic & Medicinal Chemistry Letters (2023), 79, 129066.
10.1016/j.bmcl.2022.129066
```

---

## Reaction 31-614-CAS-31915608

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `COc1ccc2[nH]cc(CCN)c2c1.CC(C)(C)OC(=O)NCC(=O)O`
  - Products: `COc1ccc2[nH]cc(CCNC(=O)CNC(=O)OC(C)(C)C)c2c1`

**Reference:**
  - **Title:** Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model
  - **Authors:** He, Feng; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(7), 3794-3812.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01940](https://doi.org/10.1021/acs.jmedchem.0c01940)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-31915608
1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Tetrahydrofuran; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum
By: Kraft, Oliver; et al
European Journal of Medicinal Chemistry (2021), 209, 112920.
10.1016/j.ejmech.2020.112920
```

---

## Reaction 31-614-CAS-32019465

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 8.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `Nc1ccccc1N.COC(=O)COc1ccc(-c2nc3ccc(C(=O)O)cc3[nH]2)cc1`
  - Products: `COC(=O)COc1ccc(-c2nc3ccc(C(=O)Nc4ccccc4N)cc3[nH]2)cc1`

**Reference:**
  - **Title:** Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity
  - **Authors:** Chen, Chen; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 3667-3683.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c02225](https://doi.org/10.1021/acs.jmedchem.1c02225)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-32019465
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide; 6 - 8 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors
By: Meena, Chhuttan L.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.
10.1016/j.bmcl.2020.127039
```

---

## Reaction 31-614-CAS-32020154

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 6.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `CC(C)CN.Nc1cccc(F)c1C(=O)O`
  - Products: `CC(C)CNC(=O)c1c(N)cccc1F`

**Reference:**
  - **Title:** Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease
  - **Authors:** Li, Feng; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01544](https://doi.org/10.1021/acs.jmedchem.0c01544)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-32020154
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; 6 h, rt
HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells
By: Liang, Tao; et al
Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.
10.1021/acs.jmedchem.0c01454
```

---

## Reaction 31-614-CAS-32020159

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 6.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)N.Nc1cccc(F)c1C(=O)O`
  - Products: `CC(C)NC(=O)c1c(N)cccc1F`

**Reference:**
  - **Title:** Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease
  - **Authors:** Li, Feng; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01544](https://doi.org/10.1021/acs.jmedchem.0c01544)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-32020159
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; 6 h, rt
Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway
By: Rastelli, Ettore J.; et al
Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.
10.1016/j.bmcl.2021.128167
```

---

## Reaction 31-614-CAS-32020179

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)c1c(F)cccc1[N+](=O)[O-].NCc1ccccc1`
  - Products: `O=C(NCc1ccccc1)c1c(F)cccc1[N+](=O)[O-]`

**Reference:**
  - **Title:** Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease
  - **Authors:** Li, Feng; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01544](https://doi.org/10.1021/acs.jmedchem.0c01544)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-32020179
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Tetrahydrofuran; 0 °C; 1 h, 0 °C; 5 h, 0 °C → rt
1.2|Reagents: Diisopropylethylamine
Solvents: Tetrahydrofuran; 0 °C; 6 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide
By: Sampaio-Dias, Ivo E.; et al
Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.
10.1021/acs.jmedchem.1c00252
```

---

## Reaction 31-614-CAS-32038501

**Type:** Other

**Reaction Conditions:**
  - Temperature: 130.0°C
  - Time: 4.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `NC=O.Nc1ccc(Br)cc1C(=O)O`
  - Products: `O=c1nc[nH]c2ccc(Br)cc12`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of novel 6-(pyridin-3-yl) quinazolin-4(3H)-one derivatives as potential anticancer agents via PI3K inhibition
  - **Authors:** Yang, Huarong; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 46, 116346.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116346](https://doi.org/10.1016/j.bmc.2021.116346)

**Original Text:**
```
Steps: 1, Yield: 88-95%
CAS Reaction Number: 31-614-CAS-32038501
1.1|4 h, 130 °C
Discovery of novel quinazoline derivatives as potent PI3Kδ inhibitors with high selectivity
By: Teng, Yu; et al
European Journal of Medicinal Chemistry (2020), 208, 112865.
10.1016/j.ejmech.2020.112865
```

---

## Reaction 31-614-CAS-32085759

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `Nc1ccc(F)cc1.O=C(O)C1(c2ccc(Br)cc2)COC1`
  - Products: `O=C(Nc1ccc(F)cc1)C1(c2ccc(Br)cc2)COC1`

**Reference:**
  - **Title:** Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing
  - **Authors:** Li, Derun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(8), 6001-6016.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01670](https://doi.org/10.1021/acs.jmedchem.1c01670)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-32085759
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C → rt; 1 h, rt
1.2|Reagents: Water; rt
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor
By: Huestis, Malcolm P.; et al
ACS Medicinal Chemistry Letters (2021), 12(5), 791-797.
10.1021/acsmedchemlett.1c00063
```

---

## Reaction 31-614-CAS-32142486

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Nc1ccc(Cl)cc1Cl.O=C(O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1`
  - Products: `O=C(Nc1ccc(Cl)cc1Cl)c1ccc(S(=O)(=O)Nc2ccccc2)cc1`

**Reference:**
  - **Title:** Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27
  - **Authors:** Pillaiyar, Thanigaimalai; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 225, 113777.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113777](https://doi.org/10.1016/j.ejmech.2021.113777)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-32142486
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 12 h, rt
Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow
By: Alder, Catherine M.; et al
Organic Process Research & Development (2022), 26(2), 365-379.
10.1021/acs.oprd.1c00422
```

---

## Reaction 31-614-CAS-32142514

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Cl)cc1Cl.Nc1ccc(C(=O)Nc2ccccc2)cc1`
  - Products: `O=C(Nc1ccccc1)c1ccc(NC(=O)c2ccc(Cl)cc2Cl)cc1`

**Reference:**
  - **Title:** Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27
  - **Authors:** Pillaiyar, Thanigaimalai; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 225, 113777.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113777](https://doi.org/10.1016/j.ejmech.2021.113777)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-32142514
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 12 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release
By: Meiers, Joscha; et al
Journal of Medicinal Chemistry (2022), 65(20), 13988-14014.
10.1021/acs.jmedchem.2c01214
```

---

## Reaction 31-614-CAS-32260332

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - BOP (CAS: 56602-33-6) - Role: UNK (Registry: ACTIVATOR)
  - BOP reagent - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CN.Cc1nc2[nH]c3ccccc3c2cc1C(=O)O`
  - Products: `CNC(=O)c1cc2c(nc1C)[nH]c1ccccc12`

**Reference:**
  - **Title:** Design, synthesis, and in vitro protective effect evaluation of α-carboline derivatives against H2O2-induced cardiomyocyte injury
  - **Authors:** Zhang, Rong-Hong; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 238, 114469.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114469](https://doi.org/10.1016/j.ejmech.2022.114469)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-32260332
1.1|Reagents: Triethylamine, BOP reagent
Solvents: Tetrahydrofuran, Water; 24 h, rt
Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors
By: Zheng, Jia; et al
ACS Medicinal Chemistry Letters (2024), 15(11), 2019-2031.
10.1021/acsmedchemlett.4c00431
```

---

## Reaction 31-614-CAS-32437851

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Na2CO3 (CAS: 497-19-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - Sodium carbonate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.167 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.NCCC1CC1`
  - Products: `CC(C)(C)OC(=O)NCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)NCCC1CC1`

**Reference:**
  - **Title:** Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics
  - **Authors:** Garsi, Jean-Baptiste; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(6), 949-954.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00094](https://doi.org/10.1021/acsmedchemlett.2c00094)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-32437851
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide; 10 min, rt
1.2|1 h, rt
1.3|Reagents: Sodium carbonate
Solvents: Water; rt
Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety
By: Pandrala, Mallesh; et al
Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.
10.1021/acs.jmedchem.1c01853
```

---

## Reaction 31-614-CAS-32438839

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1cc2cccnc2n(Cc2ccc(F)c(F)c2)c1=O.NCC(=O)Nc1ccc2c(c1)CC(=O)N2`
  - Products: `O=C(CNC(=O)c1cc2cccnc2n(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)CC(=O)N2`

**Reference:**
  - **Title:** Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile
  - **Authors:** Sestito, Simona; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 226, 113895.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113895](https://doi.org/10.1016/j.ejmech.2021.113895)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-32438839
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide; 30 min, 0 °C
1.2|30 min, 0 °C; 0 °C → rt; overnight, rt
First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo
By: Sharma, Sachin; et al
Journal of Medicinal Chemistry (2024), 67(4), 2963-2985.
10.1021/acs.jmedchem.3c02053
```

---

## Reaction 31-614-CAS-32519335

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 100.0°C
  - Time: 0.2 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)C(=O)O.Nc1ccc(F)cc1N`
  - Products: `O=c1[nH]c2ccc(F)cc2[nH]c1=O`

**Reference:**
  - **Title:** Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale
  - **Authors:** McCoy, Michael A.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(10), 7246-7261.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00228](https://doi.org/10.1021/acs.jmedchem.2c00228)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-32519335
1.1|Reagents: Hydrochloric acid
Solvents: Water; 80 °C → 100 °C; 0.2 h, 100 °C
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease
By: Amblard, Franck; et al
European Journal of Medicinal Chemistry (2024), 268, 116263.
10.1016/j.ejmech.2024.116263
```

---

## Reaction 31-614-CAS-32532467

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `COc1ccc(CC(=O)O)cc1OC.COC(=O)[C@@H](N)Cc1ccc(OC)c(OC)c1`
  - Products: `COC(=O)[C@H](Cc1ccc(OC)c(OC)c1)NC(=O)Cc1ccc(OC)c(OC)c1`

**Reference:**
  - **Title:** Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors
  - **Authors:** Liu, Zhihao; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 227, 113929.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113929](https://doi.org/10.1016/j.ejmech.2021.113929)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-32532467
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 0 °C; 12 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome
By: Gotz, Marion G.; et al
ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.
10.1021/acsmedchemlett.4c00017
```

---

## Reaction 31-614-CAS-32657022

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CC(C)[C@@H](Oc1ccccc1)[C@H](C)OC(=O)[C@H](C)NC(=O)OC(C)(C)C.COc1ccnc(C(=O)O)c1O`
  - Products: `COc1ccnc(C(=O)N[C@@H](C)C(=O)O[C@@H](C)[C@H](Oc2ccccc2)C(C)C)c1O`

**Reference:**
  - **Title:** Discovery of florylpicoxamid, a mimic of a macrocyclic natural product
  - **Authors:** Meyer, Kevin G.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 50, 116455.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116455](https://doi.org/10.1016/j.bmc.2021.116455)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-32657022
1.1|Reagents: Hydrochloric acid
Solvents: 1,4-Dioxane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, PyBOP
Solvents: Dichloromethane; overnight, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo
By: Zhang, Songxuan; et al
European Journal of Medicinal Chemistry (2021), 213, 113185.
10.1016/j.ejmech.2021.113185
```

---

## Reaction 31-614-CAS-32762773

**Type:** Other

**Reagents:**
  - NaOH (CAS: 1310-73-2) - Role: BASE
  - AcOH (CAS: 64-19-7) - Role: UNK (Registry: SOLVENT)
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 150.0°C
  - Time: 13.25 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `NC(N)=O.Nc1ccccc1C(=O)O`
  - Products: `O=c1[nH]c(=O)c2ccccc2[nH]1`

**Reference:**
  - **Title:** Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis
  - **Authors:** Biteau, Nicolas G.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 46, 116351.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116351](https://doi.org/10.1016/j.bmc.2021.116351)

**Original Text:**
```
Steps: 1, Yield: 89-92%
CAS Reaction Number: 31-614-CAS-32762773
1.1|12 h, 150 °C; 150 °C → 100 °C
1.2|Solvents: Water; 15 min, 100 °C; 100 °C → rt
1.3|Reagents: Sodium hydroxide
Solvents: Water; 1 h, rt
1.4|Reagents: Acetic acid; pH 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Identification of highly potent and selective HTRA1 inhibitors
By: Dennis, David G.; et al
Bioorganic & Medicinal Chemistry Letters (2024), 109, 129814.
10.1016/j.bmcl.2024.129814
```

---

## Reaction 31-614-CAS-32762777

**Type:** Other

**Reagents:**
  - NaOH (CAS: 1310-73-2) - Role: BASE
  - AcOH (CAS: 64-19-7) - Role: UNK (Registry: SOLVENT)
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 150.0°C
  - Time: 13.25 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `NC(N)=O.Cc1ccc(N)c(C(=O)O)c1`
  - Products: `Cc1ccc2[nH]c(=O)[nH]c(=O)c2c1`

**Reference:**
  - **Title:** Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis
  - **Authors:** Biteau, Nicolas G.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 46, 116351.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116351](https://doi.org/10.1016/j.bmc.2021.116351)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-32762777
1.1|12 h, 150 °C; 150 °C → 100 °C
1.2|Solvents: Water; 15 min, 100 °C; 100 °C → rt
1.3|Reagents: Sodium hydroxide
Solvents: Water; 1 h, rt
1.4|Reagents: Acetic acid; pH 5, rt
Development of a Robust and Scalable Process for the Large-Scale Preparation of Vadadustat
By: Lin, Biyue; et al
Organic Process Research & Development (2021), 25(4), 960-968.
10.1021/acs.oprd.1c00004
```

---

## Reaction 31-614-CAS-33066357

**Type:** Other

**Reagents:**
  - Lithium hydroxide (CAS: 1310-65-2) - Role: BASE

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCCN.Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)O)[nH]c3ccc(Cl)cc23)c1`
  - Products: `Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCNC(=O)OC(C)(C)C)[nH]c3ccc(Cl)cc23)c1`

**Reference:**
  - **Title:** Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
  - **Authors:** Xu, Shujing; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 53, 116531.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116531](https://doi.org/10.1016/j.bmc.2021.116531)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-33066357
1.1|Reagents: Lithium hydroxide
Solvents: Tetrahydrofuran; 24 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
By: Wang, Xu; et al
Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.
10.1021/acs.jmedchem.4c02009
```

---

## Reaction 31-614-CAS-33066360

**Type:** Other

**Reagents:**
  - Lithium hydroxide (CAS: 1310-65-2) - Role: BASE

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCCCN.Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)O)[nH]c3ccc(Cl)cc23)c1`
  - Products: `Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCCNC(=O)OC(C)(C)C)[nH]c3ccc(Cl)cc23)c1`

**Reference:**
  - **Title:** Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
  - **Authors:** Xu, Shujing; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 53, 116531.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116531](https://doi.org/10.1016/j.bmc.2021.116531)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-33066360
1.1|Reagents: Lithium hydroxide
Solvents: Tetrahydrofuran; 24 h, rt
Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction
By: Hec-Galazka, Aleksandra; et al
ACS Medicinal Chemistry Letters (2024), 15(6), 828-836.
10.1021/acsmedchemlett.4c00042
```

---

## Reaction 31-614-CAS-33066374

**Type:** Other

**Full Catalytic System:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE

**Catalyst Core:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE

**Generic Catalyst:** N-Diisopropylethylamine

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Yield: 84%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCC(N)CC1.Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)O)[nH]c3ccc(Cl)cc23)c1`
  - Products: `Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC3CCN(C(=O)OC(C)(C)C)CC3)[nH]c3ccc(Cl)cc23)c1`

**Reference:**
  - **Title:** Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
  - **Authors:** Xu, Shujing; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 53, 116531.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116531](https://doi.org/10.1016/j.bmc.2021.116531)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-33066374
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Catalysts: Diisopropylethylamine
Solvents: Dimethylformamide; rt
Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors
By: Xin, Zhili; et al
ACS Medicinal Chemistry Letters (2020), 11(4), 485-490.
10.1021/acsmedchemlett.9b00611
```

---

## Reaction 31-614-CAS-33309068

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `O=C(O)c1cncc(Br)c1.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N`
  - Products: `Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cncc(Br)c1`

**Reference:**
  - **Title:** Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain
  - **Authors:** van der Wildt, Berend; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2021), 42, 116245.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2021.116245](https://doi.org/10.1016/j.bmc.2021.116245)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-33309068
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane, Tetrahydrofuran; 2 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; overnight, rt
1.3|Reagents: Hydrochloric acid
Solvents: Dichloromethane, Water; rt
Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
By: Fang, Wei; et al
Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
10.1021/acs.jmedchem.3c02063
```

---

## Reaction 31-614-CAS-33408939

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `Cc1nn(COCC[Si](C)(C)C)c(C)c1-c1ccc(N)cc1.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C1CC1)C1CC1`
  - Products: `Cc1nn(COCC[Si](C)(C)C)c(C)c1-c1ccc(NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C2CC2)C2CC2)cc1`

**Reference:**
  - **Title:** Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases
  - **Authors:** Andrews, Mark D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(13), 8828-8842.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00422](https://doi.org/10.1021/acs.jmedchem.2c00422)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-33408939
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 18 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology
By: Lu, Min; et al
ACS Medicinal Chemistry Letters (2021), 12(9), 1380-1388.
10.1021/acsmedchemlett.1c00195
```

---

## Reaction 31-614-CAS-33408941

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CC(C)n1nccc1C(=O)O.Cc1nn(COCC[Si](C)(C)C)c(C)c1-c1ccc(NC(=O)[C@@H](N)C(C2CC2)C2CC2)cc1`
  - Products: `Cc1nn(COCC[Si](C)(C)C)c(C)c1-c1ccc(NC(=O)[C@@H](NC(=O)c2ccnn2C(C)C)C(C2CC2)C2CC2)cc1`

**Reference:**
  - **Title:** Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases
  - **Authors:** Andrews, Mark D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(13), 8828-8842.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00422](https://doi.org/10.1021/acs.jmedchem.2c00422)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-33408941
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 18 h, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-33447248

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CN.CC(C)Nc1cc(Cl)ncc1C(=O)O`
  - Products: `CNC(=O)c1cnc(Cl)cc1NC(C)C`

**Reference:**
  - **Title:** Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer
  - **Authors:** Eno, Meredith S.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(14), 9662-9677.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00704](https://doi.org/10.1021/acs.jmedchem.2c00704)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-33447248
1.1|Reagents: Triethylamine, Hydrochloric acid, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 3 h, 25 °C
Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties
By: Morozova, Alisa; et al
European Journal of Medicinal Chemistry (2024), 266, 116101.
10.1016/j.ejmech.2023.116101
```

---

## Reaction 31-614-CAS-33504028

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 1.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `NCCCO.CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O`
  - Products: `CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCO`

**Reference:**
  - **Title:** Process Development and GMP Production of a Conjugate Warhead: Auristatin F-HPA-Ala/TFA (XMT-1864/TFA)
  - **Authors:** Conlon, Patrick R.; et al
  - **Citation:** Organic Process Research & Development (2022), 26(8), 2124-2137.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00449](https://doi.org/10.1021/acs.oprd.1c00449)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-33504028
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 - 30 °C; 30 °C → 5 °C; 1 h, 0 - 5 °C
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
By: Hiesinger, Kerstin; et al
Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.
10.1021/acs.jmedchem.0c00561
```

---

## Reaction 31-614-CAS-33604392

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - PhMe (CAS: 108-88-3) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 10.0°C
  - Time: 2.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `O=C(O)c1cncc(Br)c1.Nc1ccc(OC(F)(F)F)cc1`
  - Products: `O=C(Nc1ccc(OC(F)(F)F)cc1)c1cncc(Br)c1`

**Reference:**
  - **Title:** A kinase inhibitor which specifically targets the ABL myristate pocket (STAMP), but unlike asciminib crosses the blood-brain barrier
  - **Authors:** Manley, Paul W.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2022), 59, 128577.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.128577](https://doi.org/10.1016/j.bmcl.2022.128577)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-33604392
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide
Solvents: Toluene; 8 °C; 1.5 h, 8 °C
1.2|Reagents: Diisopropylethylamine
Solvents: Tetrahydrofuran; -15 °C; 0.5 h, 10 °C
Structural and Functional Study of the Klebsiella pneumoniae VapBC Toxin-Antitoxin System, Including the Development of an Inhibitor That Activates VapC
By: Kang, Sung-Min; et al
Journal of Medicinal Chemistry (2020), 63(22), 13669-13679.
10.1021/acs.jmedchem.0c01118
```

---

## Reaction 31-614-CAS-33804705

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.25 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `C[C@@H](NC(=O)OC(C)(C)C)C(=O)O.NCc1ccccc1`
  - Products: `C[C@@H](NC(=O)OC(C)(C)C)C(=O)NCc1ccccc1`

**Reference:**
  - **Title:** Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo
  - **Authors:** Abram, Michal; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00534](https://doi.org/10.1021/acs.jmedchem.2c00534)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-33804705
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 15 min, rt
1.2|Solvents: Dichloromethane; rt; 1 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo
By: Abram, Michal; et al
Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.
10.1021/acs.jmedchem.2c00534
```

---

## Reaction 31-614-CAS-33822229

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `O=C(O)c1cccc([N+](=O)[O-])c1.COc1ccc(N)cn1`
  - Products: `COc1ccc(NC(=O)c2cccc([N+](=O)[O-])c2)cn1`

**Reference:**
  - **Title:** [11C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins
  - **Authors:** Liu, Longbin; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12003-12021.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00667](https://doi.org/10.1021/acs.jmedchem.1c00667)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-33822229
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 24 h, rt
A kinase inhibitor which specifically targets the ABL myristate pocket (STAMP), but unlike asciminib crosses the blood-brain barrier
By: Manley, Paul W.; et al
Bioorganic & Medicinal Chemistry Letters (2022), 59, 128577.
10.1016/j.bmcl.2022.128577
```

---

## Reaction 31-614-CAS-33920075

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 48.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `COc1ccc(C(=O)O)cc1I.CN1CCN(Cc2ccc(N)cc2C(F)(F)F)CC1`
  - Products: `COc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1I`

**Reference:**
  - **Title:** Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety
  - **Authors:** Pandrala, Mallesh; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01853](https://doi.org/10.1021/acs.jmedchem.1c01853)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-33920075
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; rt; 48 h, 40 °C
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-33920089

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DMAP (CAS: 1122-58-3) - Role: LIGAND
  - 4-(Dimethylamino)pyridine

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DMAP (CAS: 1122-58-3) - Role: LIGAND
  - 4-(Dimethylamino)pyridine

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 21.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(I)c1.Cc1cn(-c2cc(N)cc(C(F)(F)F)c2)cn1`
  - Products: `Cc1cn(-c2cc(NC(=O)c3cccc(I)c3)cc(C(F)(F)F)c2)cn1`

**Reference:**
  - **Title:** Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety
  - **Authors:** Pandrala, Mallesh; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01853](https://doi.org/10.1021/acs.jmedchem.1c01853)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-33920089
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide; rt; 5 h, reflux; reflux → rt
1.2|Reagents: Diisopropylethylamine
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; overnight, rt
1.3|Reagents: Water; rt
Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
By: Tormaehlen, Niklas M.; et al
Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
10.1021/acs.jmedchem.0c01773
```

---

## Reaction 31-614-CAS-33920091

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DMAP (CAS: 1122-58-3) - Role: LIGAND
  - 4-(Dimethylamino)pyridine

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DMAP (CAS: 1122-58-3) - Role: LIGAND
  - 4-(Dimethylamino)pyridine

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 21.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `Cc1ccc(C(=O)O)cc1I.Cc1cn(-c2cc(N)cc(C(F)(F)F)c2)cn1`
  - Products: `Cc1cn(-c2cc(NC(=O)c3ccc(C)c(I)c3)cc(C(F)(F)F)c2)cn1`

**Reference:**
  - **Title:** Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety
  - **Authors:** Pandrala, Mallesh; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01853](https://doi.org/10.1021/acs.jmedchem.1c01853)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-33920091
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide; rt; 5 h, reflux; reflux → rt
1.2|Reagents: Diisopropylethylamine
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; overnight, rt
1.3|Reagents: Water; rt
Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis
By: Zhao, Hongyi; et al
Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.
10.1021/acs.jmedchem.2c00718
```

---

## Reaction 31-614-CAS-33986158

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 12.667 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `O=C(O)C(F)(F)c1ccc(Cl)cc1.CS(=O)(=O)O.NCc1ccc2c(c1)CN(C1CCC(=O)NC1=O)C2=O`
  - Products: `O=C1CCC(N2Cc3cc(CNC(=O)C(F)(F)c4ccc(Cl)cc4)ccc3C2=O)C(=O)N1`

**Reference:**
  - **Title:** Advancing Scalable Chemistry toward Novel CELMoDs: Process Development for the Synthesis of CC-90009
  - **Authors:** Zacuto, Michael J.; et al
  - **Citation:** Organic Process Research & Development (2022), 26(9), 2739-2748.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.2c00199](https://doi.org/10.1021/acs.oprd.2c00199)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-33986158
1.1|Reagents: 4-Methylmorpholine
Solvents: Dimethylformamide; 10 min, 20 °C
1.2|Reagents: Propylphosphonic anhydride
Solvents: Dimethylformamide; 12 h, 20 °C → 40 °C; 30 min, 40 °C → 20 °C
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-33998211

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `O=C(O)c1cc2c(Cl)cccc2s1.CN1CCC[C@@H](N)C1.Cl`
  - Products: `CN1CCC[C@@H](NC(=O)c2cc3c(Cl)cccc3s2)C1`

**Reference:**
  - **Title:** Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin
  - **Authors:** Schiffers, Ingo; et al
  - **Citation:** Organic Process Research & Development (2022), 26(10), 2811-2822.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.2c00152](https://doi.org/10.1021/acs.oprd.2c00152)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-33998211
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; overnight, rt
Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells
By: Takashima, Katsuki; et al
Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034.
10.1016/j.bmcl.2022.129034
```

---

## Reaction 31-614-CAS-33998214

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)c1cc2cccc(Br)c2s1.Cl.N[C@@H]1CCCN(Cc2ccccc2)C1`
  - Products: `O=C(N[C@@H]1CCCN(Cc2ccccc2)C1)c1cc2cccc(Br)c2s1`

**Reference:**
  - **Title:** Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin
  - **Authors:** Schiffers, Ingo; et al
  - **Citation:** Organic Process Research & Development (2022), 26(10), 2811-2822.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.2c00152](https://doi.org/10.1021/acs.oprd.2c00152)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-33998214
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; overnight, rt
Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
By: Fang, Wei; et al
Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
10.1021/acs.jmedchem.3c02063
```

---

## Reaction 31-614-CAS-34006665

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)O.COc1cc(N)ccc1Br`
  - Products: `COc1cc(NC(=O)[C@@H](CC(C)C)NC(=O)OC(C)(C)C)ccc1Br`

**Reference:**
  - **Title:** Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain
  - **Authors:** Hartz, Richard A.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(15), 11090-11128.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00472](https://doi.org/10.1021/acs.jmedchem.1c00472)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-34006665
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 12 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (-)
Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
By: Falkenstein, Markus; et al
Bioorganic & Medicinal Chemistry (2021), 50, 116462.
10.1016/j.bmc.2021.116462
```

---

## Reaction 31-614-CAS-34006692

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - 1,2-Dichloroethane (CAS: 107-06-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 18.167 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)O.Nc1ccc(-c2cnco2)c(Br)c1`
  - Products: `CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc(-c2cnco2)c(Br)c1`

**Reference:**
  - **Title:** Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain
  - **Authors:** Hartz, Richard A.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(15), 11090-11128.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00472](https://doi.org/10.1021/acs.jmedchem.1c00472)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-34006692
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: 1,2-Dichloroethane; 10 min, rt; 18 h, 40 °C
Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus
By: Liu, Yonghua; et al
European Journal of Medicinal Chemistry (2022), 228, 114033.
10.1016/j.ejmech.2021.114033
```

---

## Reaction 31-614-CAS-34105356

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.25 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `C[C@H](NC(=O)OC(C)(C)C)C(=O)O.NCc1ccccc1`
  - Products: `C[C@H](NC(=O)OC(C)(C)C)C(=O)NCc1ccccc1`

**Reference:**
  - **Title:** Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo
  - **Authors:** Abram, Michal; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00534](https://doi.org/10.1021/acs.jmedchem.2c00534)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-34105356
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 15 min, rt
1.2|Solvents: Dichloromethane; rt; 1 h, rt
Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6
By: Osko, Jeremy D.; et al
Journal of Medicinal Chemistry (2020), 63(1), 295-308.
10.1021/acs.jmedchem.9b01540
```

---

## Reaction 31-614-CAS-34105360

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.25 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `C[C@@H](NC(=O)OC(C)(C)C)C(=O)O.NCc1ccccc1F`
  - Products: `C[C@@H](NC(=O)OC(C)(C)C)C(=O)NCc1ccccc1F`

**Reference:**
  - **Title:** Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo
  - **Authors:** Abram, Michal; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00534](https://doi.org/10.1021/acs.jmedchem.2c00534)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-34105360
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 15 min, rt
1.2|Solvents: Dichloromethane; rt; 1 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo
By: Abram, Michal; et al
Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.
10.1021/acs.jmedchem.2c00534
```

---

## Reaction 31-614-CAS-34105361

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.25 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `C[C@H](NC(=O)OC(C)(C)C)C(=O)O.NCc1ccccc1F`
  - Products: `C[C@H](NC(=O)OC(C)(C)C)C(=O)NCc1ccccc1F`

**Reference:**
  - **Title:** Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo
  - **Authors:** Abram, Michal; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00534](https://doi.org/10.1021/acs.jmedchem.2c00534)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-34105361
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 15 min, rt
1.2|Solvents: Dichloromethane; rt; 1 h, rt
Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway
By: Rastelli, Ettore J.; et al
Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.
10.1016/j.bmcl.2021.128167
```

---

## Reaction 31-614-CAS-34105538

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `Nc1ccccc1N.C[C@@H]1CN(c2sc(C(F)(F)F)nc2C(=O)O)CCN1C(=O)OC(C)(C)C`
  - Products: `C[C@@H]1CN(c2sc(C(F)(F)F)nc2C(=O)Nc2ccccc2N)CCN1C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125
  - **Authors:** Caroff, Eva; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(16), 10918-10933.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00676](https://doi.org/10.1021/acs.jmedchem.2c00676)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-34105538
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 24 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist
By: Glen, Angela; et al
Bioorganic & Medicinal Chemistry Letters (2024), 100, 129629.
10.1016/j.bmcl.2024.129629
```

---

## Reaction 31-614-CAS-34105610

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.5 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `Nc1ccccc1O.C[C@@H]1CN(c2sc(C(F)(F)F)nc2C(=O)O)CCN1C(=O)OC(C)(C)C`
  - Products: `C[C@@H]1CN(c2sc(C(F)(F)F)nc2C(=O)Nc2ccccc2O)CCN1C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125
  - **Authors:** Caroff, Eva; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(16), 10918-10933.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00676](https://doi.org/10.1021/acs.jmedchem.2c00676)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-34105610
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 1.5 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
By: Wang, Xu; et al
Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.
10.1021/acs.jmedchem.4c02009
```

---

## Reaction 31-614-CAS-34105800

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(F)nc1F.CC(C)(C)NS(=O)(=O)c1cccc(N)c1`
  - Products: `CC(C)(C)NS(=O)(=O)c1cccc(NC(=O)c2ccc(F)nc2F)c1`

**Reference:**
  - **Title:** Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe
  - **Authors:** Tamayo, Nuria A.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(6), 4972-4990.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c02030](https://doi.org/10.1021/acs.jmedchem.1c02030)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-34105800
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors
By: Liu, Zhihao; et al
European Journal of Medicinal Chemistry (2022), 227, 113929.
10.1016/j.ejmech.2021.113929
```

---

## Reaction 31-614-CAS-34105912

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - PyBOP (CAS: 132705-51-2) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - Phosphorus(1+) - Role: UNK
  - bromotri-1-pyrrolidinyl- - Role: UNK
  - (T-4)- - Role: UNK
  - hexafluorophosphate(1-) (1:1) - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `N#Cc1cccc(-n2nc(C(F)(F)F)cc2C(=O)O)c1.Nc1cc(F)cc(CO)c1`
  - Products: `N#Cc1cccc(-n2nc(C(F)(F)F)cc2C(=O)Nc2cc(F)cc(CO)c2)c1`

**Reference:**
  - **Title:** Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)
  - **Authors:** Kotian, Pravin L.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(17), 12453-12468.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00511](https://doi.org/10.1021/acs.jmedchem.1c00511)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-34105912
1.1|Reagents: Diisopropylethylamine, Phosphorus(1+), bromotri-1-pyrrolidinyl-, (T-4)-, hexafluorophosphate(1-) (1:1)
Solvents: Dimethylformamide; 16 h, rt
Absolute stereochemistry shown
Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
By: Tormaehlen, Niklas M.; et al
Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
10.1021/acs.jmedchem.0c01773
```

---

## Reaction 31-614-CAS-34105968

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `O=C(O)CCCc1ccccc1.CC(C)(C)OC(=O)NC(CN)(CN)CN`
  - Products: `CC(C)(C)OC(=O)NC(CNC(=O)CCCc1ccccc1)(CNC(=O)CCCc1ccccc1)CNC(=O)CCCc1ccccc1`

**Reference:**
  - **Title:** A Mitochondria-Targeted Phenylbutyric Acid Prodrug Confers Drastically Improved Anticancer Activities
  - **Authors:** Huang, Ding; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(14), 9955-9973.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00640](https://doi.org/10.1021/acs.jmedchem.2c00640)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-34105968
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 5 h, rt
Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers
By: Braconi, Laura; et al
European Journal of Medicinal Chemistry (2023), 259, 115716.
10.1016/j.ejmech.2023.115716
```

---

## Reaction 31-614-CAS-34106977

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `CCc1cccc(CC)c1N.Cn1nc(C(=O)O)cc1-c1nc(Cl)nc2c1ccn2COCC[Si](C)(C)C`
  - Products: `CCc1cccc(CC)c1NC(=O)c1cc(-c2nc(Cl)nc3c2ccn3COCC[Si](C)(C)C)n(C)n1`

**Reference:**
  - **Title:** Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity
  - **Authors:** Elsner, Jan; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(17), 12670-12679.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00635](https://doi.org/10.1021/acs.jmedchem.1c00635)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-34106977
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; overnight, rt
1.2|Reagents: Water; rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-34107357

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.5 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `C=C[C@@H]1C[C@]1(N)C(=O)NS(=O)(=O)C1(C)CC1.Cl.C=CCCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)N1C[C@H](Oc2nc3cc(OC)ccc3nc2C)C[C@H]1C(=O)O`
  - Products: `C=CCCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)N1C[C@H](Oc2nc3cc(OC)ccc3nc2C)C[C@H]1C(=O)N[C@]1(C(=O)NS(=O)(=O)C2(C)CC2)C[C@H]1C=C`

**Reference:**
  - **Title:** Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants
  - **Authors:** Nageswara Rao, Desaboini; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 11972-11989.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00554](https://doi.org/10.1021/acs.jmedchem.1c00554)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-34107357
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2.5 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs
By: Anderson, Niall A.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127106.
10.1016/j.bmcl.2020.127106
```

---

## Reaction 31-614-CAS-34283447

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.25 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](COCc1ccccc1)C(=O)O.CCOC(=O)CC[C@@H](N)C(=O)OCC.Cl`
  - Products: `CCOC(=O)CC[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)OC(C)(C)C)C(=O)OCC`

**Reference:**
  - **Title:** Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity
  - **Authors:** Guzelj, Samo; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(11), 7809-7838.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00644](https://doi.org/10.1021/acs.jmedchem.1c00644)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-34283447
1.1|Reagents: Triethylamine, Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole
Solvents: Ethyl acetate; 15 min, cooled
1.2|Catalysts: 4-(Dimethylamino)pyridine; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
By: Fuchs, Natalie; et al
ChemMedChem (2023), 18(15), e202300160.
10.1002/cmdc.202300160
```

---

## Reaction 31-614-CAS-34283448

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.25 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(=O)O.CCOC(=O)CC[C@@H](NC(=O)[C@@H](N)COCc1ccccc1)C(=O)OCC.O=C(O)C(F)(F)F`
  - Products: `CCOC(=O)CC[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)CNC(=O)OC(C)(C)C)C(=O)OCC`

**Reference:**
  - **Title:** Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity
  - **Authors:** Guzelj, Samo; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(11), 7809-7838.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00644](https://doi.org/10.1021/acs.jmedchem.1c00644)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-34283448
1.1|Reagents: Triethylamine, Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole
Solvents: Ethyl acetate; 15 min, cooled
1.2|Catalysts: 4-(Dimethylamino)pyridine; overnight, rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-34334401

**Type:** Other

**Reagents:**
  - Py (CAS: 110-86-1) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -10.0°C
  - Time: 20.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `C=C[C@@H](C)C(=O)O.C=CC[C@H](NC(=O)OC(C)(C)C)c1cc(-c2c(N)cnn2C(F)F)ccn1`
  - Products: `C=CC[C@H](NC(=O)OC(C)(C)C)c1cc(-c2c(NC(=O)[C@H](C)C=C)cnn2C(F)F)ccn1`

**Reference:**
  - **Title:** Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy
  - **Authors:** Dilger, Andrew K.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(3), 1770-1785.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00613](https://doi.org/10.1021/acs.jmedchem.1c00613)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-34334401
1.1|Reagents: Pyridine, Propylphosphonic anhydride
Solvents: Ethyl acetate; -10 °C → rt; 20 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S
By: Rathman, Benjamin M.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283.
10.1016/j.bmcl.2020.127283
```

---

## Reaction 31-614-CAS-34382490

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(O)c(O)c1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccc(O)c(O)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-34382490
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-34382491

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(O)cc1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccc(O)cc1O)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-34382491
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis
By: Yang, Liu; et al
Journal of Medicinal Chemistry (2024), 67(3), 1914-1931.
10.1021/acs.jmedchem.3c01703
```

---

## Reaction 31-614-CAS-34382493

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1O)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-34382493
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
By: Jung, Sascha; et al
Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
10.1021/acs.jmedchem.1c01002
```

---

## Reaction 31-614-CAS-34382498

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(C(=O)O)c(O)c1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`
  - Products: `COc1ccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc([N+](=O)[O-])cc2)c(O)c1`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-34382498
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)
By: Chen, Young; et al
Journal of Medicinal Chemistry (2023), 66(23), 15750-15760.
10.1021/acs.jmedchem.3c01137
```

---

## Reaction 31-614-CAS-34382499

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(O)cc1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(C(F)(F)F)cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccc(O)cc1O)S(=O)(=O)c1ccc(C(F)(F)F)cc1`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-34382499
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Serine-/Cysteine-Based sp2-Iminoglycolipids as Novel TLR4 Agonists: Evaluation of Their Adjuvancy and Immunotherapeutic Properties in a Murine Model of Asthma
By: Gonzalez-Cuesta, Manuel; et al
Journal of Medicinal Chemistry (2023), 66(7), 4768-4783.
10.1021/acs.jmedchem.2c01948
```

---

## Reaction 31-614-CAS-34382505

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `COc1ccc(C(=O)O)c(O)c1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(C(F)(F)F)cc1`
  - Products: `COc1ccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(C(F)(F)F)cc2)c(O)c1`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-34382505
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2
By: Zhang, Yi; et al
Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.
10.1021/acs.jmedchem.3c00504
```

---

## Reaction 31-614-CAS-34382506

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `COc1cc(C(=O)O)cc(OC)c1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(C(F)(F)F)cc1`
  - Products: `COc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(C(F)(F)F)cc2)cc(OC)c1O`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-34382506
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-614-CAS-34382507

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1cc(O)cc(O)c1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(C(F)(F)F)cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc(O)cc(O)c1)S(=O)(=O)c1ccc(C(F)(F)F)cc1`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-34382507
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-614-CAS-34382509

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(F)cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1O)S(=O)(=O)c1ccc(F)cc1`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-34382509
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity
By: Guzelj, Samo; et al
Journal of Medicinal Chemistry (2021), 64(11), 7809-7838.
10.1021/acs.jmedchem.1c00644
```

---

## Reaction 31-614-CAS-34382510

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(O)cc1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(F)cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccc(O)cc1O)S(=O)(=O)c1ccc(F)cc1`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-34382510
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands
By: Shaik, Anver Basha; et al
Journal of Medicinal Chemistry (2021), 64(20), 15313-15333.
10.1021/acs.jmedchem.1c01353
```

---

## Reaction 31-614-CAS-34382512

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1cc(O)cc(O)c1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(F)cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc(O)cc(O)c1)S(=O)(=O)c1ccc(F)cc1`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-34382512
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Discovery of a potent and subtype-selective TYK2 degrader based on an allosteric TYK2 inhibitor
By: Kato, Jun-ya; et al
Bioorganic & Medicinal Chemistry Letters (2023), 79, 129083.
10.1016/j.bmcl.2022.129083
```

---

## Reaction 31-614-CAS-34382514

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `COc1cc(C(=O)O)cc(OC)c1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(F)cc1`
  - Products: `COc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(F)cc2)cc(OC)c1O`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-34382514
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Relative stereochemistry shown
Relative stereochemistry shown
Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer
By: Xiang, Weiguo; et al
Journal of Medicinal Chemistry (2021), 64(18), 13487-13509.
10.1021/acs.jmedchem.1c00900
```

---

## Reaction 31-614-CAS-34382516

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `COc1ccc(C(=O)O)c(O)c1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(F)cc1`
  - Products: `COc1ccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(F)cc2)c(O)c1`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-34382516
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Relative stereochemistry shown
Relative stereochemistry shown
The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure
By: Cadilla, Rodolfo; et al
Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.
10.1016/j.bmc.2020.115791
```

---

## Reaction 31-614-CAS-34382517

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.167 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Cl)cc1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(F)cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Cl)cc1O)S(=O)(=O)c1ccc(F)cc1`

**Reference:**
  - **Title:** A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
  - **Authors:** Hu, Shangjiu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 64, 116760.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116760](https://doi.org/10.1016/j.bmc.2022.116760)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-34382517
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C
Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety
By: Pandrala, Mallesh; et al
Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.
10.1021/acs.jmedchem.1c01853
```

---

## Reaction 31-614-CAS-34405403

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 10.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CN.Cl.O=C(O)c1nnc(Cl)cc1Cl.[Li]`
  - Products: `[2H]C([2H])([2H])NC(=O)c1nnc(Cl)cc1Cl`

**Reference:**
  - **Title:** Novel TYK2 Inhibitors with an N-(Methyl-d3)pyridazine-3-carboxamide Skeleton for the Treatment of Autoimmune Diseases
  - **Authors:** Liu, Fei; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(11), 1730-1738.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00334](https://doi.org/10.1021/acsmedchemlett.2c00334)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-34405403
1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride
Solvents: Dimethylformamide; 10 h, 25 °C
Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties
By: Morozova, Alisa; et al
European Journal of Medicinal Chemistry (2024), 266, 116101.
10.1016/j.ejmech.2023.116101
```

---

## Reaction 31-614-CAS-34440323

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 21.0°C
  - Time: 2.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `N[C@@H]1CCC[C@@H](O)C1.Cc1ccc(F)c2cc(C(=O)O)[nH]c12`
  - Products: `Cc1ccc(F)c2cc(C(=O)N[C@@H]3CCC[C@@H](O)C3)[nH]c12`

**Reference:**
  - **Title:** Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies
  - **Authors:** Lampe, John W.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2021), 12(10), 1539-1545.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00272](https://doi.org/10.1021/acsmedchemlett.1c00272)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-34440323
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, 21 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand
By: Amin, Toufiq Ul; et al
Journal of Medicinal Chemistry (2022), 65(22), 15473-15486.
10.1021/acs.jmedchem.2c01423
```

---

## Reaction 31-614-CAS-34491577

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 21.5 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)c1cc(-c2ccccc2)[nH]n1.COC(=O)c1ccc(C(C)N)cc1.Cl`
  - Products: `COC(=O)c1ccc(C(C)NC(=O)c2cc(-c3ccccc3)n[nH]2)cc1`

**Reference:**
  - **Title:** Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe
  - **Authors:** Roehm, Sandra; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(18), 13451-13474.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00868](https://doi.org/10.1021/acs.jmedchem.1c00868)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-34491577
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 1.5 h, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 20 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin
By: Schiffers, Ingo; et al
Organic Process Research & Development (2022), 26(10), 2811-2822.
10.1021/acs.oprd.2c00152
```

---

## Reaction 31-614-CAS-34504603

**Type:** Other

**Reagents:**
  - N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate (CAS: 1075198-30-9) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - THF (CAS: 96-47-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 2.583 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `C=CC(=O)N[C@H](Cc1ccc(OC)c(Cl)c1)C(=O)N[C@@H](C)C(C)(C)C(=O)O.C=CC[C@H](OC(=O)[C@@H](N)CC(C)(C)C)[C@H](C)COCc1ccc(OC)cc1`
  - Products: `C=CC[C@H](OC(=O)[C@H](CC(C)(C)C)NC(=O)C(C)(C)[C@H](C)NC(=O)[C@@H](Cc1ccc(OC)c(Cl)c1)NC(=O)C=C)[C@H](C)COCc1ccc(OC)cc1`

**Reference:**
  - **Title:** Fit-for-Purpose Synthesis of an Aza-Cryptophycin Analogue as the Payload for an Antibody-Drug Conjugate
  - **Authors:** Bendelac, Audrey; et al
  - **Citation:** Organic Process Research & Development (2022), 26(8), 2145-2154.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.2c00080](https://doi.org/10.1021/acs.oprd.2c00080)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-34504603
1.1|Reagents: N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate
Solvents: 2-Methyltetrahydrofuran; 5 min, 20 °C
1.2|Reagents: Diisopropylethylamine
Solvents: 2-Methyltetrahydrofuran; 20 °C; 2.5 h, 20 °C
1.3|Reagents: Sodium bicarbonate
Solvents: Water
Relative stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists
By: Granberg, Kenneth L.; et al
Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.
10.1021/acs.jmedchem.3c02183
```

---

## Reaction 31-614-CAS-34513955

**Type:** Other

**Reaction Conditions:**
  - Temperature: 160.0°C
  - Time: 16.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `NC(N)=O.Nc1ccccc1C(=O)O`
  - Products: `O=c1[nH]c(=O)c2ccccc2[nH]1`

**Reference:**
  - **Title:** High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists
  - **Authors:** Bolteau, Raphael; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 241, 114620.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114620](https://doi.org/10.1016/j.ejmech.2022.114620)

**Original Text:**
```
Steps: 1, Yield: 89-92%
CAS Reaction Number: 31-614-CAS-34513955
1.1|overnight, 160 °C
Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis
By: Biteau, Nicolas G.; et al
Bioorganic & Medicinal Chemistry (2021), 46, 116351.
10.1016/j.bmc.2021.116351
```

---

## Reaction 31-614-CAS-34513976

**Type:** Other

**Reagents:**
  - NaOH (CAS: 1310-73-2) - Role: BASE
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 160.0°C
  - Time: 16.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `NC(N)=O.Nc1ccc(Br)cc1C(=O)O`
  - Products: `O=c1[nH]c(=O)c2cc(Br)ccc2[nH]1`

**Reference:**
  - **Title:** High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists
  - **Authors:** Bolteau, Raphael; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 241, 114620.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114620](https://doi.org/10.1016/j.ejmech.2022.114620)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-34513976
1.1|overnight, 160 °C
1.2|Reagents: Sodium hydroxide
Solvents: Water; rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; acidified
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
By: Novotna, Katerina; et al
Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
10.1021/acs.jmedchem.3c01681
```

---

## Reaction 31-614-CAS-34560348

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 24.5 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)CSSCC(=O)O.CCN(CC)C1=CC2OC3=CC(=[N+](CC)CC)C=CC3=C(c3ccccc3C(=O)NCCCCN)C2C=C1`
  - Products: `CCN(CC)C1=CC2OC3=CC(=[N+](CC)CC)C=CC3=C(c3ccccc3C(=O)NCCCCNC(=O)CSSCC(=O)O)C2C=C1`

**Reference:**
  - **Title:** Tumor-microenvironmental-response Bi-functional molecules for efficient imaging and anti-tumor activity therapy
  - **Authors:** Wang, Jin; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 230, 114120.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114120](https://doi.org/10.1016/j.ejmech.2022.114120)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-34560348
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 30 min, 0 °C
1.2|Reagents: Triethylamine; rt; 24 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
By: Wang, Xu; et al
Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.
10.1021/acs.jmedchem.4c02009
```

---

## Reaction 31-614-CAS-34568026

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.667 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)O)cc2)CC1.N#Cc1ccc(O[C@H]2CC[C@H](N)CC2)cc1Cl`
  - Products: `CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)N[C@H]3CC[C@H](Oc4ccc(C#N)c(Cl)c4)CC3)cc2)CC1`

**Reference:**
  - **Title:** Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer
  - **Authors:** Xiang, Weiguo; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(18), 13487-13509.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00900](https://doi.org/10.1021/acs.jmedchem.1c00900)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-34568026
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 10 min, basified, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 0.5 h, basified, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125
By: Caroff, Eva; et al
Journal of Medicinal Chemistry (2022), 65(16), 10918-10933.
10.1021/acs.jmedchem.2c00676
```

---

## Reaction 31-614-CAS-34568109

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.667 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCN(C2CCN(c3ccc(C(=O)O)cc3)CC2)CC1.CN(c1ccc(C#N)c(Cl)c1)[C@H]1CC[C@H](N)CC1`
  - Products: `CN(c1ccc(C#N)c(Cl)c1)[C@H]1CC[C@H](NC(=O)c2ccc(N3CCC(N4CCN(C(=O)OC(C)(C)C)CC4)CC3)cc2)CC1`

**Reference:**
  - **Title:** Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer
  - **Authors:** Xiang, Weiguo; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(18), 13487-13509.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00900](https://doi.org/10.1021/acs.jmedchem.1c00900)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-34568109
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 10 min, basified, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 0.5 h, basified, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases
By: Andrews, Mark D.; et al
Journal of Medicinal Chemistry (2022), 65(13), 8828-8842.
10.1021/acs.jmedchem.2c00422
```

---

## Reaction 31-614-CAS-34588001

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Water (CAS: 7732-18-5) - Role: WORKUP (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 28.0°C
  - Time: 16.5 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `N#Cc1cc(F)cc(C(=O)O)c1.C[C@H](N)c1ccccc1`
  - Products: `C[C@H](NC(=O)c1cc(F)cc(C#N)c1)c1ccccc1`

**Reference:**
  - **Title:** The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria
  - **Authors:** de Lera Ruiz, Manuel; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00355](https://doi.org/10.1021/acsmedchemlett.2c00355)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-34588001
1.1|Reagents: Diisopropylethylamine
Solvents: Tetrahydrofuran; 30 min, rt
1.2|16 h, 28 °C
1.3|Reagents: Water
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide
By: Sampaio-Dias, Ivo E.; et al
Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.
10.1021/acs.jmedchem.1c00252
```

---

## Reaction 31-614-CAS-34588037

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 20.5 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=Cc1cccc(C(=O)O)c1.C[C@H](N)c1ccccc1`
  - Products: `C[C@H](NC(=O)c1cccc(C=O)c1)c1ccccc1`

**Reference:**
  - **Title:** The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria
  - **Authors:** de Lera Ruiz, Manuel; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00355](https://doi.org/10.1021/acsmedchemlett.2c00355)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-34588037
1.1|Reagents: Diisopropylethylamine
Solvents: Tetrahydrofuran; 30 min, rt
1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 16 h, 25 °C
1.3|Reagents: Water; 25 °C
1.4|Reagents: Hydrochloric acid
Solvents: Tetrahydrofuran; 2 h, 25 °C
1.5|Reagents: Water
Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors
By: Li, Zizhou; et al
Journal of Medicinal Chemistry (2020), 63(8), 3956-3975.
10.1021/acs.jmedchem.9b01784
```

---

## Reaction 31-614-CAS-34588150

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 22.0°C
  - Time: 5.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `CC1(C)C[C@H](N)c2ccccc2O1.CCC1(CC)CC(=O)N([C@@H]2CCOc3ccc(C(=O)O)cc32)C(NC(=O)OC(C)(C)C)=N1`
  - Products: `CCC1(CC)CC(=O)N([C@@H]2CCOc3ccc(C(=O)N[C@H]4CC(C)(C)Oc5ccccc54)cc32)C(NC(=O)OC(C)(C)C)=N1`

**Reference:**
  - **Title:** The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria
  - **Authors:** de Lera Ruiz, Manuel; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00355](https://doi.org/10.1021/acsmedchemlett.2c00355)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-34588150
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Tetrahydrofuran; 5 h, 22 °C
1.2|Reagents: Water
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design
By: Krieger, Johannes; et al
ChemMedChem (2023), 18(8), e202200615.
10.1002/cmdc.202200615
```

---

## Reaction 31-614-CAS-34601305

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 10.5 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)c1cc(F)cc(F)c1.Nc1cccc([N+](=O)[O-])c1`
  - Products: `O=C(Nc1cccc([N+](=O)[O-])c1)c1cc(F)cc(F)c1`

**Reference:**
  - **Title:** Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors
  - **Authors:** Wang, Xinyu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 72, 116995.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116995](https://doi.org/10.1016/j.bmc.2022.116995)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-34601305
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; rt; 30 min, rt
1.2|10 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (-)
A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities
By: Wang, Juan; et al
European Journal of Medicinal Chemistry (2021), 215, 113267.
10.1016/j.ejmech.2021.113267
```

---

## Reaction 31-614-CAS-34601332

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 10.5 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)c1cc(F)cc(F)c1.CC(=O)c1cccc(N)c1`
  - Products: `CC(=O)c1cccc(NC(=O)c2cc(F)cc(F)c2)c1`

**Reference:**
  - **Title:** Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors
  - **Authors:** Wang, Xinyu; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 72, 116995.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.116995](https://doi.org/10.1016/j.bmc.2022.116995)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-34601332
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; rt; 30 min, rt
1.2|10 h, rt
Virtual Screening Approach to Identifying a Novel and Tractable Series of Pseudomonas aeruginosa Elastase Inhibitors
By: Leiris, Simon; et al
ACS Medicinal Chemistry Letters (2021), 12(2), 217-227.
10.1021/acsmedchemlett.0c00554
```

---

## Reaction 31-614-CAS-34604232

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 10.5 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)c1cc(F)cc(F)c1.Nc1cccc([N+](=O)[O-])c1`
  - Products: `O=C(Nc1cccc([N+](=O)[O-])c1)c1cc(F)cc(F)c1`

**Reference:**
  - **Title:** Fragment-based discovery of novel phenyltriazolyl derivatives as allosteric type ALK inhibitors with promising antitumor effects
  - **Authors:** Cui, Youbao; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2022), 75, 128990.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.128990](https://doi.org/10.1016/j.bmcl.2022.128990)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-34604232
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 30 min, rt
1.2|10 h, rt
Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors
By: Wang, Xinyu; et al
Bioorganic & Medicinal Chemistry (2022), 72, 116995.
10.1016/j.bmc.2022.116995
```

---

## Reaction 31-614-CAS-34609720

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - PyBOP (CAS: 132705-51-2) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - Phosphorus(1+) - Role: UNK
  - bromotri-1-pyrrolidinyl- - Role: UNK
  - (T-4)- - Role: UNK
  - hexafluorophosphate(1-) (1:1) - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `N#Cc1cccc(-n2nc(C(F)(F)F)cc2C(=O)O)c1.Nc1cccc(C(O)(CCC2CC2)c2cccnc2)c1`
  - Products: `N#Cc1cccc(-n2nc(C(F)(F)F)cc2C(=O)Nc2cccc(C(O)(CCC3CC3)c3cccnc3)c2)c1`

**Reference:**
  - **Title:** Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon
  - **Authors:** Zhang, Weihe; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2022), 73, 117035.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.117035](https://doi.org/10.1016/j.bmc.2022.117035)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-34609720
1.1|Reagents: Diisopropylethylamine, Phosphorus(1+), bromotri-1-pyrrolidinyl-, (T-4)-, hexafluorophosphate(1-) (1:1)
Solvents: Dimethylformamide; 16 h, 25 °C
1.2|Reagents: Water
Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders
By: Roehrig, Susanne; et al
Journal of Medicinal Chemistry (2023), 66(17), 12203-12224.
10.1021/acs.jmedchem.3c00795
```

---

## Reaction 31-614-CAS-34611184

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: BASE (Registry: ACTIVATOR)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - 4-Methylmorpholine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `O=C(O)[C@@H]1CCCN1C(=O)Cc1cccc2ccccc12.COC(=O)c1ccccc1NC(=O)[C@@H](N)CCCCNC(=O)OC(C)(C)C`
  - Products: `COC(=O)c1ccccc1NC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)[C@@H]1CCCN1C(=O)Cc1cccc2ccccc12`

**Reference:**
  - **Title:** Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1
  - **Authors:** Zhou, Qilong; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 244, 114830.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114830](https://doi.org/10.1016/j.ejmech.2022.114830)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-34611184
1.1|Reagents: 4-Methylmorpholine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Relative stereochemistry shown
Relative stereochemistry shown
A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors
By: Schulte, Christie A.; et al
Bioorganic & Medicinal Chemistry Letters (2021), 47, 128113.
10.1016/j.bmcl.2021.128113
```

---

## Reaction 31-614-CAS-34611186

**Type:** Other

**Reagents:**
  - Phosphorus oxychloride (CAS: 10025-87-3) - Role: WORKUP
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)

**Solvents:**
  - Py (CAS: 110-86-1) - Role: BASE

**Reaction Conditions:**
  - Temperature: -15.0°C
  - Time: 0.5 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `COC(=O)c1ccccc1N.CC(C)(C)OC(=O)NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O`
  - Products: `COC(=O)c1ccccc1NC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)OCC1c2ccccc2-c2ccccc21`

**Reference:**
  - **Title:** Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1
  - **Authors:** Zhou, Qilong; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 244, 114830.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114830](https://doi.org/10.1016/j.ejmech.2022.114830)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-34611186
1.1|Reagents: Phosphorus oxychloride
Solvents: Pyridine; -15 °C; 30 min, -15 °C
1.2|Reagents: Water; cooled
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
By: Novotna, Katerina; et al
Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
10.1021/acs.jmedchem.3c01681
```

---

## Reaction 31-614-CAS-34611287

**Type:** Other

**Reagents:**
  - Water (CAS: 7732-18-5) - Role: WORKUP (Registry: SOLVENT)

**Reaction Conditions:**
  - Temperature: 160.0°C
  - Time: 16.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `NC(N)=S.Nc1cnccc1C(=O)O`
  - Products: `O=c1[nH]c(=S)[nH]c2cnccc12`

**Reference:**
  - **Title:** Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d]pyrimidine derivatives
  - **Authors:** Guo, Wen-Ge; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2022), 76, 129020.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.129020](https://doi.org/10.1016/j.bmcl.2022.129020)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-34611287
1.1|16 h, 160 °C; 160 °C → 100 °C
1.2|Reagents: Water
Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase
By: Russ, Nadine; et al
Journal of Medicinal Chemistry (2021), 64(19), 14358-14376.
10.1021/acs.jmedchem.1c00845
```

---

## Reaction 31-614-CAS-34628433

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - PhMe (CAS: 108-88-3) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 17.5 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1cnc(Cl)c(Br)c1.Nc1ccc(OC(F)(F)Cl)cc1`
  - Products: `O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(Cl)c(Br)c1`

**Reference:**
  - **Title:** Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor
  - **Authors:** Liu, Haixia; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 244, 114810.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114810](https://doi.org/10.1016/j.ejmech.2022.114810)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-34628433
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide
Solvents: Toluene; 1.5 h, 80 °C
1.2|Reagents: Diisopropylethylamine
Solvents: Tetrahydrofuran; -16 °C; overnight, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
By: Falkenstein, Markus; et al
Bioorganic & Medicinal Chemistry (2021), 50, 116462.
10.1016/j.bmc.2021.116462
```

---

## Reaction 31-614-CAS-34637960

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1.CC1(C)OB(c2ccc(N)cc2)OC1(C)C`
  - Products: `CC1(C)OB(c2ccc(NC(=O)c3ccccc3)cc2)OC1(C)C`

**Reference:**
  - **Title:** Boronic Acid: A Novel Pharmacophore Targeting Src Homology 2 (SH2) Domain of STAT3
  - **Authors:** Deng, Lin; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(19), 13094-13111.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00940](https://doi.org/10.1021/acs.jmedchem.2c00940)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-34637960
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; overnight, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide
By: Sampaio-Dias, Ivo E.; et al
Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.
10.1021/acs.jmedchem.1c00252
```

---

## Reaction 31-614-CAS-34638576

**Type:** Other

**Reagents:**
  - EDC (CAS: 1892-57-5) - Role: BASE (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.167 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `Cn1cc(C(=O)O)cn1.Cl.N#Cc1ccc2c(c1)CC[C@H]2N`
  - Products: `Cn1cc(C(=O)N[C@@H]2CCc3cc(C#N)ccc32)cn1`

**Reference:**
  - **Title:** Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy
  - **Authors:** Chuang, Chihyuan; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01290](https://doi.org/10.1021/acs.jmedchem.1c01290)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-34638576
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine
Solvents: Dimethylformamide; 10 min, rt
1.2|overnight, rt
Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation
By: Bayrak, Alp; et al
Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.
10.1021/acs.jmedchem.2c01198
```

---

## Reaction 31-614-CAS-34638590

**Type:** Other

**Reagents:**
  - EDC (CAS: 1892-57-5) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.25 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Cn1cc(C(=O)O)cn1.CCc1nc(-c2ccc3c(c2)CC[C@H]3N)no1`
  - Products: `CCc1nc(-c2ccc3c(c2)CC[C@H]3NC(=O)c2cnn(C)c2)no1`

**Reference:**
  - **Title:** Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy
  - **Authors:** Chuang, Chihyuan; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01290](https://doi.org/10.1021/acs.jmedchem.1c01290)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-34638590
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, Diisopropylethylamine, HOAt
Solvents: Dimethylformamide; 15 min, rt
1.2|3 h, rt
Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis
By: Biteau, Nicolas G.; et al
Bioorganic & Medicinal Chemistry (2021), 46, 116351.
10.1016/j.bmc.2021.116351
```

---

## Reaction 31-614-CAS-34638596

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - 1,2-Dichloroethane (CAS: 107-06-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 10.0°C
  - Time: 18.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `Cn1cc(C(=O)O)cn1.Cc1ccc(S(=O)(=O)O)cc1.N#Cc1ccc2c(c1)CC[C@H]2N`
  - Products: `Cn1cc(C(=O)N[C@@H]2CCc3cc(C#N)ccc32)cn1`

**Reference:**
  - **Title:** Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy
  - **Authors:** Chuang, Chihyuan; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01290](https://doi.org/10.1021/acs.jmedchem.1c01290)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-34638596
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: 1,2-Dichloroethane; rt; 2 h, rt
1.2|rt → 0 °C
1.3|Reagents: Triethylamine; < 10 °C; overnight, < 10 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy
By: Chuang, Chihyuan; et al
Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.
10.1021/acs.jmedchem.1c01290
```

---

## Reaction 31-614-CAS-34638611

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 38.0°C
  - Time: 16.25 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `Cc1cc(C(=O)O)ccn1.CCc1nc(-c2ccc3c(c2)CC[C@H]3N)no1.Cl`
  - Products: `CCc1nc(-c2ccc3c(c2)CC[C@H]3NC(=O)c2ccnc(C)c2)no1`

**Reference:**
  - **Title:** Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy
  - **Authors:** Chuang, Chihyuan; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01290](https://doi.org/10.1021/acs.jmedchem.1c01290)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-34638611
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 min, rt
1.2|overnight, 38 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy
By: Chuang, Chihyuan; et al
Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.
10.1021/acs.jmedchem.1c01290
```

---

## Reaction 31-614-CAS-34684560

**Type:** Other

**Reagents:**
  - 2,6-Lutidine (CAS: 108-48-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Nc1ccc(CO)cc1.C=CCOC(=O)NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O`
  - Products: `C=CCOC(=O)NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)Nc1ccc(CO)cc1`

**Reference:**
  - **Title:** Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor
  - **Authors:** Zhang, Yong; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(21), 15787-15798.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02043](https://doi.org/10.1021/acs.jmedchem.0c02043)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-34684560
1.1|Reagents: 2,6-Lutidine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2
By: Dai, Wenhao; et al
Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.
10.1021/acs.jmedchem.0c02258
```

---

## Reaction 31-614-CAS-34698514

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CC(C)(N)CO.CCOc1cccnc1O[C@@H]1CCCN(c2ncc(C(=O)O)cn2)C1`
  - Products: `CCOc1cccnc1O[C@@H]1CCCN(c2ncc(C(=O)NC(C)(C)CO)cn2)C1`

**Reference:**
  - **Title:** Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis
  - **Authors:** Futatsugi, Kentaro; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(22), 15000-15013.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01200](https://doi.org/10.1021/acs.jmedchem.2c01200)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-34698514
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
By: Behring, Lydia; et al
Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
10.1021/acs.jmedchem.2c01360
```

---

## Reaction 31-614-CAS-34708767

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `C#CCCCCN.CC(C)(C)OC(=O)NC(=NCCCC[C@H](NC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)C(=O)O)NC(=O)OC(C)(C)C`
  - Products: `C#CCCCCNC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Pillar[5]arene-Based Polycationic Glyco[2]rotaxanes Designed as Pseudomonas aeruginosa Antibiofilm Agents
  - **Authors:** Mohy El Dine, Tharwat; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(19), 14728-14744.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01241](https://doi.org/10.1021/acs.jmedchem.1c01241)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-34708767
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; rt → 0 °C
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 16 h, 0 °C → rt
1.3|Reagents: Sodium bicarbonate
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
By: Behring, Lydia; et al
Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
10.1021/acs.jmedchem.2c01360
```

---

## Reaction 31-614-CAS-34708798

**Type:** Other

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `O=C(O)c1ncc(C(F)(F)F)cc1Cl.CC(C)(C)OC(=O)NC1=N[C@](C)(c2nc(N)ccc2F)CO[C@@]1(C)C(F)(F)F`
  - Products: `CC(C)(C)OC(=O)NC1=N[C@](C)(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@]1(C)C(F)(F)F`

**Reference:**
  - **Title:** Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer’s Disease
  - **Authors:** Machauer, Rainer; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(20), 15262-15279.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01300](https://doi.org/10.1021/acs.jmedchem.1c01300)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-34708798
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt
Solvents: Dimethylformamide; 18 h, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Double bond geometry shown
Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury
By: Cui, Yingjun; et al
Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.
10.1021/acs.jmedchem.1c01583
```

---

## Reaction 31-614-CAS-34709092

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.5 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O[C@H](/C=C/CCSC(c1ccccc1)(c1ccccc1)c1ccccc1)CC(=O)OCC[Si](C)(C)C.C/C=C(\NC(=O)c1csc(CNC(=O)OC(C)(C)C)n1)C(=O)O`
  - Products: `C/C=C(\NC(=O)c1csc(CNC(=O)OC(C)(C)C)n1)C(=O)N[C@@H](CCCCNC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O[C@H](/C=C/CCSC(c1ccccc1)(c1ccccc1)c1ccccc1)CC(=O)OCC[Si](C)(C)C`

**Reference:**
  - **Title:** Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC)
  - **Authors:** Zhang, Kuojun; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(7), 4020-4033.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02161](https://doi.org/10.1021/acs.jmedchem.0c02161)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-34709092
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 30 min, 0 °C
1.2|Reagents: Diisopropylethylamine, HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 0 °C → rt; 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360
By: Rueeger, Heinrich; et al
Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.
10.1021/acs.jmedchem.0c02143
```

---

## Reaction 31-614-CAS-34716368

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `NC(=O)c1ccccc1N.O=C(O)c1ccccn1`
  - Products: `NC(=O)c1ccccc1NC(=O)c1ccccn1`

**Reference:**
  - **Title:** Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection
  - **Authors:** Tawaraishi, Taisuke; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(2), 1221-1238.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00775](https://doi.org/10.1021/acs.jmedchem.2c00775)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-34716368
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 24 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-34870693

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 3.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCCOCCOCCN.COc1ccc2c(c1)C(c1ccc(Cl)cc1)=N[C@@H]([C@@H](C)C(=O)O)c1nnc(C)n1-2`
  - Products: `COc1ccc2c(c1)C(c1ccc(Cl)cc1)=N[C@@H]([C@@H](C)C(=O)NCCOCCOCCNC(=O)OC(C)(C)C)c1nnc(C)n1-2`

**Reference:**
  - **Title:** Structure-Guided Design of a “Bump-and-Hole” Bromodomain-Based Degradation Tag
  - **Authors:** Nowak, Radoslaw P.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(15), 11637-11650.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00958](https://doi.org/10.1021/acs.jmedchem.1c00958)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-34870693
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 0 °C; 2 h, rt
Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors
By: Ushiki, Yasunobu; et al
Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.
10.1016/j.bmcl.2022.128572
```

---

## Reaction 31-614-CAS-34871210

**Type:** Other

**Reagents:**
  - Proton sponge (CAS: 20734-58-1) - Role: UNK
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 70.0°C
  - Time: 1.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `NCCc1ccccc1.CC(C)(C(=O)O)c1ccccc1[N+](=O)[O-]`
  - Products: `CC(C)(C(=O)NCCc1ccccc1)c1ccccc1[N+](=O)[O-]`

**Reference:**
  - **Title:** Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells
  - **Authors:** Takashima, Katsuki; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.129034](https://doi.org/10.1016/j.bmcl.2022.129034)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-34871210
1.1|Reagents: Proton sponge, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt
Solvents: Dimethylformamide; 1 h, 70 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
By: Behring, Lydia; et al
Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
10.1021/acs.jmedchem.2c01360
```

---

## Reaction 31-614-CAS-34871213

**Type:** Other

**Reagents:**
  - Proton sponge (CAS: 20734-58-1) - Role: UNK
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 70.0°C
  - Time: 1.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1cccc(CCN)c1.COc1ccc([N+](=O)[O-])c(C(C)(C)C(=O)O)c1`
  - Products: `COc1cccc(CCNC(=O)C(C)(C)c2cc(OC)ccc2[N+](=O)[O-])c1`

**Reference:**
  - **Title:** Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells
  - **Authors:** Takashima, Katsuki; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.129034](https://doi.org/10.1016/j.bmcl.2022.129034)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-34871213
1.1|Reagents: Proton sponge, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt
Solvents: Dimethylformamide; 1 h, 70 °C
Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
By: Tormaehlen, Niklas M.; et al
Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
10.1021/acs.jmedchem.0c01773
```

---

## Reaction 31-614-CAS-34894088

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CN.Cl.CC(C)(C)OC(=O)N1CCc2nc(C(=O)O)ccc2C1`
  - Products: `CNC(=O)c1ccc2c(n1)CCN(C(=O)OC(C)(C)C)C2`

**Reference:**
  - **Title:** Synthesis and in vitro biological evaluation of 3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective inhibitors and PARP-1 DNA trappers
  - **Authors:** Ren, Junkang; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2022), 78, 129046.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.129046](https://doi.org/10.1016/j.bmcl.2022.129046)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-34894088
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; overnight, rt
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-614-CAS-34952224

**Type:** Other

**Full Catalytic System:**
  - Tetrabutylammonium chloride (CAS: 1112-67-0)

**Catalyst Core:**
  - Tetrabutylammonium chloride (CAS: 1112-67-0)

**Solvents:**
  - PhMe (CAS: 108-88-3) - Role: SOLVENT
  - Py (CAS: 110-86-1) - Role: BASE

**Reaction Conditions:**
  - Temperature: 70.0°C
  - Time: 9.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(B(O)O)cc1.Nc1ccccn1`
  - Products: `O=C(Nc1ccccn1)c1ccc(B(O)O)cc1`

**Reference:**
  - **Title:** Development of Commercial Manufacturing Processes for Acalabrutinib
  - **Authors:** Bethel, Paul A.; et al
  - **Citation:** Organic Process Research & Development (2022), 26(12), 3303-3311.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.2c00304](https://doi.org/10.1021/acs.oprd.2c00304)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-34952224
1.1|Catalysts: Tetrabutylammonium chloride
Solvents: Toluene; rt; rt → 70 °C; 6 h, 70 °C; 70 °C → 60 °C
1.2|Solvents: Pyridine; rt → 70 °C; 3 h, 70 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594
By: Aydin, Gulsevim; et al
Organic Process Research & Development (2024), 28(2), 559-576.
10.1021/acs.oprd.3c00393
```

---

## Reaction 31-614-CAS-34952962

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `Cc1ccc(C(=O)O)cc1Cl.NCCO`
  - Products: `Cc1ccc(C(=O)NCCO)cc1Cl`

**Reference:**
  - **Title:** Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon Cancer
  - **Authors:** Li, Xing; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(24), 16622-16639.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01444](https://doi.org/10.1021/acs.jmedchem.2c01444)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-34952962
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 2 h, rt
1.3|Solvents: Water; rt
Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels
By: Fernandez, Ariadna; et al
ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809.
10.1021/acsmedchemlett.1c00416
```

---

## Reaction 31-614-CAS-34955247

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 36.5 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NC/C=C/C(=O)N(Cc1ccccc1)Cc1ccccc1.CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O`
  - Products: `CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)NC/C=C/C(=O)N(Cc1ccccc1)Cc1ccccc1`

**Reference:**
  - **Title:** An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity
  - **Authors:** Lemke, Carina; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(18), 13793-13806.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01178](https://doi.org/10.1021/acs.jmedchem.1c01178)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-34955247
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 20 h, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Dichloromethane
1.3|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane, Water; 30 min, rt; 16 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists
By: Mhamane, Tukaram B.; et al
Bioorganic & Medicinal Chemistry (2023), 88-89, 117296.
10.1016/j.bmc.2023.117296
```

---

## Reaction 31-614-CAS-34972319

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: WORKUP (Registry: BASE)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Na2CO3 (CAS: 497-19-8) - Role: UNK (Registry: BASE)
  - Sodium carbonate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 10.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)C1(c2ccccc2F)CC1.Nc1ccn(-c2ccnc(F)c2)n1`
  - Products: `O=C(Nc1ccn(-c2ccnc(F)c2)n1)C1(c2ccccc2F)CC1`

**Reference:**
  - **Title:** Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1
  - **Authors:** Come, Jon H.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(24), 17753-17776.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00944](https://doi.org/10.1021/acs.jmedchem.1c00944)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-34972319
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide; 1 h, rt; 3 h, rt → 30 °C
1.2|Reagents: Triethylamine
Solvents: Tetrahydrofuran; 1 h, 0 °C; < 8 °C; 5 h, rt
1.3|Reagents: Water; rt
1.4|Reagents: Sodium carbonate
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma
By: Wang, Xueyuan; et al
European Journal of Medicinal Chemistry (2023), 250, 115187.
10.1016/j.ejmech.2023.115187
```

---

## Reaction 31-614-CAS-34998057

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 19.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CCOC(=O)CC[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C)C(=O)OCC.CC(C)(C)OC(=O)NCC(=O)O`
  - Products: `CCOC(=O)CC[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)OC(C)(C)C)C(C)C)C(=O)OCC`

**Reference:**
  - **Title:** Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
  - **Authors:** Guzelj, Samo; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00808](https://doi.org/10.1021/acs.jmedchem.2c00808)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-34998057
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 0 °C → rt; 3 h, rt
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → rt; overnight, rt
Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands
By: Andreasson, Maans; et al
Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.
10.1021/acs.jmedchem.3c02127
```

---

## Reaction 31-614-CAS-34998067

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 19.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CCOC(=O)[C@@H](CCC(=O)OCc1ccccc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C.CC(C)(C)OC(=O)NCC(=O)O`
  - Products: `CCOC(=O)[C@@H](CCC(=O)OCc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)OC(C)(C)C)C(C)C`

**Reference:**
  - **Title:** Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
  - **Authors:** Guzelj, Samo; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00808](https://doi.org/10.1021/acs.jmedchem.2c00808)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-34998067
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 0 °C → rt; 3 h, rt
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → rt; overnight, rt
Double bond geometry shown
Double bond geometry shown
Development of photoactivable phenanthroline-based manganese(I) CO-Releasing molecules (PhotoCORMs) active against ESKAPE bacteria and bacterial biofilms
By: Toscani, Anita; et al
European Journal of Medicinal Chemistry (2021), 213, 113172.
10.1016/j.ejmech.2021.113172
```

---

## Reaction 31-614-CAS-34998076

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 19.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CCOC(=O)[C@H](CCC(=O)OCc1ccccc1)NC(=O)OC(C)(C)C.CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O`
  - Products: `CCOC(=O)[C@@H](CCC(=O)OCc1ccccc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C`

**Reference:**
  - **Title:** Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
  - **Authors:** Guzelj, Samo; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00808](https://doi.org/10.1021/acs.jmedchem.2c00808)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-34998076
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 0 °C → rt; 3 h, rt
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C → rt; overnight, rt
Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors
By: Specker, Edgar; et al
Journal of Medicinal Chemistry (2022), 65(16), 11126-11149.
10.1021/acs.jmedchem.2c00598
```

---

## Reaction 31-614-CAS-35008193

**Type:** Other

**Reagents:**
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - Py (CAS: 110-86-1) - Role: BASE

**Reaction Conditions:**
  - Time: 12.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `Nc1ccc(Cl)cc1.C[C@@H](C(=O)O)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1`
  - Products: `C[C@@H](C(=O)Nc1ccc(Cl)cc1)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1`

**Reference:**
  - **Title:** Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma
  - **Authors:** Bollu, Lakshmi R.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(23), 15642-15662.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00771](https://doi.org/10.1021/acs.jmedchem.2c00771)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-35008193
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide
Solvents: Pyridine; 0 °C; 12 h, rt
Double bond geometry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Development of a Novel, Small-Molecule Brain-Penetrant Histone Deacetylase Inhibitor That Enhances Spatial Memory Formation in Mice
By: Belayet, Jawad B.; et al
Journal of Medicinal Chemistry (2022), 65(4), 3388-3403.
10.1021/acs.jmedchem.1c01928
```

---

## Reaction 31-614-CAS-35008196

**Type:** Other

**Reagents:**
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCC(Oc2ccc(N)cc2)CC1.C[C@@H](C(=O)O)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1`
  - Products: `C[C@@H](C(=O)Nc1ccc(OC2CCN(C(=O)OC(C)(C)C)CC2)cc1)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1`

**Reference:**
  - **Title:** Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma
  - **Authors:** Bollu, Lakshmi R.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(23), 15642-15662.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00771](https://doi.org/10.1021/acs.jmedchem.2c00771)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-35008196
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide
Solvents: Tetrahydrofuran; 0 °C; 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy
By: Dilger, Andrew K.; et al
Journal of Medicinal Chemistry (2022), 65(3), 1770-1785.
10.1021/acs.jmedchem.1c00613
```

---

## Reaction 31-614-CAS-35026067

**Type:** Other

**Reagents:**
  - N,N-Diisopropylcarbodiimide (CAS: 693-13-0) - Role: UNK (Registry: N'-DIISOPROPYLCARBODIIMIDE)
  - Ethyl 2-cyano-2-(hydroxyimino)acetate (CAS: 3849-21-6) - Role: UNK
  - TFA (CAS: 76-05-1) - Role: UNK (Registry: SOLVENT)
  - Triisopropylsilane (CAS: 6485-79-6) - Role: UNK
  - 2,2′-(Ethylenedioxy)diethanethiol (CAS: 14970-87-7) - Role: UNK
  - Diisopropylcarbodiimide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Diisopropyl (CAS: 108-20-3) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 90.0°C
  - Time: 24.733 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(N[C@@H](CS)C(=O)O)OCC1c2ccccc2-c2ccccc21.O=C(O)[C@@H]1CCCN1C(=O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)n1cc(C[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)c2ccccc21.CC(C)(C)OC(=O)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.O=C(O)CNC(=O)OCC1c2ccccc2-c2ccccc21.Cc1c(C)c(S(=O)(=O)NC(=N)NCCCC[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)c(C)c2c1OC(C)(C)C2.O=C(O)CCSC(c1ccccc1)(c1ccccc1)c1ccccc1`
  - Products: `N=C(N)NCCCC[C@H](NC(=O)CCS)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(N)=O`

**Reference:**
  - **Title:** An optimized safe process from bench to pilot cGMP production of API eptifibatide using a multigram-scale microwave-assisted solid-phase peptide synthesizer
  - **Authors:** D’Ercole, Annunziata; et al
  - **Citation:** Organic Process Research & Development (2021), 25(12), 2754-2771.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00368](https://doi.org/10.1021/acs.oprd.1c00368)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-35026067
1.1|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate
Solvents: Dimethylformamide; 2 min, 90 °C
1.2|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate
Solvents: Dimethylformamide; 2 min, 90 °C
1.3|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate
Solvents: Dimethylformamide; 2 min, 90 °C
1.4|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate
Solvents: Dimethylformamide; 2 min, 90 °C
1.5|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate
Solvents: Dimethylformamide; 2 min, 90 °C
1.6|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate
Solvents: Dimethylformamide; 2 min, 90 °C
1.7|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate
Solvents: Dimethylformamide; 2 min, 90 °C
1.8|Reagents: Trifluoroacetic acid
Solvents: Diisopropyl ether; 3 - 24 h, 0 °C
1.9|Reagents: Trifluoroacetic acid, Triisopropylsilane, 2,2′-(Ethylenedioxy)diethanethiol
Solvents: Water; 30 min, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (+)
Development, synthesis and evaluation of novel fluorescent Endothelin-B receptor probes
By: Delahaye, Juliette; et al
European Journal of Medicinal Chemistry (2023), 258, 115568.
10.1016/j.ejmech.2023.115568
```

---

## Reaction 31-614-CAS-35037410

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 5.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(Br)c1.CN`
  - Products: `CNC(=O)c1cccc(Br)c1`

**Reference:**
  - **Title:** Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates
  - **Authors:** Ota, Yosuke; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(10), 1568-1573.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00126](https://doi.org/10.1021/acsmedchemlett.2c00126)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-35037410
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0 °C; 4 h, rt
1.2|Solvents: Tetrahydrofuran; 0 °C; 1 h, rt
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
By: Li, Bing-yan; et al
Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.
10.1021/acs.jmedchem.3c02407
```

---

## Reaction 31-614-CAS-35038127

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Cl.NCC(=O)OCc1ccccc1.C[C@H](NC(=O)OC(C)(C)C)C(=O)O`
  - Products: `C[C@H](NC(=O)OC(C)(C)C)C(=O)NCC(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release
  - **Authors:** Meiers, Joscha; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(20), 13988-14014.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01214](https://doi.org/10.1021/acs.jmedchem.2c01214)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-35038127
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; rt; 5 h, rt
Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection
By: Tawaraishi, Taisuke; et al
Journal of Medicinal Chemistry (2023), 66(2), 1221-1238.
10.1021/acs.jmedchem.2c00775
```

---

## Reaction 31-614-CAS-35038130

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `C[C@H](N)C(=O)OCc1ccccc1.Cl.CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O`
  - Products: `CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release
  - **Authors:** Meiers, Joscha; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(20), 13988-14014.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01214](https://doi.org/10.1021/acs.jmedchem.2c01214)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-35038130
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; rt; 24 h, rt
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
By: Hiesinger, Kerstin; et al
Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.
10.1021/acs.jmedchem.0c00561
```

---

## Reaction 31-614-CAS-35039294

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Piperidine (CAS: 110-89-4) - Role: UNK (Registry: BASE)
  - TFA (CAS: 76-05-1) - Role: UNK (Registry: SOLVENT)
  - i-PrOH (CAS: 920-66-1) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 21.583 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CC(C)[C@H](N)C(=O)O.CC(C)(C)OC(=O)CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.O.O=C(CCCCCN1C(=O)C=CC1=O)ON1C(=O)CCC1=O`
  - Products: `CC(C)[C@H](NC(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)CCCCCN1C(=O)C=CC1=O)C(=O)O`

**Reference:**
  - **Title:** Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand
  - **Authors:** Amin, Toufiq Ul; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(22), 15473-15486.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01423](https://doi.org/10.1021/acs.jmedchem.2c01423)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-35039294
1.1|-
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 5 min, rt; 3 h, rt
1.3|Reagents: Piperidine
Solvents: Dimethylformamide; 30 min, rt
1.4|Reagents: Diisopropylethylamine; overnight, rt
1.5|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; rt
1.6|Reagents: 1,1,1,3,3,3-Hexafluoro-2-propanol
Solvents: Dichloromethane; 2 h, rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-35040165

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - MeOH (CAS: 67-56-1) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.167 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CN.Cl.CNC(=O)c1cnc(Cl)cc1Nc1cccc(C(=O)O)c1OC`
  - Products: `CNC(=O)c1cnc(Cl)cc1Nc1cccc(C(=O)NC)c1OC`

**Reference:**
  - **Title:** Discovery of a potent and subtype-selective TYK2 degrader based on an allosteric TYK2 inhibitor
  - **Authors:** Kato, Jun-ya; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2023), 79, 129083.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.129083](https://doi.org/10.1016/j.bmcl.2022.129083)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-35040165
1.1|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 30 min, 0 °C
1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 10 min, 0 °C; 17 h, rt
1.3|Reagents: Sodium bicarbonate
Solvents: Methanol, Ethyl acetate, Water; 30 min, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1
By: Ryu, SeongShick; et al
Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.
10.1021/acs.jmedchem.1c01359
```

---

## Reaction 31-614-CAS-35040293

**Type:** Other

**Reaction Conditions:**
  - Temperature: 155.0°C
  - Time: 16.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `NC=O.Nc1ccc(F)cc1C(=O)O`
  - Products: `O=c1nc[nH]c2ccc(F)cc12`

**Reference:**
  - **Title:** Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells
  - **Authors:** Elsocht, Mathias; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2023), 79, 129066.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.129066](https://doi.org/10.1016/j.bmcl.2022.129066)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-35040293
1.1|overnight, 155 °C
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacement
By: Barton, Linda S.; et al
Bioorganic & Medicinal Chemistry (2024), 100, 117618.
10.1016/j.bmc.2024.117618
```

---

## Reaction 31-614-CAS-35054318

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: WORKUP (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.083 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NC[C@H](NC(=O)OCc1ccccc1)C(=O)O.CCC[C@H](N)C(=O)OC`
  - Products: `CCC[C@H](NC(=O)[C@H](CNC(=O)OC(C)(C)C)NC(=O)OCc1ccccc1)C(=O)OC`

**Reference:**
  - **Title:** Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury
  - **Authors:** Cui, Yingjun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01583](https://doi.org/10.1021/acs.jmedchem.1c01583)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-35054318
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 5 min, 0 °C
1.2|Reagents: Diisopropylethylamine; overnight, rt
1.3|Reagents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of a novel series of medium-sized cyclic enteropeptidase inhibitors
By: Kikuchi, Fumiaki; et al
Bioorganic & Medicinal Chemistry (2023), 93, 117462.
10.1016/j.bmc.2023.117462
```

---

## Reaction 31-614-CAS-35054320

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `C=CCOc1ccc(C(=O)NCC(=O)O)cc1.CCC[C@H](NC(=O)[C@H](CNC(=O)OC(C)(C)C)NC(=O)[C@H](C)N)C(=O)OC`
  - Products: `C=CCOc1ccc(C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CNC(=O)OC(C)(C)C)C(=O)N[C@@H](CCC)C(=O)OC)cc1`

**Reference:**
  - **Title:** Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury
  - **Authors:** Cui, Yingjun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01583](https://doi.org/10.1021/acs.jmedchem.1c01583)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-35054320
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 0 °C; overnight, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models
By: Winter-Holt, Jon J.; et al
Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.
10.1021/acs.jmedchem.1c01871
```

---

## Reaction 31-614-CAS-35054346

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.083 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CCC[C@H](NC(=O)[C@H](CNC(=O)OCC1c2ccccc2-c2ccccc21)NC(=O)[C@H](C)NC(=O)CNC(=O)c1ccc(O)cc1)C(=O)N[C@H](C(O[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](Cc1ccc(O[Si](C)(C)C(C)(C)C)cc1)c1nc(/C=C/C(=O)O)cs1)[C@@H](C)CC.C=CCOC(=O)[C@@H](N)CSC(c1ccccc1)(c1ccccc1)c1ccccc1`
  - Products: `C=CCOC(=O)[C@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)NC(=O)/C=C/c1csc([C@H](Cc2ccc(O[Si](C)(C)C(C)(C)C)cc2)NC(=O)C(O[Si](C)(C)C(C)(C)C)[C@@H](NC(=O)[C@H](CCC)NC(=O)[C@H](CNC(=O)OCC2c3ccccc3-c3ccccc32)NC(=O)[C@H](C)NC(=O)CNC(=O)c2ccc(O)cc2)[C@@H](C)CC)n1`

**Reference:**
  - **Title:** Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury
  - **Authors:** Cui, Yingjun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01583](https://doi.org/10.1021/acs.jmedchem.1c01583)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-35054346
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 5 min, 0 °C
1.2|Solvents: Dichloromethane; overnight, rt
Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa
By: Wang, Yuan-Yuan; et al
Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.
10.1021/acs.jmedchem.2c02044
```

---

## Reaction 31-614-CAS-35110941

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 3.167 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)c1cc2ccccc2o1.COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1`
  - Products: `COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc3ccccc3o2)cc1`

**Reference:**
  - **Title:** Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 246, 114981.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114981](https://doi.org/10.1016/j.ejmech.2022.114981)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-35110941
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 10 min, 0 °C; 0 °C → rt; 3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2023), 246, 114981.
10.1016/j.ejmech.2022.114981
```

---

## Reaction 31-614-CAS-35111050

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 3.167 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)c1cc2ccccc2o1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(N)cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2ccccc2o1)S(=O)(=O)c1ccc(N)cc1`

**Reference:**
  - **Title:** Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 246, 114981.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114981](https://doi.org/10.1016/j.ejmech.2022.114981)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-35111050
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 10 min, 0 °C; 0 °C → rt; 3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase
By: Stachura, Damian L.; et al
ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.
10.1021/acsmedchemlett.2c00505
```

---

## Reaction 31-614-CAS-35111055

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 3.167 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)c1cc2ccccc2[nH]1.COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1`
  - Products: `COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc3ccccc3[nH]2)cc1`

**Reference:**
  - **Title:** Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors
  - **Authors:** Zhu, Mei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 246, 114981.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114981](https://doi.org/10.1016/j.ejmech.2022.114981)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-35111055
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 10 min, 0 °C; 0 °C → rt; 3 h, rt
Relative stereochemistry shown
Relative stereochemistry shown
The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure
By: Cadilla, Rodolfo; et al
Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.
10.1016/j.bmc.2020.115791
```

---

## Reaction 31-614-CAS-35153686

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 8.25 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `O=C(O)Cc1ccc(Cl)cc1.Cl.NCCc1nc2ccccc2[nH]1`
  - Products: `O=C(Cc1ccc(Cl)cc1)NCCc1nc2ccccc2[nH]1`

**Reference:**
  - **Title:** Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease
  - **Authors:** de Oliveira Rezende, Celso Junior; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 246, 114925.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.114925](https://doi.org/10.1016/j.ejmech.2022.114925)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-35153686
1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole
Solvents: Dimethylformamide; 8 h, rt
1.2|Solvents: Water; 15 min, rt
A new chemotype with promise against Trypanosoma cruzi
By: Wang, Xiaofang; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.
10.1016/j.bmcl.2019.126778
```

---

## Reaction 31-614-CAS-35191378

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.5 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `COCCN.O=C(O)c1cc(I)cc(CNc2ccc(Cl)c(O)c2)c1`
  - Products: `COCCNC(=O)c1cc(I)cc(CNc2ccc(Cl)c(O)c2)c1`

**Reference:**
  - **Title:** DNA-Encoded Library Hit Confirmation: Bridging the Gap Between On-DNA and Off-DNA Chemistry
  - **Authors:** Xia, Bing; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2021), 12(7), 1166-1172.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00156](https://doi.org/10.1021/acsmedchemlett.1c00156)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-35191378
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1.5 h, rt
Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity
By: Fang, Jing-jie; et al
Journal of Medicinal Chemistry (2023), 66(22), 15288-15308.
10.1021/acs.jmedchem.3c01351
```

---

## Reaction 31-614-CAS-35200662

**Type:** Other

**Solvents:**
  - EtOH (CAS: 64-17-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 24.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `Nc1cccc(Cl)c1C(=O)O.CC(=O)O.N=CN`
  - Products: `O=c1nc[nH]c2cccc(Cl)c12`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel 3,4-dihydro-2H-[1,4]oxazino[2,3-f]quinazoline derivatives as EGFR-TKIs
  - **Authors:** Qin, Xuemei; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2023), 80, 129104.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2022.129104](https://doi.org/10.1016/j.bmcl.2022.129104)

**Original Text:**
```
Steps: 1, Yield: 85-89%
CAS Reaction Number: 31-614-CAS-35200662
1.1|Solvents: Ethanol; 24 h, reflux
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-35231135

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 20.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(-c2ccccc2)c1.Cc1cc(N)no1`
  - Products: `Cc1cc(NC(=O)c2cccc(-c3ccccc3)c2)no1`

**Reference:**
  - **Title:** Identification and Optimization of Novel Small-Molecule Cas9 Inhibitors by Cell-Based High-Throughput Screening
  - **Authors:** Lee, Sang-Woo; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 3266-3305.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01834](https://doi.org/10.1021/acs.jmedchem.1c01834)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-35231135
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 2 h, 0 °C
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 18 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; rt
Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma
By: Perry, Matthew W. D.; et al
Journal of Medicinal Chemistry (2021), 64(12), 8053-8075.
10.1021/acs.jmedchem.1c00434
```

---

## Reaction 31-614-CAS-35272077

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 3.583 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)c1cnc2ccc(Cl)nn12.NCCc1ccccc1`
  - Products: `O=C(NCCc1ccccc1)c1cnc2ccc(Cl)nn12`

**Reference:**
  - **Title:** Function-oriented synthesis of Imidazo[1,2-a]pyrazine and Imidazo[1,2-b]pyridazine derivatives as potent PI3K/mTOR dual inhibitors
  - **Authors:** Li, Chuchu; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 247, 115030.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.115030](https://doi.org/10.1016/j.ejmech.2022.115030)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-35272077
1.1|Reagents: Diisopropylethylamine
Solvents: Tetrahydrofuran; 15 min, rt
1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 20 min, 0 °C
1.3|0 °C → rt; 3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy
By: Chuang, Chihyuan; et al
Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.
10.1021/acs.jmedchem.1c01290
```

---

## Reaction 31-614-CAS-35275925

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.25 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C.C#CCN`
  - Products: `C#CCNC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C`

**Reference:**
  - **Title:** Targeting Vancomycin-Resistant Enterococci (VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid-Peptide Conjugates
  - **Authors:** Saini, Varsha; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(22), 15312-15326.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01293](https://doi.org/10.1021/acs.jmedchem.2c01293)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-35275925
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 min, rt
1.2|rt; 24 h, rt
Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP
By: Wu, Fangrui; et al
Journal of Medicinal Chemistry (2020), 63(9), 4716-4731.
10.1021/acs.jmedchem.9b02164
```

---

## Reaction 31-614-CAS-35297620

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.5 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)C(c1ccc(C(F)(F)F)cc1)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1.COc1ccc(N)cc1`
  - Products: `COc1ccc(NC(=O)C(c2ccc(C(F)(F)F)cc2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1`

**Reference:**
  - **Title:** Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
  - **Authors:** Pal, Kavita; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115055.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.115055](https://doi.org/10.1016/j.ejmech.2022.115055)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-35297620
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dichloromethane; 0.5 h, rt
1.2|overnight, rt
Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo
By: Ojha, Ritu; et al
European Journal of Medicinal Chemistry (2020), 190, 112086pp..
10.1016/j.ejmech.2020.112086
```

---

## Reaction 31-614-CAS-35297621

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.5 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)C(c1ccc(Cl)c(Cl)c1)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1.COc1ccc(N)cc1`
  - Products: `COc1ccc(NC(=O)C(c2ccc(Cl)c(Cl)c2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1`

**Reference:**
  - **Title:** Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
  - **Authors:** Pal, Kavita; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115055.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.115055](https://doi.org/10.1016/j.ejmech.2022.115055)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-35297621
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dichloromethane; 0.5 h, rt
1.2|overnight, rt
Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process
By: Smith, Daniel; et al
Organic Process Research & Development (2020), 24(6), 1157-1163.
10.1021/acs.oprd.0c00198
```

---

## Reaction 31-614-CAS-35297623

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.5 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `Cc1ccc(C(C(=O)O)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1.COc1ccc(N)cc1`
  - Products: `COc1ccc(NC(=O)C(c2ccc(C)cc2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1`

**Reference:**
  - **Title:** Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
  - **Authors:** Pal, Kavita; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115055.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.115055](https://doi.org/10.1016/j.ejmech.2022.115055)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-35297623
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dichloromethane; 0.5 h, rt
1.2|overnight, rt
Advancing Scalable Chemistry toward Novel CELMoDs: Process Development for the Synthesis of CC-90009
By: Zacuto, Michael J.; et al
Organic Process Research & Development (2022), 26(9), 2739-2748.
10.1021/acs.oprd.2c00199
```

---

## Reaction 31-614-CAS-35297624

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.5 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `O=C(O)C(c1ccc(F)c(Cl)c1)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1.COc1ccc(N)cc1`
  - Products: `COc1ccc(NC(=O)C(c2ccc(F)c(Cl)c2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1`

**Reference:**
  - **Title:** Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
  - **Authors:** Pal, Kavita; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115055.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.115055](https://doi.org/10.1016/j.ejmech.2022.115055)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-35297624
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dichloromethane; 0.5 h, rt
1.2|overnight, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Development and Scale-Up of a Key Copper-Catalyzed Biaryl Ether Formation for the Multikilogram Synthesis of Emprumapimod
By: Brearley, Christopher; et al
Organic Process Research & Development (2024), 28(4), 1253-1259.
10.1021/acs.oprd.4c00052
```

---

## Reaction 31-614-CAS-35297626

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.5 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)C(c1ccc(F)c(F)c1)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1.COc1ccc(N)cc1`
  - Products: `COc1ccc(NC(=O)C(c2ccc(F)c(F)c2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1`

**Reference:**
  - **Title:** Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
  - **Authors:** Pal, Kavita; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115055.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.115055](https://doi.org/10.1016/j.ejmech.2022.115055)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-35297626
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dichloromethane; 0.5 h, rt
1.2|overnight, rt
Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
By: Pal, Kavita; et al
European Journal of Medicinal Chemistry (2023), 248, 115055.
10.1016/j.ejmech.2022.115055
```

---

## Reaction 31-614-CAS-35297627

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.5 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `COc1ccc(C(C(=O)O)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1.COc1ccc(N)cc1`
  - Products: `COc1ccc(NC(=O)C(c2ccc(OC)cc2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1`

**Reference:**
  - **Title:** Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
  - **Authors:** Pal, Kavita; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115055.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.115055](https://doi.org/10.1016/j.ejmech.2022.115055)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-35297627
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dichloromethane; 0.5 h, rt
1.2|overnight, rt
First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy
By: Huber, Andrew D.; et al
Journal of Medicinal Chemistry (2024), 67(20), 18549-18575.
10.1021/acs.jmedchem.4c01926
```

---

## Reaction 31-614-CAS-35297629

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.5 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)C(c1ccc(OC(F)(F)F)cc1)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1.COc1ccc(N)cc1`
  - Products: `COc1ccc(NC(=O)C(c2ccc(OC(F)(F)F)cc2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1`

**Reference:**
  - **Title:** Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
  - **Authors:** Pal, Kavita; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115055.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.115055](https://doi.org/10.1016/j.ejmech.2022.115055)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-35297629
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dichloromethane; 0.5 h, rt
1.2|overnight, rt
1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
By: Chen, Bei; et al
Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.
10.1021/acs.jmedchem.3c01326
```

---

## Reaction 31-614-CAS-35297639

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.5 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)C(c1ccc(F)cc1)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1.COc1ccc(N)cc1`
  - Products: `COc1ccc(NC(=O)C(c2ccc(F)cc2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1`

**Reference:**
  - **Title:** Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
  - **Authors:** Pal, Kavita; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115055.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.115055](https://doi.org/10.1016/j.ejmech.2022.115055)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-35297639
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dichloromethane; 0.5 h, rt
1.2|overnight, rt
Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
By: Pal, Kavita; et al
European Journal of Medicinal Chemistry (2023), 248, 115055.
10.1016/j.ejmech.2022.115055
```

---

## Reaction 31-614-CAS-35314251

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `O=C(O)C(F)F.CCNC(=O)c1ccc(N[C@H]2CCN(C(=O)OC(C)(C)C)C[C@@H]2C)c(N)c1`
  - Products: `CCNC(=O)c1ccc(N[C@H]2CCN(C(=O)OC(C)(C)C)C[C@@H]2C)c(NC(=O)C(F)F)c1`

**Reference:**
  - **Title:** Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4
  - **Authors:** Londregan, Allyn T.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(1), 460-472.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01421](https://doi.org/10.1021/acs.jmedchem.2c01421)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-35314251
1.1|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide, Tetrahydrofuran, Ethyl acetate; 0 °C → rt; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
By: Behring, Lydia; et al
Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
10.1021/acs.jmedchem.2c01360
```

---

## Reaction 31-614-CAS-35314257

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 26.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `CCN.Cl.Cc1cc2ccc(C(=O)O)cn2n1`
  - Products: `CCNC(=O)c1ccc2cc(C)nn2c1`

**Reference:**
  - **Title:** Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4
  - **Authors:** Londregan, Allyn T.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(1), 460-472.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01421](https://doi.org/10.1021/acs.jmedchem.2c01421)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-35314257
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 16 h, rt
Discovery of 10H-Benzo[b]pyrido[2,3-e][1,4]oxazine AXL Inhibitors via Structure-Based Drug Design Targeting c-Met Kinase
By: Zhan, Zhengsheng; et al
Journal of Medicinal Chemistry (2023), 66(1), 220-234.
10.1021/acs.jmedchem.2c00962
```

---

## Reaction 31-614-CAS-35336755

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.5 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)CCCCCCCBr.Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](N)C(C)(C)C)cc1`
  - Products: `Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCBr)C(C)(C)C)cc1`

**Reference:**
  - **Title:** Discovery of potent small molecule PROTACs targeting mutant EGFR
  - **Authors:** Zhao, Hong-Yi; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 208, 112781.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112781](https://doi.org/10.1016/j.ejmech.2020.112781)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-35336755
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 3.5 h, rt
Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma
By: Tseng, Hui-Ju; et al
European Journal of Medicinal Chemistry (2023), 256, 115459.
10.1016/j.ejmech.2023.115459
```

---

## Reaction 31-614-CAS-35396616

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O.C=CC[C@H]1[C@@H](C(=O)OC)N(C(=O)OC(C)(C)C)C[C@@H]1N`
  - Products: `C=CC[C@@H]1[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C)CN(C(=O)OC(C)(C)C)[C@@H]1C(=O)OC`

**Reference:**
  - **Title:** Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology
  - **Authors:** Lu, Min; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2021), 12(9), 1380-1388.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00195](https://doi.org/10.1021/acsmedchemlett.1c00195)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-35396616
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-35431759

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)OC(C)(C)C)nc5ccccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1.O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21`
  - Products: `COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)Cn5nc(C(F)F)c6c5C(F)(F)[C@@H]5C[C@H]65)nc5ccccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1`

**Reference:**
  - **Title:** Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
  - **Authors:** Gillis, Eric P.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01732](https://doi.org/10.1021/acs.jmedchem.2c01732)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-35431759
1.1|Reagents: Hydrochloric acid
Solvents: Dichloromethane, 1,4-Dioxane; overnight, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530)
By: Randolph, John T.; et al
Journal of Medicinal Chemistry (2020), 63(19), 11034-11044.
10.1021/acs.jmedchem.0c00956
```

---

## Reaction 31-614-CAS-35431762

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 4-Methylmorpholine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 12.0°C
  - Time: 4.5 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)Cc1cc(F)cc(F)c1.O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21`
  - Products: `COC(=O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21`

**Reference:**
  - **Title:** Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
  - **Authors:** Gillis, Eric P.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01732](https://doi.org/10.1021/acs.jmedchem.2c01732)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-35431762
1.1|Reagents: 4-Methylmorpholine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, HOAt
Solvents: Dimethylformamide; 4.5 h, rt
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C
By: Kettle, Jason G.; et al
Journal of Medicinal Chemistry (2022), 65(9), 6940-6952.
10.1021/acs.jmedchem.2c00369
```

---

## Reaction 31-614-CAS-35431767

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.COc1ccc(CN(c2nn(C)c3c(-n4c([C@@H](N)Cc5cc(F)cc(F)c5)nc5cc(F)ccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1.Cl`
  - Products: `COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)Cn5nc(C(F)F)c6c5C(F)(F)[C@@H]5C[C@H]65)nc5cc(F)ccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1`

**Reference:**
  - **Title:** Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
  - **Authors:** Gillis, Eric P.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01732](https://doi.org/10.1021/acs.jmedchem.2c01732)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-35431767
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
By: Gillis, Eric P.; et al
Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
10.1021/acs.jmedchem.2c01732
```

---

## Reaction 31-614-CAS-35431768

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.COc1ccc(CN(c2nn(C)c3c(-n4c([C@@H](N)Cc5cc(F)cc(F)c5)nc5cc(OC)ccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1.Cl`
  - Products: `COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)Cn5nc(C(F)F)c6c5C(F)(F)[C@@H]5C[C@H]65)nc5cc(OC)ccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1`

**Reference:**
  - **Title:** Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
  - **Authors:** Gillis, Eric P.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01732](https://doi.org/10.1021/acs.jmedchem.2c01732)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-35431768
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor, Furaprevir
By: Zhang, Weihong; et al
Organic Process Research & Development (2022), 26(4), 1078-1093.
10.1021/acs.oprd.1c00315
```

---

## Reaction 31-614-CAS-35431771

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.COc1ccc(CN(c2nn(C)c3c(-n4c([C@@H](N)Cc5cc(F)cc(F)c5)nc5ccc(F)cc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1.Cl`
  - Products: `COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)Cn5nc(C(F)F)c6c5C(F)(F)[C@@H]5C[C@H]65)nc5ccc(F)cc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1`

**Reference:**
  - **Title:** Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
  - **Authors:** Gillis, Eric P.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01732](https://doi.org/10.1021/acs.jmedchem.2c01732)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-35431771
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
By: Gillis, Eric P.; et al
Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
10.1021/acs.jmedchem.2c01732
```

---

## Reaction 31-614-CAS-35431775

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.COc1ccc(CN(c2nn(C)c3c(-n4c([C@@H](N)Cc5cc(F)cc(F)c5)nc5cc(Cl)ccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1`
  - Products: `COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)Cn5nc(C(F)F)c6c5C(F)(F)[C@@H]5C[C@H]65)nc5cc(Cl)ccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1`

**Reference:**
  - **Title:** Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
  - **Authors:** Gillis, Eric P.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01732](https://doi.org/10.1021/acs.jmedchem.2c01732)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-35431775
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
By: Gillis, Eric P.; et al
Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
10.1021/acs.jmedchem.2c01732
```

---

## Reaction 31-614-CAS-35431776

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.COc1ccc(CN(c2nn(C)c3c(-n4c([C@@H](N)Cc5cc(F)cc(F)c5)nc5cccc(F)c5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1.Cl`
  - Products: `COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)Cn5nc(C(F)F)c6c5C(F)(F)[C@@H]5C[C@H]65)nc5cccc(F)c5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1`

**Reference:**
  - **Title:** Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
  - **Authors:** Gillis, Eric P.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01732](https://doi.org/10.1021/acs.jmedchem.2c01732)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-35431776
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
By: Gillis, Eric P.; et al
Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
10.1021/acs.jmedchem.2c01732
```

---

## Reaction 31-614-CAS-35431795

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Ammonia (CAS: 7664-41-7) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - MeOH (CAS: 67-56-1) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.5 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.Cn1nc(NS(C)(=O)=O)c2c(Cl)ccc(-n3c([C@@H](N)Cc4cc(F)cc(F)c4)nc4cc(Br)ccc4c3=O)c21`
  - Products: `Cn1nc(NS(C)(=O)=O)c2c(Cl)ccc(-n3c(C(Cc4cc(F)cc(F)c4)NC(=O)Cn4nc(C(F)F)c5c4C(F)(F)C4CC54)nc4cc(Br)ccc4c3=O)c21`

**Reference:**
  - **Title:** Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
  - **Authors:** Gillis, Eric P.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01732](https://doi.org/10.1021/acs.jmedchem.2c01732)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-35431795
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 3 h, rt
1.2|Reagents: Ammonia
Solvents: Methanol; 30 min, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles
By: Lao, Zhiqi; et al
European Journal of Medicinal Chemistry (2023), 259, 115578.
10.1016/j.ejmech.2023.115578
```

---

## Reaction 31-614-CAS-35443131

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 16.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `Cc1cc(N)ccc1F.CC(C)(C)OC(=O)N1CCC[C@H](C(=O)O)C1`
  - Products: `Cc1cc(NC(=O)[C@H]2CCCN(C(=O)OC(C)(C)C)C2)ccc1F`

**Reference:**
  - **Title:** Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice
  - **Authors:** Yin, Jiaxin; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 249, 115141.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115141](https://doi.org/10.1016/j.ejmech.2023.115141)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-35443131
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; overnight, 40 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria
By: Zhang, Yinyong; et al
Journal of Medicinal Chemistry (2024), 67(8), 6585-6609.
10.1021/acs.jmedchem.4c00018
```

---

## Reaction 31-614-CAS-35443486

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CCC(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `CCC(=O)Nc1ccc(-c2ccc(C(=O)N3CCc4cc(OC)c(OC)cc4C3)o2)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-35443486
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
By: Pasqua, A. Elisa; et al
Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.
10.1021/acs.jmedchem.3c00156
```

---

## Reaction 31-614-CAS-35443488

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CCCCC(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `CCCCC(=O)Nc1ccc(-c2ccc(C(=O)N3CCc4cc(OC)c(OC)cc4C3)o2)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-35443488
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) Inhibitors
By: Heitmann, Tyler; et al
ACS Medicinal Chemistry Letters (2023), 14(12), 1760-1766.
10.1021/acsmedchemlett.3c00409
```

---

## Reaction 31-614-CAS-35443491

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CC(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(C)=O)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-35443491
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase
By: Stachura, Damian L.; et al
ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.
10.1021/acsmedchemlett.2c00505
```

---

## Reaction 31-614-CAS-35443493

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `CC(C)C(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)C(C)C)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-35443493
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-35443495

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CC(C)(C)C(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)C(C)(C)C)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-35443495
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1
By: Ryu, SeongShick; et al
Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.
10.1021/acs.jmedchem.1c01359
```

---

## Reaction 31-614-CAS-35443497

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `C/C=C/C(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `C/C=C/C(=O)Nc1ccc(-c2ccc(C(=O)N3CCc4cc(OC)c(OC)cc4C3)o2)cc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-35443497
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-35443498

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)C=Cc1ccccc1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)C=Cc4ccccc4)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-35443498
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Relative stereochemistry shown
Relative stereochemistry shown
Relative stereochemistry shown
Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow
By: Alder, Catherine M.; et al
Organic Process Research & Development (2022), 26(2), 365-379.
10.1021/acs.oprd.1c00422
```

---

## Reaction 31-614-CAS-35443500

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 5.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `O=C(O)C1CC1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)C4CC4)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-35443500
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
By: Sheppard, George S.; et al
Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.
10.1021/acs.jmedchem.0c00628
```

---

## Reaction 31-614-CAS-35443501

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)C1CCC1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)C4CCC4)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-35443501
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-35443502

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)c1cccc2ccccc12.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4cccc5ccccc45)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-35443502
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-35443503

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)Cc1cccc2ccccc12.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)Cc4cccc5ccccc45)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-35443503
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
By: Novotna, Katerina; et al
Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
10.1021/acs.jmedchem.3c01681
```

---

## Reaction 31-614-CAS-35443504

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)c1cc2ccccc2o1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4cc5ccccc5o4)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-35443504
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification
By: Schafer, Gabriel; et al
Organic Process Research & Development (2024), 28(6), 2103-2116.
10.1021/acs.oprd.3c00446
```

---

## Reaction 31-614-CAS-35443505

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1csc2ccccc12.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4csc5ccccc45)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-35443505
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
An optimized safe process from bench to pilot cGMP production of API eptifibatide using a multigram-scale microwave-assisted solid-phase peptide synthesizer
By: D’Ercole, Annunziata; et al
Organic Process Research & Development (2021), 25(12), 2754-2771.
10.1021/acs.oprd.1c00368
```

---

## Reaction 31-614-CAS-35443506

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CC(C)(C)CC(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)CC(C)(C)C)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-35443506
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-35443508

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)c1cc2ccccc2s1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4cc5ccccc5s4)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-35443508
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome
By: Gotz, Marion G.; et al
ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.
10.1021/acsmedchemlett.4c00017
```

---

## Reaction 31-614-CAS-35443510

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)c1cc2ccccc2[nH]1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4cc5ccccc5[nH]4)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-35443510
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Antimicrobial Peptide Mimetics Based on a Diphenylacetylene Scaffold: Synthesis, Conformational Analysis, and Activity
By: Peacock, Hayden; et al
ChemMedChem (2020), 15(20), 1932-1939.
10.1002/cmdc.202000474
```

---

## Reaction 31-614-CAS-35443513

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)C1CCCC1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)C4CCCC4)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-35443513
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-35443514

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1cc2cc(Cl)ccc2[nH]1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4cc5cc(Cl)ccc5[nH]4)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-35443514
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification
By: Schafer, Gabriel; et al
Organic Process Research & Development (2024), 28(6), 2103-2116.
10.1021/acs.oprd.3c00446
```

---

## Reaction 31-614-CAS-35443515

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `COc1ccc2cc(C(=O)O)[nH]c2c1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1ccc2cc(C(=O)Nc3ccc(-c4ccc(C(=O)N5CCc6cc(OC)c(OC)cc6C5)o4)cc3)[nH]c2c1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-35443515
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
By: Bothe, Ulrich; et al
Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.
10.1021/acs.jmedchem.3c01714
```

---

## Reaction 31-614-CAS-35443526

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `Cc1cccc2[nH]c(C(=O)O)cc12.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4cc5c(C)cccc5[nH]4)cc3)o1)CC2`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115092.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115092](https://doi.org/10.1016/j.ejmech.2023.115092)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-35443526
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations
By: Thomson, Clare; et al
Journal of Medicinal Chemistry (2024), 67(11), 8988-9027.
10.1021/acs.jmedchem.4c00227
```

---

## Reaction 31-614-CAS-35464719

**Type:** Other

**Reagents:**
  - N-Methylimidazole (CAS: 616-47-7) - Role: BASE (Registry: AMIDE_CATALYST)
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Methylimidazole - Role: UNK

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 1.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)CC(C)C.Cl.COc1cccc2[nH]c(C(=O)O)cc12`
  - Products: `COC(=O)[C@H](CC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1`

**Reference:**
  - **Title:** Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19
  - **Authors:** Allais, Christophe; et al
  - **Citation:** Organic Process Research & Development (2023), 27(12), 2223-2239.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.2c00375](https://doi.org/10.1021/acs.oprd.2c00375)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-35464719
1.1|Reagents: 1-Methylimidazole
Solvents: Acetonitrile; 0.5 - 1 h, 15 - 30 °C
1.2|Reagents: Propylphosphonic anhydride
Solvents: Acetonitrile; 15 - 30 °C
Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction
By: Ding, Jian; et al
Journal of Medicinal Chemistry (2023), 66(12), 8310-8323.
10.1021/acs.jmedchem.3c00787
```

---

## Reaction 31-614-CAS-35464726

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - 2-Hydroxypyridine N-oxide (CAS: 13161-30-3) - Role: UNK
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - Methyl (CAS: 78-93-3) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 8.333 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `COc1cccc2[nH]c(C(=O)N[C@@H](CC(C)C)C(=O)O)cc12.COC(=O)[C@@H](N)C[C@@H]1CCNC1=O.Cc1ccc(S(=O)(=O)O)cc1`
  - Products: `COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1`

**Reference:**
  - **Title:** Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19
  - **Authors:** Allais, Christophe; et al
  - **Citation:** Organic Process Research & Development (2023), 27(12), 2223-2239.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.2c00375](https://doi.org/10.1021/acs.oprd.2c00375)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-35464726
1.1|Reagents: Diisopropylethylamine, 2-Hydroxypyridine N-oxide, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Methyl ethyl ketone; rt → 0 °C; 20 min, 0 °C; 0 °C → 20 °C; 8 h, 20 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine
By: Zhang, Liang; et al
Journal of Medicinal Chemistry (2023), 66(6), 4150-4166.
10.1021/acs.jmedchem.3c00006
```

---

## Reaction 31-614-CAS-35473515

**Type:** Other

**Reagents:**
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 16.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCCC(=O)O.CCOC(=O)c1sc(N)nc1C`
  - Products: `CCOC(=O)c1sc(NC(=O)CCNC(=O)OC(C)(C)C)nc1C`

**Reference:**
  - **Title:** Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes
  - **Authors:** Saint-Dizier, Francois; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(4), 2622-2645.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01591](https://doi.org/10.1021/acs.jmedchem.2c01591)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-35473515
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole
Solvents: Dimethylformamide; rt; overnight, 50 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit
By: Zhan, Wenhu; et al
Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.
10.1021/acs.jmedchem.2c00733
```

---

## Reaction 31-614-CAS-35473530

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 20.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `COC(=O)CCN.Cl.Cc1nc(-c2cccc(C(=O)O)c2)no1`
  - Products: `COC(=O)CCNC(=O)c1cccc(-c2noc(C)n2)c1`

**Reference:**
  - **Title:** Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes
  - **Authors:** Saint-Dizier, Francois; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(4), 2622-2645.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01591](https://doi.org/10.1021/acs.jmedchem.2c01591)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-35473530
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 20 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain
By: Gallo, Francesca; et al
Journal of Medicinal Chemistry (2021), 64(7), 4117-4129.
10.1021/acs.jmedchem.1c00003
```

---

## Reaction 31-614-CAS-35625641

**Type:** Other

**Full Catalytic System:**
  - Dimethylaminopyridine (CAS: 57951-36-7)

**Catalyst Core:**
  - Dimethylaminopyridine (CAS: 57951-36-7)

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Cn1cc(OCc2ccccc2)c(=O)cc1CN.O=C(O)CCCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1`
  - Products: `Cn1cc(OCc2ccccc2)c(=O)cc1CNC(=O)CCCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1`

**Reference:**
  - **Title:** Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa
  - **Authors:** Wang, Yuan-Yuan; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02044](https://doi.org/10.1021/acs.jmedchem.2c02044)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-35625641
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: Dimethylaminopyridine
Solvents: Dichloromethane; 16 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties
By: Dragovich, Peter S.; et al
Journal of Medicinal Chemistry (2021), 64(5), 2534-2575.
10.1021/acs.jmedchem.0c01845
```

---

## Reaction 31-614-CAS-35625659

**Type:** Other

**Full Catalytic System:**
  - Dimethylaminopyridine (CAS: 57951-36-7)

**Catalyst Core:**
  - Dimethylaminopyridine (CAS: 57951-36-7)

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `NCc1ccccc1.O=C(O)CCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1`
  - Products: `O=C(CCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1)NCc1ccccc1`

**Reference:**
  - **Title:** Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa
  - **Authors:** Wang, Yuan-Yuan; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02044](https://doi.org/10.1021/acs.jmedchem.2c02044)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-35625659
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: Dimethylaminopyridine
Solvents: Dichloromethane; 16 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Six-Step Gram-Scale Synthesis of the Human Immunodeficiency Virus Integrase Inhibitor Dolutegravir Sodium
By: Dietz, Jule-Philipp; et al
Organic Process Research & Development (2021), 25(8), 1898-1910.
10.1021/acs.oprd.1c00139
```

---

## Reaction 31-614-CAS-35625660

**Type:** Other

**Full Catalytic System:**
  - Dimethylaminopyridine (CAS: 57951-36-7)

**Catalyst Core:**
  - Dimethylaminopyridine (CAS: 57951-36-7)

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `Cn1cc(OCc2ccccc2)c(=O)cc1CN.O=C(O)CCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1`
  - Products: `Cn1cc(OCc2ccccc2)c(=O)cc1CNC(=O)CCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1`

**Reference:**
  - **Title:** Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa
  - **Authors:** Wang, Yuan-Yuan; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02044](https://doi.org/10.1021/acs.jmedchem.2c02044)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-35625660
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: Dimethylaminopyridine
Solvents: Dichloromethane; 16 h, 25 °C
Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy
By: Wu, Shanchao; et al
Journal of Medicinal Chemistry (2022), 65(6), 4818-4831.
10.1021/acs.jmedchem.1c02026
```

---

## Reaction 31-614-CAS-35625672

**Type:** Other

**Full Catalytic System:**
  - Dimethylaminopyridine (CAS: 57951-36-7)

**Catalyst Core:**
  - Dimethylaminopyridine (CAS: 57951-36-7)

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)CCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1.Cc1cc(=O)c(OCc2ccccc2)cn1CCCN`
  - Products: `Cc1cc(=O)c(OCc2ccccc2)cn1CCCNC(=O)CCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1`

**Reference:**
  - **Title:** Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa
  - **Authors:** Wang, Yuan-Yuan; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02044](https://doi.org/10.1021/acs.jmedchem.2c02044)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-35625672
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: Dimethylaminopyridine
Solvents: Dichloromethane; 16 h, 25 °C
Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa
By: Wang, Yuan-Yuan; et al
Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.
10.1021/acs.jmedchem.2c02044
```

---

## Reaction 31-614-CAS-35647799

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - MeCN (CAS: 75-05-8) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 22.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Cl)nn1.COC(=O)c1cc(F)c(F)cc1N`
  - Products: `COC(=O)c1cc(F)c(F)cc1NC(=O)c1ccc(Cl)nn1`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists
  - **Authors:** Shan, Bin; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01714](https://doi.org/10.1021/acs.jmedchem.2c01714)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-35647799
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0 °C; 6 h, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Acetonitrile; overnight, rt
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
By: Pasqua, A. Elisa; et al
Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.
10.1021/acs.jmedchem.3c00156
```

---

## Reaction 31-614-CAS-35647834

**Type:** Other

**Reagents:**
  - EtOAc (CAS: 141-78-6) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - 1,2-Dichloroethane (CAS: 107-06-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 11.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `COC(=O)c1cc(OC)ccc1N.O=C(O)c1ccc(-c2ccnnc2)nn1`
  - Products: `COC(=O)c1cc(OC)ccc1NC(=O)c1ccc(-c2ccnnc2)nn1`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists
  - **Authors:** Shan, Bin; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01714](https://doi.org/10.1021/acs.jmedchem.2c01714)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-35647834
1.1|Reagents: Ethyl acetate, Diisopropylethylamine, Propylphosphonic anhydride
Solvents: 1,2-Dichloroethane; 10 h, 80 °C
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-614-CAS-35647835

**Type:** Other

**Reagents:**
  - EtOAc (CAS: 141-78-6) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - 1,2-Dichloroethane (CAS: 107-06-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 10.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `COC(=O)c1ccc(OC)cc1N.O=C(O)c1ccc(-c2ccnnc2)nn1`
  - Products: `COC(=O)c1ccc(OC)cc1NC(=O)c1ccc(-c2ccnnc2)nn1`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists
  - **Authors:** Shan, Bin; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01714](https://doi.org/10.1021/acs.jmedchem.2c01714)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-35647835
1.1|Reagents: Ethyl acetate, Diisopropylethylamine, Propylphosphonic anhydride
Solvents: 1,2-Dichloroethane; 10 h, 80 °C
Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists
By: Shan, Bin; et al
Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.
10.1021/acs.jmedchem.2c01714
```

---

## Reaction 31-614-CAS-35647838

**Type:** Other

**Reagents:**
  - EtOAc (CAS: 141-78-6) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - 1,2-Dichloroethane (CAS: 107-06-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 10.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `COC(=O)c1cc(OC)c(OC)cc1N.O=C(O)c1ccc(-c2ccnnc2)nn1`
  - Products: `COC(=O)c1cc(OC)c(OC)cc1NC(=O)c1ccc(-c2ccnnc2)nn1`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists
  - **Authors:** Shan, Bin; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01714](https://doi.org/10.1021/acs.jmedchem.2c01714)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-35647838
1.1|Reagents: Ethyl acetate, Diisopropylethylamine, Propylphosphonic anhydride
Solvents: 1,2-Dichloroethane; 10 h, 80 °C
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
By: Breidenbach, Julian; et al
Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
10.1021/acs.jmedchem.4c00053
```

---

## Reaction 31-614-CAS-35647846

**Type:** Other

**Reagents:**
  - EtOAc (CAS: 141-78-6) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - 1,2-Dichloroethane (CAS: 107-06-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 10.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `COC(=O)c1cc(Br)ccc1N.O=C(O)c1ccc(-c2ccnnc2)nn1`
  - Products: `COC(=O)c1cc(Br)ccc1NC(=O)c1ccc(-c2ccnnc2)nn1`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists
  - **Authors:** Shan, Bin; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01714](https://doi.org/10.1021/acs.jmedchem.2c01714)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-35647846
1.1|Reagents: Ethyl acetate, Diisopropylethylamine, Propylphosphonic anhydride
Solvents: 1,2-Dichloroethane; 10 h, 80 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
By: Jung, Sascha; et al
Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
10.1021/acs.jmedchem.1c01002
```

---

## Reaction 31-614-CAS-35966979

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - EtOH (CAS: 64-17-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.333 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `Nc1cc(Br)ccc1C(=O)O.CN`
  - Products: `CNC(=O)c1ccc(Br)cc1N`

**Reference:**
  - **Title:** Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
  - **Authors:** Ashton, Trent D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02092](https://doi.org/10.1021/acs.jmedchem.2c02092)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-35966979
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Tetrahydrofuran; 200 min, rt
1.2|Solvents: Ethanol; 2 w, rt
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
By: Ashton, Trent D.; et al
Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
10.1021/acs.jmedchem.2c02092
```

---

## Reaction 31-614-CAS-35966982

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - EtOH (CAS: 64-17-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 21.0°C
  - Time: 73.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `Nc1cc(Cl)ccc1C(=O)O.CN`
  - Products: `CNC(=O)c1ccc(Cl)cc1N`

**Reference:**
  - **Title:** Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
  - **Authors:** Ashton, Trent D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02092](https://doi.org/10.1021/acs.jmedchem.2c02092)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-35966982
1.1|Solvents: Tetrahydrofuran; 23 h, 21 °C
1.2|Reagents: 1,1′-Carbonyldiimidazole; 25 h, 21 °C
1.3|Solvents: Ethanol; 25 h, 21 °C
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
By: Ashton, Trent D.; et al
Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
10.1021/acs.jmedchem.2c02092
```

---

## Reaction 31-614-CAS-35966986

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - EtOH (CAS: 64-17-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 40.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `Nc1cc(F)ccc1C(=O)O.CN`
  - Products: `CNC(=O)c1ccc(F)cc1N`

**Reference:**
  - **Title:** Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
  - **Authors:** Ashton, Trent D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02092](https://doi.org/10.1021/acs.jmedchem.2c02092)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-35966986
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Tetrahydrofuran; 21 h, rt
1.2|Solvents: Ethanol; 19 h, rt
NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer
By: Xu, Zhongren; et al
Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.
10.1021/acs.jmedchem.3c00063
```

---

## Reaction 31-614-CAS-35966990

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `Nc1cccc(F)c1C(=O)O.CN.Cl`
  - Products: `CNC(=O)c1c(N)cccc1F`

**Reference:**
  - **Title:** Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
  - **Authors:** Ashton, Trent D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02092](https://doi.org/10.1021/acs.jmedchem.2c02092)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-35966990
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
By: Ashton, Trent D.; et al
Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
10.1021/acs.jmedchem.2c02092
```

---

## Reaction 31-614-CAS-35966994

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CN.Cl.Nc1c(F)cccc1C(=O)O`
  - Products: `CNC(=O)c1cccc(F)c1N`

**Reference:**
  - **Title:** Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
  - **Authors:** Ashton, Trent D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02092](https://doi.org/10.1021/acs.jmedchem.2c02092)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-35966994
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
By: Li, Bing-yan; et al
Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.
10.1021/acs.jmedchem.3c02407
```

---

## Reaction 31-614-CAS-35966995

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Nc1ccc(F)cc1C(=O)O.CN.Cl`
  - Products: `CNC(=O)c1cc(F)ccc1N`

**Reference:**
  - **Title:** Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
  - **Authors:** Ashton, Trent D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02092](https://doi.org/10.1021/acs.jmedchem.2c02092)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-35966995
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B
By: Lv, Gang; et al
Bioorganic & Medicinal Chemistry (2023), 80, 117173.
10.1016/j.bmc.2023.117173
```

---

## Reaction 31-614-CAS-35967000

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `CN.Cl.Nc1ccc(Cl)cc1C(=O)O`
  - Products: `CNC(=O)c1cc(Cl)ccc1N`

**Reference:**
  - **Title:** Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
  - **Authors:** Ashton, Trent D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02092](https://doi.org/10.1021/acs.jmedchem.2c02092)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-35967000
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
By: Ashton, Trent D.; et al
Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
10.1021/acs.jmedchem.2c02092
```

---

## Reaction 31-614-CAS-36054210

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -10.0°C
  - Time: 13.167 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(=O)O.CC(C)C[C@H](N)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C.O=C(O)C(F)(F)F`
  - Products: `CC(C)C[C@H](NC(=O)CNC(=O)OC(C)(C)C)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C`

**Reference:**
  - **Title:** Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma
  - **Authors:** Wang, Xueyuan; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 250, 115187.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115187](https://doi.org/10.1016/j.ejmech.2023.115187)

**Original Text:**
```
Steps: 1, Yield: 89-99%
CAS Reaction Number: 31-614-CAS-36054210
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -10 °C
1.2|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, -10 °C; 12 h, rt
High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists
By: Bolteau, Raphael; et al
European Journal of Medicinal Chemistry (2022), 241, 114620.
10.1016/j.ejmech.2022.114620
```

---

## Reaction 31-614-CAS-36054230

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -10.0°C
  - Time: 13.167 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)c1cc(Cl)ccc1Cl.CC(C)C[C@H](NC(=O)CN)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C`
  - Products: `CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C`

**Reference:**
  - **Title:** Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma
  - **Authors:** Wang, Xueyuan; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 250, 115187.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115187](https://doi.org/10.1016/j.ejmech.2023.115187)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-36054230
1.1|Reagents: 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 10 min, -10 °C
1.2|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, -10 °C; 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of florylpicoxamid, a mimic of a macrocyclic natural product
By: Meyer, Kevin G.; et al
Bioorganic & Medicinal Chemistry (2021), 50, 116455.
10.1016/j.bmc.2021.116455
```

---

## Reaction 31-614-CAS-36116266

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `O=C(N[C@@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CCCCCCCCCCCCN`
  - Products: `CCCCCCCCCCCCNC(=O)[C@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21`

**Reference:**
  - **Title:** Serine-/Cysteine-Based sp2-Iminoglycolipids as Novel TLR4 Agonists: Evaluation of Their Adjuvancy and Immunotherapeutic Properties in a Murine Model of Asthma
  - **Authors:** Gonzalez-Cuesta, Manuel; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(7), 4768-4783.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01948](https://doi.org/10.1021/acs.jmedchem.2c01948)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-36116266
1.1|Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole
Solvents: Tetrahydrofuran; rt
1.2|18 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor
By: Zhang, Yong; et al
Journal of Medicinal Chemistry (2021), 64(21), 15787-15798.
10.1021/acs.jmedchem.0c02043
```

---

## Reaction 31-614-CAS-36136857

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 6.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `C[C@H](C(=O)O)c1ccccc1.Cl.[N-]=[N+]=NC[C@H](N)c1ccc(OCC2CCC2)cc1`
  - Products: `C[C@H](C(=O)N[C@@H](CN=[N+]=[N-])c1ccc(OCC2CCC2)cc1)c1ccccc1`

**Reference:**
  - **Title:** Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies
  - **Authors:** Rahman, Toufiqur Md; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12397-12413.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01075](https://doi.org/10.1021/acs.jmedchem.1c01075)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-36136857
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Acetonitrile; 0 °C; 5 h, rt
1.2|Reagents: Sodium bicarbonate
Solvents: Water; rt
Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis
By: Zimmermann, Thomas; et al
Journal of Medicinal Chemistry (2024), 67(13), 10710-10742.
10.1021/acs.jmedchem.4c00230
```

---

## Reaction 31-614-CAS-36136965

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 6.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `C[C@H](C(=O)O)c1ccccc1.CC[C@H](C)COc1ccc([C@@H](N)CN=[N+]=[N-])cc1.Cl`
  - Products: `CC[C@H](C)COc1ccc([C@H](CN=[N+]=[N-])NC(=O)[C@@H](C)c2ccccc2)cc1`

**Reference:**
  - **Title:** Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies
  - **Authors:** Rahman, Toufiqur Md; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(16), 12397-12413.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01075](https://doi.org/10.1021/acs.jmedchem.1c01075)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-36136965
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Acetonitrile; 0 °C; 5 h, rt
1.2|Reagents: Sodium bicarbonate
Solvents: Water; rt
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target
By: Wilson, Caroline; et al
Journal of Medicinal Chemistry (2022), 65(1), 409-423.
10.1021/acs.jmedchem.1c01586
```

---

## Reaction 31-614-CAS-36137304

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 0.5 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](CCc1ccccc1)C(=O)O.COC(=O)[C@@H](N)CCCCOCc1ccccc1.Cl`
  - Products: `COC(=O)[C@H](CCCCOCc1ccccc1)NC(=O)[C@H](CCc1ccccc1)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors
  - **Authors:** Zhang, Hao; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00611](https://doi.org/10.1021/acs.jmedchem.2c00611)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-36137304
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 10 min, 0 °C
1.2|Solvents: Dimethylformamide; 0 °C; 20 min, 20 °C
Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists
By: Shan, Bin; et al
Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.
10.1021/acs.jmedchem.2c01714
```

---

## Reaction 31-614-CAS-36137356

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 1.5 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `Cl.N[C@@H](Cc1cccc(OCc2ccccc2)c1)C(=O)OCc1ccccc1.O=C(O)CCCBr`
  - Products: `O=C(CCCBr)N[C@@H](Cc1cccc(OCc2ccccc2)c1)C(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors
  - **Authors:** Zhang, Hao; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00611](https://doi.org/10.1021/acs.jmedchem.2c00611)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-36137356
1.1|Reagents: Thionyl chloride
Solvents: Dimethylformamide, Dichloromethane; 1 h, 0 °C
1.2|Reagents: Diisopropylethylamine
Solvents: Dichloromethane; 30 min, 20 °C
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models
By: Winter-Holt, Jon J.; et al
Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.
10.1021/acs.jmedchem.1c01871
```

---

## Reaction 31-614-CAS-36137379

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `NC1CCCC1.O=C(N[C@@H](CCCCO)C(=O)O)OCc1ccccc1`
  - Products: `O=C(N[C@@H](CCCCO)C(=O)NC1CCCC1)OCc1ccccc1`

**Reference:**
  - **Title:** Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors
  - **Authors:** Zhang, Hao; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00611](https://doi.org/10.1021/acs.jmedchem.2c00611)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-36137379
1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride
Solvents: Dimethylformamide; 0 °C; 1 h, 0 °C
1.2|Solvents: Water
Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans
By: Binjubair, Faizah A.; et al
ChemMedChem (2020), 15(14), 1294-1309.
10.1002/cmdc.202000250
```

---

## Reaction 31-614-CAS-36146371

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 98.0°C
  - Time: 28.167 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `O=C(O)c1c(F)cccc1Br.CC(C)(C)OC(=O)N1CCC(c2ccc3nc(N)n(C4CCCC4)c3c2)CC1`
  - Products: `CC(C)(C)OC(=O)N1CCC(c2ccc3nc(NC(=O)c4c(F)cccc4Br)n(C4CCCC4)c3c2)CC1`

**Reference:**
  - **Title:** Process Development for the Synthesis of BI 1702135: A Concise Design Enabled by Selective Acylation of a 2-Aminobenzimidazole Intermediate
  - **Authors:** Wu, Jiang-Ping; et al
  - **Citation:** Organic Process Research & Development (2023), 27(4), 788-797.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.3c00050](https://doi.org/10.1021/acs.oprd.3c00050)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-36146371
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: 1,4-Dioxane; 1.5 h, 98 °C
1.2|Reagents: 1-Hydroxybenzotriazole
Solvents: 1,4-Dioxane; 24 h, 98 °C; 98 °C → 65 °C
1.3|Solvents: Water; 40 min, 20 °C; 2 h
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1
By: Ryu, SeongShick; et al
Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.
10.1021/acs.jmedchem.1c01359
```

---

## Reaction 31-614-CAS-36209034

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 24.333 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(F)cc1.Nc1cccc(C(F)(F)F)c1`
  - Products: `O=C(Nc1cccc(C(F)(F)F)c1)c1ccc(F)cc1`

**Reference:**
  - **Title:** Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni
  - **Authors:** Kanyanta, Masebe; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2023.129164](https://doi.org/10.1016/j.bmcl.2023.129164)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-36209034
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 5 min, 0 °C; 0 °C → 30 °C; 15 min, 25 - 30 °C
1.2|19 - 24 h, 25 - 30 °C
Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitors
By: Yan, Yu-Hang; et al
European Journal of Medicinal Chemistry (2023), 257, 115473.
10.1016/j.ejmech.2023.115473
```

---

## Reaction 31-614-CAS-36209050

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 24.333 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1.COc1ccc(N)cc1OC`
  - Products: `COc1ccc(NC(=O)c2ccccc2)cc1OC`

**Reference:**
  - **Title:** Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni
  - **Authors:** Kanyanta, Masebe; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2023.129164](https://doi.org/10.1016/j.bmcl.2023.129164)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-36209050
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 5 min, 0 °C; 0 °C → 30 °C; 15 min, 25 - 30 °C
1.2|19 - 24 h, 25 - 30 °C
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor
By: Huestis, Malcolm P.; et al
ACS Medicinal Chemistry Letters (2021), 12(5), 791-797.
10.1021/acsmedchemlett.1c00063
```

---

## Reaction 31-614-CAS-36226435

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.25 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `C=CCN.O=C(O)CCCNC(=O)OCc1ccccc1`
  - Products: `C=CCNC(=O)CCCNC(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors
  - **Authors:** Balestri, Lorenzo Jacopo Ilic; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2023), 14(4), 417-424.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00472](https://doi.org/10.1021/acsmedchemlett.2c00472)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-36226435
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 min, 0 °C; 16 h, rt
1.2|Reagents: Sodium bicarbonate
Solvents: Water
HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells
By: Liang, Tao; et al
Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.
10.1021/acs.jmedchem.0c01454
```

---

## Reaction 31-614-CAS-36300086

**Type:** Other

**Reagents:**
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `NCc1ccco1.[N-]=[N+]=NCCCCCCCC(=O)O`
  - Products: `[N-]=[N+]=NCCCCCCCC(=O)NCc1ccco1`

**Reference:**
  - **Title:** Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancer
  - **Authors:** Fratta, Simone; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 250, 115170.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115170](https://doi.org/10.1016/j.ejmech.2023.115170)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-36300086
1.1|Reagents: PyBOP
Solvents: Dimethylformamide; rt → 0 °C
1.2|Reagents: Diisopropylethylamine; 0 °C; 16 h, rt
Development of Commercial Manufacturing Processes for Acalabrutinib
By: Bethel, Paul A.; et al
Organic Process Research & Development (2022), 26(12), 3303-3311.
10.1021/acs.oprd.2c00304
```

---

## Reaction 31-614-CAS-36342034

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `Cc1cc([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)O)C(C)C)on1.Cl.NCc1ccc(-c2scnc2Cl)cc1`
  - Products: `Cc1cc([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3Cl)cc2)C(C)C)on1`

**Reference:**
  - **Title:** Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design
  - **Authors:** Krieger, Johannes; et al
  - **Citation:** ChemMedChem (2023), 18(8), e202200615.
  - **DOI:** [https://doi.org/10.1002/cmdc.202200615](https://doi.org/10.1002/cmdc.202200615)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-36342034
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase
By: Stachura, Damian L.; et al
ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.
10.1021/acsmedchemlett.2c00505
```

---

## Reaction 31-614-CAS-36342043

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Lithium hydroxide (CAS: 1310-65-2) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)O)c1nnc(C)n1-2.COC(=O)[C@@H](c1cc(OCCCCCN)no1)C(C)C.Cl`
  - Products: `Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCCCOc1cc(C(C(=O)O)C(C)C)on1)c1nnc(C)n1-2`

**Reference:**
  - **Title:** Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design
  - **Authors:** Krieger, Johannes; et al
  - **Citation:** ChemMedChem (2023), 18(8), e202200615.
  - **DOI:** [https://doi.org/10.1002/cmdc.202200615](https://doi.org/10.1002/cmdc.202200615)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-36342043
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
1.2|Reagents: Lithium hydroxide
Solvents: Water; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo
By: Peschiulli, Aldo; et al
ACS Medicinal Chemistry Letters (2022), 13(1), 76-83.
10.1021/acsmedchemlett.1c00445
```

---

## Reaction 31-614-CAS-36491257

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 8.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(O)cc1.CC(C)(C)OC(=O)N1CC[C@H](CC(=O)O)C1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)C[C@H]1CCN(C(=O)OC(C)(C)C)C1)S(=O)(=O)c1ccc(O)cc1`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant
  - **Authors:** Zhou, Huiyu; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 255, 115389.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115389](https://doi.org/10.1016/j.ejmech.2023.115389)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-36491257
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant
By: Zhou, Huiyu; et al
European Journal of Medicinal Chemistry (2023), 255, 115389.
10.1016/j.ejmech.2023.115389
```

---

## Reaction 31-614-CAS-36491262

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 9.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1.CC(C)(C)OC(=O)N1CC[C@@H](CC(=O)O)C1`
  - Products: `COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)C[C@@H]2CCN(C(=O)OC(C)(C)C)C2)cc1`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant
  - **Authors:** Zhou, Huiyu; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 255, 115389.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115389](https://doi.org/10.1016/j.ejmech.2023.115389)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-36491262
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C
Design and Optimization of 1H-1,2,3-Triazole-4-carboxamides as Novel, Potent, and Selective Inverse Agonists and Antagonists of PXR
By: Li, Yongtao; et al
Journal of Medicinal Chemistry (2022), 65(24), 16829-16859.
10.1021/acs.jmedchem.2c01640
```

---

## Reaction 31-614-CAS-36491264

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 8.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CC[C@@H](C(=O)O)C1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(N)cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCN(C(=O)OC(C)(C)C)C1)S(=O)(=O)c1ccc(N)cc1`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant
  - **Authors:** Zhou, Huiyu; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 255, 115389.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115389](https://doi.org/10.1016/j.ejmech.2023.115389)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-36491264
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-614-CAS-36491266

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 8.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CC[C@@H](C(=O)O)C1.COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1`
  - Products: `COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCN(C(=O)OC(C)(C)C)C2)cc1`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant
  - **Authors:** Zhou, Huiyu; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 255, 115389.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115389](https://doi.org/10.1016/j.ejmech.2023.115389)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-36491266
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C
Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2
By: Zhang, Yi; et al
Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.
10.1021/acs.jmedchem.3c00504
```

---

## Reaction 31-614-CAS-36491274

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 8.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CC[C@@H](C(=O)O)C1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`
  - Products: `CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCN(C(=O)OC(C)(C)C)C1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant
  - **Authors:** Zhou, Huiyu; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 255, 115389.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115389](https://doi.org/10.1016/j.ejmech.2023.115389)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-36491274
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C
Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
By: Xu, Shujing; et al
Bioorganic & Medicinal Chemistry (2022), 53, 116531.
10.1016/j.bmc.2021.116531
```

---

## Reaction 31-614-CAS-36512451

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - Isobutyl chloroformate (CAS: 543-27-1) - Role: UNK
  - Potassium bisulfate (CAS: 7646-93-7) - Role: UNK
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)O.Cl.NCc1ccc(CNC(=O)OCc2ccccc2)cc1`
  - Products: `CC(C)(C)OC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)NCc1ccc(CNC(=O)OCc2ccccc2)cc1`

**Reference:**
  - **Title:** Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors
  - **Authors:** Wiedemeyer, Simon J. A.; et al
  - **Citation:** ChemMedChem (2023), 18(6), e202200632.
  - **DOI:** [https://doi.org/10.1002/cmdc.202200632](https://doi.org/10.1002/cmdc.202200632)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-36512451
1.1|Reagents: 4-Methylmorpholine
Solvents: Dimethylformamide, Tetrahydrofuran; rt → 0 °C
1.2|Reagents: Isobutyl chloroformate; 90 min, 0 °C; 30 min, 0 °C; 2 h, rt
1.3|Reagents: Potassium bisulfate
Solvents: Ethyl acetate, Water; rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies
By: Barlaam, Bernard; et al
Journal of Medicinal Chemistry (2020), 63(24), 15564-15590.
10.1021/acs.jmedchem.0c01754
```

---

## Reaction 31-614-CAS-36512482

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - Isobutyl chloroformate (CAS: 543-27-1) - Role: UNK
  - Potassium bisulfate (CAS: 7646-93-7) - Role: UNK
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)O.NCc1ccc(CNC(=O)C(F)(F)F)cc1`
  - Products: `CC(C)(C)OC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)NCc1ccc(CNC(=O)C(F)(F)F)cc1`

**Reference:**
  - **Title:** Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors
  - **Authors:** Wiedemeyer, Simon J. A.; et al
  - **Citation:** ChemMedChem (2023), 18(6), e202200632.
  - **DOI:** [https://doi.org/10.1002/cmdc.202200632](https://doi.org/10.1002/cmdc.202200632)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-36512482
1.1|Reagents: 4-Methylmorpholine
Solvents: Dichloromethane, Tetrahydrofuran; rt → 0 °C
1.2|Reagents: Isobutyl chloroformate
Solvents: Dichloromethane; 90 min, 0 °C; 30 min, 0 °C; 0 °C → rt; overnight, rt
1.3|Reagents: Potassium bisulfate
Solvents: Ethyl acetate, Water; rt
Design, synthesis, and optimization of a series of 2-azaspiro[3.3]heptane derivatives as orally bioavailable fetal hemoglobin inducers
By: Katayama, Katsushi; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127425.
10.1016/j.bmcl.2020.127425
```

---

## Reaction 31-614-CAS-36513480

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)c1cnc(Oc2ccccc2)nc1.CC(C)(C)OC(=O)C1CCN(c2ccc(N)cc2)CC1`
  - Products: `CC(C)(C)OC(=O)C1CCN(c2ccc(NC(=O)c3cnc(Oc4ccccc4)nc3)cc2)CC1`

**Reference:**
  - **Title:** CRBN ligand expansion for hematopoietic prostaglandin D2 synthase (H-PGDS) targeting PROTAC design and their in vitro ADME profiles
  - **Authors:** Osawa, Hinata; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 84, 117259.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117259](https://doi.org/10.1016/j.bmc.2023.117259)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-36513480
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 5 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma
By: Rango, Enrico; et al
European Journal of Medicinal Chemistry (2021), 223, 113653.
10.1016/j.ejmech.2021.113653
```

---

## Reaction 31-614-CAS-36550984

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 7.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `C#CCN(C)CCCOc1ccc(N)cc1Cl.CC(C)c1cc(C(=O)O)c(OCc2ccccc2)cc1OCc1ccccc1`
  - Products: `C#CCN(C)CCCOc1ccc(NC(=O)c2cc(C(C)C)c(OCc3ccccc3)cc2OCc2ccccc2)cc1Cl`

**Reference:**
  - **Title:** Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma
  - **Authors:** Tseng, Hui-Ju; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 256, 115459.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115459](https://doi.org/10.1016/j.ejmech.2023.115459)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-36550984
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 30 min, rt; 30 min, rt
1.2|6 h, rt
Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
By: Xu, Shujing; et al
Bioorganic & Medicinal Chemistry (2022), 53, 116531.
10.1016/j.bmc.2021.116531
```

---

## Reaction 31-614-CAS-36589101

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 72.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `COc1ccc(-n2nccn2)c(C(=O)N2C(=O)CC[C@@]2(C)C(=O)O)c1.Nc1ccc(Cl)c(CO)c1N`
  - Products: `COc1ccc(-n2nccn2)c(C(=O)N2C(=O)CC[C@@]2(C)C(=O)Nc2ccc(Cl)c(CO)c2N)c1`

**Reference:**
  - **Title:** CYP3A4 Catalyzes the Rearrangement of the Dual Orexin Receptor Antagonist Daridorexant to 4-Hydroxypiperidinol Metabolites
  - **Authors:** Treiber, Alexander; et al
  - **Citation:** ChemMedChem (2023), 18(10), e202300030.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300030](https://doi.org/10.1002/cmdc.202300030)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-36589101
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 3 d, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug
By: Ross, Catherine L.; et al
Journal of Medicinal Chemistry (2024), 67(11), 9599-9612.
10.1021/acs.jmedchem.4c00724
```

---

## Reaction 31-614-CAS-36693522

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `Cc1ccc(S(=O)(=O)O)cc1.NCCC(=O)OCc1ccccc1.CC(C)(C)OC(=O)Nc1cccc(C(=O)O)c1`
  - Products: `CC(C)(C)OC(=O)Nc1cccc(C(=O)NCCC(=O)OCc2ccccc2)c1`

**Reference:**
  - **Title:** Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation
  - **Authors:** Tokarski, Robert J. II; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 254, 115342.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115342](https://doi.org/10.1016/j.ejmech.2023.115342)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-36693522
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
By: Fuchs, Natalie; et al
ChemMedChem (2023), 18(15), e202300160.
10.1002/cmdc.202300160
```

---

## Reaction 31-614-CAS-36735488

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 6.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1[N+](=O)[O-].CN.Cl`
  - Products: `CNC(=O)c1ccccc1[N+](=O)[O-]`

**Reference:**
  - **Title:** Synthesis and evaluation of sulfonamide derivatives targeting EGFR790M/L858R mutations and ALK rearrangement as anticancer agents
  - **Authors:** Cao, Longcai; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 85, 117241.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117241](https://doi.org/10.1016/j.bmc.2023.117241)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-36735488
1.1|Reagents: Thionyl chloride; 2 h, 80 °C
1.2|Reagents: Sodium bicarbonate
Solvents: Acetonitrile; 4 h, 80 °C
Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors
By: Feng, Zi-Qiang; et al
European Journal of Medicinal Chemistry (2024), 266, 116113.
10.1016/j.ejmech.2023.116113
```

---

## Reaction 31-614-CAS-36772493

**Type:** Other

**Reagents:**
  - Py (CAS: 110-86-1) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -15.0°C
  - Time: 3.833 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CS(=O)(=O)c1cccc(Nc2ncc(F)c(-c3c[nH]c4c(N)cccc34)n2)c1F.COC[C@H](C(=O)O)N1CCN(C)CC1.Cl`
  - Products: `COC[C@H](C(=O)Nc1cccc2c(-c3nc(Nc4cccc(S(C)(=O)=O)c4F)ncc3F)c[nH]c12)N1CCN(C)CC1`

**Reference:**
  - **Title:** Practical and Scalable Method for Manufacturing AZD4604, A Potent and Selective JAK1 Inhibitor
  - **Authors:** Pithani, Subhash; et al
  - **Citation:** Organic Process Research & Development (2023), 27(7), 1317-1329.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.3c00077](https://doi.org/10.1021/acs.oprd.3c00077)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-36772493
1.1|Reagents: Pyridine
Solvents: Dimethylformamide; 5 min, -20 °C
1.2|Reagents: Propylphosphonic anhydride; 75 min, < -15 °C
1.3|Reagents: Water; 1 h, -15 °C; 30 min, -15 °C
Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa
By: Wang, Yuan-Yuan; et al
Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.
10.1021/acs.jmedchem.2c02044
```

---

## Reaction 31-614-CAS-36813239

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `C1CCC(NC2CCCCC2)CC1.CC(C)(C)OC(=O)NCCOCCOCC(=O)O.CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(N)cc4)cc23)c1F`
  - Products: `CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(NC(=O)COCCOCCNC(=O)OC(C)(C)C)cc4)cc23)c1F`

**Reference:**
  - **Title:** A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells
  - **Authors:** Barresi, Elisabetta; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 256, 115446.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115446](https://doi.org/10.1016/j.ejmech.2023.115446)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-36813239
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Double bond geometry shown
Double bond geometry shown
Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
By: Tang, Sheng; et al
European Journal of Medicinal Chemistry (2024), 263, 115939.
10.1016/j.ejmech.2023.115939
```

---

## Reaction 31-614-CAS-36826801

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `CCN(c1cc([N+](=O)[O-])cc(C(=O)O)c1C)C1CCOCC1.Cc1cc(C)c(CN)c(=O)[nH]1`
  - Products: `CCN(c1cc([N+](=O)[O-])cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1`

**Reference:**
  - **Title:** Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2
  - **Authors:** Zhang, Yi; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00504](https://doi.org/10.1021/acs.jmedchem.3c00504)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-36826801
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 1 h, rt
1.2|overnight, rt
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
By: Pasqua, A. Elisa; et al
Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.
10.1021/acs.jmedchem.3c00156
```

---

## Reaction 31-614-CAS-36826816

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `CCN(c1cc(C#N)cc(C(=O)O)c1C)C1CCOCC1.CCCc1cc(C)[nH]c(=O)c1CN`
  - Products: `CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(C#N)cc(N(CC)C2CCOCC2)c1C`

**Reference:**
  - **Title:** Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2
  - **Authors:** Zhang, Yi; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00504](https://doi.org/10.1021/acs.jmedchem.3c00504)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-36826816
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 1 h, rt
1.2|overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
By: Wang, Xu; et al
Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.
10.1021/acs.jmedchem.4c02009
```

---

## Reaction 31-614-CAS-36826818

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CCN(c1cc(C#N)cc(C(=O)O)c1C)C1CCOCC1.Cc1cc(C)c(CN)c(=O)[nH]1`
  - Products: `CCN(c1cc(C#N)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1`

**Reference:**
  - **Title:** Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2
  - **Authors:** Zhang, Yi; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00504](https://doi.org/10.1021/acs.jmedchem.3c00504)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-36826818
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 1 h, rt
1.2|overnight, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers
By: Cao, Chaoguo; et al
Journal of Medicinal Chemistry (2020), 63(19), 11012-11033.
10.1021/acs.jmedchem.0c00821
```

---

## Reaction 31-614-CAS-36826820

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CCN(c1cc(C#N)cc(C(=O)O)c1C)C1CCOCC1.CSc1cc(C)[nH]c(=O)c1CN`
  - Products: `CCN(c1cc(C#N)cc(C(=O)NCc2c(SC)cc(C)[nH]c2=O)c1C)C1CCOCC1`

**Reference:**
  - **Title:** Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2
  - **Authors:** Zhang, Yi; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00504](https://doi.org/10.1021/acs.jmedchem.3c00504)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-36826820
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 1 h, rt
1.2|overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2
By: Dai, Wenhao; et al
Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.
10.1021/acs.jmedchem.0c02258
```

---

## Reaction 31-614-CAS-36826830

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CCN(c1cc(C#N)cc(C(=O)O)c1C)C1CCOCC1.COc1cc(C)[nH]c(=O)c1CN`
  - Products: `CCN(c1cc(C#N)cc(C(=O)NCc2c(OC)cc(C)[nH]c2=O)c1C)C1CCOCC1`

**Reference:**
  - **Title:** Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2
  - **Authors:** Zhang, Yi; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00504](https://doi.org/10.1021/acs.jmedchem.3c00504)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-36826830
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 1 h, rt
1.2|overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability
By: Gao, Shenghua; et al
Journal of Medicinal Chemistry (2023), 66(23), 16426-16440.
10.1021/acs.jmedchem.3c01876
```

---

## Reaction 31-614-CAS-36827354

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.5 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(I)c1.Nc1ccc2[nH]ncc2c1`
  - Products: `O=C(Nc1ccc2[nH]ncc2c1)c1cccc(I)c1`

**Reference:**
  - **Title:** Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors
  - **Authors:** Rullo, Mariagrazia; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 255, 115352.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115352](https://doi.org/10.1016/j.ejmech.2023.115352)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-36827354
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 30 min, rt
1.2|overnight, rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-36827360

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.5 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(I)cc1.Nc1ccc2[nH]ncc2c1`
  - Products: `O=C(Nc1ccc2[nH]ncc2c1)c1ccc(I)cc1`

**Reference:**
  - **Title:** Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors
  - **Authors:** Rullo, Mariagrazia; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 255, 115352.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115352](https://doi.org/10.1016/j.ejmech.2023.115352)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-36827360
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 30 min, rt
1.2|overnight, rt
Driving Potency with Rotationally Stable Atropisomers: Discovery of Pyridopyrimidinedione-Carbazole Inhibitors of BTK
By: Srivastava, Anurag S.; et al
ACS Medicinal Chemistry Letters (2020), 11(11), 2195-2203.
10.1021/acsmedchemlett.0c00335
```

---

## Reaction 31-614-CAS-36827364

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.5 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `COc1ccc(C(=O)O)cc1.Nc1ccc2[nH]ncc2c1`
  - Products: `COc1ccc(C(=O)Nc2ccc3[nH]ncc3c2)cc1`

**Reference:**
  - **Title:** Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors
  - **Authors:** Rullo, Mariagrazia; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 255, 115352.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115352](https://doi.org/10.1016/j.ejmech.2023.115352)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-36827364
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 30 min, rt
1.2|overnight, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways
By: Ma, Xiaoyu; et al
Journal of Medicinal Chemistry (2024), 67(11), 8791-8816.
10.1021/acs.jmedchem.4c00131
```

---

## Reaction 31-614-CAS-36830487

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(F)c1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5cccc(F)c5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-36830487
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-36830488

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(C(F)(F)F)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(C(F)(F)F)cc5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-36830488
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon
By: Zhang, Weihe; et al
Bioorganic & Medicinal Chemistry (2022), 73, 117035.
10.1016/j.bmc.2022.117035
```

---

## Reaction 31-614-CAS-36830489

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(Cl)c1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5cccc(Cl)c5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-36830489
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-36830490

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1F.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccccc5F)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-36830490
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Design and Structural Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability
By: Zhang, Silong; et al
Journal of Medicinal Chemistry (2023), 66(7), 4849-4867.
10.1021/acs.jmedchem.2c02006
```

---

## Reaction 31-614-CAS-36830491

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(F)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(F)cc5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-36830491
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19
By: Allerton, Charlotte M. N.; et al
Journal of Medicinal Chemistry (2024), 67(16), 13550-13571.
10.1021/acs.jmedchem.3c02469
```

---

## Reaction 31-614-CAS-36830492

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `N#Cc1ccc(C(=O)O)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(C#N)cc5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-36830492
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-36830493

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(I)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(I)cc5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-36830493
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1
By: Sabat, Mark; et al
Journal of Medicinal Chemistry (2024), 67(12), 10306-10320.
10.1021/acs.jmedchem.4c00743
```

---

## Reaction 31-614-CAS-36830494

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccccc5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-36830494
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-614-CAS-36830495

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Oc2ccccc2)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(Oc6ccccc6)cc5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-36830495
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-614-CAS-36830496

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Br)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(Br)cc5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-36830496
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-36830497

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `COc1ccccc1C(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccccc5OC)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-36830497
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma
By: Zhou, Yi; et al
Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.
10.1021/acs.jmedchem.9b02161
```

---

## Reaction 31-614-CAS-36830498

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1Cl.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccccc5Cl)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-36830498
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-36830499

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1cccc(C(=O)O)c1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cccc(C(=O)Nc2ccc(-c3ccc4[nH]c(C(=O)N5CCc6cc(OC)c(OC)cc6C5)cc4c3)cc2)c1`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-36830499
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors
By: Martinez-Gualda, Belen; et al
Journal of Medicinal Chemistry (2020), 63(1), 349-368.
10.1021/acs.jmedchem.9b01737
```

---

## Reaction 31-614-CAS-36830500

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Cl)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(Cl)cc5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-36830500
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-36830501

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `COc1ccc(C(=O)O)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1ccc(C(=O)Nc2ccc(-c3ccc4[nH]c(C(=O)N5CCc6cc(OC)c(OC)cc6C5)cc4c3)cc2)cc1`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-36830501
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer’s Disease
By: Lee, Min Jae; et al
Journal of Medicinal Chemistry (2021), 64(15), 10934-10950.
10.1021/acs.jmedchem.1c00291
```

---

## Reaction 31-614-CAS-36830502

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(OC(F)(F)F)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(OC(F)(F)F)cc5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-36830502
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia
By: Hansen, Joshua D.; et al
Journal of Medicinal Chemistry (2021), 64(4), 1835-1843.
10.1021/acs.jmedchem.0c01489
```

---

## Reaction 31-614-CAS-36830503

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CCOc1ccc(C(=O)O)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `CCOc1ccc(C(=O)Nc2ccc(-c3ccc4[nH]c(C(=O)N5CCc6cc(OC)c(OC)cc6C5)cc4c3)cc2)cc1`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-36830503
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
By: Bothe, Ulrich; et al
Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.
10.1021/acs.jmedchem.3c01714
```

---

## Reaction 31-614-CAS-36830504

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CC(C)(C)Oc1ccc(C(=O)O)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(OC(C)(C)C)cc5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-36830504
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead
By: Dayan Elshan, N. G. R.; et al
Journal of Medicinal Chemistry (2024), 67(4), 2369-2378.
10.1021/acs.jmedchem.3c01938
```

---

## Reaction 31-614-CAS-36830505

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1cc(C(=O)O)cc(OC)c1OC.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5cc(OC)c(OC)c(OC)c5)cc4)ccc3[nH]1)CC2`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-36830505
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-36830507

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1ccc(C(=O)O)cc1OC.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2`
  - Products: `COc1ccc(C(=O)Nc2ccc(-c3ccc4[nH]c(C(=O)N5CCc6cc(OC)c(OC)cc6C5)cc4c3)cc2)cc1OC`

**Reference:**
  - **Title:** Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
  - **Authors:** Yang, Zhikun; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01999](https://doi.org/10.1021/acs.jmedchem.2c01999)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-36830507
1.1|Reagents: Oxalyl chloride
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 4 - 5, rt
Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13
By: Yang, Jianzhang; et al
Journal of Medicinal Chemistry (2022), 65(16), 11066-11083.
10.1021/acs.jmedchem.2c00384
```

---

## Reaction 31-614-CAS-36846458

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)CNC(=O)OCc1ccccc1.CC(C)(C)OC(=O)[C@@H](N)Cc1ccc(O)cc1`
  - Products: `CC(C)(C)OC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)OCc1ccccc1`

**Reference:**
  - **Title:** N-Alkyl Carbamoylimidazoles as Versatile Synthons for the Synthesis of Urea-Based PSMA Inhibitors
  - **Authors:** Gade, Narendar Reddy; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2023), 14(7), 943-948.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.3c00087](https://doi.org/10.1021/acsmedchemlett.3c00087)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-36846458
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; overnight, rt
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-614-CAS-36873887

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 28.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CC(=O)N1CCC(C(=O)O)CC1.Cc1ccc(N)cc1Cl`
  - Products: `CC(=O)N1CCC(C(=O)Nc2ccc(C)c(Cl)c2)CC1`

**Reference:**
  - **Title:** A “Two-Birds-One-Stone” Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region
  - **Authors:** Wang, Chao; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(15), 11460-11471.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00781](https://doi.org/10.1021/acs.jmedchem.1c00781)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-36873887
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Tetrahydrofuran; 4 h, rt
1.2|24 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide
By: Sampaio-Dias, Ivo E.; et al
Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.
10.1021/acs.jmedchem.1c00252
```

---

## Reaction 31-614-CAS-36966232

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 24.333 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)c1ccncc1.CCOC(=O)[C@@H](N)Cc1ccccc1.Cl`
  - Products: `CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccncc1`

**Reference:**
  - **Title:** Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
  - **Authors:** Fuchs, Natalie; et al
  - **Citation:** ChemMedChem (2023), 18(15), e202300160.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300160](https://doi.org/10.1002/cmdc.202300160)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-36966232
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C
1.2|12 - 24 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
By: Behring, Lydia; et al
Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
10.1021/acs.jmedchem.2c01360
```

---

## Reaction 31-614-CAS-36966237

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 24.333 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)c1ccncc1.CCOC(=O)[C@@H](N)CC(C)C.Cl`
  - Products: `CCOC(=O)[C@H](CC(C)C)NC(=O)c1ccncc1`

**Reference:**
  - **Title:** Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
  - **Authors:** Fuchs, Natalie; et al
  - **Citation:** ChemMedChem (2023), 18(15), e202300160.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300160](https://doi.org/10.1002/cmdc.202300160)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-36966237
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C
1.2|12 - 24 h, rt
Double bond geometry shown
Double bond geometry shown
Determination of Slow-Binding HDAC Inhibitor Potency and Subclass Selectivity
By: Moreno-Yruela, Carlos; et al
ACS Medicinal Chemistry Letters (2022), 13(5), 779-785.
10.1021/acsmedchemlett.1c00702
```

---

## Reaction 31-614-CAS-36966239

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 24.333 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `O=C(O)c1ccncc1.CCOC(=O)[C@@H](N)CC1CCCCC1`
  - Products: `CCOC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccncc1`

**Reference:**
  - **Title:** Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
  - **Authors:** Fuchs, Natalie; et al
  - **Citation:** ChemMedChem (2023), 18(15), e202300160.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300160](https://doi.org/10.1002/cmdc.202300160)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-36966239
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C
1.2|12 - 24 h, rt
Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
By: Fang, Wei; et al
Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
10.1021/acs.jmedchem.3c02063
```

---

## Reaction 31-614-CAS-36966240

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 24.333 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1.CCOC(=O)[C@@H](N)Cc1ccccc1.Cl`
  - Products: `CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1`

**Reference:**
  - **Title:** Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
  - **Authors:** Fuchs, Natalie; et al
  - **Citation:** ChemMedChem (2023), 18(15), e202300160.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300160](https://doi.org/10.1002/cmdc.202300160)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-36966240
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C
1.2|12 - 24 h, rt
Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein-Protein Interactions Involving Autophagy-Related 5
By: Xiang, Honggang; et al
Journal of Medicinal Chemistry (2023), 66(4), 2457-2476.
10.1021/acs.jmedchem.2c01233
```

---

## Reaction 31-614-CAS-36966242

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 24.333 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `O=C(O)c1ccsc1.CCOC(=O)[C@@H](N)Cc1ccccc1.Cl`
  - Products: `CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccsc1`

**Reference:**
  - **Title:** Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
  - **Authors:** Fuchs, Natalie; et al
  - **Citation:** ChemMedChem (2023), 18(15), e202300160.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300160](https://doi.org/10.1002/cmdc.202300160)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-36966242
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C
1.2|12 - 24 h, rt
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
By: Hiesinger, Kerstin; et al
Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.
10.1021/acs.jmedchem.0c00561
```

---

## Reaction 31-614-CAS-36966243

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 24.333 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)c1ccncc1.CCOC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.Cl`
  - Products: `CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccncc1`

**Reference:**
  - **Title:** Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
  - **Authors:** Fuchs, Natalie; et al
  - **Citation:** ChemMedChem (2023), 18(15), e202300160.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300160](https://doi.org/10.1002/cmdc.202300160)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-36966243
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C
1.2|12 - 24 h, rt
Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors
By: Shu, Lei; et al
European Journal of Medicinal Chemistry (2020), 191, 112148pp..
10.1016/j.ejmech.2020.112148
```

---

## Reaction 31-614-CAS-36966246

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 24.333 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)Nc1ccc(C(=O)O)cc1.CCOC(=O)[C@@H](N)CC1CCCCC1.Cl`
  - Products: `CCOC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(NC(=O)OC(C)(C)C)cc1`

**Reference:**
  - **Title:** Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
  - **Authors:** Fuchs, Natalie; et al
  - **Citation:** ChemMedChem (2023), 18(15), e202300160.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300160](https://doi.org/10.1002/cmdc.202300160)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-36966246
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C
1.2|12 - 24 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models
By: Winter-Holt, Jon J.; et al
Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.
10.1021/acs.jmedchem.1c01871
```

---

## Reaction 31-614-CAS-36967878

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)CCCCBr.Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](N)C(C)(C)C)cc1`
  - Products: `Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCBr)C(C)(C)C)cc1`

**Reference:**
  - **Title:** Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction
  - **Authors:** Si, Ru; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 257, 115497.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115497](https://doi.org/10.1016/j.ejmech.2023.115497)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-36967878
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 0 °C; 1 h, rt
Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells
By: Comeo, Eleonora; et al
Journal of Medicinal Chemistry (2021), 64(10), 6670-6695.
10.1021/acs.jmedchem.0c02067
```

---

## Reaction 31-614-CAS-36975263

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.25 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `Cc1cc(=O)c(C(=O)O)nn1-c1ccccc1.Cl.NCc1c(F)cc(Br)cc1F`
  - Products: `Cc1cc(=O)c(C(=O)NCc2c(F)cc(Br)cc2F)nn1-c1ccccc1`

**Reference:**
  - **Title:** Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction
  - **Authors:** Ding, Jian; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(12), 8310-8323.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00787](https://doi.org/10.1021/acs.jmedchem.3c00787)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-36975263
1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride
Solvents: Dimethylformamide; 15 min, 0 °C
1.2|16 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the influenza cap-dependent endonuclease inhibitor
By: Taoda, Yoshiyuki; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(22), 127547.
10.1016/j.bmcl.2020.127547
```

---

## Reaction 31-614-CAS-37041496

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCCOCCN.COCCn1nc(C(=O)O)c2cc(Nc3nccc(-n4cc(C=O)c(C)n4)n3)ccc21`
  - Products: `COCCn1nc(C(=O)NCCOCCNC(=O)OC(C)(C)C)c2cc(Nc3nccc(-n4cc(C=O)c(C)n4)n3)ccc21`

**Reference:**
  - **Title:** Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors
  - **Authors:** Grimster, Neil P.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2023), 91, 129352.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2023.129352](https://doi.org/10.1016/j.bmcl.2023.129352)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-37041496
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
By: Chen, Bei; et al
Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.
10.1021/acs.jmedchem.3c01326
```

---

## Reaction 31-614-CAS-37043002

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Reaction Conditions:**
  - Time: 26.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `COc1ccc2cc([C@H](C)C(=O)O)ccc2c1.C#CCN`
  - Products: `C#CCNC(=O)[C@@H](C)c1ccc2cc(OC)ccc2c1`

**Reference:**
  - **Title:** NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer
  - **Authors:** Xu, Zhongren; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00063](https://doi.org/10.1021/acs.jmedchem.3c00063)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-37043002
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, 0 °C
1.2|24 h, rt
Design, synthesis and biological evaluation of 1H-indazole derivatives as novel ASK1 inhibitors
By: Hou, Shaohua; et al
European Journal of Medicinal Chemistry (2021), 220, 113482.
10.1016/j.ejmech.2021.113482
```

---

## Reaction 31-614-CAS-37043005

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Reaction Conditions:**
  - Time: 25.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)=O)cc1.C#CCN`
  - Products: `C#CCNC(=O)CC1=C(C)C(=Cc2ccc(S(C)=O)cc2)c2ccc(F)cc21`

**Reference:**
  - **Title:** NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer
  - **Authors:** Xu, Zhongren; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00063](https://doi.org/10.1021/acs.jmedchem.3c00063)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-37043005
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, 0 °C
1.2|24 h, rt
Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
By: Fang, Wei; et al
Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
10.1021/acs.jmedchem.3c02063
```

---

## Reaction 31-614-CAS-37043008

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Reaction Conditions:**
  - Time: 25.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)Cc1cccc2ccccc12.C#CCN`
  - Products: `C#CCNC(=O)Cc1cccc2ccccc12`

**Reference:**
  - **Title:** NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer
  - **Authors:** Xu, Zhongren; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00063](https://doi.org/10.1021/acs.jmedchem.3c00063)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-37043008
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, 0 °C
1.2|24 h, rt
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
By: Ashton, Trent D.; et al
Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
10.1021/acs.jmedchem.2c02092
```

---

## Reaction 31-614-CAS-37043010

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Reaction Conditions:**
  - Time: 26.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1.C#CCN`
  - Products: `C#CCNC(=O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1`

**Reference:**
  - **Title:** NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer
  - **Authors:** Xu, Zhongren; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00063](https://doi.org/10.1021/acs.jmedchem.3c00063)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-37043010
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, 0 °C
1.2|24 h, rt
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-614-CAS-37102940

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.5 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Br)cc1.CCCCCc1cc(OC)c(N)c(OC)c1`
  - Products: `CCCCCc1cc(OC)c(NC(=O)c2ccc(Br)cc2)c(OC)c1`

**Reference:**
  - **Title:** Design, synthesis, and analgesia evaluation of novel Transient Receptor Potential Vanilloid 1 (TRPV1) agonists modified from Cannabidiol (CBD)
  - **Authors:** Jin, Fangjie; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 90, 117379.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117379](https://doi.org/10.1016/j.bmc.2023.117379)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-37102940
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 30 min, rt
1.2|overnight, rt
1.3|Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit
By: Zhan, Wenhu; et al
Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.
10.1021/acs.jmedchem.2c00733
```

---

## Reaction 31-614-CAS-37137463

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.333 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `N#Cc1c(Nc2ccccc2)nc(SCC(=O)O)nc1-c1ccccc1.NCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1`
  - Products: `N#Cc1c(Nc2ccccc2)nc(SCC(=O)NCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)nc1-c1ccccc1`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of nitric oxide-releasing 5-cyano-6-phenyl-2, 4-disubstituted pyrimidine derivatives
  - **Authors:** Chi, Lingling; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2023), 92, 129389.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2023.129389](https://doi.org/10.1016/j.bmcl.2023.129389)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-37137463
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 20 min, rt
1.2|4 h, rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-37155046

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 11.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1cc(Br)cc(I)c1.CC[C@@H](N)c1ccccc1`
  - Products: `CC[C@@H](NC(=O)c1cc(Br)cc(I)c1)c1ccccc1`

**Reference:**
  - **Title:** Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model
  - **Authors:** Maddeboina, Krishnaiah; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(14), 9894-9915.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00732](https://doi.org/10.1021/acs.jmedchem.3c00732)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-37155046
1.1|Reagents: Thionyl chloride; 3 h, reflux
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; rt; rt → 0 °C; 8 h, rt
Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor
By: Li, Huiqiong; et al
European Journal of Medicinal Chemistry (2024), 272, 116473.
10.1016/j.ejmech.2024.116473
```

---

## Reaction 31-614-CAS-37198975

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - TFA (CAS: 76-05-1) - Role: UNK (Registry: SOLVENT)

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.5 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O.CCCC[C@@H](N)C(=O)OCc1ccc([N+](=O)[O-])cc1`
  - Products: `CCCC[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)C(=O)OCc1ccc([N+](=O)[O-])cc1`

**Reference:**
  - **Title:** Development, synthesis and evaluation of novel fluorescent Endothelin-B receptor probes
  - **Authors:** Delahaye, Juliette; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 258, 115568.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115568](https://doi.org/10.1016/j.ejmech.2023.115568)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-37198975
1.1|Reagents: Triethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide; 30 min, rt
1.2|Reagents: Trifluoroacetic acid
Solvents: Dimethylformamide; overnight, rt
Process Development for the Synthesis of BI 1702135: A Concise Design Enabled by Selective Acylation of a 2-Aminobenzimidazole Intermediate
By: Wu, Jiang-Ping; et al
Organic Process Research & Development (2023), 27(4), 788-797.
10.1021/acs.oprd.3c00050
```

---

## Reaction 31-614-CAS-37200035

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - 1,2-Dichloroethane (CAS: 107-06-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)[C@H]1CCc2ccccc2O1.C[C@@H](N)c1cccc2ccccc12`
  - Products: `C[C@@H](NC(=O)[C@H]1CCc2ccccc2O1)c1cccc2ccccc12`

**Reference:**
  - **Title:** Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism
  - **Authors:** Shukla, Manojkumar R.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(14), 9418-9444.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00698](https://doi.org/10.1021/acs.jmedchem.3c00698)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-37200035
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide
Solvents: 1,2-Dichloroethane; 0 °C → reflux
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 1 h, 0 °C
Nitrile-based peptoids as cysteine protease inhibitors
By: Alves, Luana; et al
Bioorganic & Medicinal Chemistry (2021), 41, 116211.
10.1016/j.bmc.2021.116211
```

---

## Reaction 31-614-CAS-37213507

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 85.0°C
  - Time: 9.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)c1nc(Cl)ccc1Cl.Nc1ccccc1`
  - Products: `O=C(Nc1ccccc1)c1nc(Cl)ccc1Cl`

**Reference:**
  - **Title:** Rhodium(III)-Picolinamide Complexes Act as Anticancer and Antimetastasis Agents via Inducing Apoptosis and Autophagy
  - **Authors:** Gu, Yun-Qiong; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(14), 9592-9606.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00318](https://doi.org/10.1021/acs.jmedchem.3c00318)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-37213507
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide; 3 h, 85 °C
1.2|Reagents: Triethylamine
Solvents: Acetonitrile; 6 h, 80 °C
Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors
By: Karim, Rezaul Md; et al
Journal of Medicinal Chemistry (2021), 64(21), 15772-15786.
10.1021/acs.jmedchem.1c01096
```

---

## Reaction 31-614-CAS-37215001

**Type:** Other

**Reagents:**
  - EDC (CAS: 1892-57-5) - Role: BASE (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)Cc1ccccc1.Cl.O=C(O)[C@H](Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccccc1[N+](=O)[O-]`
  - Products: `COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccccc1[N+](=O)[O-]`

**Reference:**
  - **Title:** Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine template
  - **Authors:** Marciniak, Monika; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 258, 115587.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115587](https://doi.org/10.1016/j.ejmech.2023.115587)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-37215001
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine
Solvents: Dimethylformamide; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis
By: Futatsugi, Kentaro; et al
Journal of Medicinal Chemistry (2022), 65(22), 15000-15013.
10.1021/acs.jmedchem.2c01200
```

---

## Reaction 31-614-CAS-37217821

**Type:** Other

**Reagents:**
  - 2,6-Lutidine (CAS: 108-48-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 15.0°C
  - Time: 15.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `C[C@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(=O)O.C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1C[C@H]1O[C@@H](c3ccc(Cc4cccc(N)c4)cc3)O[C@]12C(=O)CO`
  - Products: `C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)Nc1cccc(Cc2ccc([C@@H]3O[C@@H]4C[C@H]5[C@@H]6CCC7=CC(=O)C=C[C@]7(C)[C@H]6[C@@H](O)C[C@]5(C)[C@]4(C(=O)CO)O3)cc2)c1`

**Reference:**
  - **Title:** Optimization of Drug-Linker to Enable Long-term Storage of Antibody-Drug Conjugate for Subcutaneous Dosing
  - **Authors:** Hobson, Adrian D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(13), 9161-9173.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00794](https://doi.org/10.1021/acs.jmedchem.3c00794)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-37217821
1.1|Reagents: 2,6-Lutidine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; 15 h, 15 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Practical and Scalable Method for Manufacturing AZD4604, A Potent and Selective JAK1 Inhibitor
By: Pithani, Subhash; et al
Organic Process Research & Development (2023), 27(7), 1317-1329.
10.1021/acs.oprd.3c00077
```

---

## Reaction 31-614-CAS-37259405

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(=O)O.C#Cc1cccc(N)c1`
  - Products: `C#Cc1cccc(NC(=O)CNC(=O)OC(C)(C)C)c1`

**Reference:**
  - **Title:** Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitors
  - **Authors:** Yan, Yu-Hang; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 257, 115473.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115473](https://doi.org/10.1016/j.ejmech.2023.115473)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-37259405
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 3 h, rt
Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation
By: Bayrak, Alp; et al
Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.
10.1021/acs.jmedchem.2c01198
```

---

## Reaction 31-614-CAS-37263130

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMAc (CAS: 127-19-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 108.083 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)O.Nc1ccc(OCc2ccccc2)cc1`
  - Products: `CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)Nc1ccc(OCc2ccccc2)cc1`

**Reference:**
  - **Title:** [18F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging
  - **Authors:** De Dominicis, Carlo; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2020), 11(5), 933-939.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.9b00677](https://doi.org/10.1021/acsmedchemlett.9b00677)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-37263130
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylacetamide; 5 min, rt
1.2|Reagents: Diisopropylethylamine; 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)
By: Wang, Jocelyn; et al
Bioorganic & Medicinal Chemistry Letters (2023), 96, 129492.
10.1016/j.bmcl.2023.129492
```

---

## Reaction 31-614-CAS-37263132

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Na2CO3 (CAS: 497-19-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium carbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CC(C)(C)CC(=O)O.COC(=O)[C@@H](N)Cc1ccccc1.Cl`
  - Products: `COC(=O)[C@H](Cc1ccccc1)NC(=O)CC(C)(C)C`

**Reference:**
  - **Title:** Serendipitous Discovery of Leucine and Methionine Depletion Agents during the Search for Polyamine Transport Inhibitors
  - **Authors:** Massaro, Chelsea; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(6), 2814-2832.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b00568](https://doi.org/10.1021/acs.jmedchem.9b00568)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-37263132
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 24 h, rt
1.2|Reagents: Sodium carbonate
Solvents: Water; rt
Lead Optimization of the 5-Phenylpyrazolopyrimidinone NPD-2975 toward Compounds with Improved Antitrypanosomal Efficacy
By: Zheng, Yang; et al
Journal of Medicinal Chemistry (2024), 67(4), 2849-2863.
10.1021/acs.jmedchem.3c01976
```

---

## Reaction 31-614-CAS-37264191

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.167 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `Cc1ccc(C(=O)O)cc1N.NCc1cccnc1`
  - Products: `Cc1ccc(C(=O)NCc2cccnc2)cc1N`

**Reference:**
  - **Title:** Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site
  - **Authors:** Lin, Songwen; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(24), 16372-16391.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01208](https://doi.org/10.1021/acs.jmedchem.2c01208)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-37264191
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; overnight, rt
1.2|Solvents: Water; 10 min, rt
Double bond geometry shown
Double bond geometry shown
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
By: Zhang, Kuojun; et al
Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
10.1021/acs.jmedchem.2c00077
```

---

## Reaction 31-614-CAS-37268467

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - N-Methylmorpholine (CAS: 109-02-4) - Role: AMIDE_BASE
  - 4-Methylmorpholine

**Reaction Conditions:**
  - Time: 8.167 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](CCCNC(=O)OCc1ccccc1)C(=O)O.NCc1ccccc1`
  - Products: `CC(C)(C)OC(=O)N[C@@H](CCCNC(=O)OCc1ccccc1)C(=O)NCc1ccccc1`

**Reference:**
  - **Title:** Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils
  - **Authors:** Zhu, Di; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 258, 115619.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115619](https://doi.org/10.1016/j.ejmech.2023.115619)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-37268467
1.1|Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole
Solvents: Tetrahydrofuran; 10 min, 0 °C
1.2|Solvents: 4-Methylmorpholine; pH 8.0, rt; 8 h, rt
Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
By: Bothe, Ulrich; et al
Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.
10.1021/acs.jmedchem.3c01714
```

---

## Reaction 31-614-CAS-37275693

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 15.833 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `Cc1cccc(Nc2ccccc2C(=O)O)c1C.CCCCCCCCCCCC[N+](C)(CCN)CCCCCCCCCCCC.[I-]`
  - Products: `CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CCNC(=O)c1ccccc1Nc1cccc(C)c1C.[I-]`

**Reference:**
  - **Title:** Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers
  - **Authors:** Vaidya, Sandeep; et al
  - **Citation:** ChemMedChem (2023), 18(16), e202300097.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300097](https://doi.org/10.1002/cmdc.202300097)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-37275693
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 20 min, rt
1.2|Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt
Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
By: Narayanan, Dilip; et al
Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.
10.1021/acs.jmedchem.2c00830
```

---

## Reaction 31-614-CAS-37275694

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 15.833 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)Cc1ccc(C(C)C(=O)O)cc1.CCCCCCCCCCCC[N+](C)(CCN)CCCCCCCCCCCC.[I-]`
  - Products: `CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CCNC(=O)C(C)c1ccc(CC(C)C)cc1.[I-]`

**Reference:**
  - **Title:** Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers
  - **Authors:** Vaidya, Sandeep; et al
  - **Citation:** ChemMedChem (2023), 18(16), e202300097.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300097](https://doi.org/10.1002/cmdc.202300097)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-37275694
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 20 min, rt
1.2|Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-37275697

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.833 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1.CCCCCCCCCCCC[N+](C)(CCN)CCCCCCCCCCCC.[I-]`
  - Products: `CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CCNC(=O)C(C)c1cccc(C(=O)c2ccccc2)c1.[I-]`

**Reference:**
  - **Title:** Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers
  - **Authors:** Vaidya, Sandeep; et al
  - **Citation:** ChemMedChem (2023), 18(16), e202300097.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300097](https://doi.org/10.1002/cmdc.202300097)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-37275697
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 20 min, rt
1.2|Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt
Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
By: Sheppard, George S.; et al
Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.
10.1021/acs.jmedchem.0c00628
```

---

## Reaction 31-614-CAS-37275700

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 15.833 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12.CCCCCCCCCCCC[N+](C)(CCN)CCCCCCCCCCCC.[I-]`
  - Products: `CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CCNC(=O)C(C)c1ccc2c(c1)[nH]c1ccc(Cl)cc12.[I-]`

**Reference:**
  - **Title:** Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers
  - **Authors:** Vaidya, Sandeep; et al
  - **Citation:** ChemMedChem (2023), 18(16), e202300097.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300097](https://doi.org/10.1002/cmdc.202300097)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-37275700
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 20 min, rt
1.2|Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
By: Jung, Sascha; et al
Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
10.1021/acs.jmedchem.1c01002
```

---

## Reaction 31-614-CAS-37275703

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 15.833 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1.CCCCCCCCCCCC[N+](C)(CCN)CCCCCCCCCCCC.[I-]`
  - Products: `CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CCNC(=O)Cc1c(C)n(C(=O)c2ccc(Cl)cc2)c2ccc(OC)cc12.[I-]`

**Reference:**
  - **Title:** Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers
  - **Authors:** Vaidya, Sandeep; et al
  - **Citation:** ChemMedChem (2023), 18(16), e202300097.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300097](https://doi.org/10.1002/cmdc.202300097)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-37275703
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Dichloromethane; 20 min, rt
1.2|Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer
By: Cordella, Fabiana; et al
ChemMedChem (2024), 19(14), e202300727.
10.1002/cmdc.202300727
```

---

## Reaction 31-614-CAS-37291176

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 22.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `CN1CCc2nc(C(=O)O)sc2C1.Cl.Br.CN(C)C(=O)[C@H]1CC[C@@H](O)[C@H](N)C1`
  - Products: `CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@H]3O)sc2C1`

**Reference:**
  - **Title:** Stereoinvertive Deoxyamination of trans-2-Aminocyclohexanol Using Bose-Mitsunobu Azidation and Staudinger Reaction for the Stereoselective Synthesis of Edoxaban
  - **Authors:** Ochiai, Hidenori; et al
  - **Citation:** Organic Process Research & Development (2023), 27(8), 1517-1532.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.3c00189](https://doi.org/10.1021/acs.oprd.3c00189)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-37291176
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 0 °C; 22 h, 25 °C
Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors
By: Huang, Daowei; et al
European Journal of Medicinal Chemistry (2021), 223, 113648.
10.1016/j.ejmech.2021.113648
```

---

## Reaction 31-614-CAS-37335626

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - Pivaloyl chloride (CAS: 3282-30-2) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `O=C(O)CCc1c[nH]c2ccccc12.COC(=O)C(C)N.Cl`
  - Products: `COC(=O)C(C)NC(=O)CCc1c[nH]c2ccccc12`

**Reference:**
  - **Title:** Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease
  - **Authors:** Kilpelainen, Tommi P.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00235](https://doi.org/10.1021/acs.jmedchem.3c00235)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-37335626
1.1|Reagents: Triethylamine, Pivaloyl chloride
Solvents: Dichloromethane; 0 °C; 1 h, 0 °C
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C → rt; 3 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
By: Falkenstein, Markus; et al
Bioorganic & Medicinal Chemistry (2021), 50, 116462.
10.1016/j.bmc.2021.116462
```

---

## Reaction 31-614-CAS-37335627

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - Pivaloyl chloride (CAS: 3282-30-2) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)CCC(=O)N1CCCCCC1.COC(=O)C(C)N.Cl`
  - Products: `COC(=O)C(C)NC(=O)CCC(=O)N1CCCCCC1`

**Reference:**
  - **Title:** Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease
  - **Authors:** Kilpelainen, Tommi P.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00235](https://doi.org/10.1021/acs.jmedchem.3c00235)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-37335627
1.1|Reagents: Triethylamine, Pivaloyl chloride
Solvents: Dichloromethane; 0 °C; 1 h, 0 °C
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C → rt; 3 h, rt
Absolute stereochemistry shown,
Rotation (+)
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine
By: Aguirre-Renteria, Saul A.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.
10.1016/j.bmcl.2020.127074
```

---

## Reaction 31-614-CAS-37335664

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)CCCc1ccccn1.C[C@H](N)C(=O)N1CCC[C@H]1C(N)=O.O=C(O)C(F)(F)F`
  - Products: `C[C@H](NC(=O)CCCc1ccccn1)C(=O)N1CCC[C@H]1C(N)=O`

**Reference:**
  - **Title:** Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease
  - **Authors:** Kilpelainen, Tommi P.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00235](https://doi.org/10.1021/acs.jmedchem.3c00235)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-37335664
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 4 h, rt
Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe
By: Tamayo, Nuria A.; et al
Journal of Medicinal Chemistry (2022), 65(6), 4972-4990.
10.1021/acs.jmedchem.1c02030
```

---

## Reaction 31-614-CAS-37375870

**Type:** Other

**Reaction Conditions:**
  - Temperature: 140.0°C
  - Time: 5.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `NC=O.Nc1cnc(Cl)cc1C(=O)O`
  - Products: `O=c1nc[nH]c2cnc(Cl)cc12`

**Reference:**
  - **Title:** Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors
  - **Authors:** Kim, Namkyoung; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 259, 115635.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115635](https://doi.org/10.1016/j.ejmech.2023.115635)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-37375870
1.1|5 h, 140 °C
Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation
By: Fioravanti, Rossella; et al
ChemMedChem (2020), 15(7), 643-658.
10.1002/cmdc.201900730
```

---

## Reaction 31-614-CAS-37376179

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `NC1CC1.O=C(O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1`
  - Products: `O=C(CC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1)NC1CC1`

**Reference:**
  - **Title:** Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors
  - **Authors:** Zhu, Junjie; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 259, 115666.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115666](https://doi.org/10.1016/j.ejmech.2023.115666)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-37376179
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; overnight, rt
1.2|Reagents: Sodium bicarbonate
Solvents: Water; rt
Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality
By: Chen, Yuanguang; et al
Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.
10.1021/acs.jmedchem.3c02006
```

---

## Reaction 31-614-CAS-37376180

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CC(C)(C)N.O=C(O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1`
  - Products: `CC(C)(C)NC(=O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors
  - **Authors:** Zhu, Junjie; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 259, 115666.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115666](https://doi.org/10.1016/j.ejmech.2023.115666)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-37376180
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; overnight, rt
1.2|Reagents: Sodium bicarbonate
Solvents: Water; rt
Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation
By: Tokarski, Robert J. II; et al
European Journal of Medicinal Chemistry (2023), 254, 115342.
10.1016/j.ejmech.2023.115342
```

---

## Reaction 31-614-CAS-37376187

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1.CC(C)N.Cl`
  - Products: `CC(C)NC(=O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors
  - **Authors:** Zhu, Junjie; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 259, 115666.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115666](https://doi.org/10.1016/j.ejmech.2023.115666)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-37376187
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; overnight, rt
1.2|Reagents: Sodium bicarbonate
Solvents: Water; rt
Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
By: Narayanan, Dilip; et al
Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.
10.1021/acs.jmedchem.2c00830
```

---

## Reaction 31-614-CAS-37387770

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Py (CAS: 110-86-1) - Role: UNK (Registry: BASE)
  - DMAP (CAS: 1122-58-3) - Role: UNK (Registry: LIGAND)
  - 4-(Dimethylamino)pyridine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 2.5 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COc1nn(-c2cncc(Br)c2)cc1C(=O)O.CC(C)n1cnnc1-c1cccc(N)n1`
  - Products: `COc1nn(-c2cncc(Br)c2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1`

**Reference:**
  - **Title:** Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors
  - **Authors:** Xin, Zhili; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2020), 11(4), 485-490.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.9b00611](https://doi.org/10.1021/acsmedchemlett.9b00611)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-37387770
1.1|Reagents: Thionyl chloride; 2 h, pH 8, 60 °C
1.2|Reagents: Pyridine
Solvents: Dichloromethane; pH 8, rt
1.3|Reagents: 4-(Dimethylamino)pyridine; 0.5 h, 29 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2
By: Roussel, Emile; et al
European Journal of Medicinal Chemistry (2020), 202, 112503.
10.1016/j.ejmech.2020.112503
```

---

## Reaction 31-614-CAS-37428756

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - TFA (CAS: 76-05-1) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.5 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O.CC(C)(C)OC(=O)NCCOCCOCCOCC(=O)O`
  - Products: `NCCOCCOCCOCC(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O`

**Reference:**
  - **Title:** PROTACs Targeting MLKL Protect Cells from Necroptosis
  - **Authors:** Rathje, Oliver H.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(16), 11216-11236.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00665](https://doi.org/10.1021/acs.jmedchem.3c00665)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-37428756
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.2|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 30 min, rt
Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
By: Pal, Kavita; et al
European Journal of Medicinal Chemistry (2023), 248, 115055.
10.1016/j.ejmech.2022.115055
```

---

## Reaction 31-614-CAS-37481032

**Type:** Other

**Reagents:**
  - HCOOH (CAS: 64-18-6) - Role: UNK (Registry: ACID)

**Reaction Conditions:**
  - Temperature: 145.0°C
  - Time: 8.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `NC=O.Nc1cc(Br)ccc1C(=O)O`
  - Products: `O=c1nc[nH]c2cc(Br)ccc12`

**Reference:**
  - **Title:** Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy
  - **Authors:** Meng, Yangyang; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(17), 11815-11830.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00264](https://doi.org/10.1021/acs.jmedchem.3c00264)

**Original Text:**
```
Steps: 1, Yield: 87-89%
CAS Reaction Number: 31-614-CAS-37481032
1.1|Reagents: Formic acid; 8 h, 145 °C
Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists
By: Bae, Inhwan; et al
Bioorganic & Medicinal Chemistry Letters (2021), 34, 127676.
10.1016/j.bmcl.2020.127676
```

---

## Reaction 31-614-CAS-37616100

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - Chloroform (CAS: 67-66-3) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 23.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `COc1cc(/C=C/C(=O)O)cc(OC)c1OC.COC(=O)Cc1ccc(N)cc1`
  - Products: `COC(=O)Cc1ccc(NC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)cc1`

**Reference:**
  - **Title:** Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers
  - **Authors:** Braconi, Laura; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 259, 115716.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115716](https://doi.org/10.1016/j.ejmech.2023.115716)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-37616100
1.1|Reagents: Thionyl chloride
Solvents: Chloroform; 5 h, reflux; reflux → rt
1.2|Solvents: Chloroform; 18 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design, synthesis and biological evaluation of 6-chloro-quinolin-2-one derivatives as novel FXIa inhibitors
By: Wang, Yanshi; et al
Bioorganic & Medicinal Chemistry Letters (2024), 99, 129610.
10.1016/j.bmcl.2024.129610
```

---

## Reaction 31-614-CAS-37616116

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - Chloroform (CAS: 67-66-3) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 23.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `COc1cc(C(=O)O)cc(OC)c1OC.COC(=O)Cc1ccc(N)cc1`
  - Products: `COC(=O)Cc1ccc(NC(=O)c2cc(OC)c(OC)c(OC)c2)cc1`

**Reference:**
  - **Title:** Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers
  - **Authors:** Braconi, Laura; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 259, 115716.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115716](https://doi.org/10.1016/j.ejmech.2023.115716)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-37616116
1.1|Reagents: Thionyl chloride
Solvents: Chloroform; 5 h, reflux; reflux → rt
1.2|Solvents: Chloroform; 18 h, rt
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
By: Pasqua, A. Elisa; et al
Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.
10.1021/acs.jmedchem.3c00156
```

---

## Reaction 31-614-CAS-37690207

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.25 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `Cn1nc(C(=O)O)cc1-c1ccc(C(F)(F)F)cc1.NCC1CCCOC1`
  - Products: `Cn1nc(C(=O)NCC2CCCOC2)cc1-c1ccc(C(F)(F)F)cc1`

**Reference:**
  - **Title:** Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction
  - **Authors:** Christie, Louisa A.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00630](https://doi.org/10.1021/acs.jmedchem.3c00630)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-37690207
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Tetrahydrofuran; 15 min, rt
1.2|16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1-Nrf2 Protein-Protein Interaction
By: Begnini, Fabio; et al
Journal of Medicinal Chemistry (2022), 65(4), 3473-3517.
10.1021/acs.jmedchem.1c01975
```

---

## Reaction 31-614-CAS-37690229

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.083 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Cn1nc(C(=O)O)cc1-c1ccc(C(F)(F)F)cc1Cl.CN1CCCC(N)C1`
  - Products: `CN1CCCC(NC(=O)c2cc(-c3ccc(C(F)(F)F)cc3Cl)n(C)n2)C1`

**Reference:**
  - **Title:** Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction
  - **Authors:** Christie, Louisa A.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00630](https://doi.org/10.1021/acs.jmedchem.3c00630)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-37690229
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; 5 min, rt
1.2|16 h, rt
1.3|Reagents: Sodium bicarbonate
Solvents: Water; rt
Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
By: Bothe, Ulrich; et al
Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.
10.1021/acs.jmedchem.3c01714
```

---

## Reaction 31-614-CAS-37690250

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.083 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `COc1ccc(-c2cc(C(=O)O)nn2C)c(Cl)c1.CN1CCC[C@H](N)C1`
  - Products: `COc1ccc(-c2cc(C(=O)N[C@H]3CCCN(C)C3)nn2C)c(Cl)c1`

**Reference:**
  - **Title:** Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction
  - **Authors:** Christie, Louisa A.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00630](https://doi.org/10.1021/acs.jmedchem.3c00630)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-37690250
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; 5 min, rt
1.2|16 h, rt
1.3|Reagents: Sodium bicarbonate
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4
By: Londregan, Allyn T.; et al
Journal of Medicinal Chemistry (2023), 66(1), 460-472.
10.1021/acs.jmedchem.2c01421
```

---

## Reaction 31-614-CAS-37690313

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.083 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `[2H]C([2H])([2H])Oc1ccc(-c2cc(C(=O)O)nn2C([2H])([2H])[2H])c(Cl)c1.CC(C)(C)OC(=O)N1CCC[C@H](N)C1`
  - Products: `[2H]C([2H])([2H])Oc1ccc(-c2cc(C(=O)N[C@H]3CCCN(C(=O)OC(C)(C)C)C3)nn2C([2H])([2H])[2H])c(Cl)c1`

**Reference:**
  - **Title:** Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction
  - **Authors:** Christie, Louisa A.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00630](https://doi.org/10.1021/acs.jmedchem.3c00630)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-37690313
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; 5 min, rt
1.2|16 h, rt
1.3|Reagents: Sodium bicarbonate
Solvents: Water; rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-37692131

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)c1ccc(N)cc1.COc1cn(C(C)C(=O)O)c(=O)cc1-c1cc(Cl)ccc1C#N`
  - Products: `COc1cn(C(C)C(=O)Nc2ccc(C(=O)OC(C)(C)C)cc2)c(=O)cc1-c1cc(Cl)ccc1C#N`

**Reference:**
  - **Title:** Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders
  - **Authors:** Roehrig, Susanne; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(17), 12203-12224.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00795](https://doi.org/10.1021/acs.jmedchem.3c00795)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-37692131
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction
By: Christie, Louisa A.; et al
Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.
10.1021/acs.jmedchem.3c00630
```

---

## Reaction 31-614-CAS-37692197

**Type:** Other

**Reagents:**
  - N,N-Diisopropylcarbodiimide (CAS: 693-13-0) - Role: UNK (Registry: N'-DIISOPROPYLCARBODIIMIDE)
  - Ethyl 2-cyano-2-(hydroxyimino)acetate (CAS: 3849-21-6) - Role: UNK
  - Diisopropylcarbodiimide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 16.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CCOC(=O)c1ccc(N)cc1.COCCC(C(=O)O)n1cc(OC)c(-c2cc(Cl)ccc2C#N)cc1=O`
  - Products: `CCOC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(-c3cc(Cl)ccc3C#N)cc2=O)cc1`

**Reference:**
  - **Title:** Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders
  - **Authors:** Roehrig, Susanne; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(17), 12203-12224.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00795](https://doi.org/10.1021/acs.jmedchem.3c00795)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-37692197
1.1|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate
Solvents: Dimethylformamide; rt; overnight, 40 °C
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C
By: Kettle, Jason G.; et al
Journal of Medicinal Chemistry (2022), 65(9), 6940-6952.
10.1021/acs.jmedchem.2c00369
```

---

## Reaction 31-614-CAS-37713121

**Type:** Other

**Reagents:**
  - 2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline (CAS: 16357-59-8) - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 72.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `Nc1ccc(CO)cc1.CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)O`
  - Products: `CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)Nc1ccc(CO)cc1`

**Reference:**
  - **Title:** Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain
  - **Authors:** Gallo, Francesca; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(7), 4117-4129.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00003](https://doi.org/10.1021/acs.jmedchem.1c00003)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-37713121
1.1|Reagents: 2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline
Solvents: Tetrahydrofuran; 3 d, rt
Double bond geometry shown
Double bond geometry shown
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
By: Zhang, Kuojun; et al
Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
10.1021/acs.jmedchem.2c00077
```

---

## Reaction 31-614-CAS-37713554

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 0.25 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)C(=O)CCc1cccnc1.NCc1cccnc1`
  - Products: `O=C(CCc1cccnc1)C(=O)NCc1cccnc1`

**Reference:**
  - **Title:** Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei
  - **Authors:** Scheuplein, Nicolas J.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(13), 8876-8895.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00458](https://doi.org/10.1021/acs.jmedchem.3c00458)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-37713554
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 15 min, 0 °C
1.2|0 °C → rt; rt
Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
By: Fang, Wei; et al
Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
10.1021/acs.jmedchem.3c02063
```

---

## Reaction 31-614-CAS-37713576

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 97.25 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCCC[C@H]1C(=O)O.C=CCOC(=O)[C@@H](N)Cc1ccc(F)cc1.Cl`
  - Products: `C=CCOC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@@H]1CCCCN1C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei
  - **Authors:** Scheuplein, Nicolas J.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(13), 8876-8895.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00458](https://doi.org/10.1021/acs.jmedchem.3c00458)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-37713576
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dichloromethane; 15 min, 0 °C
1.2|0 °C → rt; 4 d, rt
Relative stereochemistry shown
Relative stereochemistry shown
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson’s Disease Models
By: Kamakolanu, Uma Gayathri; et al
Journal of Medicinal Chemistry (2020), 63(5), 2688-2704.
10.1021/acs.jmedchem.9b02134
```

---

## Reaction 31-614-CAS-37777542

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 15.167 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CC(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(=O)O.C[C@H](N)C(=O)Nc1cccc(C(=O)Oc2ccccc2)c1C#Cc1c(NC(=O)[C@H](C)N)cccc1C(=O)Oc1ccccc1.O=C(O)C(F)(F)F`
  - Products: `CC(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)Nc1cccc(C(=O)Oc2ccccc2)c1C#Cc1c(NC(=O)[C@H](C)NC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(C)=O)cccc1C(=O)Oc1ccccc1`

**Reference:**
  - **Title:** Antimicrobial Peptide Mimetics Based on a Diphenylacetylene Scaffold: Synthesis, Conformational Analysis, and Activity
  - **Authors:** Peacock, Hayden; et al
  - **Citation:** ChemMedChem (2020), 15(20), 1932-1939.
  - **DOI:** [https://doi.org/10.1002/cmdc.202000474](https://doi.org/10.1002/cmdc.202000474)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-37777542
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; rt → 0 °C; 10 min, 0 °C
1.2|Solvents: Dimethylformamide; 0 °C → rt; 15 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
An improved commercial process for the preparation of Lifitegrast
By: Girkar, Arvind; et al
Organic Process Research & Development (2024), 28(12), 4374-4379.
10.1021/acs.oprd.4c00356
```

---

## Reaction 31-614-CAS-37832985

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 6.5 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COC(=O)[C@@]1(n2cc(CNC(=O)OC(C)(C)C)nn2)C[C@H](OC(C)=O)[C@@H](NC(C)=O)[C@H]([C@H](OC(C)=O)[C@@H](COC(C)=O)OC(C)=O)O1.[N-]=[N+]=NCCCCCC(=O)O`
  - Products: `COC(=O)[C@@]1(n2cc(CNC(=O)CCCCCN=[N+]=[N-])nn2)C[C@H](OC(C)=O)[C@@H](NC(C)=O)[C@H]([C@H](OC(C)=O)[C@@H](COC(C)=O)OC(C)=O)O1`

**Reference:**
  - **Title:** Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles
  - **Authors:** Lao, Zhiqi; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 259, 115578.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115578](https://doi.org/10.1016/j.ejmech.2023.115578)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-37832985
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 0.5 h, 0 °C
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 6 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants
By: Nageswara Rao, Desaboini; et al
Journal of Medicinal Chemistry (2021), 64(16), 11972-11989.
10.1021/acs.jmedchem.1c00554
```

---

## Reaction 31-614-CAS-37842851

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `Cc1c(O)cccc1C(=O)O.CC(C)(C)OC(=O)C[C@H](N)C(=O)OC(C)(C)C.Cl`
  - Products: `Cc1c(O)cccc1C(=O)N[C@@H](CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Discovery of a novel series of medium-sized cyclic enteropeptidase inhibitors
  - **Authors:** Kikuchi, Fumiaki; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 93, 117462.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117462](https://doi.org/10.1016/j.bmc.2023.117462)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-37842851
1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole
Solvents: Dimethylformamide; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors
By: Zhu, Junjie; et al
European Journal of Medicinal Chemistry (2023), 259, 115666.
10.1016/j.ejmech.2023.115666
```

---

## Reaction 31-614-CAS-37843363

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate (CAS: 1075198-30-9) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 41.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)C[C@H](N)C(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@@H](C(=O)O)C(C)(C)C`
  - Products: `CC(C)C[C@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties
  - **Authors:** Tsuji, Kohei; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(19), 13516-13529.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00777](https://doi.org/10.1021/acs.jmedchem.3c00777)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-37843363
1.1|Reagents: Diisopropylethylamine, N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate
Solvents: Dichloromethane; 0 °C; 41 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-37912635

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.25 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1cccc(OC(F)(F)F)c1.COc1ccc2c3ccnc(C)c3n(CCN)c2c1`
  - Products: `COc1ccc2c3ccnc(C)c3n(CCNC(=O)/C=C/c3cccc(OC(F)(F)F)c3)c2c1`

**Reference:**
  - **Title:** Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines
  - **Authors:** Marinovic, Marina; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 94, 117468.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117468](https://doi.org/10.1016/j.bmc.2023.117468)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-37912635
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 15 min, rt
1.2|1 - 2 h, rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-37912636

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.25 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1cccc(Cl)c1.COc1ccc2c3ccnc(C)c3n(CCN)c2c1`
  - Products: `COc1ccc2c3ccnc(C)c3n(CCNC(=O)/C=C/c3cccc(Cl)c3)c2c1`

**Reference:**
  - **Title:** Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines
  - **Authors:** Marinovic, Marina; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 94, 117468.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117468](https://doi.org/10.1016/j.bmc.2023.117468)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-37912636
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 15 min, rt
1.2|1 - 2 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1
By: Zhou, Qilong; et al
European Journal of Medicinal Chemistry (2022), 244, 114830.
10.1016/j.ejmech.2022.114830
```

---

## Reaction 31-614-CAS-37984060

**Type:** Other

**Full Catalytic System:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE

**Catalyst Core:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE

**Generic Catalyst:** N-Diisopropylethylamine

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Yield: 92%

**SMILES:**
  - Reactants: `NC1CCOCC1.O=C(O)CN1CCn2c(cc3sccc32)C1=O`
  - Products: `O=C(CN1CCn2c(cc3sccc32)C1=O)NC1CCOCC1`

**Reference:**
  - **Title:** Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis
  - **Authors:** Li, Na; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(19), 13428-13451.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00696](https://doi.org/10.1021/acs.jmedchem.3c00696)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-37984060
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Catalysts: Diisopropylethylamine
Solvents: Dichloromethane; rt
Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke
By: Chen, Weilin; et al
European Journal of Medicinal Chemistry (2023), 261, 115871.
10.1016/j.ejmech.2023.115871
```

---

## Reaction 31-614-CAS-37984123

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 6.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1.COC(=O)[C@@H](N)CCCNC(=N)N.Cl`
  - Products: `COC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@]12CCC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2`

**Reference:**
  - **Title:** Pentacyclic triterpene-amino acid derivatives induced apoptosis and autophagy in tumor cells, affected the JNK and PI3K/AKT/mTOR pathway
  - **Authors:** Zhang, Li-qiong; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 94, 117478.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117478](https://doi.org/10.1016/j.bmc.2023.117478)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-37984123
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dimethylformamide, Tetrahydrofuran; 1 h, rt
1.2|4 h, 60 °C
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 3 - 4
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
By: Tormaehlen, Niklas M.; et al
Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
10.1021/acs.jmedchem.0c01773
```

---

## Reaction 31-614-CAS-38045830

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 12.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(F)cc1.CCOC(=O)CSc1ccc(N)cc1`
  - Products: `CCOC(=O)CSc1ccc(NC(=O)c2ccc(F)cc2)cc1`

**Reference:**
  - **Title:** Structure-Based Ligand Discovery Targeting the Transmembrane Domain of Frizzled Receptor FZD7
  - **Authors:** Li, Cuixia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(17), 11855-11868.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01795](https://doi.org/10.1021/acs.jmedchem.2c01795)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-38045830
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 12 h, 60 °C
Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers
By: Vaidya, Sandeep; et al
ChemMedChem (2023), 18(16), e202300097.
10.1002/cmdc.202300097
```

---

## Reaction 31-614-CAS-38047630

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `NC(=O)c1ccccc1N.Cc1cccc(C(=O)O)n1`
  - Products: `Cc1cccc(C(=O)Nc2ccccc2C(N)=O)n1`

**Reference:**
  - **Title:** Dual inhibition of Mycobacterium tuberculosis and the host TGFBR1 by an anilinoquinazoline
  - **Authors:** Nandakumar, Meganathan; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(21), 14724-14734.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01273](https://doi.org/10.1021/acs.jmedchem.3c01273)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-38047630
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 4 h, rt
Identification and Optimization of Novel Small-Molecule Cas9 Inhibitors by Cell-Based High-Throughput Screening
By: Lee, Sang-Woo; et al
Journal of Medicinal Chemistry (2022), 65(4), 3266-3305.
10.1021/acs.jmedchem.1c01834
```

---

## Reaction 31-614-CAS-38064665

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `Cc1cn2cc(N)cc(F)c2n1.CN(C(=O)OC(C)(C)C)[C@@H]1CCN(c2ccc(C(=O)O)nn2)C1`
  - Products: `Cc1cn2cc(NC(=O)c3ccc(N4CC[C@@H](N(C)C(=O)OC(C)(C)C)C4)nn3)cc(F)c2n1`

**Reference:**
  - **Title:** Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease
  - **Authors:** Liu, Longbin; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(18), 13205-13246.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01173](https://doi.org/10.1021/acs.jmedchem.3c01173)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-38064665
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 16 h, rt
1.2|Reagents: Sodium bicarbonate
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice
By: Narayanan, Sanju; et al
Journal of Medicinal Chemistry (2021), 64(6), 3006-3025.
10.1021/acs.jmedchem.0c01448
```

---

## Reaction 31-614-CAS-38064680

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `Cc1cn2cc(N)cc(F)c2n1.CN(C(=O)OC(C)(C)C)[C@@H]1CCN(c2cnc(C(=O)O)nc2)C1`
  - Products: `Cc1cn2cc(NC(=O)c3ncc(N4CC[C@@H](N(C)C(=O)OC(C)(C)C)C4)cn3)cc(F)c2n1`

**Reference:**
  - **Title:** Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease
  - **Authors:** Liu, Longbin; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(18), 13205-13246.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01173](https://doi.org/10.1021/acs.jmedchem.3c01173)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-38064680
1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dimethylformamide; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer
By: Sun, Li-ping; et al
Journal of Medicinal Chemistry (2023), 66(21), 14700-14715.
10.1021/acs.jmedchem.3c01210
```

---

## Reaction 31-614-CAS-38094931

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.667 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)(O)[C@H]1CC[C@H](N)CC1.O=C(O)c1cnc2nc(C3CC3)c(Cl)cc2c1`
  - Products: `CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc3nc(C4CC4)c(Cl)cc3c2)CC1`

**Reference:**
  - **Title:** The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure
  - **Authors:** Cadilla, Rodolfo; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2020.115791](https://doi.org/10.1016/j.bmc.2020.115791)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-38094931
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 100 min, rt
2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAFV600E/C-RAF kinase inhibitory effects: Design, synthesis, in-vitro cell-based and oncogenic kinase assessments
By: El-Damasy, Ashraf K.; et al
European Journal of Medicinal Chemistry (2020), 208, 112756.
10.1016/j.ejmech.2020.112756
```

---

## Reaction 31-614-CAS-38094932

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 14.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(C)(O)[C@H]1CC[C@H](N)CC1.COc1nc2ncc(C(=O)O)cc2cc1Cl`
  - Products: `COc1nc2ncc(C(=O)N[C@H]3CC[C@H](C(C)(C)O)CC3)cc2cc1Cl`

**Reference:**
  - **Title:** The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure
  - **Authors:** Cadilla, Rodolfo; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2020.115791](https://doi.org/10.1016/j.bmc.2020.115791)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-38094932
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 14 h, rt
Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2
By: Zhang, Yi; et al
Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.
10.1021/acs.jmedchem.3c00504
```

---

## Reaction 31-614-CAS-38094948

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.083 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `C[C@]1(O)C[C@H](N)C1.C[C@H]1CCN1c1nc2ncc(C(=O)O)cc2cc1Cl.[Li]`
  - Products: `C[C@H]1CCN1c1nc2ncc(C(=O)N[C@H]3C[C@](C)(O)C3)cc2cc1Cl`

**Reference:**
  - **Title:** The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure
  - **Authors:** Cadilla, Rodolfo; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2020.115791](https://doi.org/10.1016/j.bmc.2020.115791)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-38094948
1.1|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 5 min, rt
1.2|Reagents: Propylphosphonic anhydride; 16 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2023), 246, 114981.
10.1016/j.ejmech.2022.114981
```

---

## Reaction 31-614-CAS-38105797

**Type:** Other

**Reagents:**
  - HBTU (CAS: 94790-37-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.5 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(C)(C)[Si](Oc1cc(CC(=O)O)c(Br)cc1OCc1ccccc1)(c1ccccc1)c1ccccc1.NCCc1ccc(OCc2ccccc2)c(O)c1`
  - Products: `CC(C)(C)[Si](Oc1cc(CC(=O)NCCc2ccc(OCc3ccccc3)c(O)c2)c(Br)cc1OCc1ccccc1)(c1ccccc1)c1ccccc1`

**Reference:**
  - **Title:** Discovery of Selective Dopamine Receptor Ligands Derived from (-)-Stepholidine via C-3 Alkoxylation and C-3/C-9 Dialkoxylation
  - **Authors:** Namballa, Hari K.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(14), 10060-10079.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00976](https://doi.org/10.1021/acs.jmedchem.3c00976)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-38105797
1.1|Reagents: 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dimethylformamide; 30 min, rt
1.2|Reagents: Diisopropylethylamine; 0 °C → rt; overnight, rt
1.3|Reagents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-614-CAS-38113252

**Type:** Other

**Solvents:**
  - Formamide (CAS: 75-12-7)
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 150.0°C
  - Time: 20.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `NC=O.Nc1ccc(Cl)cc1C(=O)O`
  - Products: `O=c1nc[nH]c2ccc(Cl)cc12`

**Reference:**
  - **Title:** Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR
  - **Authors:** Grossman, Scott; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 208, 112778.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112778](https://doi.org/10.1016/j.ejmech.2020.112778)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-38113252
1.1|Solvents: Formamide; 16 h, 150 °C
1.2|Solvents: Water
Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition
By: Fan, Chengcheng; et al
European Journal of Medicinal Chemistry (2020), 190, 112108pp..
10.1016/j.ejmech.2020.112108
```

---

## Reaction 31-614-CAS-38113256

**Type:** Other

**Solvents:**
  - Formamide (CAS: 75-12-7)

**Reaction Conditions:**
  - Temperature: 150.0°C
  - Time: 16.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `NC=O.Nc1cc(Cl)ccc1C(=O)O`
  - Products: `O=c1nc[nH]c2cc(Cl)ccc12`

**Reference:**
  - **Title:** Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR
  - **Authors:** Grossman, Scott; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 208, 112778.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112778](https://doi.org/10.1016/j.ejmech.2020.112778)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-38113256
1.1|Solvents: Formamide; 15 h, 150 °C
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-614-CAS-38128116

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 4-Methylmorpholine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMSO (CAS: 67-68-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 19.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `COc1ccc(N)cc1.CC(C)(C)OC(=O)N1CCC[C@@H]1C(=O)O`
  - Products: `COc1ccc(NC(=O)[C@H]2CCCN2C(=O)OC(C)(C)C)cc1`

**Reference:**
  - **Title:** Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening
  - **Authors:** Tian, Xinrong; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(21), 14391-14408.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00670](https://doi.org/10.1021/acs.jmedchem.2c00670)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-38128116
1.1|Reagents: 4-Methylmorpholine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt
Solvents: Dimethyl sulfoxide; 18 h, rt
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-614-CAS-38145041

**Type:** Other

**Reagents:**
  - Ac2O (CAS: 108-24-7) - Role: UNK (Registry: SOLVENT)

**Reaction Conditions:**
  - Temperature: 90.0°C
  - Time: 0.5 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `NC(N)=O.O=C(O)CCN1CCC(C(=O)c2ccc(O)cc2)CC1`
  - Products: `NC(=O)NC(=O)CCN1CCC(C(=O)c2ccc(O)cc2)CC1`

**Reference:**
  - **Title:** Structural and Functional Study of the Klebsiella pneumoniae VapBC Toxin-Antitoxin System, Including the Development of an Inhibitor That Activates VapC
  - **Authors:** Kang, Sung-Min; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(22), 13669-13679.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01118](https://doi.org/10.1021/acs.jmedchem.0c01118)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-38145041
1.1|Reagents: Acetic anhydride; 30 min, rt → 90 °C
Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
By: Bothe, Ulrich; et al
Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.
10.1021/acs.jmedchem.3c01714
```

---

## Reaction 31-614-CAS-38145487

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - PhMe (CAS: 108-88-3) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 110.0°C
  - Time: 20.5 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Br)o1.Cc1cc(F)ccc1N`
  - Products: `Cc1cc(F)ccc1NC(=O)c1ccc(Br)o1`

**Reference:**
  - **Title:** Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis
  - **Authors:** Mohamed, Abdelrahman; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(17), 11726-11744.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00589](https://doi.org/10.1021/acs.jmedchem.2c00589)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-38145487
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide
Solvents: Toluene; 4 h, 110 °C; 110 °C → rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 30 min, 0 °C; 0 °C → rt; overnight, rt
Human mitochondrial glutathione transferases: Kinetic parameters and accommodation of a mitochondria-targeting group in substrates
By: Cardwell, Patrick A.; et al
Bioorganic & Medicinal Chemistry (2024), 104, 117712.
10.1016/j.bmc.2024.117712
```

---

## Reaction 31-614-CAS-38145506

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: WORKUP (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Br)o1.Cc1ncccc1N`
  - Products: `Cc1ncccc1NC(=O)c1ccc(Br)o1`

**Reference:**
  - **Title:** Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis
  - **Authors:** Mohamed, Abdelrahman; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(17), 11726-11744.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00589](https://doi.org/10.1021/acs.jmedchem.2c00589)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-38145506
1.1|Reagents: Dicyclohexylcarbodiimide
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 0 °C; overnight, rt
1.2|Reagents: Water; rt
Absolute stereochemistry shown,
Rotation (+)
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Inhibition of Human Immunodeficiency Virus-1 Integrase by β-Diketo Acid Coated Gold Nanoparticles
By: Sanna, Vanna; et al
ACS Medicinal Chemistry Letters (2020), 11(5), 857-861.
10.1021/acsmedchemlett.9b00648
```

---

## Reaction 31-614-CAS-38147434

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - N-Hydroxysuccinimide (CAS: 6066-82-6) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)CCC(=O)Nc1cccc2ccccc12.NCCN`
  - Products: `NCCNC(=O)CCC(=O)Nc1cccc2ccccc12`

**Reference:**
  - **Title:** A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer’s disease
  - **Authors:** Rivera-Marrero, Suchitil; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2020), 28(20), 115700.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2020.115700](https://doi.org/10.1016/j.bmc.2020.115700)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-38147434
1.1|Reagents: Dicyclohexylcarbodiimide, N-Hydroxysuccinimide
Solvents: 1,4-Dioxane; 3 h, reflux
1.2|1 h, rt
Double bond geometry shown
Double bond geometry shown
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
By: Zhang, Kuojun; et al
Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
10.1021/acs.jmedchem.2c00077
```

---

## Reaction 31-614-CAS-38164670

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DMSO (CAS: 67-68-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 20.5 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Nc1c(C(=O)O)cnn1-c1ccccc1.COC(=O)c1ccc(CN)cc1.Cl`
  - Products: `COC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1`

**Reference:**
  - **Title:** Selective targeting of the αC and DFG-out pocket in p38 MAPK
  - **Authors:** Roehm, Sandra; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 208, 112721.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112721](https://doi.org/10.1016/j.ejmech.2020.112721)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-38164670
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 30 min, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Dimethyl sulfoxide, Dimethylformamide; 20 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity
By: Yamada, Yousuke; et al
Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.
10.1021/acs.jmedchem.0c01215
```

---

## Reaction 31-614-CAS-38179436

**Type:** Other

**Reagents:**
  - Cbz-Cl (CAS: 1609-47-8) - Role: BASE (Registry: PROTECTING_GROUP)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diethyl dicarbonate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CC(C)[C@@H](C(=O)O)N(C)C(=O)OCC1c2ccccc2-c2ccccc21.CC[C@H](C)[C@@H]([C@@H](CC(=O)OC(C)(C)C)OC)N(C)C(=O)[C@@H](N)C(C)C`
  - Products: `CC[C@H](C)[C@@H]([C@@H](CC(=O)OC(C)(C)C)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCC1c2ccccc2-c2ccccc21)C(C)C`

**Reference:**
  - **Title:** hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer
  - **Authors:** Sun, Li-ping; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(21), 14700-14715.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01210](https://doi.org/10.1021/acs.jmedchem.3c01210)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-38179436
1.1|Reagents: Diethyl dicarbonate, Diisopropylethylamine
Solvents: Ethyl acetate; overnight, rt
1.2|Reagents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
By: Wang, Xu; et al
Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.
10.1021/acs.jmedchem.4c02009
```

---

## Reaction 31-614-CAS-38179439

**Type:** Other

**Reagents:**
  - 2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline (CAS: 16357-59-8) - Role: UNK

**Solvents:**
  - MeOH (CAS: 67-56-1) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `Nc1ccc(CO)cc1.CC(C)[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N[C@@H](CCCNC(N)=O)C(=O)O`
  - Products: `CC(C)[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(CO)cc1`

**Reference:**
  - **Title:** hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer
  - **Authors:** Sun, Li-ping; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(21), 14700-14715.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01210](https://doi.org/10.1021/acs.jmedchem.3c01210)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-38179439
1.1|Reagents: 2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline
Solvents: Methanol, Dichloromethane; 5 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (+)
Betulinic acid derived amides are highly cytotoxic, apoptotic and selective
By: Hoenke, Sophie; et al
European Journal of Medicinal Chemistry (2020), 207, 112815.
10.1016/j.ejmech.2020.112815
```

---

## Reaction 31-614-CAS-38180209

**Type:** Other

**Solvents:**
  - EtOH (CAS: 64-17-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(=O)O.N=CN.Nc1cc(F)c(F)cc1C(=O)O`
  - Products: `O=c1nc[nH]c2cc(F)c(F)cc12`

**Reference:**
  - **Title:** Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)
  - **Authors:** Chen, Young; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(23), 15750-15760.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01137](https://doi.org/10.1021/acs.jmedchem.3c01137)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-38180209
1.1|Solvents: Ethanol; overnight, reflux
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-38181050

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 65.0°C
  - Time: 6.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `Nc1cc(Cl)cc(Cl)c1OCc1ccc(C(=O)O)cc1.CC(C)(C)OC(=O)NCCN`
  - Products: `CC(C)(C)OC(=O)NCCNC(=O)c1ccc(COc2c(N)cc(Cl)cc2Cl)cc1`

**Reference:**
  - **Title:** Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke
  - **Authors:** Chen, Weilin; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 261, 115871.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115871](https://doi.org/10.1016/j.ejmech.2023.115871)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-38181050
1.1|Reagents: Thionyl chloride; rt → 65 °C; 2 h, 65 °C
1.2|Solvents: Dichloromethane; 4 h, 20 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide
By: Guryanov, Ivan; et al
Organic Process Research & Development (2021), 25(7), 1598-1611.
10.1021/acs.oprd.1c00021
```

---

## Reaction 31-614-CAS-38257722

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `CN.CN(C)C(=O)[C@@H](NC(=O)c1cc(C(=O)O)ccc1-c1ccc(C(F)(F)F)cc1)c1cccc(C(F)(F)F)c1`
  - Products: `CNC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(C(=O)N[C@H](C(=O)N(C)C)c2cccc(C(F)(F)F)c2)c1`

**Reference:**
  - **Title:** Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)
  - **Authors:** Wang, Jocelyn; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2023), 96, 129492.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2023.129492](https://doi.org/10.1016/j.bmcl.2023.129492)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-38257722
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis
By: Sutherland, Hamish S.; et al
European Journal of Medicinal Chemistry (2022), 229, 114059.
10.1016/j.ejmech.2021.114059
```

---

## Reaction 31-614-CAS-38259020

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 5.667 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(N[C@H](Cc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]`
  - Products: `CC(C)(C)OC(=O)[C@H](CCC(=O)C=[N+]=[N-])NC(=O)[C@@H](Cc1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21`

**Reference:**
  - **Title:** Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
  - **Authors:** Novotna, Katerina; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01681](https://doi.org/10.1021/acs.jmedchem.3c01681)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-38259020
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 5 min, 0 °C
1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 5 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (+)
Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors
By: Meena, Chhuttan L.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.
10.1016/j.bmcl.2020.127039
```

---

## Reaction 31-614-CAS-38259023

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.167 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(N[C@@H](Cc1ccc(C(F)(F)F)cc1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]`
  - Products: `CC(C)(C)OC(=O)[C@H](CCC(=O)C=[N+]=[N-])NC(=O)[C@H](Cc1ccc(C(F)(F)F)cc1)NC(=O)OCC1c2ccccc2-c2ccccc21`

**Reference:**
  - **Title:** Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
  - **Authors:** Novotna, Katerina; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01681](https://doi.org/10.1021/acs.jmedchem.3c01681)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-38259023
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 5 min, 0 °C
1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 3.5 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
By: Gillis, Eric P.; et al
Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
10.1021/acs.jmedchem.2c01732
```

---

## Reaction 31-614-CAS-38259024

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.667 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(N[C@@H](Cc1cccc(F)c1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]`
  - Products: `CC(C)(C)OC(=O)[C@H](CCC(=O)C=[N+]=[N-])NC(=O)[C@H](Cc1cccc(F)c1)NC(=O)OCC1c2ccccc2-c2ccccc21`

**Reference:**
  - **Title:** Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
  - **Authors:** Novotna, Katerina; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01681](https://doi.org/10.1021/acs.jmedchem.3c01681)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-38259024
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 5 min, 0 °C
1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-614-CAS-38259026

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.167 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(N[C@@H](CCc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]`
  - Products: `CC(C)(C)OC(=O)[C@H](CCC(=O)C=[N+]=[N-])NC(=O)[C@H](CCc1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21`

**Reference:**
  - **Title:** Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
  - **Authors:** Novotna, Katerina; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01681](https://doi.org/10.1021/acs.jmedchem.3c01681)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-38259026
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 5 min, 0 °C
1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 1.5 h, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-38259029

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.667 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CC(C)(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]`
  - Products: `CC(C)(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N[C@@H](CCC(=O)C=[N+]=[N-])C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
  - **Authors:** Novotna, Katerina; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01681](https://doi.org/10.1021/acs.jmedchem.3c01681)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-38259029
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 5 min, 0 °C
1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 16 h, rt
Absolute stereochemistry shown
Relative stereochemistry shown
Absolute stereochemistry shown
Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen
By: Hekking, Koen F. W.; et al
Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.
10.1021/acs.jmedchem.3c02206
```

---

## Reaction 31-614-CAS-38259030

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 4.667 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]`
  - Products: `C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N[C@@H](CCC(=O)C=[N+]=[N-])C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
  - **Authors:** Novotna, Katerina; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01681](https://doi.org/10.1021/acs.jmedchem.3c01681)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-38259030
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 5 min, 0 °C
1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 4 h, rt
Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1
By: Come, Jon H.; et al
Journal of Medicinal Chemistry (2021), 64(24), 17753-17776.
10.1021/acs.jmedchem.1c00944
```

---

## Reaction 31-614-CAS-38259031

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.667 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `O=C(O)CNC(=O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]`
  - Products: `CC(C)(C)OC(=O)[C@H](CCC(=O)C=[N+]=[N-])NC(=O)CNC(=O)OCC1c2ccccc2-c2ccccc21`

**Reference:**
  - **Title:** Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
  - **Authors:** Novotna, Katerina; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01681](https://doi.org/10.1021/acs.jmedchem.3c01681)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-38259031
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 5 min, 0 °C
1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 2 h, rt
Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist
By: Baska, Ferenc; et al
Journal of Medicinal Chemistry (2024), 67(1), 643-673.
10.1021/acs.jmedchem.3c01868
```

---

## Reaction 31-614-CAS-38259246

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 16.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `NC1CCOCC1.C[C@@]1(C(=O)O)COCCN1c1nc(-c2cccc3[nH]ccc23)ncc1F`
  - Products: `C[C@@]1(C(=O)NC2CCOCC2)COCCN1c1nc(-c2cccc3[nH]ccc23)ncc1F`

**Reference:**
  - **Title:** Optimization of mTOR Inhibitors Using Property-Based Drug Design and Free-Wilson Analysis for Improved In Vivo Efficacy
  - **Authors:** Murphy, Sean T.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2023), 14(11), 1544-1550.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.3c00351](https://doi.org/10.1021/acsmedchemlett.3c00351)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-38259246
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 16 h, 20 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Structure-Guided Design of a “Bump-and-Hole” Bromodomain-Based Degradation Tag
By: Nowak, Radoslaw P.; et al
Journal of Medicinal Chemistry (2021), 64(15), 11637-11650.
10.1021/acs.jmedchem.1c00958
```

---

## Reaction 31-614-CAS-38259318

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(NC(=O)C(F)(F)F)cc1.Nc1ccc(F)c([N+](=O)[O-])c1`
  - Products: `O=C(Nc1ccc(F)c([N+](=O)[O-])c1)c1ccc(NC(=O)C(F)(F)F)cc1`

**Reference:**
  - **Title:** Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity
  - **Authors:** Fang, Jing-jie; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(22), 15288-15308.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01351](https://doi.org/10.1021/acs.jmedchem.3c01351)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-38259318
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Tetrahydrofuran; 8 h, rt
1.2|Reagents: Triethylamine
Solvents: Tetrahydrofuran; rt; 4 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities
By: Wang, Juan; et al
European Journal of Medicinal Chemistry (2021), 215, 113267.
10.1016/j.ejmech.2021.113267
```

---

## Reaction 31-614-CAS-38259319

**Type:** Other

**Reagents:**
  - DMAP (CAS: 1122-58-3) - Role: BASE (Registry: LIGAND)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaBH4 (CAS: 16940-66-2) - Role: UNK (Registry: REDUCTANT)
  - 4-(Dimethylamino)pyridine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - EtOH (CAS: 64-17-5) - Role: SOLVENT
  - MeOH (CAS: 67-56-1) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 12.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)Cc1cccc(OC(F)(F)F)c1.Nc1cc(NC(=O)c2ccc(NC(=O)C(F)(F)F)cc2)ccc1F`
  - Products: `Nc1ccc(C(=O)Nc2ccc(F)c(NC(=O)Cc3cccc(OC(F)(F)F)c3)c2)cc1`

**Reference:**
  - **Title:** Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity
  - **Authors:** Fang, Jing-jie; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(22), 15288-15308.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01351](https://doi.org/10.1021/acs.jmedchem.3c01351)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-38259319
1.1|Reagents: 4-(Dimethylamino)pyridine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 8 h, rt
1.2|Reagents: Sodium borohydride
Solvents: Ethanol, Methanol; 1 h, 0 °C; 2 h, 0 °C → rt
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-614-CAS-38275827

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 23.0°C
  - Time: 19.5 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `O=C(O)c1cc2ccccc2[nH]1.CC(C)(C)OC(=O)[C@@H](N)Cc1ccccc1.Cl`
  - Products: `CC(C)(C)OC(=O)[C@H](Cc1ccccc1)NC(=O)c1cc2ccccc2[nH]1`

**Reference:**
  - **Title:** Pyrazolidinone-based peptidomimetic SARS-CoV-2 Mpro inhibitors
  - **Authors:** Jelisejevs, Daniels; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2023), 96, 129530.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2023.129530](https://doi.org/10.1016/j.bmcl.2023.129530)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-38275827
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 30 min, 0 °C; 19 h, 23 °C
Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis
By: Zhao, Hongyi; et al
Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.
10.1021/acs.jmedchem.2c00718
```

---

## Reaction 31-614-CAS-38374432

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.333 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)O.CC(C)C[C@H](N)C(=O)NCC(=O)NC12CC3CC(CC(C3)C1)C2.O=C(O)C(F)(F)F`
  - Products: `CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C)C(=O)NCC(=O)NC12CC3CC(CC(C3)C1)C2`

**Reference:**
  - **Title:** Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors
  - **Authors:** Silva-Reis, Sara C.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2023), 14(12), 1656-1663.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.3c00264](https://doi.org/10.1021/acsmedchemlett.3c00264)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-38374432
1.1|Reagents: Triethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 15 - 20 min, rt
1.2|2 h, rt
Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus
By: Liu, Yonghua; et al
European Journal of Medicinal Chemistry (2022), 228, 114033.
10.1016/j.ejmech.2021.114033
```

---

## Reaction 31-614-CAS-38408158

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 11.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `COc1ccc2cc(C(=O)O)oc2c1.NCC(=O)O`
  - Products: `COc1ccc2cc(C(=O)NCC(=O)O)oc2c1`

**Reference:**
  - **Title:** Efficacy, Mechanism, and Structure-Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis
  - **Authors:** Zhou, Zi-ying; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(3), 1742-1760.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01377](https://doi.org/10.1021/acs.jmedchem.2c01377)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-38408158
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 1 h, rt
1.2|10 h, rt
Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors
By: Sturbaut, Manon; et al
European Journal of Medicinal Chemistry (2021), 226, 113835.
10.1016/j.ejmech.2021.113835
```

---

## Reaction 31-614-CAS-38469848

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `NC1CCC(=O)NC1=O.CC(C)(C)OC(=O)Nc1ccc(C(=O)O)cc1`
  - Products: `CC(C)(C)OC(=O)Nc1ccc(C(=O)NC2CCC(=O)NC2=O)cc1`

**Reference:**
  - **Title:** Design and synthesis of novel cereblon binders for use in targeted protein degradation
  - **Authors:** Norris, Stephen; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(23), 16388-16409.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01848](https://doi.org/10.1021/acs.jmedchem.3c01848)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-38469848
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 3 h, rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-38469900

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `NC1CCC(=O)NC1=O.CC(C)(C)OC(=O)NCc1ccc(C(=O)O)cc1`
  - Products: `CC(C)(C)OC(=O)NCc1ccc(C(=O)NC2CCC(=O)NC2=O)cc1`

**Reference:**
  - **Title:** Design and synthesis of novel cereblon binders for use in targeted protein degradation
  - **Authors:** Norris, Stephen; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(23), 16388-16409.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01848](https://doi.org/10.1021/acs.jmedchem.3c01848)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-38469900
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; 2 h, rt
1.2|Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin
By: Schiffers, Ingo; et al
Organic Process Research & Development (2022), 26(10), 2811-2822.
10.1021/acs.oprd.2c00152
```

---

## Reaction 31-614-CAS-38476171

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.25 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](CC(=O)O)c1ccccc1.CN`
  - Products: `CNC(=O)C[C@H](NC(=O)OC(C)(C)C)c1ccccc1`

**Reference:**
  - **Title:** Discovery of Nanomolar DCAF1 Small Molecule Ligands
  - **Authors:** Li, Alice Shi Ming; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(7), 5041-5060.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02132](https://doi.org/10.1021/acs.jmedchem.2c02132)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-38476171
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, rt
1.2|Solvents: Tetrahydrofuran; 18 h, rt
Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents
By: Imran Ahamad, Mohd.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(11), 127138.
10.1016/j.bmcl.2020.127138
```

---

## Reaction 31-614-CAS-38556002

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - NaHCO3 (CAS: 144-55-8) - Role: WORKUP (Registry: BASE)
  - Fe (CAS: 7439-89-6) - Role: UNK (Registry: REDUCTANT)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - EtOH (CAS: 64-17-5) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 100.0°C
  - Time: 17.517 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `COc1ccc(CCCC(=O)O)cc1.COc1cc2ncnc(Oc3ccc(N)cc3F)c2cc1[N+](=O)[O-].CCCC(=O)Cl`
  - Products: `CCCC(=O)Nc1cc2c(Oc3ccc(NC(=O)CCCc4ccc(OC)cc4)cc3F)ncnc2cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
  - **Authors:** Tang, Sheng; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 263, 115939.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115939](https://doi.org/10.1016/j.ejmech.2023.115939)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-38556002
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0.5 h, 0 °C
1.2|Reagents: Sodium bicarbonate
Solvents: Dichloromethane; 0.5 h, rt
1.3|1 min, rt; 3 h, rt
1.4|Reagents: Iron, Ammonium chloride
Solvents: Ethanol, Water; 1.5 h, 100 °C
1.5|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Synthesis of Lenacapavir Sodium: Active Pharmaceutical Ingredient Process Development and Scale-up
By: Wagner, Anna M.; et al
Organic Process Research & Development (2024), 28(8), 3382-3395.
10.1021/acs.oprd.4c00242
```

---

## Reaction 31-614-CAS-38556004

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - NaHCO3 (CAS: 144-55-8) - Role: WORKUP (Registry: BASE)
  - Fe (CAS: 7439-89-6) - Role: UNK (Registry: REDUCTANT)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - EtOH (CAS: 64-17-5) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 100.0°C
  - Time: 17.517 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)CCCc1cccs1.COc1cc2ncnc(Oc3ccc(N)cc3F)c2cc1[N+](=O)[O-].C=CC(=O)Cl`
  - Products: `C=CC(=O)Nc1cc2c(Oc3ccc(NC(=O)CCCc4cccs4)cc3F)ncnc2cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
  - **Authors:** Tang, Sheng; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 263, 115939.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115939](https://doi.org/10.1016/j.ejmech.2023.115939)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-38556004
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0.5 h, 0 °C
1.2|Reagents: Sodium bicarbonate
Solvents: Dichloromethane; 0.5 h, rt
1.3|1 min, rt; 3 h, rt
1.4|Reagents: Iron, Ammonium chloride
Solvents: Ethanol, Water; 1.5 h, 100 °C
1.5|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt
Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
By: Tang, Sheng; et al
European Journal of Medicinal Chemistry (2024), 263, 115939.
10.1016/j.ejmech.2023.115939
```

---

## Reaction 31-614-CAS-38556005

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - NaHCO3 (CAS: 144-55-8) - Role: WORKUP (Registry: BASE)
  - Fe (CAS: 7439-89-6) - Role: UNK (Registry: REDUCTANT)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - EtOH (CAS: 64-17-5) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 100.0°C
  - Time: 17.517 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `COc1ccc(CCCC(=O)O)cc1.COc1cc2ncnc(Oc3ccc(N)cc3F)c2cc1[N+](=O)[O-].CCCCC(=O)Cl`
  - Products: `CCCCC(=O)Nc1cc2c(Oc3ccc(NC(=O)CCCc4ccc(OC)cc4)cc3F)ncnc2cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
  - **Authors:** Tang, Sheng; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 263, 115939.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115939](https://doi.org/10.1016/j.ejmech.2023.115939)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-38556005
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0.5 h, 0 °C
1.2|Reagents: Sodium bicarbonate
Solvents: Dichloromethane; 0.5 h, rt
1.3|1 min, rt; 3 h, rt
1.4|Reagents: Iron, Ammonium chloride
Solvents: Ethanol, Water; 1.5 h, 100 °C
1.5|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Early Process Development of an LPAR1 Antagonist, GS-2278
By: Kadunce, Nathaniel; et al
Organic Process Research & Development (2024), 28(11), 4099-4113.
10.1021/acs.oprd.4c00369
```

---

## Reaction 31-614-CAS-38556008

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - NaHCO3 (CAS: 144-55-8) - Role: WORKUP (Registry: BASE)
  - Fe (CAS: 7439-89-6) - Role: UNK (Registry: REDUCTANT)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - EtOH (CAS: 64-17-5) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 100.0°C
  - Time: 17.517 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)CCCc1cccs1.COc1cc2ncnc(Oc3ccc(N)cc3F)c2cc1[N+](=O)[O-].C/C=C/C(=O)Cl`
  - Products: `C/C=C/C(=O)Nc1cc2c(Oc3ccc(NC(=O)CCCc4cccs4)cc3F)ncnc2cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
  - **Authors:** Tang, Sheng; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 263, 115939.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115939](https://doi.org/10.1016/j.ejmech.2023.115939)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-38556008
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0.5 h, 0 °C
1.2|Reagents: Sodium bicarbonate
Solvents: Dichloromethane; 0.5 h, rt
1.3|1 min, rt; 3 h, rt
1.4|Reagents: Iron, Ammonium chloride
Solvents: Ethanol, Water; 1.5 h, 100 °C
1.5|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Synthesis of BACE1 Inhibitors E2609/E2071 via Oxime-Olefin Cycloaddition Following Process Risk Mitigation Strategy
By: Kim, Dae-Shik; et al
Organic Process Research & Development (2022), 26(3), 804-816.
10.1021/acs.oprd.1c00223
```

---

## Reaction 31-614-CAS-38556015

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - NaHCO3 (CAS: 144-55-8) - Role: WORKUP (Registry: BASE)
  - Fe (CAS: 7439-89-6) - Role: UNK (Registry: REDUCTANT)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - EtOH (CAS: 64-17-5) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 100.0°C
  - Time: 17.517 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)CCCc1cccs1.COc1cc2ncnc(Oc3ccc(N)cc3F)c2cc1[N+](=O)[O-].CCCC(=O)Cl`
  - Products: `CCCC(=O)Nc1cc2c(Oc3ccc(NC(=O)CCCc4cccs4)cc3F)ncnc2cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
  - **Authors:** Tang, Sheng; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 263, 115939.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115939](https://doi.org/10.1016/j.ejmech.2023.115939)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-38556015
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0.5 h, 0 °C
1.2|Reagents: Sodium bicarbonate
Solvents: Dichloromethane; 0.5 h, rt
1.3|1 min, rt; 3 h, rt
1.4|Reagents: Iron, Ammonium chloride
Solvents: Ethanol, Water; 1.5 h, 100 °C
1.5|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt
Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile
By: Sestito, Simona; et al
European Journal of Medicinal Chemistry (2021), 226, 113895.
10.1016/j.ejmech.2021.113895
```

---

## Reaction 31-614-CAS-38556017

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - NaHCO3 (CAS: 144-55-8) - Role: WORKUP (Registry: BASE)
  - Fe (CAS: 7439-89-6) - Role: UNK (Registry: REDUCTANT)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - EtOH (CAS: 64-17-5) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 110.0°C
  - Time: 18.767 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `Cc1nc(-c2ccccc2)sc1C(=O)O.COc1cc2ncnc(Oc3ccc(N)cc3F)c2cc1[N+](=O)[O-].C/C=C/C(=O)Cl`
  - Products: `C/C=C/C(=O)Nc1cc2c(Oc3ccc(NC(=O)c4sc(-c5ccccc5)nc4C)cc3F)ncnc2cc1OC`

**Reference:**
  - **Title:** Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
  - **Authors:** Tang, Sheng; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 263, 115939.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.115939](https://doi.org/10.1016/j.ejmech.2023.115939)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-38556017
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0.5 h, 0 °C
1.2|Reagents: Sodium bicarbonate
Solvents: Dichloromethane; 0.5 h, rt
1.3|1 min, rt; 5 h, rt
1.4|Reagents: Iron, Ammonium chloride
Solvents: Ethanol, Water; 45 min, 110 °C
1.5|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt
Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors
By: Trinh, Phuc N. H.; et al
Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.
10.1021/acs.jmedchem.0c02169
```

---

## Reaction 31-614-CAS-38559346

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 10.5 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(Cl)c2)[C@H](C(=O)O)C1.NCc1cccs1`
  - Products: `CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(Cl)c2)[C@H](C(=O)NCc2cccs2)C1`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability
  - **Authors:** Gao, Shenghua; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(23), 16426-16440.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01876](https://doi.org/10.1021/acs.jmedchem.3c01876)

**Original Text:**
```
Steps: 1, Yield: 89-91%
CAS Reaction Number: 31-614-CAS-38559346
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 30 min, 0 °C
1.2|10 h, rt
Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors
By: Gao, Shenghua; et al
Journal of Medicinal Chemistry (2022), 65(24), 16902-16917.
10.1021/acs.jmedchem.2c01716
```

---

## Reaction 31-614-CAS-38589174

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 10.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `COc1ccc(-c2nc(C(=O)O)cc3c2[nH]c2ccccc23)cc1.Nc1ccc(CN2CCC(N3CCCCC3)CC2)cc1`
  - Products: `COc1ccc(-c2nc(C(=O)Nc3ccc(CN4CCC(N5CCCCC5)CC4)cc3)cc3c2[nH]c2ccccc23)cc1`

**Reference:**
  - **Title:** 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
  - **Authors:** Chen, Bei; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01326](https://doi.org/10.1021/acs.jmedchem.3c01326)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-38589174
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 10 h, rt
Double bond geometry shown
Double bond geometry shown
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-38589175

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 10.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `COc1cccc(-c2nc(C(=O)O)cc3c2[nH]c2ccccc23)c1.Nc1ccc(CN2CCC(N3CCCCC3)CC2)cc1`
  - Products: `COc1cccc(-c2nc(C(=O)Nc3ccc(CN4CCC(N5CCCCC5)CC4)cc3)cc3c2[nH]c2ccccc23)c1`

**Reference:**
  - **Title:** 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
  - **Authors:** Chen, Bei; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01326](https://doi.org/10.1021/acs.jmedchem.3c01326)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-38589175
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 10 h, rt
Discovery of DS44470011: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia
By: Fukuda, Takeshi; et al
Bioorganic & Medicinal Chemistry Letters (2024), 108, 129799.
10.1016/j.bmcl.2024.129799
```

---

## Reaction 31-614-CAS-38589176

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 10.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Nc1ccc(CN2CCC(N3CCCCC3)CC2)cc1.COc1cccc(-c2nc(C(=O)O)cc3c2[nH]c2ccccc23)c1OC`
  - Products: `COc1cccc(-c2nc(C(=O)Nc3ccc(CN4CCC(N5CCCCC5)CC4)cc3)cc3c2[nH]c2ccccc23)c1OC`

**Reference:**
  - **Title:** 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
  - **Authors:** Chen, Bei; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01326](https://doi.org/10.1021/acs.jmedchem.3c01326)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-38589176
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 10 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2
By: Pettus, Liping H.; et al
Journal of Medicinal Chemistry (2020), 63(5), 2263-2281.
10.1021/acs.jmedchem.9b01034
```

---

## Reaction 31-614-CAS-38589178

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 15.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `COc1ccc(-c2nc(C(=O)O)cc3c2[nH]c2ccccc23)cc1OC.Nc1ccc(CN2CCC(N3CCCCC3)CC2)cc1`
  - Products: `COc1ccc(-c2nc(C(=O)Nc3ccc(CN4CCC(N5CCCCC5)CC4)cc3)cc3c2[nH]c2ccccc23)cc1OC`

**Reference:**
  - **Title:** 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
  - **Authors:** Chen, Bei; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01326](https://doi.org/10.1021/acs.jmedchem.3c01326)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-38589178
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 10 h, rt
Identification of 2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepine with clozapine-like mixed activities at muscarinic acetylcholine, dopamine, and serotonin receptors
By: Watanabe, Hitoshi; et al
Bioorganic & Medicinal Chemistry Letters (2021), 40, 127911.
10.1016/j.bmcl.2021.127911
```

---

## Reaction 31-614-CAS-38589179

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 10.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `Nc1ccc(CN2CCC(N3CCCCC3)CC2)cc1.COc1ccc(-c2nc(C(=O)O)cc3c2[nH]c2ccccc23)c(OC)c1`
  - Products: `COc1ccc(-c2nc(C(=O)Nc3ccc(CN4CCC(N5CCCCC5)CC4)cc3)cc3c2[nH]c2ccccc23)c(OC)c1`

**Reference:**
  - **Title:** 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
  - **Authors:** Chen, Bei; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01326](https://doi.org/10.1021/acs.jmedchem.3c01326)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-38589179
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 10 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Topical ‘dual-soft’ glucocorticoid receptor agonist for dermatology
By: Dack, Kevin N.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(17), 127402.
10.1016/j.bmcl.2020.127402
```

---

## Reaction 31-614-CAS-38589180

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 10.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `Nc1ccc(CN2CCC(N3CCCCC3)CC2)cc1.COc1cc(OC)cc(-c2nc(C(=O)O)cc3c2[nH]c2ccccc23)c1`
  - Products: `COc1cc(OC)cc(-c2nc(C(=O)Nc3ccc(CN4CCC(N5CCCCC5)CC4)cc3)cc3c2[nH]c2ccccc23)c1`

**Reference:**
  - **Title:** 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
  - **Authors:** Chen, Bei; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01326](https://doi.org/10.1021/acs.jmedchem.3c01326)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-38589180
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 10 h, rt
AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2
By: Narjes, Frank; et al
Journal of Medicinal Chemistry (2021), 64(18), 13807-13829.
10.1021/acs.jmedchem.1c01197
```

---

## Reaction 31-614-CAS-38624463

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 2.5 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Nc1ccc([N+](=O)[O-])cc1C(=O)O.CCCCN`
  - Products: `CCCCNC(=O)c1cc([N+](=O)[O-])ccc1N`

**Reference:**
  - **Title:** Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis
  - **Authors:** Sarkar, Dipayan; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01431](https://doi.org/10.1021/acs.jmedchem.3c01431)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-38624463
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, 25 - 30 °C
1.2|Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C
Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones
By: Ryan, Michael C.; et al
ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.
10.1021/acsmedchemlett.1c00539
```

---

## Reaction 31-614-CAS-38624465

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 2.5 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `Nc1ccc([N+](=O)[O-])cc1C(=O)O.NCCN1CCCCC1`
  - Products: `Nc1ccc([N+](=O)[O-])cc1C(=O)NCCN1CCCCC1`

**Reference:**
  - **Title:** Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis
  - **Authors:** Sarkar, Dipayan; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01431](https://doi.org/10.1021/acs.jmedchem.3c01431)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-38624465
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, 25 - 30 °C
1.2|Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C
Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis
By: Van der Plas, Steven E.; et al
Journal of Medicinal Chemistry (2021), 64(1), 343-353.
10.1021/acs.jmedchem.0c01796
```

---

## Reaction 31-614-CAS-38624467

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 2.5 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Nc1ccc([N+](=O)[O-])cc1C(=O)O.COCCN`
  - Products: `COCCNC(=O)c1cc([N+](=O)[O-])ccc1N`

**Reference:**
  - **Title:** Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis
  - **Authors:** Sarkar, Dipayan; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01431](https://doi.org/10.1021/acs.jmedchem.3c01431)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-38624467
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, 25 - 30 °C
1.2|Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C
Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis
By: Sarkar, Dipayan; et al
Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.
10.1021/acs.jmedchem.3c01431
```

---

## Reaction 31-614-CAS-38624468

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 2.5 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `Nc1ccc([N+](=O)[O-])cc1C(=O)O.NCCN1CCOCC1`
  - Products: `Nc1ccc([N+](=O)[O-])cc1C(=O)NCCN1CCOCC1`

**Reference:**
  - **Title:** Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis
  - **Authors:** Sarkar, Dipayan; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01431](https://doi.org/10.1021/acs.jmedchem.3c01431)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-38624468
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, 25 - 30 °C
1.2|Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C
Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus
By: Liu, Yonghua; et al
European Journal of Medicinal Chemistry (2022), 228, 114033.
10.1016/j.ejmech.2021.114033
```

---

## Reaction 31-614-CAS-38624469

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 2.5 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `Nc1ccc([N+](=O)[O-])cc1C(=O)O.NCCCN1CCOCC1`
  - Products: `Nc1ccc([N+](=O)[O-])cc1C(=O)NCCCN1CCOCC1`

**Reference:**
  - **Title:** Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis
  - **Authors:** Sarkar, Dipayan; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01431](https://doi.org/10.1021/acs.jmedchem.3c01431)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-38624469
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, 25 - 30 °C
1.2|Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma
By: Bollu, Lakshmi R.; et al
Journal of Medicinal Chemistry (2022), 65(23), 15642-15662.
10.1021/acs.jmedchem.2c00771
```

---

## Reaction 31-614-CAS-38624474

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 2.5 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `Nc1ccc([N+](=O)[O-])cc1C(=O)O.CN(C)CCN`
  - Products: `CN(C)CCNC(=O)c1cc([N+](=O)[O-])ccc1N`

**Reference:**
  - **Title:** Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis
  - **Authors:** Sarkar, Dipayan; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01431](https://doi.org/10.1021/acs.jmedchem.3c01431)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-38624474
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, 25 - 30 °C
1.2|Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C
Fragment-based discovery of novel phenyltriazolyl derivatives as allosteric type ALK inhibitors with promising antitumor effects
By: Cui, Youbao; et al
Bioorganic & Medicinal Chemistry Letters (2022), 75, 128990.
10.1016/j.bmcl.2022.128990
```

---

## Reaction 31-614-CAS-38625390

**Type:** Other

**Reaction Conditions:**
  - Temperature: 200.0°C
  - Time: 4.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `NC=O.COc1cc(Br)cc(C(=O)O)c1N`
  - Products: `COc1cc(Br)cc2c(=O)nc[nH]c12`

**Reference:**
  - **Title:** Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) Inhibitors
  - **Authors:** Heitmann, Tyler; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2023), 14(12), 1760-1766.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.3c00409](https://doi.org/10.1021/acsmedchemlett.3c00409)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-38625390
1.1|4 h, rt → 200 °C
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-38700934

**Type:** Other

**Full Catalytic System:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: AMIDE_BASE

**Catalyst Core:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: AMIDE_BASE

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: WORKUP (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `CN.Cl.CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)O)cc2)CC1`
  - Products: `CNC(=O)c1ccc(N2CCN(C(=O)OC(C)(C)C)CC2)cc1`

**Reference:**
  - **Title:** Discovery of (2S)-N-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment
  - **Authors:** Zhang, Wenqiang; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(1), 322-348.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01417](https://doi.org/10.1021/acs.jmedchem.3c01417)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-38700934
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-Methylmorpholine
Solvents: Dimethylformamide; 2 h, rt
1.2|Reagents: Water; rt
Optimization of a series of potent, selective and orally bioavailable SYK inhibitors
By: Grimster, Neil P.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127433.
10.1016/j.bmcl.2020.127433
```

---

## Reaction 31-614-CAS-38701167

**Type:** Other

**Reagents:**
  - N-Methylimidazole (CAS: 616-47-7) - Role: BASE (Registry: AMIDE_CATALYST)
  - Piperidine (CAS: 110-89-4) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - 1-Methylimidazole - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CCS(=O)(=O)Cl.CCN1[C@@H](CC(C)(C)C)[C@](CNC(=O)OCC2c3ccccc3-c3ccccc32)(c2ccc(Cl)cc2F)[C@@H](c2cccc(Cl)c2)[C@@H]1C(=O)O.COC(=O)c1ccc(N)c(OC)c1`
  - Products: `CCN1[C@@H](CC(C)(C)C)[C@](CN)(c2ccc(Cl)cc2F)[C@@H](c2cccc(Cl)c2)[C@@H]1C(=O)Nc1ccc(C(=O)OC)cc1OC`

**Reference:**
  - **Title:** Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy
  - **Authors:** Cheng, Jing; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(24), 16991-17025.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01815](https://doi.org/10.1021/acs.jmedchem.3c01815)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-38701167
1.1|Reagents: 1-Methylimidazole
Solvents: Dichloromethane; 30 min, rt
1.2|2 h, rt
1.3|Solvents: Water; rt
1.4|Reagents: Piperidine
Solvents: Dimethylformamide; 30 min, rt
1.5|Reagents: Hydrochloric acid
Solvents: Water; rt
Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective Inhibitors
By: Corminboeuf, Olivier; et al
ChemMedChem (2024), 19(2), e202300606.
10.1002/cmdc.202300606
```

---

## Reaction 31-614-CAS-38824564

**Type:** Other

**Reagents:**
  - NaOH (CAS: 1310-73-2) - Role: BASE
  - (+)-Tartaric acid (CAS: 87-69-4) - Role: UNK
  - Ammonia (CAS: 7664-41-7) - Role: UNK
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 75.0°C
  - Time: 84.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `NCC(=O)O.COc1cc(Br)cc2c(=O)oc(=O)[nH]c12`
  - Products: `COc1cc(Br)cc2c1NC(=O)CNC2=O`

**Reference:**
  - **Title:** Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective Inhibitors
  - **Authors:** Corminboeuf, Olivier; et al
  - **Citation:** ChemMedChem (2024), 19(2), e202300606.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300606](https://doi.org/10.1002/cmdc.202300606)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-38824564
1.1|Reagents: Sodium hydroxide
Solvents: Water; 18 h, 75 °C
1.2|Reagents: (+)-Tartaric acid; 2 d, 75 °C; 18 h, 75 °C
1.3|Reagents: Ammonia
Solvents: Water; pH 7
Absolute stereochemistry shown
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension
By: Vakalopoulos, Alexandros; et al
Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.
10.1021/acs.jmedchem.2c02082
```

---

## Reaction 31-614-CAS-38825292

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 72.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(C(F)(F)F)n1.CC(C)(C)OC(=O)n1ncc2cc(N)c(Cl)cc21`
  - Products: `CC(C)(C)OC(=O)n1ncc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(Cl)cc21`

**Reference:**
  - **Title:** Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
  - **Authors:** Bothe, Ulrich; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01714](https://doi.org/10.1021/acs.jmedchem.3c01714)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-38825292
1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole
Solvents: Dimethylformamide; 3 d, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-38825334

**Type:** Other

**Reagents:**
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Et3N (CAS: 121-44-8) - Role: BASE

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(C(F)(F)F)n1.CCOC(=O)Cn1cc2cc(N)c(OCc3ccccc3)cc2n1`
  - Products: `CCOC(=O)Cn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(OCc3ccccc3)cc2n1`

**Reference:**
  - **Title:** Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
  - **Authors:** Bothe, Ulrich; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01714](https://doi.org/10.1021/acs.jmedchem.3c01714)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-38825334
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole
Solvents: Tetrahydrofuran, Triethylamine; 24 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma
By: Chang, Qi; et al
Journal of Medicinal Chemistry (2024), 67(4), 2466-2486.
10.1021/acs.jmedchem.3c01468
```

---

## Reaction 31-614-CAS-38825401

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `COc1cc(N)c(N)cc1[N+](=O)[O-].O=C(O)C1CCCS(=O)(=O)C1`
  - Products: `COc1cc(NC(=O)C2CCCS(=O)(=O)C2)c(N)cc1[N+](=O)[O-]`

**Reference:**
  - **Title:** Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
  - **Authors:** Bothe, Ulrich; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01714](https://doi.org/10.1021/acs.jmedchem.3c01714)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-38825401
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; 24 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma
By: Zhou, Yi; et al
Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.
10.1021/acs.jmedchem.9b02161
```

---

## Reaction 31-614-CAS-38825422

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)C1CCCS(=O)(=O)C1.CNc1cc(NC(=O)OC(C)(C)C)c(OC)cc1N`
  - Products: `CNc1cc(NC(=O)OC(C)(C)C)c(OC)cc1NC(=O)C1CCCS(=O)(=O)C1`

**Reference:**
  - **Title:** Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
  - **Authors:** Bothe, Ulrich; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01714](https://doi.org/10.1021/acs.jmedchem.3c01714)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-38825422
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, 25 °C
1.2|Reagents: Sodium bicarbonate
Solvents: Water; pH 8
Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)
By: Kotian, Pravin L.; et al
Journal of Medicinal Chemistry (2021), 64(17), 12453-12468.
10.1021/acs.jmedchem.1c00511
```

---

## Reaction 31-614-CAS-38825440

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 6.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `COC(=O)CCC(=O)O.CNc1ccc(C(=O)OC)cc1N`
  - Products: `CNc1ccc(C(=O)OC)cc1NC(=O)CCC(=O)OC`

**Reference:**
  - **Title:** Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
  - **Authors:** Bothe, Ulrich; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01714](https://doi.org/10.1021/acs.jmedchem.3c01714)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-38825440
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 6 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-38825448

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `COC(=O)CCC(=O)O.CCNc1ccc(C(=O)OC)cc1N`
  - Products: `CCNc1ccc(C(=O)OC)cc1NC(=O)CCC(=O)OC`

**Reference:**
  - **Title:** Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
  - **Authors:** Bothe, Ulrich; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01714](https://doi.org/10.1021/acs.jmedchem.3c01714)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-38825448
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 24 h, 25 °C
Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis
By: Zimmermann, Thomas; et al
Journal of Medicinal Chemistry (2024), 67(13), 10710-10742.
10.1021/acs.jmedchem.4c00230
```

---

## Reaction 31-614-CAS-38927965

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - DMSO (CAS: 67-68-5) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 4.5 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `O=C(O)c1cc(-c2ccc(F)cc2F)on1.COC(=O)[C@@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1N.O=C(O)C(F)(F)F`
  - Products: `COC(=O)[C@@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1NC(=O)c1cc(-c2ccc(F)cc2F)on1`

**Reference:**
  - **Title:** Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification
  - **Authors:** Schafer, Gabriel; et al
  - **Citation:** Organic Process Research & Development (2024), 28(6), 2103-2116.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.3c00446](https://doi.org/10.1021/acs.oprd.3c00446)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-38927965
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethyl sulfoxide; 30 min, 20 - 25 °C; 30 min, 20 - 25 °C
1.2|Solvents: Dimethyl sulfoxide; 30 min, 20 - 25 °C; 1 h, 20 - 25 °C
1.3|Solvents: Water; 1 h, 20 - 30 °C; 1 h, 20 - 25 °C
Development of a Scalable, Racemic first Generation Route for CXCR7 Antagonist ACT-1004-1239 via cis-to-trans Epimerization and Subsequent Separation of Enantiomers
By: Schafer, Gabriel; et al
Organic Process Research & Development (2024), 28(6), 2090-2102.
10.1021/acs.oprd.3c00445
```

---

## Reaction 31-614-CAS-38927970

**Type:** Other

**Reagents:**
  - N-Methylimidazole (CAS: 616-47-7) - Role: BASE (Registry: AMIDE_CATALYST)
  - Tetramethylchloroformamidinium hexafluorophosphate (CAS: 94790-35-9) - Role: UNK
  - 1-Methylimidazole - Role: UNK

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 75.0°C
  - Time: 4.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `Cl.NC1(c2ncccn2)CC1.CC(C)(C)OC(=O)N1CC[C@H](NC(=O)c2cc(-c3ccc(F)cc3F)on2)[C@@H](C(=O)O)C1`
  - Products: `CC(C)(C)OC(=O)N1CC[C@H](NC(=O)c2cc(-c3ccc(F)cc3F)on2)[C@@H](C(=O)NC2(c3ncccn3)CC2)C1`

**Reference:**
  - **Title:** Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification
  - **Authors:** Schafer, Gabriel; et al
  - **Citation:** Organic Process Research & Development (2024), 28(6), 2103-2116.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.3c00446](https://doi.org/10.1021/acs.oprd.3c00446)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-38927970
1.1|Reagents: 1-Methylimidazole, Tetramethylchloroformamidinium hexafluorophosphate
Solvents: Acetonitrile; 45 min, < 30 °C; 30 min, 20 - 25 °C
1.2|Solvents: Water; 25 °C → 75 °C; 45 min, 75 °C; 1 h, 75 °C → 25 °C; 1 h, 20 - 25 °C
Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239
By: Richard-Bildstein, Sylvia; et al
Journal of Medicinal Chemistry (2020), 63(24), 15864-15882.
10.1021/acs.jmedchem.0c01588
```

---

## Reaction 31-614-CAS-38928206

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - NaOH (CAS: 1310-73-2) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 35.0°C
  - Time: 2.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)c1cc(-c2ccc(F)cc2F)on1.COC(=O)C1CN(C(=O)OC(C)(C)C)CCC1N.O=C(O)C(F)(F)F`
  - Products: `COC(=O)C1CN(C(=O)OC(C)(C)C)CCC1NC(=O)c1cc(-c2ccc(F)cc2F)on1`

**Reference:**
  - **Title:** Development of a Scalable, Racemic first Generation Route for CXCR7 Antagonist ACT-1004-1239 via cis-to-trans Epimerization and Subsequent Separation of Enantiomers
  - **Authors:** Schafer, Gabriel; et al
  - **Citation:** Organic Process Research & Development (2024), 28(6), 2090-2102.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.3c00445](https://doi.org/10.1021/acs.oprd.3c00445)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-38928206
1.1|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 15 min, 20 - 30 °C
1.2|Reagents: Propylphosphonic anhydride
Solvents: Dimethylformamide; 45 min, 35 °C; 30 min, 20 - 25 °C
1.3|Reagents: Sodium hydroxide
Solvents: Water; 30 min, 35 °C
Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers
By: Vaidya, Sandeep; et al
ChemMedChem (2023), 18(16), e202300097.
10.1002/cmdc.202300097
```

---

## Reaction 31-614-CAS-38940080

**Type:** Other

**Reagents:**
  - Potassium bisulfate (CAS: 7646-93-7) - Role: BASE
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK
  - K2CO3 (CAS: 584-08-7) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - NaOH (CAS: 1310-73-2) - Role: UNK (Registry: BASE)
  - Potassium carbonate - Role: UNK
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - PhMe (CAS: 108-88-3) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - Isopropanol (CAS: 67-63-0) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 10.0°C
  - Time: 26.5 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `COC(=O)CC[C@@H](CC(=O)O)c1noc([C@H]2C[C@@H](CC(C)(C)C)C2)c1C1CC1.C[C@H](N)c1ccccc1.Cc1ccc(N)c(Cl)c1`
  - Products: `Cc1ccc(NC(=O)C[C@H](CCC(=O)O)c2noc([C@H]3C[C@@H](CC(C)(C)C)C3)c2C2CC2)c(Cl)c1`

**Reference:**
  - **Title:** Practical Synthesis of Chiral 3-(Hydroxyiminomethyl)adipic Acid, a Key Intermediate of the ROR-γ Inhibitor JTE-151, via Crystallization-Induced Dynamic Resolution
  - **Authors:** Takiguchi, Hiromu; et al
  - **Citation:** Organic Process Research & Development (2023), 27(12), 2355-2364.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.3c00320](https://doi.org/10.1021/acs.oprd.3c00320)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-38940080
1.1|Reagents: Potassium bisulfate
Solvents: Toluene, Water; 30 min, rt
1.2|Reagents: Thionyl chloride
Solvents: Toluene; 1 h, rt
1.3|Reagents: Potassium carbonate
Solvents: Toluene, Water; 1 h, < 10 °C
1.4|Reagents: Hydrochloric acid
Solvents: Water
1.5|Reagents: Sodium hydroxide
Solvents: Isopropanol, Water; 24 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
By: Behring, Lydia; et al
Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
10.1021/acs.jmedchem.2c01360
```

---

## Reaction 31-614-CAS-39000609

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - DMAc (CAS: 127-19-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.5 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CC(C)(C)C[C@H]1C[C@@H](c2cnn(C(CCCOCc3ccccc3)CC(=O)O)c2C2CC2)C1.Cc1ccc(N)c(Cl)c1`
  - Products: `Cc1ccc(NC(=O)CC(CCCOCc2ccccc2)n2ncc([C@H]3C[C@@H](CC(C)(C)C)C3)c2C2CC2)c(Cl)c1`

**Reference:**
  - **Title:** Discovery and SAR of JTE-151: A Novel RORγ Inhibitor for Clinical Development
  - **Authors:** Maeba, Takaki; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 952-970.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01933](https://doi.org/10.1021/acs.jmedchem.3c01933)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-39000609
1.1|Reagents: Thionyl chloride
Solvents: Dimethylacetamide; 1 h, 0 °C
1.2|0 °C; 1.5 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome
By: Gotz, Marion G.; et al
ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.
10.1021/acsmedchemlett.4c00017
```

---

## Reaction 31-614-CAS-39000809

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 5.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `COc1ccc(N)c(N)c1.O=C(O)C(=O)O`
  - Products: `COc1ccc2[nH]c(=O)c(=O)[nH]c2c1`

**Reference:**
  - **Title:** DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia
  - **Authors:** Ali, Imran; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 265, 116052.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.116052](https://doi.org/10.1016/j.ejmech.2023.116052)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-39000809
1.1|Reagents: Hydrochloric acid
Solvents: Water; 5 h, reflux
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown
Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors
By: Silva-Reis, Sara C.; et al
ACS Medicinal Chemistry Letters (2023), 14(12), 1656-1663.
10.1021/acsmedchemlett.3c00264
```

---

## Reaction 31-614-CAS-39000832

**Type:** Other

**Reagents:**
  - EDC (CAS: 1892-57-5) - Role: BASE (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 20.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NC(CC(=O)O)Cc1cc(Cl)ccc1N`
  - Products: `CC(C)(C)OC(=O)NC1CC(=O)Nc2ccc(Cl)cc2C1`

**Reference:**
  - **Title:** Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist
  - **Authors:** Baska, Ferenc; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(1), 643-673.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01868](https://doi.org/10.1021/acs.jmedchem.3c01868)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-39000832
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine
Solvents: Dimethylformamide; 20 h, rt
1.2|Reagents: Sodium bicarbonate
Solvents: Water; rt
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
By: Pasqua, A. Elisa; et al
Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.
10.1021/acs.jmedchem.3c00156
```

---

## Reaction 31-614-CAS-39011906

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(=O)Nc1ccc(C(C)(C)C)cc1N.COc1ccc(OC)c(-n2nnc(C(=O)O)c2C)c1`
  - Products: `COc1ccc(OC)c(-n2nnc(C(=O)Nc3cc(C(C)(C)C)ccc3NC(C)=O)c2C)c1`

**Reference:**
  - **Title:** Design and Optimization of 1H-1,2,3-Triazole-4-carboxamides as Novel, Potent, and Selective Inverse Agonists and Antagonists of PXR
  - **Authors:** Li, Yongtao; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(24), 16829-16859.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01640](https://doi.org/10.1021/acs.jmedchem.2c01640)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-39011906
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins
By: Sindhikara, Dan; et al
Journal of Medicinal Chemistry (2020), 63(20), 12100-12115.
10.1021/acs.jmedchem.0c01500
```

---

## Reaction 31-614-CAS-39012245

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 48.75 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `COC(=O)CCCCCCCCCCC(=O)O.CC(C)(C)OC(=O)CCOCC(N)(COCCC(=O)OC(C)(C)C)COCCC(=O)OC(C)(C)C`
  - Products: `COC(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)OC(C)(C)C)(COCCC(=O)OC(C)(C)C)COCCC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways
  - **Authors:** Kandasamy, Pachamuthu; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(4), 2506-2523.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01337](https://doi.org/10.1021/acs.jmedchem.2c01337)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-39012245
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine
Solvents: Dimethylformamide, Dichloromethane; 15 min, rt; 30 min, rt; 2 d, rt
Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones
By: Ryan, Michael C.; et al
ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.
10.1021/acsmedchemlett.1c00539
```

---

## Reaction 31-614-CAS-39026996

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 8.25 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)O.CC(C)(C)OC(=O)N1CC[C@H](N)C1`
  - Products: `Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)N[C@H]1CCN(C(=O)OC(C)(C)C)C1`

**Reference:**
  - **Title:** Economical and Practical Process Development for a Novel Multitarget Tyrosine Kinase Inhibitor Vorolanib
  - **Authors:** Xiu, Xiaomeng; et al
  - **Citation:** Organic Process Research & Development (2024), 28(2), 492-499.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.3c00311](https://doi.org/10.1021/acs.oprd.3c00311)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-39026996
1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 min, rt
1.2|Reagents: 1-Hydroxybenzotriazole; rt → 40 °C; 8 h, 40 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy
By: Cheng, Jing; et al
Journal of Medicinal Chemistry (2023), 66(24), 16991-17025.
10.1021/acs.jmedchem.3c01815
```

---

## Reaction 31-614-CAS-39099371

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - NaOH (CAS: 1310-73-2) - Role: UNK (Registry: BASE)
  - 1,1′-Carbonyldiimidazole - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT
  - MeOH (CAS: 67-56-1) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 55.0°C
  - Time: 0.75 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Nc1ncc(Cl)nc1C(=O)O.CCOC(=O)CN.Cl`
  - Products: `CCOC(=O)CNC(=O)c1nc(Cl)cnc1N`

**Reference:**
  - **Title:** Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis
  - **Authors:** Betzemeier, Bodo; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 265, 116038.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.116038](https://doi.org/10.1016/j.ejmech.2023.116038)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-39099371
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Acetonitrile; 55 °C
1.2|Reagents: Diisopropylethylamine; 45 min, 55 °C
1.3|Reagents: Sodium hydroxide
Solvents: Methanol, Water; 50 °C
Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y14R antagonists with potential high efficiency against acute gouty arthritis
By: Lu, Ran; et al
European Journal of Medicinal Chemistry (2021), 216, 113313.
10.1016/j.ejmech.2021.113313
```

---

## Reaction 31-614-CAS-39099375

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT
  - Isopropanol (CAS: 67-63-0) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 3.5 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `Nc1ncc(Cl)nc1C(=O)NCC(=O)O.CCNc1cc(OCC(=O)OC(C)C)ccc1N.Cl`
  - Products: `CCNc1cc(OCC(=O)OC(C)C)ccc1NC(=O)CNC(=O)c1nc(Cl)cnc1N`

**Reference:**
  - **Title:** Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis
  - **Authors:** Betzemeier, Bodo; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 265, 116038.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.116038](https://doi.org/10.1016/j.ejmech.2023.116038)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-39099375
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Acetonitrile; 1 h, 50 °C; 50 °C → rt
1.2|Reagents: Hydrochloric acid
Solvents: Acetonitrile; 1.5 h, rt
1.3|Solvents: Isopropanol, Water; 1 h, 40 °C
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine template
By: Marciniak, Monika; et al
European Journal of Medicinal Chemistry (2023), 258, 115587.
10.1016/j.ejmech.2023.115587
```

---

## Reaction 31-614-CAS-39101046

**Type:** Other

**Full Catalytic System:**
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: ACTIVATOR

**Catalyst Core:**
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: ACTIVATOR

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.5 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(C(F)(F)F)n1.COC(=O)c1cc2[nH]ncc2cc1N`
  - Products: `COC(=O)c1cc2[nH]ncc2cc1NC(=O)c1cccc(C(F)(F)F)n1`

**Reference:**
  - **Title:** Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma
  - **Authors:** Weiss, Matthew M.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(13), 10548-10566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01823](https://doi.org/10.1021/acs.jmedchem.3c01823)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-39101046
1.1|Reagents: Diisopropylethylamine
Catalysts: Propylphosphonic anhydride
Solvents: Tetrahydrofuran; 2 h, 0 - 5 °C
1.2|Solvents: Water; 0.5 h, 25 °C
Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
By: Tormaehlen, Niklas M.; et al
Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
10.1021/acs.jmedchem.0c01773
```

---

## Reaction 31-614-CAS-39101188

**Type:** Other

**Reagents:**
  - Py (CAS: 110-86-1) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COC(=O)c1cc(N)c(I)cc1Br.O=C(O)[C@H]1CC[C@H](COCc2ccccc2)CC1`
  - Products: `COC(=O)c1cc(NC(=O)[C@H]2CC[C@H](COCc3ccccc3)CC2)c(I)cc1Br`

**Reference:**
  - **Title:** Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma
  - **Authors:** Weiss, Matthew M.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(13), 10548-10566.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01823](https://doi.org/10.1021/acs.jmedchem.3c01823)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-39101188
1.1|Reagents: Pyridine, Propylphosphonic anhydride
Solvents: Dichloromethane; 2 h, 0 °C
Relative stereochemistry shown
Relative stereochemistry shown
GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins
By: Watson, Robert J.; et al
Journal of Medicinal Chemistry (2020), 63(17), 9045-9069.
10.1021/acs.jmedchem.0c00614
```

---

## Reaction 31-614-CAS-39174684

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `Cc1cc(C)c(CN)c(=O)[nH]1.CCN(c1cc(-c2cccc(NC(=O)c3cc(C(C)C)c(OCc4ccccc4)cc3OCc3ccccc3)c2)cc(C(=O)O)c1C)C1CCOCC1`
  - Products: `CCN(c1cc(-c2cccc(NC(=O)c3cc(C(C)C)c(OCc4ccccc4)cc3OCc3ccccc3)c2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1`

**Reference:**
  - **Title:** First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo
  - **Authors:** Sharma, Sachin; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(4), 2963-2985.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02053](https://doi.org/10.1021/acs.jmedchem.3c02053)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-39174684
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; rt; 3 h, rt
Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors
By: Ushiki, Yasunobu; et al
Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.
10.1016/j.bmcl.2022.128572
```

---

## Reaction 31-614-CAS-39174753

**Type:** Other

**Reagents:**
  - AcOH (CAS: 64-19-7) - Role: UNK (Registry: SOLVENT)

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `Nc1ccccc1N.CC(=O)C(=O)O.[Na]`
  - Products: `Cc1nc2ccccc2[nH]c1=O`

**Reference:**
  - **Title:** Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands
  - **Authors:** Andreasson, Maans; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02127](https://doi.org/10.1021/acs.jmedchem.3c02127)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-39174753
1.1|Reagents: Acetic acid
Solvents: Water; 3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Mining Natural Products for Macrocycles to Drug Difficult Targets
By: Begnini, Fabio; et al
Journal of Medicinal Chemistry (2021), 64(2), 1054-1072.
10.1021/acs.jmedchem.0c01569
```

---

## Reaction 31-614-CAS-39174754

**Type:** Other

**Reagents:**
  - AcOH (CAS: 64-19-7) - Role: UNK (Registry: SOLVENT)

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CC(=O)C(=O)O.[Na].Cc1cc(N)c(N)cc1C`
  - Products: `Cc1cc2nc(C)c(=O)[nH]c2cc1C`

**Reference:**
  - **Title:** Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands
  - **Authors:** Andreasson, Maans; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02127](https://doi.org/10.1021/acs.jmedchem.3c02127)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-39174754
1.1|Reagents: Acetic acid
Solvents: Water; 3 h, rt
Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity
By: Patel, Bhautikkumar; et al
Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853.
10.1016/j.bmcl.2021.127853
```

---

## Reaction 31-614-CAS-39174762

**Type:** Other

**Reagents:**
  - AcOH (CAS: 64-19-7) - Role: UNK (Registry: SOLVENT)

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CC(=O)C(=O)O.[Na].Nc1cc(Cl)c(Cl)cc1N`
  - Products: `Cc1nc2cc(Cl)c(Cl)cc2[nH]c1=O`

**Reference:**
  - **Title:** Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands
  - **Authors:** Andreasson, Maans; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02127](https://doi.org/10.1021/acs.jmedchem.3c02127)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-39174762
1.1|Reagents: Acetic acid
Solvents: Water; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-39179130

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.5 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)O.COC(=O)[C@@H](N)C[C@@H]1CCNC1=O`
  - Products: `COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2
  - **Authors:** Grifagni, Deborah; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(2), 250-257.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.3c00498](https://doi.org/10.1021/acsmedchemlett.3c00498)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-39179130
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0.5 h, rt
1.2|Reagents: Triethylamine
Solvents: Dimethylformamide; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-39179136

**Type:** Other

**Reagents:**
  - N,N-Diisopropylcarbodiimide (CAS: 693-13-0) - Role: BASE (Registry: N'-DIISOPROPYLCARBODIIMIDE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylcarbodiimide - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)Cc1ccccc1.Cl.CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O`
  - Products: `COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C`

**Reference:**
  - **Title:** Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2
  - **Authors:** Grifagni, Deborah; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(2), 250-257.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.3c00498](https://doi.org/10.1021/acsmedchemlett.3c00498)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-39179136
1.1|Reagents: Diisopropylcarbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine
Solvents: Dimethylformamide; 0 °C; 0 °C → rt; 16 h, rt
Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit
By: Rianjongdee, Francesco; et al
Journal of Medicinal Chemistry (2021), 64(15), 10806-10833.
10.1021/acs.jmedchem.1c00412
```

---

## Reaction 31-614-CAS-39179504

**Type:** Other

**Reagents:**
  - Water (CAS: 7732-18-5) - Role: WORKUP (Registry: SOLVENT)
  - NaOH (CAS: 1310-73-2) - Role: BASE
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 150.0°C
  - Time: 5.333 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `NC(N)=O.Nc1ccc(Cl)cc1C(=O)O`
  - Products: `O=c1[nH]c(=O)c2cc(Cl)ccc2[nH]1`

**Reference:**
  - **Title:** Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis
  - **Authors:** Yang, Liu; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(3), 1914-1931.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01703](https://doi.org/10.1021/acs.jmedchem.3c01703)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-39179504
1.1|5 h, rt → 150 °C; 150 °C → 100 °C
1.2|Reagents: Water; 10 min, 100 °C
1.3|Reagents: Sodium hydroxide
Solvents: Water; 10 min, 100 °C
1.4|Reagents: Hydrochloric acid
Solvents: Water; pH 3
High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists
By: Bolteau, Raphael; et al
European Journal of Medicinal Chemistry (2022), 241, 114620.
10.1016/j.ejmech.2022.114620
```

---

## Reaction 31-614-CAS-39248128

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `COC(=O)CCCCN.CC12CC3CC(C)(C1)CC(NC(=O)Nc1ccc(C(=O)O)cc1)(C3)C2`
  - Products: `COC(=O)CCCCNC(=O)c1ccc(NC(=O)NC23CC4CC(C)(CC(C)(C4)C2)C3)cc1`

**Reference:**
  - **Title:** Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality
  - **Authors:** Chen, Yuanguang; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02006](https://doi.org/10.1021/acs.jmedchem.3c02006)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-39248128
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 2 h, rt
Design and synthesis of novel cereblon binders for use in targeted protein degradation
By: Norris, Stephen; et al
Journal of Medicinal Chemistry (2023), 66(23), 16388-16409.
10.1021/acs.jmedchem.3c01848
```

---

## Reaction 31-614-CAS-39248129

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `COC(=O)CCCCCN.CC12CC3CC(C)(C1)CC(NC(=O)Nc1ccc(C(=O)O)cc1)(C3)C2`
  - Products: `COC(=O)CCCCCNC(=O)c1ccc(NC(=O)NC23CC4CC(C)(CC(C)(C4)C2)C3)cc1`

**Reference:**
  - **Title:** Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality
  - **Authors:** Chen, Yuanguang; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02006](https://doi.org/10.1021/acs.jmedchem.3c02006)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-39248129
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 2 h, rt
Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras
By: Takwale, Akshay D.; et al
European Journal of Medicinal Chemistry (2020), 208, 112769.
10.1016/j.ejmech.2020.112769
```

---

## Reaction 31-614-CAS-39248143

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `COC(=O)CCCCCCN.CC12CC3CC(C)(C1)CC(NC(=O)Nc1ccc(C(=O)O)cc1)(C3)C2`
  - Products: `COC(=O)CCCCCCNC(=O)c1ccc(NC(=O)NC23CC4CC(C)(CC(C)(C4)C2)C3)cc1`

**Reference:**
  - **Title:** Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality
  - **Authors:** Chen, Yuanguang; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02006](https://doi.org/10.1021/acs.jmedchem.3c02006)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-39248143
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 2 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors
By: Meena, Chhuttan L.; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.
10.1016/j.bmcl.2020.127039
```

---

## Reaction 31-614-CAS-39248170

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `COC(=O)CCN.CC(C)(C)OC(=O)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1`
  - Products: `COC(=O)CCNC(=O)c1ccc(O[C@H]2CC[C@H](NC(=O)OC(C)(C)C)CC2)cc1`

**Reference:**
  - **Title:** Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality
  - **Authors:** Chen, Yuanguang; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02006](https://doi.org/10.1021/acs.jmedchem.3c02006)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-39248170
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
By: Guzelj, Samo; et al
Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.
10.1021/acs.jmedchem.2c00808
```

---

## Reaction 31-614-CAS-39248679

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - DMAP (CAS: 1122-58-3) - Role: UNK (Registry: LIGAND)
  - Dicyclohexylcarbodiimide - Role: UNK
  - 4-(Dimethylamino)pyridine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(C)CN.O=C(O)Cc1ccc(I)cc1`
  - Products: `CC(C)CNC(=O)Cc1ccc(I)cc1`

**Reference:**
  - **Title:** Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors
  - **Authors:** Feng, Zi-Qiang; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 266, 116113.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.116113](https://doi.org/10.1016/j.ejmech.2023.116113)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-39248679
1.1|Reagents: Triethylamine, Dicyclohexylcarbodiimide, 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 3 h, rt
Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase
By: Bagal, Sharan K.; et al
Journal of Medicinal Chemistry (2021), 64(23), 17146-17183.
10.1021/acs.jmedchem.1c01161
```

---

## Reaction 31-614-CAS-39248683

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1ccccn1.Nc1cccc(/C=C/c2ccc(NC(=O)NCC3CCOCC3)cc2)c1`
  - Products: `O=C(NCC1CCOCC1)Nc1ccc(/C=C/c2cccc(NC(=O)c3ccccn3)c2)cc1`

**Reference:**
  - **Title:** Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors
  - **Authors:** Feng, Zi-Qiang; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 266, 116113.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.116113](https://doi.org/10.1016/j.ejmech.2023.116113)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-39248683
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality
By: Chen, Yuanguang; et al
Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.
10.1021/acs.jmedchem.3c02006
```

---

## Reaction 31-614-CAS-39256028

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Cc1cc(N)ccc1Br.CCS(=O)(=O)c1ccc(CC(=O)O)cc1`
  - Products: `CCS(=O)(=O)c1ccc(CC(=O)Nc2ccc(Br)c(C)c2)cc1`

**Reference:**
  - **Title:** Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
  - **Authors:** Fang, Wei; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02063](https://doi.org/10.1021/acs.jmedchem.3c02063)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-39256028
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability
By: Meta, Mergim; et al
ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.
10.1021/acsmedchemlett.4c00050
```

---

## Reaction 31-614-CAS-39256044

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `N#Cc1ccc(CC(=O)O)cc1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1C`
  - Products: `C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccc(C#N)cc2)cc1C`

**Reference:**
  - **Title:** Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
  - **Authors:** Fang, Wei; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02063](https://doi.org/10.1021/acs.jmedchem.3c02063)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-39256044
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839
By: Bothe, Ulrich; et al
Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.
10.1021/acs.jmedchem.3c01714
```

---

## Reaction 31-614-CAS-39256047

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `N#Cc1cccc(CC(=O)O)c1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1C`
  - Products: `C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2cccc(C#N)c2)cc1C`

**Reference:**
  - **Title:** Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
  - **Authors:** Fang, Wei; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02063](https://doi.org/10.1021/acs.jmedchem.3c02063)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-39256047
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus
By: Liu, Yonghua; et al
European Journal of Medicinal Chemistry (2022), 228, 114033.
10.1016/j.ejmech.2021.114033
```

---

## Reaction 31-614-CAS-39256049

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `O=C(O)Cc1ccccc1[N+](=O)[O-].C=CC(=O)Nc1ccccc1-c1ccc(N)cc1C`
  - Products: `C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccccc2[N+](=O)[O-])cc1C`

**Reference:**
  - **Title:** Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
  - **Authors:** Fang, Wei; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02063](https://doi.org/10.1021/acs.jmedchem.3c02063)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-39256049
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors
By: Kawanami, Toshio; et al
ACS Medicinal Chemistry Letters (2020), 11(2), 188-194.
10.1021/acsmedchemlett.9b00578
```

---

## Reaction 31-614-CAS-39256063

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CCS(=O)(=O)c1ccc(CC(=O)O)cc1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1C(F)(F)F`
  - Products: `C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccc(S(=O)(=O)CC)cc2)cc1C(F)(F)F`

**Reference:**
  - **Title:** Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
  - **Authors:** Fang, Wei; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02063](https://doi.org/10.1021/acs.jmedchem.3c02063)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-39256063
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors
By: Zhu, Junjie; et al
European Journal of Medicinal Chemistry (2023), 259, 115666.
10.1016/j.ejmech.2023.115666
```

---

## Reaction 31-614-CAS-39256065

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `Cc1ncc(C(=O)O)cn1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1C`
  - Products: `C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)c2cnc(C)nc2)cc1C`

**Reference:**
  - **Title:** Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
  - **Authors:** Fang, Wei; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02063](https://doi.org/10.1021/acs.jmedchem.3c02063)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-39256065
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Design, synthesis, and analgesia evaluation of novel Transient Receptor Potential Vanilloid 1 (TRPV1) agonists modified from Cannabidiol (CBD)
By: Jin, Fangjie; et al
Bioorganic & Medicinal Chemistry (2023), 90, 117379.
10.1016/j.bmc.2023.117379
```

---

## Reaction 31-614-CAS-39256072

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CCS(=O)(=O)c1ccc(CC(=O)O)cc1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1`
  - Products: `C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccc(S(=O)(=O)CC)cc2)cc1`

**Reference:**
  - **Title:** Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
  - **Authors:** Fang, Wei; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02063](https://doi.org/10.1021/acs.jmedchem.3c02063)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-39256072
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis
By: Mohamed, Abdelrahman; et al
Journal of Medicinal Chemistry (2022), 65(17), 11726-11744.
10.1021/acs.jmedchem.2c00589
```

---

## Reaction 31-614-CAS-39256075

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CCS(=O)(=O)c1ccc(CC(=O)O)cc1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1Cl`
  - Products: `C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccc(S(=O)(=O)CC)cc2)cc1Cl`

**Reference:**
  - **Title:** Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
  - **Authors:** Fang, Wei; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02063](https://doi.org/10.1021/acs.jmedchem.3c02063)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-39256075
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain
By: van der Wildt, Berend; et al
Bioorganic & Medicinal Chemistry (2021), 42, 116245.
10.1016/j.bmc.2021.116245
```

---

## Reaction 31-614-CAS-39256076

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CCS(=O)(=O)c1ccc(CC(=O)O)cc1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1F`
  - Products: `C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccc(S(=O)(=O)CC)cc2)cc1F`

**Reference:**
  - **Title:** Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
  - **Authors:** Fang, Wei; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02063](https://doi.org/10.1021/acs.jmedchem.3c02063)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-39256076
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors
By: Aylott, Helen E.; et al
Journal of Medicinal Chemistry (2021), 64(6), 3249-3281.
10.1021/acs.jmedchem.0c02156
```

---

## Reaction 31-614-CAS-39256077

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CCS(=O)(=O)c1ccc(CC(=O)O)cc1.C=CC(=O)Nc1ccccc1-c1ccc(N)cn1`
  - Products: `C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccc(S(=O)(=O)CC)cc2)cn1`

**Reference:**
  - **Title:** Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer
  - **Authors:** Fang, Wei; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02063](https://doi.org/10.1021/acs.jmedchem.3c02063)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-39256077
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents
By: Li, Baihui; et al
European Journal of Medicinal Chemistry (2020), 195, 112278.
10.1016/j.ejmech.2020.112278
```

---

## Reaction 31-614-CAS-39283196

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK
  - Sodium chloride (CAS: 7647-14-5) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - Anisole (CAS: 100-66-3)
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 12.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(Br)c1.Cl.N[C@@H]1CCOC1`
  - Products: `O=C(N[C@@H]1CCOC1)c1cccc(Br)c1`

**Reference:**
  - **Title:** Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594
  - **Authors:** Aydin, Gulsevim; et al
  - **Citation:** Organic Process Research & Development (2024), 28(2), 559-576.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.3c00393](https://doi.org/10.1021/acs.oprd.3c00393)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-39283196
1.1|Reagents: Diisopropylethylamine, Thionyl chloride
Solvents: Anisole; 1 h, rt → 80 °C; 3 h, 80 °C
1.2|Reagents: Diisopropylethylamine
Solvents: Anisole; 2 h, 50 °C; 3 h, 50 °C
1.3|Reagents: Sodium chloride
Solvents: Water; 50 °C; 3 h, 60 °C
Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections
By: Chen, Wei-Chia; et al
Journal of Medicinal Chemistry (2020), 63(3), 1313-1327.
10.1021/acs.jmedchem.9b01779
```

---

## Reaction 31-614-CAS-39283200

**Type:** Other

**Reagents:**
  - K2CO3 (CAS: 584-08-7) - Role: BASE
  - Sodium chloride (CAS: 7647-14-5) - Role: UNK
  - Pivaloyl chloride (CAS: 3282-30-2) - Role: UNK
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Potassium carbonate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 96-47-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - MeCN (CAS: 75-05-8) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 31.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `C[C@H](N)[C@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2.O=C(O)c1ccco1.CC(F)(F)C(=O)O`
  - Products: `C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2`

**Reference:**
  - **Title:** Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594
  - **Authors:** Aydin, Gulsevim; et al
  - **Citation:** Organic Process Research & Development (2024), 28(2), 559-576.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.3c00393](https://doi.org/10.1021/acs.oprd.3c00393)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-39283200
1.1|Reagents: Potassium carbonate
Solvents: 2-Methyltetrahydrofuran; 8 h, 25 °C
1.2|Reagents: Sodium chloride
Solvents: Water; 2 h, 20 - 30 °C
1.3|Reagents: Pivaloyl chloride, Diisopropylethylamine
Solvents: Acetonitrile; rt → 0 °C; 5 h, 0 °C
1.4|6 h, 0 °C; 10 h, 0 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria
By: Zhang, Yinyong; et al
Journal of Medicinal Chemistry (2024), 67(8), 6585-6609.
10.1021/acs.jmedchem.4c00018
```

---

## Reaction 31-614-CAS-39325781

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `O=C1CCC[C@@H](C(=O)O)N1.Cc1noc(C)c1-c1ccc(NC2CCN(C(=O)OCc3ccccc3)CC2)c(N)c1`
  - Products: `Cc1noc(C)c1-c1ccc(NC2CCN(C(=O)OCc3ccccc3)CC2)c(NC(=O)[C@@H]2CCCC(=O)N2)c1`

**Reference:**
  - **Title:** Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma
  - **Authors:** Chang, Qi; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(4), 2466-2486.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01468](https://doi.org/10.1021/acs.jmedchem.3c01468)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-39325781
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties
By: Dragovich, Peter S.; et al
Journal of Medicinal Chemistry (2021), 64(5), 2534-2575.
10.1021/acs.jmedchem.0c01845
```

---

## Reaction 31-614-CAS-39325848

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 6.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O.Cl.N[C@@H](C[C@@H]1CCNC1=O)C(=O)COc1c(F)c(F)cc(F)c1F`
  - Products: `CC(C)C[C@H](N)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COc1c(F)c(F)cc(F)c1F.Cl`

**Reference:**
  - **Title:** Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead
  - **Authors:** Dayan Elshan, N. G. R.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(4), 2369-2378.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01938](https://doi.org/10.1021/acs.jmedchem.3c01938)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-39325848
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; 4 h, rt
1.2|Reagents: Hydrochloric acid
Solvents: 1,4-Dioxane; 0 °C; 2 h, rt
Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
By: Pal, Kavita; et al
European Journal of Medicinal Chemistry (2023), 248, 115055.
10.1016/j.ejmech.2022.115055
```

---

## Reaction 31-614-CAS-39327163

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Br)o1.NCC(F)(F)F`
  - Products: `O=C(NCC(F)(F)F)c1ccc(Br)o1`

**Reference:**
  - **Title:** Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties
  - **Authors:** Morozova, Alisa; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 266, 116101.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.116101](https://doi.org/10.1016/j.ejmech.2023.116101)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-39327163
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 14 h, rt
Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease
By: Li, Feng; et al
Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.
10.1021/acs.jmedchem.0c01544
```

---

## Reaction 31-614-CAS-39327164

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 14.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `NCC(F)(F)F.O=C(O)c1ccc(Br)s1`
  - Products: `O=C(NCC(F)(F)F)c1ccc(Br)s1`

**Reference:**
  - **Title:** Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties
  - **Authors:** Morozova, Alisa; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 266, 116101.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.116101](https://doi.org/10.1016/j.ejmech.2023.116101)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-39327164
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 14 h, rt
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
By: Li, Bing-yan; et al
Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.
10.1021/acs.jmedchem.3c02407
```

---

## Reaction 31-614-CAS-39327165

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 15.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `NCC(F)(F)F.O=C(O)c1ccnc(Br)c1`
  - Products: `O=C(NCC(F)(F)F)c1ccnc(Br)c1`

**Reference:**
  - **Title:** Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties
  - **Authors:** Morozova, Alisa; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 266, 116101.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.116101](https://doi.org/10.1016/j.ejmech.2023.116101)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-39327165
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 14 h, rt
Discovery of the Novel 1H-Pyrrolo[2,3-b]pyridine Derivative as a Potent Type II CDK8 Inhibitor against Colorectal Cancer
By: Zhang, Xing Xing; et al
Journal of Medicinal Chemistry (2022), 65(18), 12095-12123.
10.1021/acs.jmedchem.2c00820
```

---

## Reaction 31-614-CAS-39327166

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 14.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `NCC(F)(F)F.O=C(O)c1cc(Br)cs1`
  - Products: `O=C(NCC(F)(F)F)c1cc(Br)cs1`

**Reference:**
  - **Title:** Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties
  - **Authors:** Morozova, Alisa; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 266, 116101.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.116101](https://doi.org/10.1016/j.ejmech.2023.116101)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-39327166
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 14 h, rt
From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase
By: Juillet, Charlotte; et al
Journal of Medicinal Chemistry (2021), 64(2), 1197-1219.
10.1021/acs.jmedchem.0c02064
```

---

## Reaction 31-614-CAS-39327168

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 14.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `NCC(F)(F)F.O=C(O)c1cnc(Br)s1`
  - Products: `O=C(NCC(F)(F)F)c1cnc(Br)s1`

**Reference:**
  - **Title:** Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties
  - **Authors:** Morozova, Alisa; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 266, 116101.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.116101](https://doi.org/10.1016/j.ejmech.2023.116101)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-39327168
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 14 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria
By: de Lera Ruiz, Manuel; et al
ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.
10.1021/acsmedchemlett.2c00355
```

---

## Reaction 31-614-CAS-39327172

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 14.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `NCC(F)(F)F.O=C(O)c1cc(Br)ccn1`
  - Products: `O=C(NCC(F)(F)F)c1cc(Br)ccn1`

**Reference:**
  - **Title:** Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties
  - **Authors:** Morozova, Alisa; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 266, 116101.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2023.116101](https://doi.org/10.1016/j.ejmech.2023.116101)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-39327172
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 14 h, rt
Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties
By: Morozova, Alisa; et al
European Journal of Medicinal Chemistry (2024), 266, 116101.
10.1016/j.ejmech.2023.116101
```

---

## Reaction 31-614-CAS-39410607

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - EtOH (CAS: 64-17-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 19.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `CC(C)c1n[nH]c(C(=O)O)c1[N+](=O)[O-].CN`
  - Products: `CNC(=O)c1[nH]nc(C(C)C)c1[N+](=O)[O-]`

**Reference:**
  - **Title:** Lead Optimization of the 5-Phenylpyrazolopyrimidinone NPD-2975 toward Compounds with Improved Antitrypanosomal Efficacy
  - **Authors:** Zheng, Yang; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(4), 2849-2863.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c01976](https://doi.org/10.1021/acs.jmedchem.3c01976)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-39410607
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Tetrahydrofuran; 0 °C; 1 h, 0 °C; 0 °C → rt
1.2|Solvents: Ethanol; 0 °C; 18 h, rt
HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells
By: Liang, Tao; et al
Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.
10.1021/acs.jmedchem.0c01454
```

---

## Reaction 31-614-CAS-39485373

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Calcium chloride (CAS: 10043-52-4) - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 48.5 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)CC(C)C.Cl.O=C(N[C@@H](Cc1ccc(F)cc1)C(=O)O)OCc1ccccc1`
  - Products: `COC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacement
  - **Authors:** Barton, Linda S.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2024), 100, 117618.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2024.117618](https://doi.org/10.1016/j.bmc.2024.117618)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-39485373
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 d, rt
1.2|Reagents: Sodium bicarbonate, Calcium chloride
Solvents: Water; 30 min, rt
Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity
By: Fang, Jing-jie; et al
Journal of Medicinal Chemistry (2023), 66(22), 15288-15308.
10.1021/acs.jmedchem.3c01351
```

---

## Reaction 31-614-CAS-39486271

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMAc (CAS: 127-19-5) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 19.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `O=C(O)c1ncccc1-n1nccn1.CC1(C)C2CCC1(CS(=O)(=O)O)C(=O)C2.CCc1nc(C(F)(F)F)cnc1N[C@@H]1CCC[C@H]1N`
  - Products: `CCc1nc(C(F)(F)F)cnc1N[C@@H]1CCC[C@H]1NC(=O)c1ncccc1-n1nccn1`

**Reference:**
  - **Title:** Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist
  - **Authors:** Glen, Angela; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2024), 100, 129629.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2024.129629](https://doi.org/10.1016/j.bmcl.2024.129629)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-39486271
1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dimethylacetamide; rt → 40 °C; 5 h, 40 °C
1.2|Solvents: Water; 1 h, 60 °C; 12 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant
By: Zhou, Huiyu; et al
European Journal of Medicinal Chemistry (2023), 255, 115389.
10.1016/j.ejmech.2023.115389
```

---

## Reaction 31-614-CAS-39561294

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.75 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NC(CCCCN)C(=O)O.[N-]=[N+]=Nc1ccc(N)cc1`
  - Products: `[N-]=[N+]=Nc1ccc(NC(=O)[C@@H](N)CCCCN)cc1`

**Reference:**
  - **Title:** Selective Recognition of c-KIT 1 G-Quadruplex by Structural Tuning of Heteroaromatic Scaffolds and Side Chains
  - **Authors:** Fatma, Khushnood; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(3), 388-395.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.3c00537](https://doi.org/10.1021/acsmedchemlett.3c00537)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-39561294
1.1|Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole
Solvents: Dichloromethane; 45 min, rt
1.2|Solvents: Dichloromethane; rt; 12 h, rt
Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer
By: Eno, Meredith S.; et al
Journal of Medicinal Chemistry (2022), 65(14), 9662-9677.
10.1021/acs.jmedchem.2c00704
```

---

## Reaction 31-614-CAS-39627218

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.5 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1ccccc1Nc1ccccc1.COc1ccc(CN)cc1`
  - Products: `COc1ccc(CNC(=O)c2ccccc2Nc2ccccc2)cc1`

**Reference:**
  - **Title:** N-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression
  - **Authors:** Li, Junfang; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(15), 10481-10505.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00635](https://doi.org/10.1021/acs.jmedchem.2c00635)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-39627218
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 0.5 h, rt
1.2|Reagents: Triethylamine; 24 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
By: Fuchs, Natalie; et al
ChemMedChem (2023), 18(15), e202300160.
10.1002/cmdc.202300160
```

---

## Reaction 31-614-CAS-39628847

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)(C)N.CC(C)(C)OC(=O)N[C@@H](CC(=O)O)C(=O)OCc1ccccc1`
  - Products: `CC(C)(C)NC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit
  - **Authors:** Zhan, Wenhu; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00733](https://doi.org/10.1021/acs.jmedchem.2c00733)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-39628847
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; 0 °C → rt; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-39636683

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - THF (CAS: 96-47-9) - Role: SOLVENT
  - Py (CAS: 110-86-1) - Role: BASE

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 14.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `COc1cc(N)ccn1.O=C(O)c1ccc(C(F)(F)F)cc1F`
  - Products: `COc1cc(NC(=O)c2ccc(C(F)(F)F)cc2F)ccn1`

**Reference:**
  - **Title:** Discovery of a novel series of pyridone amides as NaV1.8 inhibitors
  - **Authors:** Wang, Yanfang; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2024), 101, 129655.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2024.129655](https://doi.org/10.1016/j.bmcl.2024.129655)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-39636683
1.1|Reagents: Triethylamine, Propylphosphonic anhydride
Solvents: 2-Methyltetrahydrofuran, Pyridine; 14 h, 40 °C
Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes
By: Saint-Dizier, Francois; et al
Journal of Medicinal Chemistry (2023), 66(4), 2622-2645.
10.1021/acs.jmedchem.2c01591
```

---

## Reaction 31-614-CAS-39636949

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 7.5 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC(=O)CCCCCCC(=O)O.Nc1cc(C=O)ccc1O`
  - Products: `COC(=O)CCCCCCC(=O)Nc1cc(C=O)ccc1O`

**Reference:**
  - **Title:** Novel estrogen receptor β/histone deacetylase dual-targeted near-infrared fluorescent probes as theranostic agents for imaging and treatment of prostate cancer
  - **Authors:** He, Pei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 268, 116236.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2024.116236](https://doi.org/10.1016/j.ejmech.2024.116236)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-39636949
1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dimethylformamide; 30 min, rt
1.2|6 h, rt
Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei
By: Scheuplein, Nicolas J.; et al
Journal of Medicinal Chemistry (2023), 66(13), 8876-8895.
10.1021/acs.jmedchem.3c00458
```

---

## Reaction 31-614-CAS-39656177

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)C1CC1.COC(=O)[C@H](Cc1ccc(N)cc1)NC(=O)OC(C)(C)C`
  - Products: `COC(=O)[C@H](Cc1ccc(NC(=O)C2CC2)cc1)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of 6-chloro-quinolin-2-one derivatives as novel FXIa inhibitors
  - **Authors:** Wang, Yanshi; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2024), 99, 129610.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2024.129610](https://doi.org/10.1016/j.bmcl.2024.129610)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-39656177
1.1|Reagents: Diisopropylethylamine, PyBOP
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; rt; overnight, rt
Discovery of a novel series of pyridone amides as NaV1.8 inhibitors
By: Wang, Yanfang; et al
Bioorganic & Medicinal Chemistry Letters (2024), 101, 129655.
10.1016/j.bmcl.2024.129655
```

---

## Reaction 31-614-CAS-39721304

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)CC(C)C.O=C(N[C@@H](Cc1cccc2ccccc12)C(=O)O)OCc1ccccc1`
  - Products: `COC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cccc2ccccc12)NC(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease
  - **Authors:** Amblard, Franck; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 268, 116263.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2024.116263](https://doi.org/10.1016/j.ejmech.2024.116263)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-39721304
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; overnight, rt
Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists
By: Shan, Bin; et al
Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.
10.1021/acs.jmedchem.2c01714
```

---

## Reaction 31-614-CAS-39736960

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate (CAS: 1075198-30-9) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)C12CC3CC(CC(C3)C1)C2.CCCn1c(=O)c(N)c(N)n(Cc2ccccc2)c1=O`
  - Products: `CCCn1c(=O)c(NC(=O)C23CC4CC(CC(C4)C2)C3)c(N)n(Cc2ccccc2)c1=O`

**Reference:**
  - **Title:** Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells
  - **Authors:** Comeo, Eleonora; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(10), 6670-6695.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02067](https://doi.org/10.1021/acs.jmedchem.0c02067)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-39736960
1.1|Reagents: Diisopropylethylamine, N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, rt
Double bond geometry shown
Double bond geometry shown
Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action
By: Marinovic, Marina; et al
European Journal of Medicinal Chemistry (2021), 224, 113687.
10.1016/j.ejmech.2021.113687
```

---

## Reaction 31-614-CAS-39787033

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - K2CO3 (CAS: 584-08-7) - Role: UNK (Registry: BASE)
  - Potassium carbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.5 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1ccccc1.COC(=O)c1ccc(CN)cc1.Cl`
  - Products: `COC(=O)c1ccc(CNC(=O)/C=C/c2ccccc2)cc1`

**Reference:**
  - **Title:** Determination of Slow-Binding HDAC Inhibitor Potency and Subclass Selectivity
  - **Authors:** Moreno-Yruela, Carlos; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(5), 779-785.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00702](https://doi.org/10.1021/acsmedchemlett.1c00702)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-39787033
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; rt; 2.5 h, rt; rt → 0 °C
1.2|Reagents: Potassium carbonate
Solvents: Ethyl acetate, Water; 0 °C; 0 °C → rt; overnight, rt
Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni
By: Kanyanta, Masebe; et al
Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164.
10.1016/j.bmcl.2023.129164
```

---

## Reaction 31-614-CAS-39824402

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Isopropanol (CAS: 67-63-0) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 17.333 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(C(=O)O)cc21.CN(C)CC[C@H](N)C(N)=O.O=C(O)/C=C\C(=O)O`
  - Products: `CC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(C(=O)N[C@@H](CCN(C)C)C(N)=O)cc21`

**Reference:**
  - **Title:** Development and Scale-Up of a Key Copper-Catalyzed Biaryl Ether Formation for the Multikilogram Synthesis of Emprumapimod
  - **Authors:** Brearley, Christopher; et al
  - **Citation:** Organic Process Research & Development (2024), 28(4), 1253-1259.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.4c00052](https://doi.org/10.1021/acs.oprd.4c00052)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-39824402
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Tetrahydrofuran; 20 min, 20 °C; 1 h, 20 °C
1.2|Reagents: Triethylamine
Solvents: Isopropanol, Tetrahydrofuran; 16 h, 20 °C
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
By: Sun, Li-Qiang; et al
Journal of Medicinal Chemistry (2020), 63(23), 14740-14760.
10.1021/acs.jmedchem.0c01296
```

---

## Reaction 31-614-CAS-39864674

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 15.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `N[C@H]1[C@@H](C(=O)OCc2ccccc2)[C@@H]2C=C[C@H]1C2.CCOC(=O)[C@H]1CC[C@@H](Oc2cc(C(=O)O)c(OC)cc2F)CC1`
  - Products: `CCOC(=O)[C@H]1CC[C@@H](Oc2cc(C(=O)N[C@H]3[C@@H](C(=O)OCc4ccccc4)[C@@H]4C=C[C@H]3C4)c(OC)cc2F)CC1`

**Reference:**
  - **Title:** Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists
  - **Authors:** Granberg, Kenneth L.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02183](https://doi.org/10.1021/acs.jmedchem.3c02183)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-39864674
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 h, 20 °C
Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
By: Pal, Kavita; et al
European Journal of Medicinal Chemistry (2023), 248, 115055.
10.1016/j.ejmech.2022.115055
```

---

## Reaction 31-614-CAS-39864678

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 3.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)O.N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)Nc1cccc(S(=O)(=O)C(F)(F)F)c1`
  - Products: `COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)Nc1cccc(S(=O)(=O)C(F)(F)F)c1`

**Reference:**
  - **Title:** Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists
  - **Authors:** Granberg, Kenneth L.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02183](https://doi.org/10.1021/acs.jmedchem.3c02183)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-39864678
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 3 h, 20 °C
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Double bond geometry shown
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria
By: de Lera Ruiz, Manuel; et al
ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.
10.1021/acsmedchemlett.2c00355
```

---

## Reaction 31-614-CAS-39864712

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 14.017 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)O.Cl.N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)Nc1ccc(F)c(S(F)(F)(F)(F)F)c1`
  - Products: `COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)Nc1ccc(F)c(S(F)(F)(F)(F)F)c1`

**Reference:**
  - **Title:** Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists
  - **Authors:** Granberg, Kenneth L.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02183](https://doi.org/10.1021/acs.jmedchem.3c02183)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-39864712
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 min, 20 °C; 14 h, 30 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2
By: Roussel, Emile; et al
European Journal of Medicinal Chemistry (2020), 202, 112503.
10.1016/j.ejmech.2020.112503
```

---

## Reaction 31-614-CAS-39875252

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: WORKUP
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `COC(=O)[C@H]1CC[C@H](N)CC1.Cc1ccc2cc1OC/C=C\C/N=C1/N=CC(C(=O)O)=C(N1)N2`
  - Products: `COC(=O)[C@H]1CC[C@H](NC(=O)C2=C3N/C(=N\C/C=C\COc4cc(ccc4C)N3)N=C2)CC1`

**Reference:**
  - **Title:** Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors
  - **Authors:** Kong, Deyu; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(7), 5866-5882.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00148](https://doi.org/10.1021/acs.jmedchem.4c00148)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-39875252
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide; 16 h, 25 °C
1.2|Reagents: Water; 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
By: Novotna, Katerina; et al
Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
10.1021/acs.jmedchem.3c01681
```

---

## Reaction 31-614-CAS-39877262

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(S(=O)(=O)O)c12.[Na].CC(C)OC(=O)[C@H](O[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](O[C@H](Cc2ccccc2)C(=O)OCc2ccccc2)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(=O)O[C@H](C)CCCn1cc(CCCCC(=O)O)nn1`
  - Products: `CC(C)OC(=O)[C@H](O[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](O[C@H](Cc2ccccc2)C(=O)OCc2ccccc2)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(=O)O[C@@H](C)CCCn1cc(CCCCC(=O)Nc2cc(S(=O)(=O)O)cc3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)nn1.[Na]`

**Reference:**
  - **Title:** Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites
  - **Authors:** Belouin, Audrey; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2024), 98, 117553.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117553](https://doi.org/10.1016/j.bmc.2023.117553)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-39877262
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 24 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Dethioacylation by Sirtuins 1-3: Considerations for Drug Design Using Mechanism-Based Sirtuin Inhibition
By: Rajabi, Nima; et al
ACS Medicinal Chemistry Letters (2020), 11(10), 1886-1892.
10.1021/acsmedchemlett.9b00580
```

---

## Reaction 31-614-CAS-39877263

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Nc1ccc(OCCCS(=O)(=O)O)cc1.[Na].CC(C)OC(=O)[C@H](O[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](O[C@H](Cc2ccccc2)C(=O)OCc2ccccc2)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(=O)O[C@@H](C)CCCn1cc(CCCCC(=O)O)nn1`
  - Products: `CC(C)OC(=O)[C@H](O[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](O[C@H](Cc2ccccc2)C(=O)OCc2ccccc2)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(=O)O[C@H](C)CCCn1cc(CCCCC(=O)Nc2ccc(OCCCS(=O)(=O)O)cc2)nn1.[Na]`

**Reference:**
  - **Title:** Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites
  - **Authors:** Belouin, Audrey; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2024), 98, 117553.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117553](https://doi.org/10.1016/j.bmc.2023.117553)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-39877263
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 24 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites
By: Belouin, Audrey; et al
Bioorganic & Medicinal Chemistry (2024), 98, 117553.
10.1016/j.bmc.2023.117553
```

---

## Reaction 31-614-CAS-39877281

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `Nc1ccc(OCCCS(=O)(=O)O)cc1.[Na].CC(C)OC(=O)[C@H](O[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](O[C@H](Cc2ccccc2)C(=O)OCc2ccccc2)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(=O)O[C@H](C)CCCn1cc(CCCCC(=O)O)nn1`
  - Products: `CC(C)OC(=O)[C@H](O[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](O[C@H](Cc2ccccc2)C(=O)OCc2ccccc2)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(=O)O[C@@H](C)CCCn1cc(CCCCC(=O)Nc2ccc(OCCCS(=O)(=O)O)cc2)nn1.[Na]`

**Reference:**
  - **Title:** Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites
  - **Authors:** Belouin, Audrey; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2024), 98, 117553.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117553](https://doi.org/10.1016/j.bmc.2023.117553)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-39877281
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 24 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Early Development, Scale-Up, and Reverse-Phase Purification of a Highly Potent Pyrrolobenzodiazepine Dimer, SG3259, for Use in Antibody-Drug Conjugates
By: Holte, Dane; et al
Organic Process Research & Development (2021), 25(4), 799-809.
10.1021/acs.oprd.0c00497
```

---

## Reaction 31-614-CAS-39884154

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 6.5 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(Cl)c2)[C@H](C(=O)O)C1.NCc1cccs1`
  - Products: `CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(Cl)c2)[C@H](C(=O)NCc2cccs2)C1`

**Reference:**
  - **Title:** Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity
  - **Authors:** Gao, Shenghua; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(19), 13343-13364.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01146](https://doi.org/10.1021/acs.jmedchem.2c01146)

**Original Text:**
```
Steps: 1, Yield: 89-91%
CAS Reaction Number: 31-614-CAS-39884154
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 30 min, 0 °C
1.2|Reagents: Diisopropylethylamine; 6 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant
By: Zhou, Huiyu; et al
European Journal of Medicinal Chemistry (2023), 255, 115389.
10.1016/j.ejmech.2023.115389
```

---

## Reaction 31-614-CAS-39885681

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `NC1C2CC3CC(C2)CC1C3.O=C(O)c1cc(Br)c[nH]1`
  - Products: `O=C(NC1C2CC3CC(C2)CC1C3)c1cc(Br)c[nH]1`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis
  - **Authors:** Zhao, Hongyi; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00718](https://doi.org/10.1021/acs.jmedchem.2c00718)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-39885681
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; overnight, rt
1.2|Solvents: Water; cooled
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release
By: Meiers, Joscha; et al
Journal of Medicinal Chemistry (2022), 65(20), 13988-14014.
10.1021/acs.jmedchem.2c01214
```

---

## Reaction 31-614-CAS-39885789

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 32.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `NC12CC3CC(CC(C3)C1)C2.O=C(O)c1cc(Br)c[nH]1.CC(C)(C)OC(=O)OC(=O)OC(C)(C)C`
  - Products: `CC(C)(C)OC(=O)n1cc(Br)cc1C(=O)NC12CC3CC(CC(C3)C1)C2`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis
  - **Authors:** Zhao, Hongyi; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00718](https://doi.org/10.1021/acs.jmedchem.2c00718)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-39885789
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; overnight, rt
1.2|Solvents: Water; rt
1.3|Reagents: Triethylamine
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; overnight, rt
Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction
By: Hec-Galazka, Aleksandra; et al
ACS Medicinal Chemistry Letters (2024), 15(6), 828-836.
10.1021/acsmedchemlett.4c00042
```

---

## Reaction 31-614-CAS-39885797

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 32.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `NC1CCCCCCC1.O=C(O)c1cc(Br)c[nH]1.CC(C)(C)OC(=O)OC(=O)OC(C)(C)C`
  - Products: `CC(C)(C)OC(=O)n1cc(Br)cc1C(=O)NC1CCCCCCC1`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis
  - **Authors:** Zhao, Hongyi; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00718](https://doi.org/10.1021/acs.jmedchem.2c00718)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-39885797
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; overnight, rt
1.2|Solvents: Water; rt
1.3|Reagents: Triethylamine
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; overnight, rt
Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity
By: Zareba, Paula; et al
European Journal of Medicinal Chemistry (2021), 221, 113512.
10.1016/j.ejmech.2021.113512
```

---

## Reaction 31-614-CAS-39925568

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 14.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)OC(C)(C)C)C(N)=O.CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O`
  - Products: `CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C)C(N)=O`

**Reference:**
  - **Title:** Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome
  - **Authors:** Gotz, Marion G.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.4c00017](https://doi.org/10.1021/acsmedchemlett.4c00017)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-39925568
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 12 h, pH 8 - 9, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of potent small molecule PROTACs targeting mutant EGFR
By: Zhao, Hong-Yi; et al
European Journal of Medicinal Chemistry (2020), 208, 112781.
10.1016/j.ejmech.2020.112781
```

---

## Reaction 31-614-CAS-39925573

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 14.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CC(C)C[C@H](NC(=O)OC(C)(C)C)C(N)=O.CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O`
  - Products: `CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)OC(C)(C)C)C(N)=O`

**Reference:**
  - **Title:** Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome
  - **Authors:** Gotz, Marion G.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.4c00017](https://doi.org/10.1021/acsmedchemlett.4c00017)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-39925573
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 12 h, pH 8 - 9, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant
By: Zhou, Huiyu; et al
European Journal of Medicinal Chemistry (2023), 255, 115389.
10.1016/j.ejmech.2023.115389
```

---

## Reaction 31-614-CAS-39925583

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])c(F)c1)C(=O)O.CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@@H](N)CC(C)C)C(N)=O.O=C(O)C(F)(F)F`
  - Products: `CC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])c(F)c1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)N[C@@H](CC(C)C)C(N)=O`

**Reference:**
  - **Title:** Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome
  - **Authors:** Gotz, Marion G.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.4c00017](https://doi.org/10.1021/acsmedchemlett.4c00017)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-39925583
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 12 h, pH 8 - 9, rt
1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
By: Chen, Bei; et al
Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.
10.1021/acs.jmedchem.3c01326
```

---

## Reaction 31-614-CAS-39925599

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)Cc1ccc(O)cc1.CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O`
  - Products: `COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome
  - **Authors:** Gotz, Marion G.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.4c00017](https://doi.org/10.1021/acsmedchemlett.4c00017)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-39925599
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; overnight, pH 8 - 9, rt
Selective targeting of the αC and DFG-out pocket in p38 MAPK
By: Roehm, Sandra; et al
European Journal of Medicinal Chemistry (2020), 208, 112721.
10.1016/j.ejmech.2020.112721
```

---

## Reaction 31-614-CAS-39930090

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Py (CAS: 110-86-1) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.5 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)OCCO2.Cc1ccc(N)cc1[N+](=O)[O-]`
  - Products: `Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1[N+](=O)[O-]`

**Reference:**
  - **Title:** HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
  - **Authors:** Pasqua, A. Elisa; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00156](https://doi.org/10.1021/acs.jmedchem.3c00156)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-39930090
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; rt; 3.5 h, rt
1.2|Reagents: Pyridine
Solvents: Dichloromethane; rt; 2 h, rt
Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity
By: Karki, Anupam; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053.
10.1016/j.bmcl.2020.127053
```

---

## Reaction 31-614-CAS-39945512

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - PhMe (CAS: 108-88-3) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 65.0°C
  - Time: 21.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `O=C(O)c1c(Cl)ccnc1Cl.C[C@@H](N)CO`
  - Products: `C[C@H](CCl)NC(=O)c1c(Cl)ccnc1Cl`

**Reference:**
  - **Title:** Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate
  - **Authors:** Critcher, Douglas J.; et al
  - **Citation:** Organic Process Research & Development (2024), 28(7), 2646-2658.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.4c00049](https://doi.org/10.1021/acs.oprd.4c00049)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-39945512
1.1|Catalysts: Dimethylformamide
Solvents: Toluene; rt → 65 °C
1.2|Reagents: Thionyl chloride; 2 h, 65 °C; 16 h, 65 °C; 65 °C → 25 °C
1.3|Reagents: Triethylamine
Solvents: Dichloromethane; < 35 °C; 0.5 h, 20 °C
1.4|Reagents: Thionyl chloride
Solvents: Dichloromethane; 1.5 h, 15 °C; 1 h, 35 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model
By: Maddeboina, Krishnaiah; et al
Journal of Medicinal Chemistry (2023), 66(14), 9894-9915.
10.1021/acs.jmedchem.3c00732
```

---

## Reaction 31-614-CAS-39945521

**Type:** Other

**Reagents:**
  - NaOH (CAS: 1310-73-2) - Role: BASE
  - 2-Hydroxypyridine N-oxide (CAS: 13161-30-3) - Role: UNK
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Sodium hydroxide - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - MeCN (CAS: 75-05-8) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 20.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CC(C)n1cc(C(=O)O)c(=O)n(-c2ccc(F)cc2)c1=O.C[C@H](CO)Nc1n[nH]c2nccc(Oc3ccc(N)cc3F)c12.Cl`
  - Products: `CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(N[C@H](C)CO)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O`

**Reference:**
  - **Title:** Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate
  - **Authors:** Critcher, Douglas J.; et al
  - **Citation:** Organic Process Research & Development (2024), 28(7), 2646-2658.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.4c00049](https://doi.org/10.1021/acs.oprd.4c00049)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-39945521
1.1|Reagents: Sodium hydroxide, 2-Hydroxypyridine N-oxide, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Acetonitrile, Water; 20 h, 25 °C
Absolute stereochemistry shown
Relative stereochemistry shown
Absolute stereochemistry shown
Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists
By: Granberg, Kenneth L.; et al
Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.
10.1021/acs.jmedchem.3c02183
```

---

## Reaction 31-614-CAS-39975883

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `Cl.NCc1cccc(B(O)O)c1.CC(C)(C)NC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)O`
  - Products: `CC(C)(C)NC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)NCc1cccc(B(O)O)c1`

**Reference:**
  - **Title:** Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit
  - **Authors:** Zhan, Wenhu; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00733](https://doi.org/10.1021/acs.jmedchem.2c00733)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-39975883
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; overnight, rt
Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy
By: Abyar, Selda; et al
Journal of Medicinal Chemistry (2024), 67(13), 11086-11102.
10.1021/acs.jmedchem.4c00589
```

---

## Reaction 31-614-CAS-39975902

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `CC(C)(C)N.CC(C)(C)OC(=O)N[C@@H](CCC(=O)O)C(=O)OCc1ccccc1`
  - Products: `CC(C)(C)NC(=O)CC[C@H](NC(=O)OC(C)(C)C)C(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit
  - **Authors:** Zhan, Wenhu; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00733](https://doi.org/10.1021/acs.jmedchem.2c00733)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-39975902
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; 0 °C → rt; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit
By: Zhan, Wenhu; et al
Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.
10.1021/acs.jmedchem.2c00733
```

---

## Reaction 31-614-CAS-39977098

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 13.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `COC(=O)CCCCCCC(=O)O.C#CCN(C)CCCOc1ccc(N)cc1Cl`
  - Products: `C#CCN(C)CCCOc1ccc(NC(=O)CCCCCCC(=O)OC)cc1Cl`

**Reference:**
  - **Title:** N-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment
  - **Authors:** Mehndiratta, Samir; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(3), 2208-2224.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01726](https://doi.org/10.1021/acs.jmedchem.1c01726)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-39977098
1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dimethylformamide; 12 h, rt
1.2|Reagents: Water; rt
Relative stereochemistry shown
Relative stereochemistry shown
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
By: Granberg, Kenneth L.; et al
Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.
10.1021/acs.jmedchem.3c02184
```

---

## Reaction 31-614-CAS-40064533

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 7.667 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)CCc1cccc(Br)c1.Nc1ccccc1`
  - Products: `O=C(CCc1cccc(Br)c1)Nc1ccccc1`

**Reference:**
  - **Title:** Discovery of the Novel 1H-Pyrrolo[2,3-b]pyridine Derivative as a Potent Type II CDK8 Inhibitor against Colorectal Cancer
  - **Authors:** Zhang, Xing Xing; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(18), 12095-12123.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00820](https://doi.org/10.1021/acs.jmedchem.2c00820)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-40064533
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 40 min, 25 °C
1.2|Catalysts: 4-(Dimethylamino)pyridine; 7 h, 25 °C
Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon Cancer
By: Li, Xing; et al
Journal of Medicinal Chemistry (2022), 65(24), 16622-16639.
10.1021/acs.jmedchem.2c01444
```

---

## Reaction 31-614-CAS-40087715

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: WORKUP (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 15.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `Nc1ccccc1C(=O)O.CN`
  - Products: `CNC(=O)c1ccccc1N`

**Reference:**
  - **Title:** Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation
  - **Authors:** Bayrak, Alp; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01198](https://doi.org/10.1021/acs.jmedchem.2c01198)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-40087715
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 3 h, rt
1.2|Solvents: Water; rt; 12 h, rt
1.3|Reagents: Ammonium chloride
Solvents: Water; rt
Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates
By: Ota, Yosuke; et al
ACS Medicinal Chemistry Letters (2022), 13(10), 1568-1573.
10.1021/acsmedchemlett.2c00126
```

---

## Reaction 31-614-CAS-40093181

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 3.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)c1cc(Cl)ccc1N.O=C(O)CSCc1cc(C(F)(F)F)cc(C(F)(F)F)c1`
  - Products: `CC(C)(C)OC(=O)c1ccccc1NC(=O)CSCc1cc(C(F)(F)F)cc(C(F)(F)F)c1`

**Reference:**
  - **Title:** Identification of ss-Glucocerebrosidase Activators for Glucosylceramide hydrolysis
  - **Authors:** Schulze, Monika-Sarah E. D.; et al
  - **Citation:** ChemMedChem (2024), 19(7), e202300548.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300548](https://doi.org/10.1002/cmdc.202300548)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-40093181
1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride
Solvents: Dimethylformamide; rt; 3 h, 80 °C; 80 °C → rt
1.2|Solvents: Water; 0 °C
Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers
By: Vaidya, Sandeep; et al
ChemMedChem (2023), 18(16), e202300097.
10.1002/cmdc.202300097
```

---

## Reaction 31-614-CAS-40131683

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `O=C(O)Cc1ccc(O)cc1.CC(C)(C)OC(=O)CC[C@@H](N)C(=O)OC(C)(C)C.Cl`
  - Products: `CC(C)(C)OC(=O)CC[C@H](NC(=O)Cc1ccc(O)cc1)C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity
  - **Authors:** Ikeda, Zenichi; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(12), 8456-8477.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00463](https://doi.org/10.1021/acs.jmedchem.2c00463)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-40131683
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; overnight, rt
1.2|Solvents: Water; rt
Nitrile-based peptoids as cysteine protease inhibitors
By: Alves, Luana; et al
Bioorganic & Medicinal Chemistry (2021), 41, 116211.
10.1016/j.bmc.2021.116211
```

---

## Reaction 31-614-CAS-40131686

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `O=C(O)Cc1ccc(O)cc1.CC(C)(C)OC(=O)C[C@H](N)C(=O)OC(C)(C)C.Cl`
  - Products: `CC(C)(C)OC(=O)C[C@H](NC(=O)Cc1ccc(O)cc1)C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity
  - **Authors:** Ikeda, Zenichi; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(12), 8456-8477.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00463](https://doi.org/10.1021/acs.jmedchem.2c00463)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-40131686
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; overnight, rt
1.2|Reagents: Water; rt
Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans
By: Binjubair, Faizah A.; et al
ChemMedChem (2020), 15(14), 1294-1309.
10.1002/cmdc.202000250
```

---

## Reaction 31-614-CAS-40131864

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 6.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)NCCN`
  - Products: `CC(C)(C)OC(=O)NCCNC(=O)/C=C/c1cccnc1`

**Reference:**
  - **Title:** Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
  - **Authors:** Zhang, Kuojun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00077](https://doi.org/10.1021/acs.jmedchem.2c00077)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-40131864
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 3 - 5 h, rt
Discovery of Novel N-(5-(Pyridin-3-yl)-1H-indazol-3-yl)benzamide Derivatives as Potent Cyclin-Dependent Kinase 7 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease
By: Yang, Bowen; et al
Journal of Medicinal Chemistry (2022), 65(23), 15770-15788.
10.1021/acs.jmedchem.2c01334
```

---

## Reaction 31-614-CAS-40131881

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)NCCCN`
  - Products: `CC(C)(C)OC(=O)NCCCNC(=O)/C=C/c1cccnc1`

**Reference:**
  - **Title:** Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
  - **Authors:** Zhang, Kuojun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00077](https://doi.org/10.1021/acs.jmedchem.2c00077)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-40131881
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 3 - 5 h, rt
Double bond geometry shown
Double bond geometry shown
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
By: Zhang, Kuojun; et al
Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
10.1021/acs.jmedchem.2c00077
```

---

## Reaction 31-614-CAS-40131889

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)NCc1ccc(CN)cc1`
  - Products: `CC(C)(C)OC(=O)NCc1ccc(CNC(=O)/C=C/c2cccnc2)cc1`

**Reference:**
  - **Title:** Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
  - **Authors:** Zhang, Kuojun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00077](https://doi.org/10.1021/acs.jmedchem.2c00077)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-40131889
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 3 - 5 h, rt
N-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression
By: Li, Junfang; et al
Journal of Medicinal Chemistry (2022), 65(15), 10481-10505.
10.1021/acs.jmedchem.2c00635
```

---

## Reaction 31-614-CAS-40131890

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)NCCCCN`
  - Products: `CC(C)(C)OC(=O)NCCCCNC(=O)/C=C/c1cccnc1`

**Reference:**
  - **Title:** Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
  - **Authors:** Zhang, Kuojun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00077](https://doi.org/10.1021/acs.jmedchem.2c00077)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-40131890
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 3 - 5 h, rt
Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4
By: Londregan, Allyn T.; et al
Journal of Medicinal Chemistry (2023), 66(1), 460-472.
10.1021/acs.jmedchem.2c01421
```

---

## Reaction 31-614-CAS-40131897

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)N1CCC(CN)CC1`
  - Products: `CC(C)(C)OC(=O)N1CCC(CNC(=O)/C=C/c2cccnc2)CC1`

**Reference:**
  - **Title:** Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
  - **Authors:** Zhang, Kuojun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00077](https://doi.org/10.1021/acs.jmedchem.2c00077)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-40131897
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 3 - 5 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies
By: Rahman, Toufiqur Md; et al
Journal of Medicinal Chemistry (2021), 64(16), 12397-12413.
10.1021/acs.jmedchem.1c01075
```

---

## Reaction 31-614-CAS-40131898

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)N1CCC(N)CC1`
  - Products: `CC(C)(C)OC(=O)N1CCC(NC(=O)/C=C/c2cccnc2)CC1`

**Reference:**
  - **Title:** Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
  - **Authors:** Zhang, Kuojun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00077](https://doi.org/10.1021/acs.jmedchem.2c00077)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-40131898
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 3 - 5 h, rt
Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction injury
By: Pang, Haiying; et al
European Journal of Medicinal Chemistry (2020), 197, 112314.
10.1016/j.ejmech.2020.112314
```

---

## Reaction 31-614-CAS-40131901

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)NCCCCCCN`
  - Products: `CC(C)(C)OC(=O)NCCCCCCNC(=O)/C=C/c1cccnc1`

**Reference:**
  - **Title:** Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
  - **Authors:** Zhang, Kuojun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00077](https://doi.org/10.1021/acs.jmedchem.2c00077)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-40131901
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 3 - 5 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
By: Fuchs, Natalie; et al
ChemMedChem (2023), 18(15), e202300160.
10.1002/cmdc.202300160
```

---

## Reaction 31-614-CAS-40131908

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)N1CCC(CCN)CC1`
  - Products: `CC(C)(C)OC(=O)N1CCC(CCNC(=O)/C=C/c2cccnc2)CC1`

**Reference:**
  - **Title:** Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
  - **Authors:** Zhang, Kuojun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00077](https://doi.org/10.1021/acs.jmedchem.2c00077)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-40131908
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 3 - 5 h, rt
Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease
By: de Oliveira Rezende, Celso Junior; et al
European Journal of Medicinal Chemistry (2023), 246, 114925.
10.1016/j.ejmech.2022.114925
```

---

## Reaction 31-614-CAS-40131929

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 9.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `O=C(O)/C=C/c1cccnc1.CN(CCN)C(=O)OC(C)(C)C`
  - Products: `CN(CCNC(=O)/C=C/c1cccnc1)C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
  - **Authors:** Zhang, Kuojun; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00077](https://doi.org/10.1021/acs.jmedchem.2c00077)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-40131929
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 3 - 5 h, rt
Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease
By: Li, Feng; et al
Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.
10.1021/acs.jmedchem.0c01544
```

---

## Reaction 31-614-CAS-40132270

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 23.0°C
  - Time: 2.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)O)c1nnc(C)n1-2.CC(C)(C)OC(=O)COCC#CC#CCN`
  - Products: `Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCC#CC#CCOCC(=O)OC(C)(C)C)c1nnc(C)n1-2`

**Reference:**
  - **Title:** Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties
  - **Authors:** Dragovich, Peter S.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(5), 2534-2575.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01845](https://doi.org/10.1021/acs.jmedchem.0c01845)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-40132270
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, 23 °C
Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors
By: Grimster, Neil P.; et al
Bioorganic & Medicinal Chemistry Letters (2023), 91, 129352.
10.1016/j.bmcl.2023.129352
```

---

## Reaction 31-614-CAS-40132273

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 23.0°C
  - Time: 2.5 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCC#CC#CCOCC(=O)O)c1nnc(C)n1-2.Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](N)C(C)(C)C)cc1`
  - Products: `Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCC#CC#CCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1`

**Reference:**
  - **Title:** Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties
  - **Authors:** Dragovich, Peter S.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(5), 2534-2575.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01845](https://doi.org/10.1021/acs.jmedchem.0c01845)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-40132273
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 30 min, 23 °C
1.2|2 h, 23 °C
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C
By: Kettle, Jason G.; et al
Journal of Medicinal Chemistry (2020), 63(9), 4468-4483.
10.1021/acs.jmedchem.9b01720
```

---

## Reaction 31-614-CAS-40132684

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `CCOP(=O)(CC(=O)O)OCC.CN(C)/C=N/c1ccc(N)cc1C#N`
  - Products: `CCOP(=O)(CC(=O)Nc1ccc(/N=C/N(C)C)c(C#N)c1)OCC`

**Reference:**
  - **Title:** Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment
  - **Authors:** Li, Di; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(7), 5334-5354.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00710](https://doi.org/10.1021/acs.jmedchem.1c00710)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-40132684
1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 1 h, rt
1.2|Solvents: Water; rt
Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones
By: Ryan, Michael C.; et al
ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.
10.1021/acsmedchemlett.1c00539
```

---

## Reaction 31-614-CAS-40188144

**Type:** Other

**Solvents:**
  - EtOH (CAS: 64-17-5) - Role: SOLVENT
  - Isopropanol (CAS: 67-63-0) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 100.0°C
  - Time: 16.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CC(=O)O.N=CN.Nc1c(F)c(Br)c(Cl)c(F)c1C(=O)O`
  - Products: `O=c1nc[nH]c2c(F)c(Br)c(Cl)c(F)c12`

**Reference:**
  - **Title:** Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C
  - **Authors:** Kettle, Jason G.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(9), 6940-6952.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00369](https://doi.org/10.1021/acs.jmedchem.2c00369)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-40188144
1.1|Solvents: Ethanol, Isopropanol; rt; overnight, 100 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Fit-for-Purpose Synthesis of an Aza-Cryptophycin Analogue as the Payload for an Antibody-Drug Conjugate
By: Bendelac, Audrey; et al
Organic Process Research & Development (2022), 26(8), 2145-2154.
10.1021/acs.oprd.2c00080
```

---

## Reaction 31-614-CAS-40188152

**Type:** Other

**Solvents:**
  - EtOH (CAS: 64-17-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CC(=O)O.N=CN.Nc1c(F)c(Br)cc(F)c1C(=O)O`
  - Products: `O=c1nc[nH]c2c(F)c(Br)cc(F)c12`

**Reference:**
  - **Title:** Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C
  - **Authors:** Kettle, Jason G.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(9), 6940-6952.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00369](https://doi.org/10.1021/acs.jmedchem.2c00369)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-40188152
1.1|Solvents: Ethanol; 16 h, reflux
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19
By: Allais, Christophe; et al
Organic Process Research & Development (2023), 27(12), 2223-2239.
10.1021/acs.oprd.2c00375
```

---

## Reaction 31-614-CAS-40188463

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 75.0°C
  - Time: 8.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)CBr.Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O`
  - Products: `O=C1CCC(N2C(=O)c3cccc(NC(=O)CBr)c3C2=O)C(=O)N1`

**Reference:**
  - **Title:** Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13
  - **Authors:** Yang, Jianzhang; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(16), 11066-11083.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00384](https://doi.org/10.1021/acs.jmedchem.2c00384)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-40188463
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0 °C → rt; 3 h, rt
1.2|Solvents: Tetrahydrofuran; 5 h, 75 °C
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-40188682

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - Propylphosphonic acid (CAS: 4672-38-2) - Role: WORKUP
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `O=C(O)c1cccc(Br)n1.CC(C)(C)OC(=O)NCCCCN`
  - Products: `CC(C)(C)OC(=O)NCCCCNC(=O)c1cccc(Br)n1`

**Reference:**
  - **Title:** Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma
  - **Authors:** Perry, Matthew W. D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(12), 8053-8075.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00434](https://doi.org/10.1021/acs.jmedchem.1c00434)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-40188682
1.1|Reagents: Triethylamine, Propylphosphonic acid
Solvents: Ethyl acetate; overnight, rt
1.2|Reagents: Water; rt
Discovery of (2S)-N-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment
By: Zhang, Wenqiang; et al
Journal of Medicinal Chemistry (2024), 67(1), 322-348.
10.1021/acs.jmedchem.3c01417
```

---

## Reaction 31-614-CAS-40189380

**Type:** Other

**Reagents:**
  - Trimethylolpropane (CAS: 77-99-6) - Role: BASE
  - HOAt (CAS: 39968-33-7) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Lithium hydroxide (CAS: 1310-65-2) - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 37.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CCC(OC(=O)[C@H](C)[C@@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@H](C)[C@@H](O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O)[C@](C)(O)C[C@@H](C)CN(C)C(=O)[C@@H](N)Cc1ccc([N+](=O)[O-])cc1)C(C)=O.CC(C)[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O`
  - Products: `CO[C@]1(C)C[C@H](O[C@@H]([C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)C(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)[C@@H](N)C(C)C)[C@@H](C)C(=O)O)O[C@@H](C)[C@@H]1O`

**Reference:**
  - **Title:** Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA Interaction
  - **Authors:** Kostrun, Sanja; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(12), 8354-8383.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c00327](https://doi.org/10.1021/acs.jmedchem.1c00327)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-40189380
1.1|Reagents: Trimethylolpropane, HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 1 h, rt
1.2|20 h, rt
1.3|Reagents: Lithium hydroxide
Solvents: Tetrahydrofuran, Water; rt; overnight, rt
Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors
By: Trinh, Phuc N. H.; et al
Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.
10.1021/acs.jmedchem.0c02169
```

---

## Reaction 31-614-CAS-40275713

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.833 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CCCCn1c(=O)c2[nH]c(C34CCC(C(=O)O)(CC3)CC4)nc2n(Cc2ccc(OC)cc2OC)c1=O.[N-]=[N+]=NCCCN`
  - Products: `CCCCn1c(=O)c2[nH]c(C34CCC(C(=O)NCCCN=[N+]=[N-])(CC3)CC4)nc2n(Cc2ccc(OC)cc2OC)c1=O`

**Reference:**
  - **Title:** Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors
  - **Authors:** Trinh, Phuc N. H.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02169](https://doi.org/10.1021/acs.jmedchem.0c02169)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-40275713
1.1|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 5 min, rt
1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 15 min, rt
1.3|rt; 2.5 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists
By: Ding, Dong; et al
European Journal of Medicinal Chemistry (2024), 278, 116792.
10.1016/j.ejmech.2024.116792
```

---

## Reaction 31-614-CAS-40275716

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.833 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CCCCn1c(=O)c2[nH]c(C34CCC(C(=O)O)(CC3)CC4)nc2n(Cc2ccc(OC)cc2OC)c1=O.[N-]=[N+]=NCCCCN`
  - Products: `CCCCn1c(=O)c2[nH]c(C34CCC(C(=O)NCCCCN=[N+]=[N-])(CC3)CC4)nc2n(Cc2ccc(OC)cc2OC)c1=O`

**Reference:**
  - **Title:** Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors
  - **Authors:** Trinh, Phuc N. H.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02169](https://doi.org/10.1021/acs.jmedchem.0c02169)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-40275716
1.1|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 5 min, rt
1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 15 min, rt
1.3|rt; 2.5 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594
By: Aydin, Gulsevim; et al
Organic Process Research & Development (2024), 28(2), 559-576.
10.1021/acs.oprd.3c00393
```

---

## Reaction 31-614-CAS-40275737

**Type:** Other

**Solvents:**
  - Ac2O (CAS: 108-24-7) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 70.0°C
  - Time: 1.5 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `N#CCC(=O)O.COc1ccc(CNC(N)=O)c(OC)c1`
  - Products: `COc1ccc(CNC(=O)NC(=O)CC#N)c(OC)c1`

**Reference:**
  - **Title:** Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors
  - **Authors:** Trinh, Phuc N. H.; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c02169](https://doi.org/10.1021/acs.jmedchem.0c02169)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-40275737
1.1|Solvents: Acetic anhydride; rt → 70 °C; 1.5 h, 70 °C
Discovery of soluble epoxide hydrolase inhibitors through DNA-encoded library technology (ELT)
By: Ding, Yun; et al
Bioorganic & Medicinal Chemistry (2021), 41, 116216.
10.1016/j.bmc.2021.116216
```

---

## Reaction 31-614-CAS-40278904

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -5.0°C
  - Time: 6.5 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)CCC(=O)N(CCOC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)CCOC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21.CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](OCCOCCOCCOC(=O)[C@@H](N)CCCCNC(=O)OC(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C`
  - Products: `CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](OCCOCCOCCOC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)CCC(=O)N(CCOC(=O)CCCC[C@@H]5SC[C@@H]6NC(=O)N[C@@H]65)CCOC(=O)CCCC[C@@H]5SC[C@@H]6NC(=O)N[C@@H]65)CC[C@]4(C)[C@H]3CC[C@]12C`

**Reference:**
  - **Title:** Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer
  - **Authors:** Tang, Baolan; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 193, 112204.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112204](https://doi.org/10.1016/j.ejmech.2020.112204)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-40278904
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide, Dichloromethane; 30 min, -5 °C
1.2|Solvents: Dichloromethane; -5 °C; 6 h, -5 °C
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA Interaction
By: Kostrun, Sanja; et al
Journal of Medicinal Chemistry (2021), 64(12), 8354-8383.
10.1021/acs.jmedchem.1c00327
```

---

## Reaction 31-614-CAS-40310343

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `Cl.N#Cc1ccc(O[C@H]2CC[C@H](N)CC2)cc1Cl.CC(C)(C)[Si](C)(C)OCC1CCN(c2ccc(C(=O)O)nn2)CC1`
  - Products: `CC(C)(C)[Si](C)(C)OCC1CCN(c2ccc(C(=O)N[C@H]3CC[C@H](Oc4ccc(C#N)c(Cl)c4)CC3)nn2)CC1`

**Reference:**
  - **Title:** Novel selective agents for the degradation of AR/AR-V7 to treat advanced prostate cancer
  - **Authors:** Yang, Yifei; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 271, 116400.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2024.116400](https://doi.org/10.1016/j.ejmech.2024.116400)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-40310343
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; 4 h, 25 °C
Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2
By: Zhang, Yi; et al
Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.
10.1021/acs.jmedchem.3c00504
```

---

## Reaction 31-614-CAS-40311346

**Type:** Other

**Full Catalytic System:**
  - HATU (CAS: 148893-10-1) - Role: ACTIVATOR

**Catalyst Core:**
  - HATU (CAS: 148893-10-1) - Role: ACTIVATOR

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `COc1ccc(OC)c(/C=C/C(=O)O)c1.Nc1nc2ccccc2s1`
  - Products: `COc1ccc(OC)c(/C=C/C(=O)Nc2nc3ccccc3s2)c1`

**Reference:**
  - **Title:** In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole
  - **Authors:** Zhao, Ya-Dong; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2024), 105, 129752.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2024.129752](https://doi.org/10.1016/j.bmcl.2024.129752)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-40311346
1.1|Reagents: Triethylamine
Catalysts: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 30 min, rt
1.2|Solvents: Dichloromethane; 30 min, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
By: Guzelj, Samo; et al
Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.
10.1021/acs.jmedchem.2c00808
```

---

## Reaction 31-614-CAS-40329134

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CC(C)(C)N.Nc1cc(C(F)(F)F)ccc1C(=O)O`
  - Products: `CC(C)(C)NC(=O)c1ccc(C(F)(F)F)cc1N`

**Reference:**
  - **Title:** Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis
  - **Authors:** Yu, Wei-Chieh; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(15), 10528-10557.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00644](https://doi.org/10.1021/acs.jmedchem.3c00644)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-40329134
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 2 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo
By: Abram, Michal; et al
Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.
10.1021/acs.jmedchem.2c00534
```

---

## Reaction 31-614-CAS-40329369

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `Cn1cc2cc(C(=O)O)ccc2n1.CCOc1ncc(N)c(Nc2ccc(OC(F)F)cc2)n1`
  - Products: `CCOc1ncc(NC(=O)c2ccc3nn(C)cc3c2)c(Nc2ccc(OC(F)F)cc2)n1`

**Reference:**
  - **Title:** Design and Structural Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability
  - **Authors:** Zhang, Silong; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(7), 4849-4867.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02006](https://doi.org/10.1021/acs.jmedchem.2c02006)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-40329369
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; rt; 3 h, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-40331891

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 16.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CC(C)CN.COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)O`
  - Products: `COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)NCC(C)C`

**Reference:**
  - **Title:** Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
  - **Authors:** Granberg, Kenneth L.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02184](https://doi.org/10.1021/acs.jmedchem.3c02184)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-40331891
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 16 h, 20 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
CYP3A4 Catalyzes the Rearrangement of the Dual Orexin Receptor Antagonist Daridorexant to 4-Hydroxypiperidinol Metabolites
By: Treiber, Alexander; et al
ChemMedChem (2023), 18(10), e202300030.
10.1002/cmdc.202300030
```

---

## Reaction 31-614-CAS-40331892

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 3.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `CC(C)(CN)C(F)(F)F.COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)O`
  - Products: `COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)NCC(C)(C)C(F)(F)F`

**Reference:**
  - **Title:** Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
  - **Authors:** Granberg, Kenneth L.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02184](https://doi.org/10.1021/acs.jmedchem.3c02184)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-40331892
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 3 h, 20 °C
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells
By: Barresi, Elisabetta; et al
European Journal of Medicinal Chemistry (2023), 256, 115446.
10.1016/j.ejmech.2023.115446
```

---

## Reaction 31-614-CAS-40331900

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 15.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CC(C)(C)CN.CCOC(=O)[C@H]1CC[C@@H](Oc2cc(C(=O)N[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3C(=O)O)c(OC)cc2F)CC1`
  - Products: `CCOC(=O)[C@H]1CC[C@@H](Oc2cc(C(=O)N[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3C(=O)NCC(C)(C)C)c(OC)cc2F)CC1`

**Reference:**
  - **Title:** Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
  - **Authors:** Granberg, Kenneth L.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02184](https://doi.org/10.1021/acs.jmedchem.3c02184)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-40331900
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 20 °C; 15 h, 60 °C
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-40332110

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.167 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CC1(CN)CCC1.Cl.CC(C)(C)OC(=O)N[C@H]1[C@@H](C(=O)O)[C@H]2C=C[C@@H]1CC2`
  - Products: `CC1(CNC(=O)[C@@H]2[C@H](NC(=O)OC(C)(C)C)[C@@H]3C=C[C@H]2CC3)CCC1`

**Reference:**
  - **Title:** Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
  - **Authors:** Granberg, Kenneth L.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02184](https://doi.org/10.1021/acs.jmedchem.3c02184)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-40332110
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 10 min, rt
1.2|Reagents: Water; rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis
By: Houstecka, Radka; et al
Journal of Medicinal Chemistry (2020), 63(4), 1576-1596.
10.1021/acs.jmedchem.9b01351
```

---

## Reaction 31-614-CAS-40332116

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `COC(=O)[C@@H]1[C@H](N)[C@H]2C=C[C@@H]1C2.Cl.COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OCc3cccc4ccccc34)CC2)cc1C(=O)O`
  - Products: `COC(=O)[C@@H]1[C@H](NC(=O)c2cc(O[C@H]3CC[C@@](C)(C(=O)OCc4cccc5ccccc45)CC3)c(F)cc2OC)[C@H]2C=C[C@@H]1C2`

**Reference:**
  - **Title:** Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
  - **Authors:** Granberg, Kenneth L.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02184](https://doi.org/10.1021/acs.jmedchem.3c02184)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-40332116
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C → rt; 2 h, rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-40388161

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Pyridinium p-toluenesulfonate (CAS: 24057-28-1) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 4.5 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `N#C[C@@H]1CC(F)(F)CN1C(=O)CN.O=C(O)c1ccnc2ccc(OCC(CF)OC3CCCCO3)cc12`
  - Products: `N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccc(OCC(O)CF)cc12`

**Reference:**
  - **Title:** Druglike, 18F-labeled PET Tracers Targeting Fibroblast Activation Protein
  - **Authors:** Tanc, Muhammet; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(9), 7068-7087.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02402](https://doi.org/10.1021/acs.jmedchem.3c02402)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-40388161
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 30 min, rt; 2 h, rt
1.2|Reagents: Pyridinium p-toluenesulfonate
Solvents: Tetrahydrofuran, Water; 2 h, 40 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
By: Granberg, Kenneth L.; et al
Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.
10.1021/acs.jmedchem.3c02184
```

---

## Reaction 31-614-CAS-40401252

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 4-Methylmorpholine - Role: UNK
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 8.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `NCc1ccccc1.CC(C)(C)OC(=O)NCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O`
  - Products: `CC(C)(C)OC(=O)NCCC[C@H](NC(=O)OCc1ccccc1)C(=O)NCc1ccccc1`

**Reference:**
  - **Title:** A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer
  - **Authors:** Zhu, Di; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(10), 7973-7994.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00030](https://doi.org/10.1021/acs.jmedchem.4c00030)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-40401252
1.1|Reagents: 4-Methylmorpholine, Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole
Solvents: Tetrahydrofuran; pH 8, 0 °C; 8 h, 0 °C
Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras
By: Takwale, Akshay D.; et al
European Journal of Medicinal Chemistry (2020), 208, 112769.
10.1016/j.ejmech.2020.112769
```

---

## Reaction 31-614-CAS-40410330

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 9.5 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(Cl)c2)[C@H](C(=O)O)C1.NCc1cccs1`
  - Products: `CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(Cl)c2)[C@H](C(=O)NCc2cccs2)C1`

**Reference:**
  - **Title:** Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors
  - **Authors:** Gao, Shenghua; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(24), 16902-16917.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01716](https://doi.org/10.1021/acs.jmedchem.2c01716)

**Original Text:**
```
Steps: 1, Yield: 89-91%
CAS Reaction Number: 31-614-CAS-40410330
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 30 min, 0 °C
1.2|Reagents: Diisopropylethylamine; 9 h, rt
Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity
By: Gao, Shenghua; et al
Journal of Medicinal Chemistry (2022), 65(19), 13343-13364.
10.1021/acs.jmedchem.2c01146
```

---

## Reaction 31-614-CAS-40411251

**Type:** Other

**Reagents:**
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - N-Hydroxysuccinimide (CAS: 6066-82-6) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 8.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(NCCc1nc(-c2nc(C(=O)O)cs2)cs1)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)NCCCCN(CCCN)C(=O)OC(C)(C)C`
  - Products: `CC(C)(C)OC(=O)NCCCCN(CCCNC(=O)c1csc(-c2csc(CCNC(=O)OCC3c4ccccc4-c4ccccc43)n2)n1)C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs
  - **Authors:** Maucort, Chloe; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(15), 10639-10657.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00797](https://doi.org/10.1021/acs.jmedchem.3c00797)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-40411251
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, N-Hydroxysuccinimide
Solvents: Dimethylformamide, Dichloromethane; 4 h, rt
1.2|4 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Absolute stereochemistry shown
Structure-activity relationships of bis-intercalating peptides and their application as antibody-drug conjugate payloads
By: Petersen, Mark E.; et al
Journal of Medicinal Chemistry (2023), 66(12), 8288-8309.
10.1021/acs.jmedchem.3c00760
```

---

## Reaction 31-614-CAS-40459765

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `C[C@H](N)c1cccc(Br)n1.Cl.O=C(O)c1ccc2c(-c3ccc(C(F)(F)F)cc3)cccc2c1`
  - Products: `C[C@H](NC(=O)c1ccc2c(-c3ccc(C(F)(F)F)cc3)cccc2c1)c1cccc(Br)n1`

**Reference:**
  - **Title:** Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders
  - **Authors:** Li, Huajie; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(5), 631-639.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.4c00029](https://doi.org/10.1021/acsmedchemlett.4c00029)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-40459765
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Tetrahydrofuran; overnight, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism
By: Shukla, Manojkumar R.; et al
Journal of Medicinal Chemistry (2023), 66(14), 9418-9444.
10.1021/acs.jmedchem.3c00698
```

---

## Reaction 31-614-CAS-40470986

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 34.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]12.COC(=O)CCCCCN.Cl`
  - Products: `C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCC(=O)OC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]12`

**Reference:**
  - **Title:** Discovery of a New Anti-Inflammatory Agent from Anemoside B4 Derivatives and Its Therapeutic Effect on Colitis by Targeting Pyruvate Carboxylase
  - **Authors:** Lv, Lijuan; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(9), 7385-7405.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00222](https://doi.org/10.1021/acs.jmedchem.4c00222)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-40470986
1.1|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 4 h, rt
1.2|30 h, rt
Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer
By: Byun, Woong Sub; et al
Journal of Medicinal Chemistry (2023), 66(4), 3106-3133.
10.1021/acs.jmedchem.2c01115
```

---

## Reaction 31-614-CAS-40472116

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: BASE (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - N-Hydroxysuccinimide (CAS: 6066-82-6) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 21.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(Cl)c([N+](=O)[O-])c1.Br.NCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-]`
  - Products: `O=C(NCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)c1ccc(Cl)c([N+](=O)[O-])c1.[Cl-]`

**Reference:**
  - **Title:** Human mitochondrial glutathione transferases: Kinetic parameters and accommodation of a mitochondria-targeting group in substrates
  - **Authors:** Cardwell, Patrick A.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2024), 104, 117712.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2024.117712](https://doi.org/10.1016/j.bmc.2024.117712)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-40472116
1.1|Reagents: Dicyclohexylcarbodiimide, N-Hydroxysuccinimide
Solvents: Dichloromethane; 0 °C → rt; 2 h, rt
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 19 h, rt
Double bond geometry shown
Double bond geometry shown
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer
By: Zhang, Kuojun; et al
Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.
10.1021/acs.jmedchem.2c00077
```

---

## Reaction 31-614-CAS-40478600

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 8.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(=O)O.Nc1cncc(Br)c1`
  - Products: `CC(C)(C)OC(=O)NCC(=O)Nc1cncc(Br)c1`

**Reference:**
  - **Title:** Discovery of Novel N-(5-(Pyridin-3-yl)-1H-indazol-3-yl)benzamide Derivatives as Potent Cyclin-Dependent Kinase 7 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease
  - **Authors:** Yang, Bowen; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(23), 15770-15788.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01334](https://doi.org/10.1021/acs.jmedchem.2c01334)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-40478600
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 8 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide
By: Guryanov, Ivan; et al
Organic Process Research & Development (2021), 25(7), 1598-1611.
10.1021/acs.oprd.1c00021
```

---

## Reaction 31-614-CAS-40478987

**Type:** Other

**Reagents:**
  - HBTU (CAS: 94790-37-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `C#CCOc1ccc2[nH]c3c(C(=O)c4ccc(Br)cc4)nc(C(=O)O)cc3c2c1.NCCc1c[nH]c2ccccc12`
  - Products: `C#CCOc1ccc2[nH]c3c(C(=O)c4ccc(Br)cc4)nc(C(=O)NCCc4c[nH]c5ccccc45)cc3c2c1`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer
  - **Authors:** Byun, Woong Sub; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(4), 3106-3133.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01115](https://doi.org/10.1021/acs.jmedchem.2c01115)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-40478987
1.1|Reagents: 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dimethylformamide; 1 h, 25 °C
1.2|Reagents: Diisopropylethylamine; 3 h, 25 °C
Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
By: Tang, Sheng; et al
European Journal of Medicinal Chemistry (2024), 263, 115939.
10.1016/j.ejmech.2023.115939
```

---

## Reaction 31-614-CAS-40486251

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)O)cc2)CC1.CC1(C)[C@H](N)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1.Cl`
  - Products: `CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)N[C@H]3C(C)(C)[C@H](Oc4ccc(C#N)c(Cl)c4)C3(C)C)cc2)CC1`

**Reference:**
  - **Title:** Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras
  - **Authors:** Takwale, Akshay D.; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 208, 112769.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112769](https://doi.org/10.1016/j.ejmech.2020.112769)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-40486251
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 12 h, rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-40486257

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `O=C(O)c1cc(O)ccc1[N+](=O)[O-].Cl.NC1CCC(=O)NC1=O`
  - Products: `O=C1CCC(NC(=O)c2cc(O)ccc2[N+](=O)[O-])C(=O)N1`

**Reference:**
  - **Title:** Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras
  - **Authors:** Takwale, Akshay D.; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 208, 112769.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112769](https://doi.org/10.1016/j.ejmech.2020.112769)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-40486257
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 12 h, rt
Double bond geometry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Process Development for the Synthesis of a Monobactam Antibiotic-LYS228
By: Fei, Zhongbo; et al
Organic Process Research & Development (2020), 24(3), 363-370.
10.1021/acs.oprd.9b00330
```

---

## Reaction 31-614-CAS-40486260

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `Nc1cccc(F)c1C(=O)O.Cl.NC1CCC(=O)NC1=O`
  - Products: `Nc1cccc(F)c1C(=O)NC1CCC(=O)NC1=O`

**Reference:**
  - **Title:** Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras
  - **Authors:** Takwale, Akshay D.; et al
  - **Citation:** European Journal of Medicinal Chemistry (2020), 208, 112769.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2020.112769](https://doi.org/10.1016/j.ejmech.2020.112769)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-40486260
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 12 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice
By: Yin, Jiaxin; et al
European Journal of Medicinal Chemistry (2023), 249, 115141.
10.1016/j.ejmech.2023.115141
```

---

## Reaction 31-614-CAS-40533936

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - 4-Methylmorpholine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - MeCN (CAS: 75-05-8) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `Cl.NC(=O)[C@@H](N)C[C@@H]1CCCNC1=O.COC(=O)N[C@H](C(=O)N1C[C@H](C(F)(F)F)C[C@H]1C(=O)O)C(C)C`
  - Products: `COC(=O)N[C@H](C(=O)N1C[C@H](C(F)(F)F)C[C@H]1C(=O)N[C@@H](C[C@@H]1CCCNC1=O)C(N)=O)C(C)C`

**Reference:**
  - **Title:** A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19
  - **Authors:** Allerton, Charlotte M. N.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(16), 13550-13571.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02469](https://doi.org/10.1021/acs.jmedchem.3c02469)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-40533936
1.1|Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide, Acetonitrile; 0 °C → rt; overnight, rt
Double bond geometry shown
Double bond geometry shown
Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines
By: Marinovic, Marina; et al
Bioorganic & Medicinal Chemistry (2023), 94, 117468.
10.1016/j.bmc.2023.117468
```

---

## Reaction 31-614-CAS-40576482

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 72.667 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `COCC(NC(=O)OC(C)(C)C)C(=O)O.Nc1nnc(Cc2ccc([N+](=O)[O-])cc2)s1`
  - Products: `COCC(NC(=O)OC(C)(C)C)C(=O)Nc1nnc(Cc2ccc([N+](=O)[O-])cc2)s1`

**Reference:**
  - **Title:** Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21
  - **Authors:** Goericke, Fabian; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3431-3447.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01933](https://doi.org/10.1021/acs.jmedchem.2c01933)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-40576482
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 40 min, rt
1.2|3 d, rt
Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity
By: Zareba, Paula; et al
European Journal of Medicinal Chemistry (2021), 221, 113512.
10.1016/j.ejmech.2021.113512
```

---

## Reaction 31-614-CAS-40576505

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - 4-Methylmorpholine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `COC[C@@H](NC(=O)OC(C)(C)C)C(=O)O.N#Cc1ccc(Cc2nnc(N)s2)cc1`
  - Products: `COC[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1nnc(Cc2ccc(C#N)cc2)s1`

**Reference:**
  - **Title:** Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21
  - **Authors:** Goericke, Fabian; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(5), 3431-3447.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01933](https://doi.org/10.1021/acs.jmedchem.2c01933)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-40576505
1.1|Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe
By: Roehm, Sandra; et al
Journal of Medicinal Chemistry (2021), 64(18), 13451-13474.
10.1021/acs.jmedchem.1c00868
```

---

## Reaction 31-614-CAS-40577093

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CCCC[C@H](N)C(=O)OC.Cl.Cc1nc2c(OCc3c(F)cccc3F)cccn2c1C(=O)O`
  - Products: `CCCCC(NC(=O)c1c(C)nc2c(OCc3c(F)cccc3F)cccn12)C(=O)OC`

**Reference:**
  - **Title:** New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension
  - **Authors:** Vakalopoulos, Alexandros; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02082](https://doi.org/10.1021/acs.jmedchem.2c02082)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-40577093
1.1|Reagents: 4-Methylmorpholine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dichloromethane; 4 h, rt
Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor
By: M. Serafim, Ricardo A.; et al
Journal of Medicinal Chemistry (2022), 65(4), 3173-3192.
10.1021/acs.jmedchem.1c01165
```

---

## Reaction 31-614-CAS-40577123

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.5 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(N)c1ccc(F)c(F)c1.Cc1nc2c(OCc3c(F)cccc3F)cccn2c1C(=O)O`
  - Products: `Cc1nc2c(OCc3c(F)cccc3F)cccn2c1C(=O)NC(CNC(=O)OC(C)(C)C)c1ccc(F)c(F)c1`

**Reference:**
  - **Title:** New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension
  - **Authors:** Vakalopoulos, Alexandros; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02082](https://doi.org/10.1021/acs.jmedchem.2c02082)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-40577123
1.1|Reagents: 4-Methylmorpholine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide; 2 h, rt
1.2|Solvents: Water; 30 min, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1
By: Lu, Jian; et al
Journal of Medicinal Chemistry (2020), 63(22), 13878-13898.
10.1021/acs.jmedchem.0c01475
```

---

## Reaction 31-614-CAS-40577125

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.083 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `Cc1cc(OCc2c(F)cccc2F)c2nc(C)c(C(=O)O)n2c1.CC[C@@](C)(CN)NC(=O)OCc1ccccc1`
  - Products: `CC[C@@](C)(CNC(=O)c1c(C)nc2c(OCc3c(F)cccc3F)cc(C)cn12)NC(=O)OCc1ccccc1`

**Reference:**
  - **Title:** New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension
  - **Authors:** Vakalopoulos, Alexandros; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c02082](https://doi.org/10.1021/acs.jmedchem.2c02082)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-40577125
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 20 min, rt
1.2|overnight, rt
1.3|Solvents: Water; 45 min, rt
Absolute stereochemistry shown
Double bond geometry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC)
By: Zhang, Kuojun; et al
Journal of Medicinal Chemistry (2021), 64(7), 4020-4033.
10.1021/acs.jmedchem.0c02161
```

---

## Reaction 31-614-CAS-40578331

**Type:** Other

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Py (CAS: 110-86-1) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)OCCO2.Nc1ccc(F)c([N+](=O)[O-])c1`
  - Products: `O=C(Nc1ccc(F)c([N+](=O)[O-])c1)c1ccc2c(c1)OCCO2`

**Reference:**
  - **Title:** HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
  - **Authors:** Pasqua, A. Elisa; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00156](https://doi.org/10.1021/acs.jmedchem.3c00156)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-40578331
1.1|Reagents: Oxalyl chloride, Pyridine
Solvents: Dichloromethane; 1 h, 0 °C
1.2|Reagents: Pyridine
Solvents: Dichloromethane; 16 h, 0 °C
Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction
By: Christie, Louisa A.; et al
Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.
10.1021/acs.jmedchem.3c00630
```

---

## Reaction 31-614-CAS-40578368

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Py (CAS: 110-86-1) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 5.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Cc1ccc2cc(C(=O)O)ccc2n1.Cc1ccc([N+](=O)[O-])cc1N`
  - Products: `Cc1ccc2cc(C(=O)Nc3cc([N+](=O)[O-])ccc3C)ccc2n1`

**Reference:**
  - **Title:** HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
  - **Authors:** Pasqua, A. Elisa; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00156](https://doi.org/10.1021/acs.jmedchem.3c00156)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-40578368
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; rt; 3 h, 20 °C
1.2|Reagents: Pyridine; 2 h, rt
Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure
By: Velcicky, Juraj; et al
Journal of Medicinal Chemistry (2020), 63(17), 9856-9875.
10.1021/acs.jmedchem.0c01020
```

---

## Reaction 31-614-CAS-40578370

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Py (CAS: 110-86-1) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 6.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Cc1ccc2cc(C(=O)O)ccc2n1.Nc1cc([N+](=O)[O-])ccc1Cl`
  - Products: `Cc1ccc2cc(C(=O)Nc3cc([N+](=O)[O-])ccc3Cl)ccc2n1`

**Reference:**
  - **Title:** HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
  - **Authors:** Pasqua, A. Elisa; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00156](https://doi.org/10.1021/acs.jmedchem.3c00156)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-40578370
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; rt; 3 h, 20 °C
1.2|Reagents: Pyridine; 2 h
Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
By: Sheppard, George S.; et al
Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.
10.1021/acs.jmedchem.0c00628
```

---

## Reaction 31-614-CAS-40578371

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)OCCO2.Cc1ccc2cc(C(=O)Nc3cc(N)ccc3C)ccc2n1`
  - Products: `Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)OCCO5)ccc3C)ccc2n1`

**Reference:**
  - **Title:** HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
  - **Authors:** Pasqua, A. Elisa; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00156](https://doi.org/10.1021/acs.jmedchem.3c00156)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-40578371
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; rt; overnight, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome
By: Gotz, Marion G.; et al
ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.
10.1021/acsmedchemlett.4c00017
```

---

## Reaction 31-614-CAS-40578485

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Py (CAS: 110-86-1) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 75.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1ccc2c(c1)OCCO2.Cc1ccc2cc(C(=O)Nc3cc(N)ccc3Br)ccc2n1`
  - Products: `Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)OCCO5)ccc3Br)ccc2n1`

**Reference:**
  - **Title:** HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
  - **Authors:** Pasqua, A. Elisa; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00156](https://doi.org/10.1021/acs.jmedchem.3c00156)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-40578485
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; rt; 3 h, 20 °C
1.2|Reagents: Pyridine; 72 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-614-CAS-40592502

**Type:** Other

**Reagents:**
  - Ac2O (CAS: 108-24-7) - Role: BASE (Registry: SOLVENT)
  - NaOH (CAS: 1310-73-2) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 95.0°C
  - Time: 5.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `N#CCC(=O)O.NC(=O)NC1CC1`
  - Products: `Nc1cc(=O)[nH]c(=O)n1C1CC1`

**Reference:**
  - **Title:** Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors
  - **Authors:** Specker, Edgar; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(16), 11126-11149.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00598](https://doi.org/10.1021/acs.jmedchem.2c00598)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-40592502
1.1|Reagents: Acetic anhydride; 80 °C → 95 °C; 2 h, 95 °C
1.2|Reagents: Sodium hydroxide
Solvents: Water; 80 °C; 3 h, 80 °C
1.3|Reagents: Hydrochloric acid
Solvents: Water; pH 7
N-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment
By: Mehndiratta, Samir; et al
Journal of Medicinal Chemistry (2022), 65(3), 2208-2224.
10.1021/acs.jmedchem.1c01726
```

---

## Reaction 31-614-CAS-40615614

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `COC(=O)c1ccc(N)cc1.O=C(O)CCC(=O)c1ccccc1`
  - Products: `COC(=O)c1ccc(NC(=O)CCC(=O)c2ccccc2)cc1`

**Reference:**
  - **Title:** Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein-Protein Interactions Involving Autophagy-Related 5
  - **Authors:** Xiang, Honggang; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(4), 2457-2476.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01233](https://doi.org/10.1021/acs.jmedchem.2c01233)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-40615614
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 2 h, 0 °C
Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity
By: Karki, Anupam; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053.
10.1016/j.bmcl.2020.127053
```

---

## Reaction 31-614-CAS-40620103

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Py (CAS: 110-86-1) - Role: BASE

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 19.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(NCc1ccc(C(=O)O)cc1)OCc1ccccc1.Nc1cccnc1`
  - Products: `O=C(NCc1ccc(C(=O)Nc2cccnc2)cc1)OCc1ccccc1`

**Reference:**
  - **Title:** Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy
  - **Authors:** Abyar, Selda; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(13), 11086-11102.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00589](https://doi.org/10.1021/acs.jmedchem.4c00589)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-40620103
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Tetrahydrofuran; rt; 3 h, 50 °C
1.2|Solvents: Pyridine; rt; 16 h, rt
Relative stereochemistry shown
Relative stereochemistry shown
A new chemotype with promise against Trypanosoma cruzi
By: Wang, Xiaofang; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.
10.1016/j.bmcl.2019.126778
```

---

## Reaction 31-614-CAS-40640691

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.5 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)C1(C(=O)O)CC1.Cc1cc(N)no1`
  - Products: `Cc1cc(NC(=O)C2(C(=O)O)CC2)no1`

**Reference:**
  - **Title:** Discovery of 10H-Benzo[b]pyrido[2,3-e][1,4]oxazine AXL Inhibitors via Structure-Based Drug Design Targeting c-Met Kinase
  - **Authors:** Zhan, Zhengsheng; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(1), 220-234.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00962](https://doi.org/10.1021/acs.jmedchem.2c00962)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-40640691
1.1|Reagents: Triethylamine
Solvents: Tetrahydrofuran; 30 min, 0 °C
1.2|Reagents: Thionyl chloride; 30 min, 0 °C
1.3|Solvents: Tetrahydrofuran; 0 °C; 1.5 h, 0 °C
A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer’s disease
By: Rivera-Marrero, Suchitil; et al
Bioorganic & Medicinal Chemistry (2020), 28(20), 115700.
10.1016/j.bmc.2020.115700
```

---

## Reaction 31-614-CAS-40640858

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CNC(=O)c1ccccc1N.CN(CC(=O)O)C(=O)OC(C)(C)C`
  - Products: `CNC(=O)c1ccccc1NC(=O)CN(C)C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation
  - **Authors:** Bayrak, Alp; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01198](https://doi.org/10.1021/acs.jmedchem.2c01198)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-40640858
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 12 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (-)
Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2
By: Grifagni, Deborah; et al
ACS Medicinal Chemistry Letters (2024), 15(2), 250-257.
10.1021/acsmedchemlett.3c00498
```

---

## Reaction 31-614-CAS-40640859

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CNC(=O)c1ccccc1N.CC(C)(C)OC(=O)NCC(=O)O`
  - Products: `CNC(=O)c1ccccc1NC(=O)CNC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation
  - **Authors:** Bayrak, Alp; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01198](https://doi.org/10.1021/acs.jmedchem.2c01198)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-40640859
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 12 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown,
Rotation (+)
Synthesis and Biological Evaluation of CF3Se-Substituted α-Amino Acid Derivatives
By: Han, Zhou-Zhou; et al
ChemMedChem (2021), 16(20), 3177-3180.
10.1002/cmdc.202100451
```

---

## Reaction 31-614-CAS-40640896

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CC(C)(C)N.CC(C)(C)OC(=O)N1CCC(C(=O)O)CC1`
  - Products: `CC(C)(C)NC(=O)C1CCN(C(=O)OC(C)(C)C)CC1`

**Reference:**
  - **Title:** Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation
  - **Authors:** Bayrak, Alp; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01198](https://doi.org/10.1021/acs.jmedchem.2c01198)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-40640896
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 16 h, rt
1.2|Reagents: Water; rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate
By: Critcher, Douglas J.; et al
Organic Process Research & Development (2024), 28(7), 2646-2658.
10.1021/acs.oprd.4c00049
```

---

## Reaction 31-614-CAS-40642152

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - MeCN (CAS: 75-05-8) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 65.0°C
  - Time: 120.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CN1CCN(c2ccc(Nc3ncc4c(n3)-n3ccc(C(=O)O)c3CC4)c([N+](=O)[O-])c2)CC1.Cl.CCc1cccc(CC)c1N`
  - Products: `CCc1cccc(CC)c1NC(=O)c1ccn2c1CCc1cnc(Nc3ccc(N4CCN(C)CC4)cc3[N+](=O)[O-])nc1-2`

**Reference:**
  - **Title:** Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor
  - **Authors:** M. Serafim, Ricardo A.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 3173-3192.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01165](https://doi.org/10.1021/acs.jmedchem.1c01165)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-40642152
1.1|Reagents: Thionyl chloride
Solvents: Dichloromethane; 0 °C; 48 h, rt
1.2|Catalysts: 4-(Dimethylamino)pyridine
Solvents: Acetonitrile; 72 h, 65 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor-Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors
By: Li, Bryan; et al
Organic Process Research & Development (2021), 25(6), 1440-1453.
10.1021/acs.oprd.1c00126
```

---

## Reaction 31-614-CAS-40642694

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 4-Methylmorpholine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMSO (CAS: 67-68-5) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CCCC(CCC)C(=O)O.Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1`
  - Products: `CCCC(CCC)C(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1`

**Reference:**
  - **Title:** Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine
  - **Authors:** Zhang, Liang; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 4150-4166.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00006](https://doi.org/10.1021/acs.jmedchem.3c00006)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-40642694
1.1|Reagents: 4-Methylmorpholine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethyl sulfoxide, Dimethylformamide; 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239
By: Richard-Bildstein, Sylvia; et al
Journal of Medicinal Chemistry (2020), 63(24), 15864-15882.
10.1021/acs.jmedchem.0c01588
```

---

## Reaction 31-614-CAS-40674244

**Type:** Other

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.083 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `O=C(O)Cc1nnn[nH]1.Cc1ccc(C(=O)C[C@](N)(c2ccc(OCCCCCC(F)(F)F)cc2)C(F)(F)F)cc1`
  - Products: `Cc1ccc(C(=O)C[C@](NC(=O)Cc2nnn[nH]2)(c2ccc(OCCCCCC(F)(F)F)cc2)C(F)(F)F)cc1`

**Reference:**
  - **Title:** Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders
  - **Authors:** Turdi, Huji; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(19), 14773-14792.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01356](https://doi.org/10.1021/acs.jmedchem.1c01356)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-40674244
1.1|Reagents: Dicyclohexylcarbodiimide
Solvents: Tetrahydrofuran; 5 min, 0 °C; 1 h, 0 °C; 0 °C → rt; overnight, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
By: Breidenbach, Julian; et al
Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
10.1021/acs.jmedchem.4c00053
```

---

## Reaction 31-614-CAS-40674680

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `C#CCCCC(=O)O.COC(=O)[C@@H](N)Cc1ccc(Oc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)cc1`
  - Products: `C#CCCCC(=O)N[C@@H](Cc1ccc(Oc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)cc1)C(=O)OC`

**Reference:**
  - **Title:** Identification of New Nitric Oxide-Donating Peptides with Dual Biofilm Eradication and Antibacterial Activities for Intervention of Device-Related Infections
  - **Authors:** Fei, Yue; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(17), 9127-9135.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.9b01832](https://doi.org/10.1021/acs.jmedchem.9b01832)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-40674680
1.1|Reagents: 4-Methylmorpholine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dimethylformamide; overnight, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
By: Breidenbach, Julian; et al
Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
10.1021/acs.jmedchem.4c00053
```

---

## Reaction 31-614-CAS-40675401

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `C=C[C@@H]1C[C@]1(N)C(=O)NS(=O)(=O)C1(C)CC1.Cl.C=CCC[C@@H](C)C[C@@H](CC)[C@H](NC(=O)OC(C)(C)C)C(=O)N1C[C@H](O)C[C@H]1C(=O)O`
  - Products: `C=CCC[C@@H](C)C[C@@H](CC)[C@H](NC(=O)OC(C)(C)C)C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@]1(C(=O)NS(=O)(=O)C2(C)CC2)C[C@H]1C=C`

**Reference:**
  - **Title:** Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
  - **Authors:** Sun, Li-Qiang; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(23), 14740-14760.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c01296](https://doi.org/10.1021/acs.jmedchem.0c01296)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-40675401
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 18 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Druglike, 18F-labeled PET Tracers Targeting Fibroblast Activation Protein
By: Tanc, Muhammet; et al
Journal of Medicinal Chemistry (2024), 67(9), 7068-7087.
10.1021/acs.jmedchem.3c02402
```

---

## Reaction 31-614-CAS-40676279

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)C(c1ccccc1)c1ccccc1.Cc1cccc(C[C@H](N)C(=O)NCC#N)c1.O=C(O)C(F)(F)F`
  - Products: `Cc1cccc(C[C@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCC#N)c1`

**Reference:**
  - **Title:** Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
  - **Authors:** Behring, Lydia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01360](https://doi.org/10.1021/acs.jmedchem.2c01360)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-40676279
1.1|Reagents: Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; 3 h, rt
Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers
By: Vaidya, Sandeep; et al
ChemMedChem (2023), 18(16), e202300097.
10.1002/cmdc.202300097
```

---

## Reaction 31-614-CAS-40676289

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)C(c1ccccc1)c1ccccc1.C#CCNC(=O)[C@@H](N)Cc1cccc(C)c1.O=C(O)C(F)(F)F`
  - Products: `C#CCNC(=O)[C@H](Cc1cccc(C)c1)NC(=O)C(c1ccccc1)c1ccccc1`

**Reference:**
  - **Title:** Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
  - **Authors:** Behring, Lydia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01360](https://doi.org/10.1021/acs.jmedchem.2c01360)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-40676289
1.1|Reagents: Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; 3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-40676290

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)C(c1ccccc1)c1ccccc1.C=CCOC(=O)c1cccc(COC[C@H](NC(=O)[C@@H](N)Cc2cccc(C)c2)C(N)=O)c1.O=C(O)C(F)(F)F`
  - Products: `C=CCOC(=O)c1cccc(COC[C@H](NC(=O)[C@H](Cc2cccc(C)c2)NC(=O)C(c2ccccc2)c2ccccc2)C(N)=O)c1`

**Reference:**
  - **Title:** Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
  - **Authors:** Behring, Lydia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01360](https://doi.org/10.1021/acs.jmedchem.2c01360)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-40676290
1.1|Reagents: Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; 3 h, rt
Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma
By: Weiss, Matthew M.; et al
Journal of Medicinal Chemistry (2024), 67(13), 10548-10566.
10.1021/acs.jmedchem.3c01823
```

---

## Reaction 31-614-CAS-40676296

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)C(c1ccccc1)c1ccccc1.C=CCOC(=O)c1cccc(COC[C@H](NC(=O)[C@@H](N)Cc2cccc(I)c2)C(N)=O)c1.O=C(O)C(F)(F)F`
  - Products: `C=CCOC(=O)c1cccc(COC[C@H](NC(=O)[C@H](Cc2cccc(I)c2)NC(=O)C(c2ccccc2)c2ccccc2)C(N)=O)c1`

**Reference:**
  - **Title:** Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
  - **Authors:** Behring, Lydia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01360](https://doi.org/10.1021/acs.jmedchem.2c01360)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-40676296
1.1|Reagents: Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; 3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma
By: Bollu, Lakshmi R.; et al
Journal of Medicinal Chemistry (2022), 65(23), 15642-15662.
10.1021/acs.jmedchem.2c00771
```

---

## Reaction 31-614-CAS-40676310

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `Cc1cccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)c1.COC(=O)c1cn(CCC[C@H](N)C(N)=O)nn1.O=C(O)C(F)(F)F`
  - Products: `COC(=O)c1cn(CCC[C@H](NC(=O)[C@H](Cc2cccc(C)c2)NC(=O)OC(C)(C)C)C(N)=O)nn1`

**Reference:**
  - **Title:** Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
  - **Authors:** Behring, Lydia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01360](https://doi.org/10.1021/acs.jmedchem.2c01360)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-40676310
1.1|Reagents: Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; 3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction
By: Christie, Louisa A.; et al
Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.
10.1021/acs.jmedchem.3c00630
```

---

## Reaction 31-614-CAS-40676316

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `Cc1cccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)c1.COC(=O)Cn1cc(COC[C@H](N)C(N)=O)nn1.O=C(O)C(F)(F)F`
  - Products: `COC(=O)Cn1cc(COC[C@H](NC(=O)[C@H](Cc2cccc(C)c2)NC(=O)OC(C)(C)C)C(N)=O)nn1`

**Reference:**
  - **Title:** Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
  - **Authors:** Behring, Lydia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01360](https://doi.org/10.1021/acs.jmedchem.2c01360)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-40676316
1.1|Reagents: Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; 3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
By: Behring, Lydia; et al
Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
10.1021/acs.jmedchem.2c01360
```

---

## Reaction 31-614-CAS-40676331

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `Cc1cccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)c1.C#C[C@@H](N)COCc1cccc(C(=O)OCC=C)c1.O=C(O)C(F)(F)F`
  - Products: `C#C[C@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@H](Cc1cccc(C)c1)NC(=O)OC(C)(C)C.C#C[C@@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@H](Cc1cccc(C)c1)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
  - **Authors:** Behring, Lydia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01360](https://doi.org/10.1021/acs.jmedchem.2c01360)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-40676331
1.1|Reagents: Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; 3 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-614-CAS-40676332

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - Isobutyl chloroformate (CAS: 543-27-1) - Role: BASE
  - NaOH (CAS: 1310-73-2) - Role: UNK (Registry: BASE)
  - 4-Methylmorpholine - Role: UNK
  - Sodium hydroxide - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -25.0°C
  - Time: 1.333 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `Cc1cccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)c1.N#CCN.O=S(=O)(O)O`
  - Products: `Cc1cccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)NCC#N)c1`

**Reference:**
  - **Title:** Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
  - **Authors:** Behring, Lydia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01360](https://doi.org/10.1021/acs.jmedchem.2c01360)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-40676332
1.1|Reagents: 4-Methylmorpholine, Isobutyl chloroformate
Solvents: Tetrahydrofuran; -25 °C; 10 min, -25 °C; 30 min, rt
1.2|Reagents: Sodium hydroxide
Solvents: Water; 10 min, -25 °C; 30 min, rt
Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells
By: Takashima, Katsuki; et al
Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034.
10.1016/j.bmcl.2022.129034
```

---

## Reaction 31-614-CAS-40676337

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - Isobutyl chloroformate (CAS: 543-27-1) - Role: UNK
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -25.0°C
  - Time: 0.667 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O.C#CCN`
  - Products: `C#CCNC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
  - **Authors:** Behring, Lydia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01360](https://doi.org/10.1021/acs.jmedchem.2c01360)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-40676337
1.1|Reagents: 4-Methylmorpholine, Isobutyl chloroformate
Solvents: Tetrahydrofuran; -25 °C
1.2|10 min, -25 °C; 30 min, rt
Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties
By: Morozova, Alisa; et al
European Journal of Medicinal Chemistry (2024), 266, 116101.
10.1016/j.ejmech.2023.116101
```

---

## Reaction 31-614-CAS-40676339

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - Isobutyl chloroformate (CAS: 543-27-1) - Role: UNK
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: -25.0°C
  - Time: 0.667 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Cc1cccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)c1.C#CCN`
  - Products: `C#CCNC(=O)[C@H](Cc1cccc(C)c1)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
  - **Authors:** Behring, Lydia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01360](https://doi.org/10.1021/acs.jmedchem.2c01360)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-40676339
1.1|Reagents: 4-Methylmorpholine, Isobutyl chloroformate
Solvents: Tetrahydrofuran; -25 °C
1.2|10 min, -25 °C; 30 min, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Process Development and GMP Production of a Conjugate Warhead: Auristatin F-HPA-Ala/TFA (XMT-1864/TFA)
By: Conlon, Patrick R.; et al
Organic Process Research & Development (2022), 26(8), 2124-2137.
10.1021/acs.oprd.1c00449
```

---

## Reaction 31-614-CAS-40676380

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `O=C(O)C(c1ccccc1)c1ccccc1.C#C[C@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@@H](N)Cc1cccc(C)c1.O=C(O)C(F)(F)F.C#C[C@@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@@H](N)Cc1cccc(C)c1.O=C(O)C(F)(F)F`
  - Products: `C#C[C@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@H](Cc1cccc(C)c1)NC(=O)C(c1ccccc1)c1ccccc1.C#C[C@@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@H](Cc1cccc(C)c1)NC(=O)C(c1ccccc1)c1ccccc1`

**Reference:**
  - **Title:** Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
  - **Authors:** Behring, Lydia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01360](https://doi.org/10.1021/acs.jmedchem.2c01360)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-40676380
1.1|Reagents: Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; 3 h, rt
Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity
By: Chen, Chen; et al
Journal of Medicinal Chemistry (2022), 65(4), 3667-3683.
10.1021/acs.jmedchem.1c02225
```

---

## Reaction 31-614-CAS-40676385

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(I)cc1.C#C[C@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@@H](N)Cc1cccc(C)c1.O=C(O)C(F)(F)F.C#C[C@@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@@H](N)Cc1cccc(C)c1.O=C(O)C(F)(F)F`
  - Products: `C#C[C@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@H](Cc1cccc(C)c1)NC(=O)c1ccc(I)cc1.C#C[C@@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@H](Cc1cccc(C)c1)NC(=O)c1ccc(I)cc1`

**Reference:**
  - **Title:** Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
  - **Authors:** Behring, Lydia; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c01360](https://doi.org/10.1021/acs.jmedchem.2c01360)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-40676385
1.1|Reagents: Diisopropylethylamine, PyBOP
Solvents: Tetrahydrofuran; 3 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency
By: Guzelj, Samo; et al
ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.
10.1021/acsmedchemlett.2c00121
```

---

## Reaction 31-614-CAS-40678189

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 55.5 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)c1cccc2c1-c1ccccc1C2=O.COC(=O)[C@@H](N)Cc1ccccc1.Cl`
  - Products: `COC(=O)C(Cc1ccccc1)NC(=O)c1cccc2c1-c1ccccc1C2=O`

**Reference:**
  - **Title:** Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
  - **Authors:** Narayanan, Dilip; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00830](https://doi.org/10.1021/acs.jmedchem.2c00830)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-40678189
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 30 min, 0 °C
1.2|5 - 55 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen
By: Hekking, Koen F. W.; et al
Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.
10.1021/acs.jmedchem.3c02206
```

---

## Reaction 31-614-CAS-40678191

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 55.5 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)c1cccc2c1-c1ccccc1C2=O.COC(=O)C(N)c1ccccc1.Cl`
  - Products: `COC(=O)C(NC(=O)c1cccc2c1-c1ccccc1C2=O)c1ccccc1`

**Reference:**
  - **Title:** Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
  - **Authors:** Narayanan, Dilip; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00830](https://doi.org/10.1021/acs.jmedchem.2c00830)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-40678191
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 30 min, 0 °C
1.2|5 - 55 h, rt
Absolute stereochemistry shown,
Rotation (+)
Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
By: Narayanan, Dilip; et al
Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.
10.1021/acs.jmedchem.2c00830
```

---

## Reaction 31-614-CAS-40678197

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 55.5 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `O=C(O)c1cccc2c1-c1ccccc1C2=O.COC(=O)CC(N)Cc1ccccc1.Cl`
  - Products: `COC(=O)CC(Cc1ccccc1)NC(=O)c1cccc2c1-c1ccccc1C2=O`

**Reference:**
  - **Title:** Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
  - **Authors:** Narayanan, Dilip; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00830](https://doi.org/10.1021/acs.jmedchem.2c00830)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-40678197
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 30 min, 0 °C
1.2|5 - 55 h, rt
Identification of ss-Glucocerebrosidase Activators for Glucosylceramide hydrolysis
By: Schulze, Monika-Sarah E. D.; et al
ChemMedChem (2024), 19(7), e202300548.
10.1002/cmdc.202300548
```

---

## Reaction 31-614-CAS-40678201

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 55.5 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)c1cccc2c1-c1ccccc1C2=O.COC(=O)CC(N)c1ccccc1.Cl`
  - Products: `COC(=O)CC(NC(=O)c1cccc2c1-c1ccccc1C2=O)c1ccccc1`

**Reference:**
  - **Title:** Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
  - **Authors:** Narayanan, Dilip; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00830](https://doi.org/10.1021/acs.jmedchem.2c00830)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-40678201
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 30 min, 0 °C
1.2|5 - 55 h, rt
A new chemotype with promise against Trypanosoma cruzi
By: Wang, Xiaofang; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.
10.1016/j.bmcl.2019.126778
```

---

## Reaction 31-614-CAS-40724155

**Type:** Other

**Reagents:**
  - Py (CAS: 110-86-1) - Role: BASE
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Trimethyl borate (CAS: 121-43-7) - Role: UNK
  - Lithium diisopropylamide (CAS: 4111-54-0) - Role: UNK
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 18.25 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `CN.Cl.COc1ccc2occ(C(=O)O)c2c1`
  - Products: `CNC(=O)c1c(B(O)O)oc2ccc(OC)cc12`

**Reference:**
  - **Title:** Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target
  - **Authors:** Wilson, Caroline; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(1), 409-423.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01586](https://doi.org/10.1021/acs.jmedchem.1c01586)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-40724155
1.1|Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 16 h, 30 °C
1.2|Solvents: Water; 15 min
1.3|Reagents: Trimethyl borate, Lithium diisopropylamide
Solvents: Tetrahydrofuran; -78 °C; 2 h, -78 °C
1.4|Reagents: Hydrochloric acid
Solvents: Water
Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease
By: Kilpelainen, Tommi P.; et al
Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.
10.1021/acs.jmedchem.3c00235
```

---

## Reaction 31-614-CAS-40724397

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `O=C(O)COP(=O)(OCc1ccccc1)OCc1ccccc1.COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc(F)c([C@H]3CC[C@H](c4cc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)n(COC(=O)[C@@H](N)C(C)C)c5cc4F)N3c3cc(F)c(N4CCC(c5ccc(F)cc5)CC4)c(F)c3)cc2[nH]1)[C@@H](C)OC`
  - Products: `COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc(F)c([C@H]3CC[C@@H](c4cc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)n(COC(=O)[C@@H](NC(=O)COP(=O)(OCc6ccccc6)OCc6ccccc6)C(C)C)c5cc4F)N3c3cc(F)c(N4CCC(c5ccc(F)cc5)CC4)c(F)c3)cc2[nH]1)[C@@H](C)OC`

**Reference:**
  - **Title:** Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530)
  - **Authors:** Randolph, John T.; et al
  - **Citation:** Journal of Medicinal Chemistry (2020), 63(19), 11034-11044.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.0c00956](https://doi.org/10.1021/acs.jmedchem.0c00956)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-40724397
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
By: Gillis, Eric P.; et al
Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
10.1021/acs.jmedchem.2c01732
```

---

## Reaction 31-614-CAS-40728145

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `COc1ccc(C(=O)O)cc1[N+](=O)[O-].CN(C)c1ccc(N)cc1`
  - Products: `COc1ccc(C(=O)Nc2ccc(N(C)C)cc2)cc1[N+](=O)[O-]`

**Reference:**
  - **Title:** Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus
  - **Authors:** Liu, Yonghua; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 228, 114033.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.114033](https://doi.org/10.1016/j.ejmech.2021.114033)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-40728145
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 16 h, rt
Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis
By: Sarkar, Dipayan; et al
Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.
10.1021/acs.jmedchem.3c01431
```

---

## Reaction 31-614-CAS-40728186

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CN(C)c1ccc(N)cc1.CC(C)Oc1ccc(C(=O)O)cc1[N+](=O)[O-]`
  - Products: `CC(C)Oc1ccc(C(=O)Nc2ccc(N(C)C)cc2)cc1[N+](=O)[O-]`

**Reference:**
  - **Title:** Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus
  - **Authors:** Liu, Yonghua; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 228, 114033.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.114033](https://doi.org/10.1016/j.ejmech.2021.114033)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-40728186
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 16 h, rt
Double bond geometry shown
NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer
By: Xu, Zhongren; et al
Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.
10.1021/acs.jmedchem.3c00063
```

---

## Reaction 31-614-CAS-40728187

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `CN1CCN(Cc2ccc(N)cc2C(F)(F)F)CC1.O=C(O)c1ccc(OCCCCl)c(F)c1`
  - Products: `CN1CCN(Cc2ccc(NC(=O)c3ccc(OCCCCl)c(F)c3)cc2C(F)(F)F)CC1`

**Reference:**
  - **Title:** Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus
  - **Authors:** Liu, Yonghua; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 228, 114033.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.114033](https://doi.org/10.1016/j.ejmech.2021.114033)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-40728187
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 16 h, rt
Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine
By: Jiang, Xueyang; et al
European Journal of Medicinal Chemistry (2021), 223, 113663.
10.1016/j.ejmech.2021.113663
```

---

## Reaction 31-614-CAS-40728204

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `CN1CCN(Cc2ccc(N)cc2C(F)(F)F)CC1.O=C(O)c1ccc(OCCCCl)c(Cl)c1`
  - Products: `CN1CCN(Cc2ccc(NC(=O)c3ccc(OCCCCl)c(Cl)c3)cc2C(F)(F)F)CC1`

**Reference:**
  - **Title:** Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus
  - **Authors:** Liu, Yonghua; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 228, 114033.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.114033](https://doi.org/10.1016/j.ejmech.2021.114033)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-40728204
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 16 h, rt
Development of a Robust Scale-Up Synthetic Route for BPR1K871: A Clinical Candidate for the Treatment of Acute Myeloid Leukemia and Solid Tumors
By: Reddy, Julakanti Satyanarayana; et al
Organic Process Research & Development (2021), 25(4), 817-830.
10.1021/acs.oprd.0c00515
```

---

## Reaction 31-614-CAS-40728206

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `CN1CCN(Cc2ccc(N)cc2C(F)(F)F)CC1.O=C(O)c1ccc(OCCCl)c([N+](=O)[O-])c1`
  - Products: `CN1CCN(Cc2ccc(NC(=O)c3ccc(OCCCl)c([N+](=O)[O-])c3)cc2C(F)(F)F)CC1`

**Reference:**
  - **Title:** Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus
  - **Authors:** Liu, Yonghua; et al
  - **Citation:** European Journal of Medicinal Chemistry (2022), 228, 114033.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.114033](https://doi.org/10.1016/j.ejmech.2021.114033)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-40728206
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 16 h, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
By: Breidenbach, Julian; et al
Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
10.1021/acs.jmedchem.4c00053
```

---

## Reaction 31-614-CAS-40761032

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `O=C(O)c1cc2ccccc2o1.CC(C)(C)OC(=O)NCC1CCCN(CCCCN)C1`
  - Products: `CC(C)(C)OC(=O)NCC1CCCN(CCCCNC(=O)c2cc3ccccc3o2)C1`

**Reference:**
  - **Title:** Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands
  - **Authors:** Shaik, Anver Basha; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(20), 15313-15333.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01353](https://doi.org/10.1021/acs.jmedchem.1c01353)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-40761032
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
By: Novotna, Katerina; et al
Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
10.1021/acs.jmedchem.3c01681
```

---

## Reaction 31-614-CAS-40761033

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - 1,1′-Carbonyldiimidazole - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `O=C(O)c1cc2ccccc2[nH]1.CC(C)(C)OC(=O)NCC1CCCN(CCCCN)C1`
  - Products: `CC(C)(C)OC(=O)NCC1CCCN(CCCCNC(=O)c2cc3ccccc3[nH]2)C1`

**Reference:**
  - **Title:** Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands
  - **Authors:** Shaik, Anver Basha; et al
  - **Citation:** Journal of Medicinal Chemistry (2021), 64(20), 15313-15333.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01353](https://doi.org/10.1021/acs.jmedchem.1c01353)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-40761033
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury
By: Cui, Yingjun; et al
Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.
10.1021/acs.jmedchem.1c01583
```

---

## Reaction 31-614-CAS-40763299

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCCCCC(=O)O.COC(=O)c1cc(OC(=O)OC(C)(C)C)c2cc(N)ccc2c1`
  - Products: `COC(=O)c1cc(OC(=O)OC(C)(C)C)c2cc(NC(=O)CCCCNC(=O)OC(C)(C)C)ccc2c1`

**Reference:**
  - **Title:** Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach
  - **Authors:** Iannelli, Giulia; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(17), 11574-11606.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.2c00252](https://doi.org/10.1021/acs.jmedchem.2c00252)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-40763299
1.1|Reagents: Dicyclohexylcarbodiimide
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 8 - 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold
By: Huang, Danling; et al
Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.
10.1016/j.bmcl.2021.128006
```

---

## Reaction 31-614-CAS-40763496

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT
  - MeCN (CAS: 75-05-8) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CN(C)C(=O)[C@@H](CSCc1cc(Br)ccc1C(=O)OCC(Cl)(Cl)Cl)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](CO)C(=O)O`
  - Products: `CN(C)C(=O)[C@@H](CSCc1cc(Br)ccc1C(=O)OCC(Cl)(Cl)Cl)NC(=O)[C@@H](CO)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1-Nrf2 Protein-Protein Interaction
  - **Authors:** Begnini, Fabio; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 3473-3517.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01975](https://doi.org/10.1021/acs.jmedchem.1c01975)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-40763496
1.1|Reagents: Hydrochloric acid
Solvents: 1,4-Dioxane; 1 h, rt
1.2|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Acetonitrile; 2 h, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies
By: Jung, Sascha; et al
Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.
10.1021/acs.jmedchem.1c01002
```

---

## Reaction 31-614-CAS-40776767

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Sodium chloride (CAS: 7647-14-5) - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)CC(C)C.Cl.CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O`
  - Products: `COC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities
  - **Authors:** Wang, Juan; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 215, 113267.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113267](https://doi.org/10.1016/j.ejmech.2021.113267)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-40776767
1.1|Reagents: 1-Hydroxybenzotriazole, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; rt → 0 °C
1.2|Reagents: Diisopropylethylamine; 0 °C → rt; 1 h, rt
1.3|Reagents: Sodium chloride
Solvents: Water; rt
Structure-Based Ligand Discovery Targeting the Transmembrane Domain of Frizzled Receptor FZD7
By: Li, Cuixia; et al
Journal of Medicinal Chemistry (2023), 66(17), 11855-11868.
10.1021/acs.jmedchem.2c01795
```

---

## Reaction 31-614-CAS-40804341

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `Nc1ccccc1N.CN1c2ccc(F)cc2C(=O)N2CCc3c(n(C(=O)OC(C)(C)C)c4ccc(OCCCC(=O)O)cc34)C21`
  - Products: `CN1c2ccc(F)cc2C(=O)N2CCc3c(n(C(=O)OC(C)(C)C)c4ccc(OCCCC(=O)Nc5ccccc5N)cc34)C21`

**Reference:**
  - **Title:** Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy
  - **Authors:** Wu, Shanchao; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(6), 4818-4831.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c02026](https://doi.org/10.1021/acs.jmedchem.1c02026)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-40804341
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
By: Gillis, Eric P.; et al
Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.
10.1021/acs.jmedchem.2c01732
```

---

## Reaction 31-614-CAS-40804554

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.017 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(N[C@@H](Cc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CCOC(OCC)[C@H](N)C(C)C`
  - Products: `CCOC(OCC)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21)C(C)C`

**Reference:**
  - **Title:** Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models
  - **Authors:** Winter-Holt, Jon J.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01871](https://doi.org/10.1021/acs.jmedchem.1c01871)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-40804554
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; > 1 min, rt
1.2|Solvents: Dichloromethane; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-614-CAS-40804566

**Type:** Other

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `COC(CN)OC.O=C(N[C@@H](Cc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21`
  - Products: `COC(CNC(=O)[C@H](Cc1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21)OC`

**Reference:**
  - **Title:** Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models
  - **Authors:** Winter-Holt, Jon J.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01871](https://doi.org/10.1021/acs.jmedchem.1c01871)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-40804566
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 1 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies
By: Alford, Joshua S.; et al
ACS Medicinal Chemistry Letters (2022), 13(7), 1137-1143.
10.1021/acsmedchemlett.2c00167
```

---

## Reaction 31-614-CAS-40804610

**Type:** Other

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `C[C@@H](N)CO.O=C(N[C@@H](Cc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21`
  - Products: `C[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21`

**Reference:**
  - **Title:** Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models
  - **Authors:** Winter-Holt, Jon J.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01871](https://doi.org/10.1021/acs.jmedchem.1c01871)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-40804610
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 4 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening
By: Tian, Xinrong; et al
Journal of Medicinal Chemistry (2022), 65(21), 14391-14408.
10.1021/acs.jmedchem.2c00670
```

---

## Reaction 31-614-CAS-40807666

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - 6-Chloro-1-hydroxybenzotriazole (CAS: 26198-19-6) - Role: UNK
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.083 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](CCCNC(=O)OCc1ccccc1)C(=O)O.COC(=O)[C@@H](N)CCCNC(=O)OCc1ccccc1.Cl`
  - Products: `COC(=O)[C@H](CCCNC(=O)OCc1ccccc1)NC(=O)[C@H](CCCNC(=O)OCc1ccccc1)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Stereochemical Effects on the Antimicrobial Properties of Tetrasubstituted 2,5-Diketopiperazines
  - **Authors:** Grant, Thomas M.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(4), 632-640.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.1c00683](https://doi.org/10.1021/acsmedchemlett.1c00683)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-40807666
1.1|Reagents: Diisopropylethylamine, 6-Chloro-1-hydroxybenzotriazole, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 5 min, rt
1.2|5 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors
By: Wei, Huiqiang; et al
European Journal of Medicinal Chemistry (2022), 227, 113918.
10.1016/j.ejmech.2021.113918
```

---

## Reaction 31-614-CAS-40816897

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `C=C(F)C(=O)O.CC1(C)OB(c2ccc(N)cc2)OC1(C)C`
  - Products: `C=C(F)C(=O)Nc1ccc(B2OC(C)(C)C(C)(C)O2)cc1`

**Reference:**
  - **Title:** Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor
  - **Authors:** Li, Huiqiong; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 272, 116473.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2024.116473](https://doi.org/10.1016/j.ejmech.2024.116473)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-40816897
1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride
Solvents: Tetrahydrofuran, Ethyl acetate; 4 h, rt
From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase
By: Juillet, Charlotte; et al
Journal of Medicinal Chemistry (2021), 64(2), 1197-1219.
10.1021/acs.jmedchem.0c02064
```

---

## Reaction 31-614-CAS-40818679

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `COc1ccc(CCN)cc1OC.O=C(O)CCc1c[nH]c2ccccc12`
  - Products: `COc1ccc(CCNC(=O)CCc2c[nH]c3ccccc23)cc1OC`

**Reference:**
  - **Title:** Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease
  - **Authors:** Zhou, Jianhui; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00159](https://doi.org/10.1021/acs.jmedchem.4c00159)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-40818679
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 4 h, rt
Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
By: Tormaehlen, Niklas M.; et al
Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.
10.1021/acs.jmedchem.0c01773
```

---

## Reaction 31-614-CAS-40818683

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)CCc1c[nH]c2ccccc12.CCOc1ccc(CCN)cc1OC`
  - Products: `CCOc1ccc(CCNC(=O)CCc2c[nH]c3ccccc23)cc1OC`

**Reference:**
  - **Title:** Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease
  - **Authors:** Zhou, Jianhui; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00159](https://doi.org/10.1021/acs.jmedchem.4c00159)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-40818683
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 4 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-40818685

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)CCc1c[nH]c2ccccc12.NCCc1ccc2c(c1)OCO2`
  - Products: `O=C(CCc1c[nH]c2ccccc12)NCCc1ccc2c(c1)OCO2`

**Reference:**
  - **Title:** Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease
  - **Authors:** Zhou, Jianhui; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00159](https://doi.org/10.1021/acs.jmedchem.4c00159)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-40818685
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 4 h, rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-40832861

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 5.0°C
  - Time: 5.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CC(C)Oc1cc(Oc2cnc(C(=O)N3CCC3)cn2)cc(C(=O)O)c1.CCOP(=O)(Cn1ccc(N)n1)OCC`
  - Products: `CCOP(=O)(Cn1ccc(NC(=O)c2cc(Oc3cnc(C(=O)N4CCC4)cn3)cc(OC(C)C)c2)n1)OCC`

**Reference:**
  - **Title:** Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)
  - **Authors:** Shi, Yan; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(5), 4291-4317.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c02110](https://doi.org/10.1021/acs.jmedchem.1c02110)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-40832861
1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 5 h, 0 - 5 °C
AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2
By: Narjes, Frank; et al
Journal of Medicinal Chemistry (2021), 64(18), 13807-13829.
10.1021/acs.jmedchem.1c01197
```

---

## Reaction 31-614-CAS-40871414

**Type:** Other

**Reagents:**
  - CDI (CAS: 530-62-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1,1′-Carbonyldiimidazole - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `O=C(O)c1[nH]c(Cc2ccc(-c3ccccc3)cc2)nc(=O)c1OCc1ccccc1.CCOC(=O)CN.Cl`
  - Products: `CCOC(=O)CNC(=O)c1[nH]c(Cc2ccc(-c3ccccc3)cc2)nc(=O)c1OCc1ccccc1`

**Reference:**
  - **Title:** Discovery of DS44470011: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia
  - **Authors:** Fukuda, Takeshi; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2024), 108, 129799.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2024.129799](https://doi.org/10.1016/j.bmcl.2024.129799)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-40871414
1.1|Reagents: 1,1′-Carbonyldiimidazole
Solvents: Dimethylformamide; 1 h, rt
1.2|Reagents: Diisopropylethylamine; 15 h, rt
Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
By: Xu, Shujing; et al
Bioorganic & Medicinal Chemistry (2022), 53, 116531.
10.1016/j.bmc.2021.116531
```

---

## Reaction 31-614-CAS-40877727

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Oxalyl chloride (CAS: 79-37-8) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 26.25 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `COC(=O)C(CC(=O)O)c1ccc(C(F)(F)F)cc1.Nc1ccc(-c2ncco2)cc1`
  - Products: `COC(=O)C(CC(=O)Nc1ccc(-c2ncco2)cc1)c1ccc(C(F)(F)F)cc1`

**Reference:**
  - **Title:** Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer
  - **Authors:** Sharma, Horrick; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 275, 116598.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2024.116598](https://doi.org/10.1016/j.ejmech.2024.116598)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-40877727
1.1|Reagents: Oxalyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 0 °C; 15 min, 0 °C; 2 h, 0 °C → rt
1.2|Reagents: Triethylamine
Catalysts: Dimethylformamide
Solvents: Dichloromethane; 24 h, rt
1.3|Reagents: Hydrochloric acid
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-614-CAS-40877745

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `O=C(O)CCc1ccccc1.CCOC(=O)CC(N)c1cccc(Cl)c1`
  - Products: `CCOC(=O)CC(NC(=O)CCc1ccccc1)c1cccc(Cl)c1`

**Reference:**
  - **Title:** Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer
  - **Authors:** Sharma, Horrick; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 275, 116598.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2024.116598](https://doi.org/10.1016/j.ejmech.2024.116598)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-40877745
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 24 h, rt
Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway
By: Rastelli, Ettore J.; et al
Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.
10.1016/j.bmcl.2021.128167
```

---

## Reaction 31-614-CAS-40877747

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 24.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `O=C(O)Cc1ccccc1.CCOC(=O)CC(N)c1cccc(Cl)c1`
  - Products: `CCOC(=O)CC(NC(=O)Cc1ccccc1)c1cccc(Cl)c1`

**Reference:**
  - **Title:** Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer
  - **Authors:** Sharma, Horrick; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 275, 116598.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2024.116598](https://doi.org/10.1016/j.ejmech.2024.116598)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-40877747
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 24 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-40881641

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 13.5 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1.C[C@H](N)c1ccc([N+](=O)[O-])cc1.Cl`
  - Products: `C[C@H](NC(=O)c1cn(C2CC2)c2cc(N3CCN(C(=O)OC(C)(C)C)CC3)c(F)cc2c1=O)c1ccc([N+](=O)[O-])cc1`

**Reference:**
  - **Title:** Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug
  - **Authors:** Ross, Catherine L.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 9599-9612.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00724](https://doi.org/10.1021/acs.jmedchem.4c00724)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-40881641
1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 30 min, 25 °C
1.2|12 h, 25 °C
Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity
By: Elsner, Jan; et al
Journal of Medicinal Chemistry (2021), 64(17), 12670-12679.
10.1021/acs.jmedchem.1c00635
```

---

## Reaction 31-614-CAS-40890886

**Type:** Other

**Reagents:**
  - Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (CAS: 128625-52-5) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.333 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `CCCC[C@@H](N)C(=O)OC.Cl.O=C(O)CC(O)/C=C/CCSC(c1ccccc1)(c1ccccc1)c1ccccc1`
  - Products: `CCCC[C@H](NC(=O)CC(O)/C=C/CCSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)OC`

**Reference:**
  - **Title:** Development of a Novel, Small-Molecule Brain-Penetrant Histone Deacetylase Inhibitor That Enhances Spatial Memory Formation in Mice
  - **Authors:** Belayet, Jawad B.; et al
  - **Citation:** Journal of Medicinal Chemistry (2022), 65(4), 3388-3403.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.1c01928](https://doi.org/10.1021/acs.jmedchem.1c01928)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-40890886
1.1|Reagents: PyBOP
Solvents: Dichloromethane; 20 min, 0 °C
1.2|Reagents: Diisopropylethylamine; 12 h, 0 °C → 25 °C
1.3|Reagents: Ammonium chloride
Solvents: Water
Design, synthesis and biological evaluation of 4-aryl-5-aminoalkyl-thiazole-2-amines derivatives as ROCK II inhibitors
By: Ma, Shuchao; et al
Bioorganic & Medicinal Chemistry (2020), 28(19), 115683.
10.1016/j.bmc.2020.115683
```

---

## Reaction 31-614-CAS-40892466

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.5 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `Cc1noc(C)c1COc1ccccc1C(=O)O.NCCc1ccc(S(N)(=O)=O)cc1`
  - Products: `Cc1noc(C)c1COc1ccccc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1`

**Reference:**
  - **Title:** Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance
  - **Authors:** He, Siyu; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(8), 1286-1294.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00175](https://doi.org/10.1021/acsmedchemlett.2c00175)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-40892466
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 30 min, 25 °C
1.2|12 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity
By: Guzelj, Samo; et al
Journal of Medicinal Chemistry (2021), 64(11), 7809-7838.
10.1021/acs.jmedchem.1c00644
```

---

## Reaction 31-614-CAS-40893413

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 20.25 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CCOC(=O)CC[C@@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)OC(C)(C)C)C(=O)OCC.CC(C)(C)OC(=O)NCC(=O)O`
  - Products: `CCOC(=O)CC[C@@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)CNC(=O)OC(C)(C)C)C(=O)OCC`

**Reference:**
  - **Title:** Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency
  - **Authors:** Guzelj, Samo; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00121](https://doi.org/10.1021/acsmedchemlett.2c00121)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-40893413
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 0 °C → rt; 4 h, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole
Catalysts: 4-(Dimethylamino)pyridine; 0 °C → rt; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Stereochemical Effects on the Antimicrobial Properties of Tetrasubstituted 2,5-Diketopiperazines
By: Grant, Thomas M.; et al
ACS Medicinal Chemistry Letters (2022), 13(4), 632-640.
10.1021/acsmedchemlett.1c00683
```

---

## Reaction 31-614-CAS-40893416

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 20.25 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CCOC(=O)CC[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)C12CC3CC(CC(C3)C1)C2)C(=O)OCC.CC(C)(C)OC(=O)NCC(=O)O`
  - Products: `CCOC(=O)CC[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)OC(C)(C)C)C12CC3CC(CC(C3)C1)C2)C(=O)OCC`

**Reference:**
  - **Title:** Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency
  - **Authors:** Guzelj, Samo; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00121](https://doi.org/10.1021/acsmedchemlett.2c00121)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-40893416
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 0 °C → rt; 4 h, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole
Catalysts: 4-(Dimethylamino)pyridine; 0 °C → rt; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-40893417

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC (CAS: 1892-57-5) - Role: UNK (Registry: ACTIVATOR)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 20.25 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `CCOC(=O)CC[C@@H](NC(=O)[C@H](Cc1ccncc1)NC(=O)OC(C)(C)C)C(=O)OCC.CC(C)(C)OC(=O)NCC(=O)O`
  - Products: `CCOC(=O)CC[C@@H](NC(=O)[C@H](Cc1ccncc1)NC(=O)CNC(=O)OC(C)(C)C)C(=O)OCC`

**Reference:**
  - **Title:** Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency
  - **Authors:** Guzelj, Samo; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00121](https://doi.org/10.1021/acsmedchemlett.2c00121)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-40893417
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 0 °C → rt; 4 h, rt
1.2|Reagents: Diisopropylethylamine
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole
Catalysts: 4-(Dimethylamino)pyridine; 0 °C → rt; overnight, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-614-CAS-40893914

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `COC(=O)CCCCCCC(=O)O.COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(N)cc3)CC1)C2`
  - Products: `COC(=O)CCCCCCC(=O)Nc1ccc(CN2CCC(CC3Cc4cc(OC)c(OC)cc4C3=O)CC2)cc1`

**Reference:**
  - **Title:** Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects
  - **Authors:** Nepali, Kunal; et al
  - **Citation:** European Journal of Medicinal Chemistry (2023), 248, 115054.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2022.115054](https://doi.org/10.1016/j.ejmech.2022.115054)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-40893914
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 5 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
[18F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging
By: De Dominicis, Carlo; et al
ACS Medicinal Chemistry Letters (2020), 11(5), 933-939.
10.1021/acsmedchemlett.9b00677
```

---

## Reaction 31-614-CAS-40910307

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 21.0°C
  - Time: 2.0 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `N[C@@H]1CCC[C@@H](O)C1.Cc1ccc(F)c2cc(C(=O)O)[nH]c12`
  - Products: `Cc1ccc(F)c2cc(C(=O)N[C@@H]3CCC[C@@H](O)C3)[nH]c12`

**Reference:**
  - **Title:** Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies
  - **Authors:** Alford, Joshua S.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2022), 13(7), 1137-1143.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00167](https://doi.org/10.1021/acsmedchemlett.2c00167)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-40910307
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 2 h, 21 °C
Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies
By: Lampe, John W.; et al
ACS Medicinal Chemistry Letters (2021), 12(10), 1539-1545.
10.1021/acsmedchemlett.1c00272
```

---

## Reaction 31-614-CAS-40920475

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 20.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `NC12CC3CC(CC(C3)C1)C2.Cc1cc(C)n(C(C(=O)O)n2nc(C)cc2C)n1`
  - Products: `Cc1cc(C)n(C(C(=O)NC23CC4CC(CC(C4)C2)C3)n2nc(C)cc2C)n1`

**Reference:**
  - **Title:** Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma
  - **Authors:** Morelli, Maria Beatrice; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 9662-9685.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00821](https://doi.org/10.1021/acs.jmedchem.4c00821)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-40920475
1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide; rt; 20 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain
By: Hartz, Richard A.; et al
Journal of Medicinal Chemistry (2021), 64(15), 11090-11128.
10.1021/acs.jmedchem.1c00472
```

---

## Reaction 31-614-CAS-40922525

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.5 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `COc1cccc(C(=O)O)c1F.CC(C)(C)OC(=O)N1CC[C@H](n2cc(-c3ccncc3)c(-c3cccc(N)c3)n2)C1`
  - Products: `COc1cccc(C(=O)Nc2cccc(-c3nn([C@H]4CCN(C(=O)OC(C)(C)C)C4)cc3-c3ccncc3)c2)c1F`

**Reference:**
  - **Title:** Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations
  - **Authors:** Thomson, Clare; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8988-9027.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00227](https://doi.org/10.1021/acs.jmedchem.4c00227)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-40922525
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1.5 h, rt
1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
By: Chen, Bei; et al
Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.
10.1021/acs.jmedchem.3c01326
```

---

## Reaction 31-614-CAS-40922535

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `O=C(O)c1cn(C2CC2)cn1.CC(C)(C)OC(=O)N1CC[C@H](n2cc(-c3ccncc3)c(-c3cccc(N)c3)n2)C1`
  - Products: `CC(C)(C)OC(=O)N1CC[C@H](n2cc(-c3ccncc3)c(-c3cccc(NC(=O)c4cn(C5CC5)cn4)c3)n2)C1`

**Reference:**
  - **Title:** Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations
  - **Authors:** Thomson, Clare; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8988-9027.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00227](https://doi.org/10.1021/acs.jmedchem.4c00227)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-40922535
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 16 h, rt
Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents
By: Pal, Kavita; et al
European Journal of Medicinal Chemistry (2023), 248, 115055.
10.1016/j.ejmech.2022.115055
```

---

## Reaction 31-614-CAS-40947705

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.083 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)O.CCCCCCCCN`
  - Products: `CCCCCCCCNC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways
  - **Authors:** Ma, Xiaoyu; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8791-8816.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00131](https://doi.org/10.1021/acs.jmedchem.4c00131)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-40947705
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 5 min, 0 °C
1.2|2 h, rt
Double bond geometry shown
Double bond geometry shown
Synthesis and bioactivity evaluation of a myelin-specific contrast agent for magnetic resonance imaging of myelination in central nervous system
By: Wei, Bin; et al
Bioorganic & Medicinal Chemistry (2023), 84, 117257.
10.1016/j.bmc.2023.117257
```

---

## Reaction 31-614-CAS-41010411

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 18.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N(Cc1ccc(C(=O)O)cc1)C[C@H](O[Si](C)(C)C(C)(C)C)c1ccc(O)c2[nH]c(=O)ccc12.CN1CCC[C@@H](OC(=O)[C@](O)(c2ccccc2)c2cccc(OCCCN)c2)C1.Cl`
  - Products: `CN1CCC[C@@H](OC(=O)[C@](O)(c2ccccc2)c2cccc(OCCCNC(=O)c3ccc(CN(C[C@H](O[Si](C)(C)C(C)(C)C)c4ccc(O)c5[nH]c(=O)ccc45)C(=O)OC(C)(C)C)cc3)c2)C1`

**Reference:**
  - **Title:** Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases
  - **Authors:** Carzaniga, Laura; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(12), 9816-9841.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00298](https://doi.org/10.1021/acs.jmedchem.4c00298)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-41010411
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dimethylformamide; 18 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer
By: Tang, Baolan; et al
European Journal of Medicinal Chemistry (2020), 193, 112204.
10.1016/j.ejmech.2020.112204
```

---

## Reaction 31-614-CAS-41033862

**Type:** Other

**Reagents:**
  - 2,4,6-Trimethylpyridine (CAS: 108-75-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.167 hours
  - Yield: 96%

**SMILES:**
  - Reactants: `O=C(O)C1CCOCC1.COC(=O)[C@@H](N)CC1CCCCC1.Cl`
  - Products: `COC(=O)[C@H](CC1CCCCC1)NC(=O)C1CCOCC1`

**Reference:**
  - **Title:** Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability
  - **Authors:** Meta, Mergim; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.4c00050](https://doi.org/10.1021/acsmedchemlett.4c00050)

**Original Text:**
```
Steps: 1, Yield: 96%
CAS Reaction Number: 31-614-CAS-41033862
1.1|Reagents: 2,4,6-Trimethylpyridine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide, Dichloromethane; 0 °C; 10 min, 0 °C
1.2|Solvents: Dichloromethane; 0 °C; 0 °C → rt; overnight, rt
1.3|Solvents: Water; rt
Double bond geometry shown
Double bond geometry shown
Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment
By: Li, Di; et al
Journal of Medicinal Chemistry (2022), 65(7), 5334-5354.
10.1021/acs.jmedchem.1c00710
```

---

## Reaction 31-614-CAS-41033865

**Type:** Other

**Reagents:**
  - 2,4,6-Trimethylpyridine (CAS: 108-75-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.167 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `O=C(O)c1ccncc1.COC(=O)[C@@H](N)CC1CCCCC1.Cl`
  - Products: `COC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccncc1`

**Reference:**
  - **Title:** Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability
  - **Authors:** Meta, Mergim; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.4c00050](https://doi.org/10.1021/acsmedchemlett.4c00050)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-41033865
1.1|Reagents: 2,4,6-Trimethylpyridine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide, Dichloromethane; 0 °C; 10 min, 0 °C
1.2|Solvents: Dichloromethane; 0 °C; 0 °C → rt; overnight, rt
1.3|Solvents: Water; rt
Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis
By: Betzemeier, Bodo; et al
European Journal of Medicinal Chemistry (2024), 265, 116038.
10.1016/j.ejmech.2023.116038
```

---

## Reaction 31-614-CAS-41033879

**Type:** Other

**Reagents:**
  - 2,4,6-Trimethylpyridine (CAS: 108-75-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.167 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CS(=O)(=O)C[C@H](N[C@@H](c1ccc([N+](=O)[O-])cc1)C(F)(F)F)C(=O)O.N#C[C@@H](N)COCc1ccccc1`
  - Products: `CS(=O)(=O)C[C@H](N[C@@H](c1ccc([N+](=O)[O-])cc1)C(F)(F)F)C(=O)N[C@H](C#N)COCc1ccccc1`

**Reference:**
  - **Title:** Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability
  - **Authors:** Meta, Mergim; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.4c00050](https://doi.org/10.1021/acsmedchemlett.4c00050)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-41033879
1.1|Reagents: 2,4,6-Trimethylpyridine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide, Dichloromethane; 0 °C; 10 min, 0 °C
1.2|Solvents: Dichloromethane; 0 °C; 0 °C → rt; overnight, rt
1.3|Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-614-CAS-41034407

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `COC(=O)c1ccc(C(=O)O)nc1.Cc1c(N)cccc1-c1cccc(NC(=O)OC(C)(C)C)c1C`
  - Products: `COC(=O)c1ccc(C(=O)Nc2cccc(-c3cccc(NC(=O)OC(C)(C)C)c3C)c2C)nc1`

**Reference:**
  - **Title:** Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction
  - **Authors:** Hec-Galazka, Aleksandra; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(6), 828-836.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.4c00042](https://doi.org/10.1021/acsmedchemlett.4c00042)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-41034407
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 0 °C; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Pillar[5]arene-Based Polycationic Glyco[2]rotaxanes Designed as Pseudomonas aeruginosa Antibiofilm Agents
By: Mohy El Dine, Tharwat; et al
Journal of Medicinal Chemistry (2021), 64(19), 14728-14744.
10.1021/acs.jmedchem.1c01241
```

---

## Reaction 31-614-CAS-41034446

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `COC(=O)c1ccc(C(=O)O)nc1.Cc1c(N)cccc1-c1cccc(NC(=O)c2ccc(CN3CCC(O[Si](C)(C)C(C)(C)C)CC3)cn2)c1C`
  - Products: `COC(=O)c1ccc(C(=O)Nc2cccc(-c3cccc(NC(=O)c4ccc(CN5CCC(O[Si](C)(C)C(C)(C)C)CC5)cn4)c3C)c2C)nc1`

**Reference:**
  - **Title:** Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction
  - **Authors:** Hec-Galazka, Aleksandra; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(6), 828-836.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.4c00042](https://doi.org/10.1021/acsmedchemlett.4c00042)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-41034446
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 0 °C; overnight, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Discovery of the potent covalent inhibitor with an acrylate warhead for SARS-CoV-2 3CL protease
By: Shen, Wen; et al
Bioorganic & Medicinal Chemistry Letters (2024), 112, 129942.
10.1016/j.bmcl.2024.129942
```

---

## Reaction 31-614-CAS-41034619

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.333 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)[C@H](CN)NC(=O)OCc1ccccc1.O=C(O)Cn1c(=O)[nH]c2ncccc21`
  - Products: `CC(C)(C)OC(=O)[C@H](CNC(=O)Cn1c(=O)[nH]c2ncccc21)NC(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1
  - **Authors:** Sabat, Mark; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(12), 10306-10320.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00743](https://doi.org/10.1021/acs.jmedchem.4c00743)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-41034619
1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride
Solvents: Dimethylformamide, Water; 20 min, < 10 °C; 3 h, 10 °C → 25 °C
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-41035940

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 13.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `COC(=O)[C@@H](N)CC(C)C.Cl.CC(C)(C)OC(=O)N[C@@H](Cc1cccc(Cl)c1)C(=O)O`
  - Products: `COC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cccc(Cl)c1)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Identification of highly potent and selective HTRA1 inhibitors
  - **Authors:** Dennis, David G.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2024), 109, 129814.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2024.129814](https://doi.org/10.1016/j.bmcl.2024.129814)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-41035940
1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dichloromethane; 12 h, 0 °C → rt
Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21
By: Goericke, Fabian; et al
Journal of Medicinal Chemistry (2023), 66(5), 3431-3447.
10.1021/acs.jmedchem.2c01933
```

---

## Reaction 31-614-CAS-41060792

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - 7647-14-5 (CAS: 7647-14-5) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - Sodium chloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.5 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCc1ccc(C(=O)O)cc1.COc1ccccc1CN`
  - Products: `COc1ccccc1CNC(=O)c1ccc(CNC(=O)OC(C)(C)C)cc1`

**Reference:**
  - **Title:** Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis
  - **Authors:** Zimmermann, Thomas; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(13), 10710-10742.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00230](https://doi.org/10.1021/acs.jmedchem.4c00230)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-41060792
1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dichloromethane; 30 min, 0 °C
1.2|0 °C; overnight, rt
1.3|Reagents: Sodium chloride
Solvents: Water; rt
Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27
By: Pillaiyar, Thanigaimalai; et al
European Journal of Medicinal Chemistry (2021), 225, 113777.
10.1016/j.ejmech.2021.113777
```

---

## Reaction 31-614-CAS-41060811

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - 7647-14-5 (CAS: 7647-14-5) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - Sodium chloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.5 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCc1ccc(C(=O)O)cc1.CCOc1ccccc1CN`
  - Products: `CCOc1ccccc1CNC(=O)c1ccc(CNC(=O)OC(C)(C)C)cc1`

**Reference:**
  - **Title:** Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis
  - **Authors:** Zimmermann, Thomas; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(13), 10710-10742.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00230](https://doi.org/10.1021/acs.jmedchem.4c00230)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-41060811
1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dichloromethane; 30 min, 0 °C
1.2|overnight, rt
1.3|Reagents: Sodium chloride
Solvents: Water; rt
Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme
By: Hamilton, Matthew M.; et al
Journal of Medicinal Chemistry (2021), 64(15), 11302-11329.
10.1021/acs.jmedchem.1c00679
```

---

## Reaction 31-614-CAS-41063829

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `C[C@H](NC(=O)OC(C)(C)C)C(=O)O.COC(=O)[C@@H](N)Cc1ccc(OC)cc1`
  - Products: `COC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)[C@H](C)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities
  - **Authors:** Wang, Juan; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 215, 113267.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113267](https://doi.org/10.1016/j.ejmech.2021.113267)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-41063829
1.1|Reagents: 1-Hydroxybenzotriazole, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Tetrahydrofuran; rt → 0 °C
1.2|Reagents: Diisopropylethylamine; 1 h, 0 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2
By: Chhabra, Mohit; et al
Journal of Medicinal Chemistry (2024), 67(14), 11885-11916.
10.1021/acs.jmedchem.4c00487
```

---

## Reaction 31-614-CAS-41063830

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - Sodium chloride (CAS: 7647-14-5) - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)O.COC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.Cl`
  - Products: `COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1`

**Reference:**
  - **Title:** A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities
  - **Authors:** Wang, Juan; et al
  - **Citation:** European Journal of Medicinal Chemistry (2021), 215, 113267.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2021.113267](https://doi.org/10.1016/j.ejmech.2021.113267)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-41063830
1.1|Reagents: 1-Hydroxybenzotriazole, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; rt → 0 °C
1.2|Reagents: Diisopropylethylamine; 0 °C → rt; 1 h, rt
1.3|Reagents: Sodium chloride
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease
By: Liu, Longbin; et al
Journal of Medicinal Chemistry (2023), 66(18), 13205-13246.
10.1021/acs.jmedchem.3c01173
```

---

## Reaction 31-614-CAS-41112180

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.5 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `C=CCOC(=O)Nc1ccc(C[C@@H](CO)NC(=O)OC(C)(C)C)cc1.CCOP(=O)(CC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)O)OCC`
  - Products: `C=CCOC(=O)Nc1ccc(C[C@@H](CO)NC(=O)[C@H](CCCCNC(=O)CP(=O)(OCC)OCC)NC(=O)OC(C)(C)C)cc1`

**Reference:**
  - **Title:** Development of small molecule-drug conjugates based on derivatives of natural proteasome inhibitors that exhibit selectivity for PSMA-expressing cancer cells
  - **Authors:** Obara, Takahiro; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2024), 108, 117773.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2024.117773](https://doi.org/10.1016/j.bmc.2024.117773)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-41112180
1.1|Reagents: Hydrochloric acid
Solvents: 1,4-Dioxane; 30 min, rt
1.2|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 2 h, rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-41293635

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCC[C@H](N)C1.Cc1ccc([C@@H](Oc2ccc(C(=O)O)nc2)[C@H](C)NC(=O)C(F)(F)F)cc1`
  - Products: `Cc1ccc([C@@H](Oc2ccc(C(=O)N[C@H]3CCCN(C(=O)OC(C)(C)C)C3)nc2)[C@H](C)NC(=O)C(F)(F)F)cc1`

**Reference:**
  - **Title:** Topical ‘dual-soft’ glucocorticoid receptor agonist for dermatology
  - **Authors:** Dack, Kevin N.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(17), 127402.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127402](https://doi.org/10.1016/j.bmcl.2020.127402)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-41293635
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
By: Granberg, Kenneth L.; et al
Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.
10.1021/acs.jmedchem.3c02184
```

---

## Reaction 31-614-CAS-41302566

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.167 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.COc1cc(/C=C/c2ccc(N)cc2)cc(OC)c1`
  - Products: `COc1cc(/C=C/c2ccc(NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)OC(C)(C)C)cc2)cc(OC)c1`

**Reference:**
  - **Title:** A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer
  - **Authors:** Cordella, Fabiana; et al
  - **Citation:** ChemMedChem (2024), 19(14), e202300727.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300727](https://doi.org/10.1002/cmdc.202300727)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-41302566
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 10 min, rt
1.2|Reagents: Triethylamine; rt; 2 h, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors
By: Martinez-Gualda, Belen; et al
Journal of Medicinal Chemistry (2020), 63(1), 349-368.
10.1021/acs.jmedchem.9b01737
```

---

## Reaction 31-614-CAS-41302576

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.167 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@@H](Cc1cncn1C(=O)OC(C)(C)C)C(=O)O.COc1cc(/C=C/c2ccc(N)cc2)cc(OC)c1`
  - Products: `COc1cc(/C=C/c2ccc(NC(=O)[C@H](Cc3cncn3C(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)cc2)cc(OC)c1`

**Reference:**
  - **Title:** A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer
  - **Authors:** Cordella, Fabiana; et al
  - **Citation:** ChemMedChem (2024), 19(14), e202300727.
  - **DOI:** [https://doi.org/10.1002/cmdc.202300727](https://doi.org/10.1002/cmdc.202300727)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-41302576
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 10 min, rt
1.2|Reagents: Triethylamine; rt; 4 h, rt
Discovery of selective platelet-derived growth factor receptor-beta (PDGFR-β) bifunctional small-molecule degraders
By: Si, Ru; et al
Bioorganic & Medicinal Chemistry (2023), 77, 117115.
10.1016/j.bmc.2022.117115
```

---

## Reaction 31-614-CAS-41322613

**Type:** Other

**Reagents:**
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT
  - MeOH (CAS: 67-56-1) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 20.167 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `Nc1ccccc1.O=C(O)C#Cc1ccccc1`
  - Products: `O=C(C#Cc1ccccc1)Nc1ccccc1`

**Reference:**
  - **Title:** Optimization and Development of a Scalable Palladium-Catalyzed C-H Activation Process for the Geometry-Selective Preparation of Kilograms of YLF466D, a Potent AMP-Activated Protein Kinase Activator
  - **Authors:** Yin, Jianpeng; et al
  - **Citation:** Organic Process Research & Development (2021), 25(10), 2260-2269.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.1c00150](https://doi.org/10.1021/acs.oprd.1c00150)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-41322613
1.1|Solvents: Dichloromethane; 30 min, rt
1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 30 min, 10 - 20 °C; 16 h, 25 °C
1.3|Reagents: Hydrochloric acid
Solvents: Water; 10 min
1.4|Solvents: Methanol, Water; 1 h, 15 - 20 °C; 2 h, 15 °C
Synthesis and evaluation of sulfonamide derivatives targeting EGFR790M/L858R mutations and ALK rearrangement as anticancer agents
By: Cao, Longcai; et al
Bioorganic & Medicinal Chemistry (2023), 85, 117241.
10.1016/j.bmc.2023.117241
```

---

## Reaction 31-614-CAS-41431404

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 5.167 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `Cn1nc(C(=O)O)c2cc([N+](=O)[O-])ccc21.CN`
  - Products: `CNC(=O)c1nn(C)c2ccc([N+](=O)[O-])cc12`

**Reference:**
  - **Title:** Optimization of a series of potent, selective and orally bioavailable SYK inhibitors
  - **Authors:** Grimster, Neil P.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127433.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127433](https://doi.org/10.1016/j.bmcl.2020.127433)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-41431404
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 10 min, rt
1.2|Reagents: Hydrochloric acid
Solvents: Water; 5 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
By: Behring, Lydia; et al
Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
10.1021/acs.jmedchem.2c01360
```

---

## Reaction 31-614-CAS-41433749

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - MeCN (CAS: 75-05-8) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 35.0°C
  - Time: 3.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `O=C(O)Cn1nc(C(F)(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.CC(C)(C#Cc1ccc(Br)c([C@@H](N)Cc2cc(F)cc(F)c2)n1)S(C)(=O)=O`
  - Products: `CC(C)(C#Cc1ccc(Br)c([C@H](Cc2cc(F)cc(F)c2)NC(=O)Cn2nc(C(F)(F)F)c3c2C(F)(F)[C@@H]2C[C@H]32)n1)S(C)(=O)=O`

**Reference:**
  - **Title:** Synthesis of Lenacapavir Sodium: Active Pharmaceutical Ingredient Process Development and Scale-up
  - **Authors:** Wagner, Anna M.; et al
  - **Citation:** Organic Process Research & Development (2024), 28(8), 3382-3395.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.4c00242](https://doi.org/10.1021/acs.oprd.4c00242)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-41433749
1.1|Reagents: Triethylamine, Propylphosphonic anhydride
Solvents: Dimethylformamide, Acetonitrile; < 35 °C; 3 h, 20 °C
Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
By: Tang, Sheng; et al
European Journal of Medicinal Chemistry (2024), 263, 115939.
10.1016/j.ejmech.2023.115939
```

---

## Reaction 31-614-CAS-41446153

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1C[C@@H](O)C[C@H]1C(=O)O.Cc1ncsc1-c1ccc(CN)cc1`
  - Products: `Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)OC(C)(C)C)cc1`

**Reference:**
  - **Title:** Structure-guided design and optimization of covalent VHL-targeted sulfonyl fluoride PROTACs
  - **Authors:** Shah, Rishi R.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(6), 4641-4654.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02123](https://doi.org/10.1021/acs.jmedchem.3c02123)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-41446153
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants
By: Hu, Shangjiu; et al
Bioorganic & Medicinal Chemistry (2022), 64, 116760.
10.1016/j.bmc.2022.116760
```

---

## Reaction 31-614-CAS-41746955

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - Dioxane (CAS: 123-91-1) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 11.5 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `CC(=O)/C(C)=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)C(F)(F)F)C(C)(C)C)C2(C)C.CC(C)(C)OC(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)O)C2(C)C`
  - Products: `CC(C)(C)OC(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(N)=O)C2(C)C`

**Reference:**
  - **Title:** Discovery of the potent covalent inhibitor with an acrylate warhead for SARS-CoV-2 3CL protease
  - **Authors:** Shen, Wen; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2024), 112, 129942.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2024.129942](https://doi.org/10.1016/j.bmcl.2024.129942)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-41746955
1.1|Reagents: Hydrochloric acid
Solvents: 1,4-Dioxane; rt → 40 °C; 1 h, 40 °C
1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 30 min, 25 °C
1.3|Reagents: Diisopropylethylamine; 10 h, 25 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists
By: Cooper, Martin; et al
Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.
10.1021/acs.jmedchem.0c00828
```

---

## Reaction 31-614-CAS-41763296

**Type:** Other

**Reaction Conditions:**
  - Temperature: 162.0°C
  - Time: 40.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `CC(O)CN.O=C(O)CCCS(=O)(=O)c1ccccc1`
  - Products: `CC(O)CNC(=O)CCCS(=O)(=O)c1ccccc1`

**Reference:**
  - **Title:** Efficient Total Synthesis of Bilirubin IXα from Butyrolactone
  - **Authors:** Chen, Fapu; et al
  - **Citation:** Organic Process Research & Development (2024), 28(7), 2777-2788.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.4c00122](https://doi.org/10.1021/acs.oprd.4c00122)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-41763296
1.1|40 h, 155 - 162 °C
Novel TYK2 Inhibitors with an N-(Methyl-d3)pyridazine-3-carboxamide Skeleton for the Treatment of Autoimmune Diseases
By: Liu, Fei; et al
ACS Medicinal Chemistry Letters (2022), 13(11), 1730-1738.
10.1021/acsmedchemlett.2c00334
```

---

## Reaction 31-614-CAS-41860736

**Type:** Other

**Full Catalytic System:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Catalyst Core:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - Et3N (CAS: 121-44-8) - Role: UNK (Registry: BASE)

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 5.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `O=C(O)c1cc(-c2ccccc2)no1.CC(C)(C)OC(=O)N1CC2(CC(N)C2)C1`
  - Products: `CC(C)(C)OC(=O)N1CC2(CC(NC(=O)c3cc(-c4ccccc4)no3)C2)C1`

**Reference:**
  - **Title:** Design, synthesis, and optimization of a series of 2-azaspiro[3.3]heptane derivatives as orally bioavailable fetal hemoglobin inducers
  - **Authors:** Katayama, Katsushi; et al
  - **Citation:** Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127425.
  - **DOI:** [https://doi.org/10.1016/j.bmcl.2020.127425](https://doi.org/10.1016/j.bmcl.2020.127425)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-41860736
1.1|Reagents: Thionyl chloride
Catalysts: Dimethylformamide
Solvents: Dichloromethane; rt; 4 h, 50 °C
1.2|Reagents: Triethylamine
Solvents: Dichloromethane; 0 °C; 1 h, rt
Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers
By: Vaidya, Sandeep; et al
ChemMedChem (2023), 18(16), e202300097.
10.1002/cmdc.202300097
```

---

## Reaction 31-614-CAS-41901045

**Type:** Other

**Reagents:**
  - Py (CAS: 110-86-1) - Role: BASE
  - Propylphosphonic anhydride (CAS: 68957-94-8) - Role: UNK (Registry: ACTIVATOR)

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 40.0°C
  - Time: 18.167 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `Cn1ccc([C@H]2C[C@H](N(c3cc(F)c(N)cc3F)c3nccn4nccc34)C2)n1.O=C(O)c1ccnn(-c2ccc(F)cn2)c1=O`
  - Products: `Cn1ccc([C@H]2C[C@H](N(c3cc(F)c(NC(=O)c4ccnn(-c5ccc(F)cn5)c4=O)cc3F)c3nccn4nccc34)C2)n1`

**Reference:**
  - **Title:** Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy
  - **Authors:** Bumpers, Quinn A.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(16), 14466-14477.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c01232](https://doi.org/10.1021/acs.jmedchem.4c01232)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-41901045
1.1|Reagents: Pyridine, Propylphosphonic anhydride
Solvents: Ethyl acetate; 0 °C; 10 min, rt; 18 h, 40 °C
Relative stereochemistry shown
Relative stereochemistry shown
Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360
By: Rueeger, Heinrich; et al
Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.
10.1021/acs.jmedchem.0c02143
```

---

## Reaction 31-614-CAS-42074935

**Type:** Other

**Reagents:**
  - 1,1′-carbonylbis- (CAS: 37868-93-2) - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 50.0°C
  - Time: 30.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(=O)O.Nc1ccccc1`
  - Products: `CC(C)(C)OC(=O)NCC(=O)Nc1ccccc1`

**Reference:**
  - **Title:** Discovery of aromatic 2-(3-(methylcarbamoyl) guanidino)-N-aylacetamides as highly potent chitinase inhibitors
  - **Authors:** Zhao, Zhixiang; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 80, 117172.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117172](https://doi.org/10.1016/j.bmc.2023.117172)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-42074935
1.1|Reagents: 1H-Pyrazole, 1,1′-carbonylbis-
Solvents: Tetrahydrofuran; 5 h, rt
1.2|rt → 50 °C; 24 h, 50 °C
Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties
By: Morozova, Alisa; et al
European Journal of Medicinal Chemistry (2024), 266, 116101.
10.1016/j.ejmech.2023.116101
```

---

## Reaction 31-614-CAS-42085179

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - 4-Methylmorpholine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CN.Cl.C[C@@H](c1ccccc1)N(Cc1ccccc1)[C@@H](CCC(C)(F)F)[C@H](O)C(=O)O`
  - Products: `CNC(=O)[C@@H](O)[C@H](CCC(C)(F)F)N(Cc1ccccc1)[C@@H](C)c1ccccc1`

**Reference:**
  - **Title:** Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic
  - **Authors:** Shurtleff, Valerie W.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(5), 3935-3958.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02248](https://doi.org/10.1021/acs.jmedchem.3c02248)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-42085179
1.1|Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer
By: Fuchs, Natalie; et al
ChemMedChem (2023), 18(15), e202300160.
10.1002/cmdc.202300160
```

---

## Reaction 31-614-CAS-42085218

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - 156311-85-2 (CAS: 156311-85-2) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - Phosphorus(1+) - Role: UNK
  - [3-(hydroxy-κO)-1,2,3-triazolo[4,5-b]pyridinato]tris(N-methylmethanaminato)- - Role: UNK
  - (T-4)- - Role: UNK
  - hexafluorophosphate(1-) (1:1) - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.167 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `COC(OC)[C@@H](N)CCC(C)(F)F.O=C(O)[C@@H]1CC2(CCCCC2)CN1C(=O)OCc1ccccc1`
  - Products: `COC(OC)[C@H](CCC(C)(F)F)NC(=O)[C@@H]1CC2(CCCCC2)CN1C(=O)OCc1ccccc1`

**Reference:**
  - **Title:** Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic
  - **Authors:** Shurtleff, Valerie W.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(5), 3935-3958.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02248](https://doi.org/10.1021/acs.jmedchem.3c02248)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-42085218
1.1|Reagents: Diisopropylethylamine, Phosphorus(1+), [3-(hydroxy-κO)-1,2,3-triazolo[4,5-b]pyridinato]tris(N-methylmethanaminato)-, (T-4)-, hexafluorophosphate(1-) (1:1)
Solvents: Dimethylformamide; 10 min, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-42203010

**Type:** Other

**Solvents:**
  - EtOH (CAS: 64-17-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 50.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `Nc1cccc(Cl)c1C(=O)O.CC(=O)O.N=CN`
  - Products: `O=c1nc[nH]c2cccc(Cl)c12`

**Reference:**
  - **Title:** Discovery of Novel 5,6-Dihydro-4H-pyrido[2,3,4-de]quinazoline Irreversible Inhibitors Targeting Both Wild-Type and A775_G776insYVMA Mutated HER2 Kinases
  - **Authors:** Yang, Leifu; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(7), 5662-5682.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02302](https://doi.org/10.1021/acs.jmedchem.3c02302)

**Original Text:**
```
Steps: 1, Yield: 85-89%
CAS Reaction Number: 31-614-CAS-42203010
1.1|Solvents: Ethanol; 48 h, 80 °C
Design, synthesis and biological evaluation of novel 3,4-dihydro-2H-[1,4]oxazino[2,3-f]quinazoline derivatives as EGFR-TKIs
By: Qin, Xuemei; et al
Bioorganic & Medicinal Chemistry Letters (2023), 80, 129104.
10.1016/j.bmcl.2022.129104
```

---

## Reaction 31-614-CAS-42356617

**Type:** Other

**Reagents:**
  - DBU (CAS: 6674-22-2) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - 1,8-Diazabicyclo[5.4.0]undec-7-ene - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.333 hours
  - Yield: 81%

**SMILES:**
  - Reactants: `C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O.CC(=O)N[C@H]1[C@H](OCCN=[N+]=[N-])O[C@@H]2COC(c3ccccc3)O[C@H]2[C@@H]1O[C@H](C)C(=O)O`
  - Products: `CC(=O)N[C@H]1[C@H](OCCN=[N+]=[N-])O[C@@H]2COC(c3ccccc3)O[C@H]2[C@@H]1O[C@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O`

**Reference:**
  - **Title:** Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists
  - **Authors:** Ding, Dong; et al
  - **Citation:** European Journal of Medicinal Chemistry (2024), 278, 116792.
  - **DOI:** [https://doi.org/10.1016/j.ejmech.2024.116792](https://doi.org/10.1016/j.ejmech.2024.116792)

**Original Text:**
```
Steps: 1, Yield: 81%
CAS Reaction Number: 31-614-CAS-42356617
1.1|Reagents: 1,8-Diazabicyclo[5.4.0]undec-7-ene
Solvents: Dimethylformamide; 20 min, rt
1.2|Reagents: 1-Hydroxybenzotriazole
1.3|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 12 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases
By: Carzaniga, Laura; et al
Journal of Medicinal Chemistry (2024), 67(12), 9816-9841.
10.1021/acs.jmedchem.4c00298
```

---

## Reaction 31-614-CAS-42622979

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `Cc1ccc(N)cc1Cl.Cc1nnsc1C(=O)O`
  - Products: `Cc1ccc(NC(=O)c2snnc2C)cc1Cl`

**Reference:**
  - **Title:** On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System
  - **Authors:** Fang, Zhengqi; et al
  - **Citation:** Organic Process Research & Development (2024), 28(8), 3143-3151.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.4c00043](https://doi.org/10.1021/acs.oprd.4c00043)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-42622979
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 min, rt
1.2|Reagents: Hydrochloric acid
Solvents: Water
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
By: Hiesinger, Kerstin; et al
Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.
10.1021/acs.jmedchem.0c00561
```

---

## Reaction 31-614-CAS-42622982

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - HCl (CAS: 7647-01-0) - Role: UNK (Registry: ACID)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 0.25 hours
  - Yield: 88%

**SMILES:**
  - Reactants: `Cc1cnc(N)s1.Cc1nnsc1C(=O)O`
  - Products: `Cc1cnc(NC(=O)c2snnc2C)s1`

**Reference:**
  - **Title:** On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System
  - **Authors:** Fang, Zhengqi; et al
  - **Citation:** Organic Process Research & Development (2024), 28(8), 3143-3151.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.4c00043](https://doi.org/10.1021/acs.oprd.4c00043)

**Original Text:**
```
Steps: 1, Yield: 88%
CAS Reaction Number: 31-614-CAS-42622982
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dimethylformamide; 15 min, rt
1.2|Reagents: Hydrochloric acid
Solvents: Water
Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors
By: Wang, Xinyu; et al
Bioorganic & Medicinal Chemistry (2022), 72, 116995.
10.1016/j.bmc.2022.116995
```

---

## Reaction 31-614-CAS-42806224

**Type:** Other

**Reagents:**
  - N-Methylmorpholine (CAS: 109-02-4) - Role: NUC (Registry: AMIDE_BASE)
  - HBTU (CAS: 94790-37-1) - Role: UNK (Registry: ACTIVATOR)
  - 4-Methylmorpholine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.5 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCCC(=O)O.Nc1ccc(Cl)c(Cl)c1`
  - Products: `CC(C)(C)OC(=O)NCCC(=O)Nc1ccc(Cl)c(Cl)c1`

**Reference:**
  - **Title:** Structure-Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT
  - **Authors:** Wannowius, Marie; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(21), 19342-19364.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c01743](https://doi.org/10.1021/acs.jmedchem.4c01743)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-42806224
1.1|Reagents: 4-Methylmorpholine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dimethylformamide; 0.5 h, rt
1.2|16 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis
By: Koralewski, Robert; et al
Journal of Medicinal Chemistry (2020), 63(24), 15527-15540.
10.1021/acs.jmedchem.0c01179
```

---

## Reaction 31-614-CAS-42806422

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 4.5 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `COc1cc(OCc2ccccc2)c(C)cc1-n1nnc(C(=O)O)c1C.CCCCOc1ccc(C(C)(C)C)cc1N`
  - Products: `CCCCOc1ccc(C(C)(C)C)cc1NC(=O)c1nnn(-c2cc(C)c(OCc3ccccc3)cc2OC)c1C`

**Reference:**
  - **Title:** First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy
  - **Authors:** Huber, Andrew D.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(20), 18549-18575.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c01926](https://doi.org/10.1021/acs.jmedchem.4c01926)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-42806422
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 30 min, 20 °C
1.2|4 h, 25 °C
1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
By: Chen, Bei; et al
Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.
10.1021/acs.jmedchem.3c01326
```

---

## Reaction 31-614-CAS-42895413

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (CAS: 125700-67-6) - Role: UNK
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `CN.Cl.CC(C)(C)OC(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)O`
  - Products: `CNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
  - **Authors:** Wang, Xu; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c02009](https://doi.org/10.1021/acs.jmedchem.4c02009)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-42895413
1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
Solvents: Dimethylformamide; 2 h, 0 °C
1.2|Reagents: Water
Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni
By: Kanyanta, Masebe; et al
Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164.
10.1016/j.bmcl.2023.129164
```

---

## Reaction 31-614-CAS-42895443

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 3.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `C=CCCCCCCOC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N1CCC[C@@H]1CC(=O)O`
  - Products: `C=CCCCCCCOC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C[C@H]1CCCN1C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
  - **Authors:** Wang, Xu; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c02009](https://doi.org/10.1021/acs.jmedchem.4c02009)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-42895443
1.1|Reagents: Hydrochloric acid
Solvents: Ethyl acetate; 1 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 0 °C; 2 h, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold
By: Huang, Danling; et al
Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.
10.1016/j.bmcl.2021.128006
```

---

## Reaction 31-614-CAS-42895446

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 3.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `C=CCCCCCOC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N1CCC[C@@H]1CC(=O)O`
  - Products: `C=CCCCCCOC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C[C@H]1CCCN1C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
  - **Authors:** Wang, Xu; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c02009](https://doi.org/10.1021/acs.jmedchem.4c02009)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-42895446
1.1|Reagents: Hydrochloric acid
Solvents: Ethyl acetate; 1 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 0 °C; 2 h, rt
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity
By: Yang, Zhikun; et al
Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.
10.1021/acs.jmedchem.2c01999
```

---

## Reaction 31-614-CAS-42895448

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 3.0 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `C=CCCCCOC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N1CCC[C@@H]1CC(=O)O`
  - Products: `C=CCCCCOC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C[C@H]1CCCN1C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
  - **Authors:** Wang, Xu; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c02009](https://doi.org/10.1021/acs.jmedchem.4c02009)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-42895448
1.1|Reagents: Hydrochloric acid
Solvents: Ethyl acetate; 1 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 2 h, rt
Absolute stereochemistry shown,
Rotation (-)
Double bond geometry shown
Absolute stereochemistry shown
Double bond geometry shown
A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer
By: Cordella, Fabiana; et al
ChemMedChem (2024), 19(14), e202300727.
10.1002/cmdc.202300727
```

---

## Reaction 31-614-CAS-42895457

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 12.5 hours
  - Yield: 86%

**SMILES:**
  - Reactants: `C=CCCCCCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N1CCC[C@@H]1CC(=O)O`
  - Products: `C=CCCCCCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C[C@H]1CCCN1C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
  - **Authors:** Wang, Xu; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c02009](https://doi.org/10.1021/acs.jmedchem.4c02009)

**Original Text:**
```
Steps: 1, Yield: 86%
CAS Reaction Number: 31-614-CAS-42895457
1.1|Reagents: Hydrochloric acid
Solvents: Ethyl acetate; 30 min, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 12 h, rt
1.3|Reagents: Water; rt
Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents
By: Amblard, Franck; et al
Bioorganic & Medicinal Chemistry (2021), 31, 115952.
10.1016/j.bmc.2020.115952
```

---

## Reaction 31-614-CAS-42895499

**Type:** Other

**Reagents:**
  - HCl (CAS: 7647-01-0) - Role: BASE (Registry: ACID)
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 2.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `C=CCCCCCNC(=O)[C@@H](Cc1ccc(Cl)cc1Cl)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N1CC2(CC2)C[C@@H]1CC(=O)O`
  - Products: `C=CCCCCCNC(=O)[C@@H](Cc1ccc(Cl)cc1Cl)NC(=O)C[C@H]1CC2(CC2)CN1C(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
  - **Authors:** Wang, Xu; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c02009](https://doi.org/10.1021/acs.jmedchem.4c02009)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-42895499
1.1|Reagents: Hydrochloric acid
Solvents: Ethyl acetate; 1 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 1 h, rt
1.3|Reagents: Water; rt
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
By: Yang, Zhikun; et al
European Journal of Medicinal Chemistry (2023), 248, 115092.
10.1016/j.ejmech.2023.115092
```

---

## Reaction 31-614-CAS-43022053

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 30.0°C
  - Time: 5.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N1CCc2c(cc(Cl)c(C(=O)O)c2Cl)C1.CS(=O)(=O)c1cccc(C[C@H](N)C(=O)OCc2ccccc2)c1.Cl`
  - Products: `CC(C)(C)OC(=O)N1CCc2c(cc(Cl)c(C(=O)N[C@@H](Cc3cccc(S(C)(=O)=O)c3)C(=O)OCc3ccccc3)c2Cl)C1`

**Reference:**
  - **Title:** An improved commercial process for the preparation of Lifitegrast
  - **Authors:** Girkar, Arvind; et al
  - **Citation:** Organic Process Research & Development (2024), 28(12), 4374-4379.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.4c00356](https://doi.org/10.1021/acs.oprd.4c00356)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-43022053
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 4 - 5 h, 25 - 30 °C
1.2|Solvents: Water; 20 - 25 °C
Relative stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
By: Granberg, Kenneth L.; et al
Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.
10.1021/acs.jmedchem.3c02184
```

---

## Reaction 31-614-CAS-43597120

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.0 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCCCC(=O)O.Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O`
  - Products: `CC(C)(C)OC(=O)NCCCC(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O`

**Reference:**
  - **Title:** Discovery of selective platelet-derived growth factor receptor-beta (PDGFR-β) bifunctional small-molecule degraders
  - **Authors:** Si, Ru; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 77, 117115.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2022.117115](https://doi.org/10.1016/j.bmc.2022.117115)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-43597120
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dichloromethane; 0 °C; overnight, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-614-CAS-43646483

**Type:** Other

**Reagents:**
  - HATU (CAS: 148893-10-1) - Role: BASE (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.25 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `COc1cc(N)cc(OC)c1.Nc1ncc(Br)nc1C(=O)O`
  - Products: `COc1cc(NC(=O)c2nc(Br)cnc2N)cc(OC)c1`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors
  - **Authors:** Zheng, Jia; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2024), 15(11), 2019-2031.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.4c00431](https://doi.org/10.1021/acsmedchemlett.4c00431)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-43646483
1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, rt
1.2|Reagents: Diisopropylethylamine; overnight, rt
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
By: Pasqua, A. Elisa; et al
Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.
10.1021/acs.jmedchem.3c00156
```

---

## Reaction 31-614-CAS-43877333

**Type:** Other

**Reagents:**
  - N-Methylimidazole (CAS: 616-47-7) - Role: BASE (Registry: AMIDE_CATALYST)
  - Tetramethylchloroformamidinium hexafluorophosphate (CAS: 94790-35-9) - Role: UNK
  - 1-Methylimidazole - Role: UNK

**Solvents:**
  - DMAc (CAS: 127-19-5) - Role: SOLVENT
  - Isopropanol (CAS: 67-63-0) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 20.0°C
  - Time: 11.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)c1cnc(C(F)(F)F)nc1.C[C@@H](OC(=O)Nc1c(-c2ccc(N)cn2)nnn1C)c1cc(F)cnc1F.Cc1ccc(S(=O)(=O)O)cc1`
  - Products: `C[C@@H](OC(=O)Nc1c(-c2ccc(NC(=O)c3cnc(C(F)(F)F)nc3)cn2)nnn1C)c1cc(F)cnc1F`

**Reference:**
  - **Title:** Early Process Development of an LPAR1 Antagonist, GS-2278
  - **Authors:** Kadunce, Nathaniel; et al
  - **Citation:** Organic Process Research & Development (2024), 28(11), 4099-4113.
  - **DOI:** [https://doi.org/10.1021/acs.oprd.4c00369](https://doi.org/10.1021/acs.oprd.4c00369)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-43877333
1.1|Reagents: 1-Methylimidazole, Tetramethylchloroformamidinium hexafluorophosphate
Solvents: Dimethylacetamide; 15 min, 0 °C; 15 min, 0 °C
1.2|30 min, 0 °C
1.3|Solvents: Isopropanol, Water; 0 °C → 20 °C; 8 h, 20 °C; 2 h, 20 °C → 0 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of a New Anti-Inflammatory Agent from Anemoside B4 Derivatives and Its Therapeutic Effect on Colitis by Targeting Pyruvate Carboxylase
By: Lv, Lijuan; et al
Journal of Medicinal Chemistry (2024), 67(9), 7385-7405.
10.1021/acs.jmedchem.4c00222
```

---

## Reaction 31-614-CAS-43930961

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 8.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `CN.Cl.COc1cc(Br)cc(C(=O)O)c1`
  - Products: `CNC(=O)c1cc(Br)cc(OC)c1`

**Reference:**
  - **Title:** Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B
  - **Authors:** Lv, Gang; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 80, 117173.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117173](https://doi.org/10.1016/j.bmc.2023.117173)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-43930961
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 8 h, rt
Efficient Total Synthesis of Bilirubin IXα from Butyrolactone
By: Chen, Fapu; et al
Organic Process Research & Development (2024), 28(7), 2777-2788.
10.1021/acs.oprd.4c00122
```

---

## Reaction 31-614-CAS-43967946

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - Piperidine (CAS: 110-89-4) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - i-PrOH (CAS: 920-66-1) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 8.25 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `O=C(O)[C@@H]1CCCCN1C(=O)OCC1c2ccccc2-c2ccccc21.O=C(NC[C@@H](NC(=O)OCc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CC(C)[C@@H](C(=O)O)N(C)C(=O)OCC1c2ccccc2-c2ccccc21.CN(CC(=O)O)C(=O)OCC1c2ccccc2-c2ccccc21.O=C(O)CNC(=O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)N[C@H](CNC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O`
  - Products: `CC(C)[C@@H](C(=O)NC[C@@H](NC(=O)OC(C)(C)C)C(=O)N1CCCC[C@H]1C(=O)NCC(=O)N(C)CC(=O)N(C)[C@H](C(=O)NC[C@@H](NC(=O)OCc1ccccc1)C(=O)N1CCCC[C@H]1C(=O)O)C(C)C)N(C)C(=O)CN(C)C(=O)CN`

**Reference:**
  - **Title:** Structure-activity relationships of bis-intercalating peptides and their application as antibody-drug conjugate payloads
  - **Authors:** Petersen, Mark E.; et al
  - **Citation:** Journal of Medicinal Chemistry (2023), 66(12), 8288-8309.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c00760](https://doi.org/10.1021/acs.jmedchem.3c00760)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-43967946
1.1|Reagents: Diisopropylethylamine
Solvents: Dichloromethane; 3 h, rt
1.2|Reagents: Piperidine
Solvents: Dimethylformamide; rt
1.3|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.4|Reagents: Piperidine
Solvents: Dimethylformamide; rt
1.5|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.6|Reagents: Piperidine
Solvents: Dimethylformamide; rt
1.7|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.8|Reagents: Piperidine
Solvents: Dimethylformamide; rt
1.9|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.10|Reagents: Piperidine
Solvents: Dimethylformamide; rt
1.11|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
1.12|Reagents: Piperidine
Solvents: Dimethylformamide; rt
1.13|Reagents: 1,1,1,3,3,3-Hexafluoro-2-propanol
Solvents: Dichloromethane; 15 min, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery
By: Novotna, Katerina; et al
Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.
10.1021/acs.jmedchem.3c01681
```

---

## Reaction 31-614-CAS-43968811

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `NCc1cccnc1.O=C1N[C@H]2[C@H](CS[C@H]2CCCCCc2cn(C(c3ccc(C(=O)O)cc3)c3cccc(F)c3)nn2)N1`
  - Products: `O=C1N[C@H]2[C@H](CS[C@H]2CCCCCc2cn(C(c3ccc(C(=O)NCc4cccnc4)cc3)c3cccc(F)c3)nn2)N1`

**Reference:**
  - **Title:** Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase
  - **Authors:** Stachura, Damian L.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00505](https://doi.org/10.1021/acsmedchemlett.2c00505)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-43968811
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 16 h, rt
1.2|Reagents: Ammonium chloride
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic
By: Shurtleff, Valerie W.; et al
Journal of Medicinal Chemistry (2024), 67(5), 3935-3958.
10.1021/acs.jmedchem.3c02248
```

---

## Reaction 31-614-CAS-43968812

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `NCc1ccccn1.O=C1N[C@H]2[C@H](CS[C@H]2CCCCCc2cn(C(c3ccc(C(=O)O)cc3)c3cccc(F)c3)nn2)N1`
  - Products: `O=C1N[C@H]2[C@H](CS[C@H]2CCCCCc2cn(C(c3ccc(C(=O)NCc4ccccn4)cc3)c3cccc(F)c3)nn2)N1`

**Reference:**
  - **Title:** Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase
  - **Authors:** Stachura, Damian L.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00505](https://doi.org/10.1021/acsmedchemlett.2c00505)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-43968812
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 16 h, rt
1.2|Reagents: Ammonium chloride
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists
By: Cooper, Martin; et al
Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.
10.1021/acs.jmedchem.0c00828
```

---

## Reaction 31-614-CAS-43968813

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 93%

**SMILES:**
  - Reactants: `Cl.NCc1ccc(N)cc1.O=C1N[C@H]2[C@H](CS[C@H]2CCCCCc2cn(C(c3ccc(C(=O)O)cc3)c3cccc(F)c3)nn2)N1`
  - Products: `Nc1ccc(CNC(=O)c2ccc(C(c3cccc(F)c3)n3cc(CCCCC[C@@H]4SC[C@@H]5NC(=O)N[C@@H]54)nn3)cc2)cc1`

**Reference:**
  - **Title:** Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase
  - **Authors:** Stachura, Damian L.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00505](https://doi.org/10.1021/acsmedchemlett.2c00505)

**Original Text:**
```
Steps: 1, Yield: 93%
CAS Reaction Number: 31-614-CAS-43968813
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 16 h, rt
1.2|Reagents: Ammonium chloride
Solvents: Water; rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-43968824

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Ammonium chloride (CAS: 12125-02-9) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 16.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCCCN.O=C1N[C@H]2[C@H](CS[C@H]2CCCCCc2cn(C(c3ccc(C(=O)O)cc3)c3cccc(F)c3)nn2)N1`
  - Products: `CC(C)(C)OC(=O)NCCCNC(=O)c1ccc(C(c2cccc(F)c2)n2cc(CCCCC[C@@H]3SC[C@@H]4NC(=O)N[C@@H]43)nn2)cc1`

**Reference:**
  - **Title:** Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase
  - **Authors:** Stachura, Damian L.; et al
  - **Citation:** ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.
  - **DOI:** [https://doi.org/10.1021/acsmedchemlett.2c00505](https://doi.org/10.1021/acsmedchemlett.2c00505)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-43968824
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 16 h, rt
1.2|Reagents: Ammonium chloride
Solvents: Water; rt
Relative stereochemistry shown
Relative stereochemistry shown
Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras
By: Takwale, Akshay D.; et al
European Journal of Medicinal Chemistry (2020), 208, 112769.
10.1016/j.ejmech.2020.112769
```

---

## Reaction 31-614-CAS-44298691

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 5.0 hours
  - Yield: 92%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(CBr)cc1.COCCCN`
  - Products: `COCCCNC(=O)c1ccc(CBr)cc1`

**Reference:**
  - **Title:** Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
  - **Authors:** Li, Bing-yan; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02407](https://doi.org/10.1021/acs.jmedchem.3c02407)

**Original Text:**
```
Steps: 1, Yield: 92%
CAS Reaction Number: 31-614-CAS-44298691
1.1|Reagents: Thionyl chloride
Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt
1.2|Solvents: Dichloromethane; 0 °C; 1 h, rt
Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties
By: Morozova, Alisa; et al
European Journal of Medicinal Chemistry (2024), 266, 116101.
10.1016/j.ejmech.2023.116101
```

---

## Reaction 31-614-CAS-44298735

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 5.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(CBr)cc1.CCCCCN`
  - Products: `CCCCCNC(=O)c1ccc(CBr)cc1`

**Reference:**
  - **Title:** Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
  - **Authors:** Li, Bing-yan; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02407](https://doi.org/10.1021/acs.jmedchem.3c02407)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-44298735
1.1|Reagents: Thionyl chloride
Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt
1.2|Solvents: Dichloromethane; 0 °C; 1 h, rt
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
By: Ashton, Trent D.; et al
Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
10.1021/acs.jmedchem.2c02092
```

---

## Reaction 31-614-CAS-44298736

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 5.0 hours
  - Yield: 83%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(CBr)cc1.COCCN`
  - Products: `COCCNC(=O)c1ccc(CBr)cc1`

**Reference:**
  - **Title:** Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
  - **Authors:** Li, Bing-yan; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02407](https://doi.org/10.1021/acs.jmedchem.3c02407)

**Original Text:**
```
Steps: 1, Yield: 83%
CAS Reaction Number: 31-614-CAS-44298736
1.1|Reagents: Thionyl chloride
Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt
1.2|Solvents: Dichloromethane; 0 °C; 1 h, rt
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
By: Ashton, Trent D.; et al
Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.
10.1021/acs.jmedchem.2c02092
```

---

## Reaction 31-614-CAS-44298740

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 5.0 hours
  - Yield: 89%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(CBr)cc1.CCCCN`
  - Products: `CCCCNC(=O)c1ccc(CBr)cc1`

**Reference:**
  - **Title:** Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
  - **Authors:** Li, Bing-yan; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02407](https://doi.org/10.1021/acs.jmedchem.3c02407)

**Original Text:**
```
Steps: 1, Yield: 89%
CAS Reaction Number: 31-614-CAS-44298740
1.1|Reagents: Thionyl chloride
Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt
1.2|Solvents: Dichloromethane; 0 °C; 1 h, rt
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
By: Li, Bing-yan; et al
Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.
10.1021/acs.jmedchem.3c02407
```

---

## Reaction 31-614-CAS-44298741

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 11189.0 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(CBr)cc1.CCCN`
  - Products: `CCCNC(=O)c1ccc(CBr)cc1`

**Reference:**
  - **Title:** Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
  - **Authors:** Li, Bing-yan; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02407](https://doi.org/10.1021/acs.jmedchem.3c02407)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-44298741
1.1|Reagents: Thionyl chloride
Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt
1.2|Solvents: Dichloromethane; 0 °C; 1 h, rt
Optimization and Development of a Scalable Palladium-Catalyzed C-H Activation Process for the Geometry-Selective Preparation of Kilograms of YLF466D, a Potent AMP-Activated Protein Kinase Activator
By: Yin, Jianpeng; et al
Organic Process Research & Development (2021), 25(10), 2260-2269.
10.1021/acs.oprd.1c00150
```

---

## Reaction 31-614-CAS-44298742

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: UNK

**Solvents:**
  - EtOAc (CAS: 141-78-6) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 80.0°C
  - Time: 5.0 hours
  - Yield: 87%

**SMILES:**
  - Reactants: `O=C(O)c1ccc(CBr)cc1.CCN`
  - Products: `CCNC(=O)c1ccc(CBr)cc1`

**Reference:**
  - **Title:** Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
  - **Authors:** Li, Bing-yan; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02407](https://doi.org/10.1021/acs.jmedchem.3c02407)

**Original Text:**
```
Steps: 1, Yield: 87%
CAS Reaction Number: 31-614-CAS-44298742
1.1|Reagents: Thionyl chloride
Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt
1.2|Solvents: Dichloromethane; 0 °C; 1 h, rt
The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles
By: Reddyrajula, Rajkumar; et al
Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.
10.1016/j.bmcl.2019.126846
```

---

## Reaction 31-614-CAS-44299839

**Type:** Other

**Full Catalytic System:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Catalyst Core:**
  - DMAP (CAS: 1122-58-3) - Role: LIGAND

**Reagents:**
  - N,N-Dicyclohexylcarbodiimide (CAS: 538-75-0) - Role: UNK (Registry: N'-DICYCLOHEXYLCARBODIIMIDE)
  - Dicyclohexylcarbodiimide - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `C#CCN.CC(=O)O[C@@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]32)C1`
  - Products: `C#CCNC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(C)=O)CC[C@]4(C)[C@H]3CC[C@]12C`

**Reference:**
  - **Title:** Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2
  - **Authors:** Chhabra, Mohit; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(14), 11885-11916.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00487](https://doi.org/10.1021/acs.jmedchem.4c00487)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-44299839
1.1|Reagents: Dicyclohexylcarbodiimide
Catalysts: 4-(Dimethylamino)pyridine
Solvents: Dichloromethane; 1 h, rt
Double bond geometry shown
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown
Double bond geometry shown
An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity
By: Lemke, Carina; et al
Journal of Medicinal Chemistry (2021), 64(18), 13793-13806.
10.1021/acs.jmedchem.1c01178
```

---

## Reaction 31-614-CAS-44479951

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: BASE (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 16.25 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(=O)N[C@H]1[C@@H](OCc2ccccc2)O[C@@H]2CO[C@@H](c3ccccc3)O[C@H]2[C@@H]1O[C@H](C)C(=O)O.C[C@H](N)C(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O`
  - Products: `CC(=O)N[C@H]1[C@@H](OCc2ccccc2)O[C@@H]2CO[C@@H](c3ccccc3)O[C@H]2[C@@H]1O[C@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists
  - **Authors:** Mhamane, Tukaram B.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 88-89, 117296.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117296](https://doi.org/10.1016/j.bmc.2023.117296)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-44479951
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Tetrahydrofuran; 15 min, rt
1.2|Reagents: Diisopropylethylamine; 0 °C; 16 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites
By: Belouin, Audrey; et al
Bioorganic & Medicinal Chemistry (2024), 98, 117553.
10.1016/j.bmc.2023.117553
```

---

## Reaction 31-614-CAS-44479962

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - THF (CAS: 109-99-9) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 17.0 hours
  - Yield: 85%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O.C[C@H](NC(=O)OC(C)(C)C)C(=O)O`
  - Products: `C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O`

**Reference:**
  - **Title:** Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists
  - **Authors:** Mhamane, Tukaram B.; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 88-89, 117296.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117296](https://doi.org/10.1016/j.bmc.2023.117296)

**Original Text:**
```
Steps: 1, Yield: 85%
CAS Reaction Number: 31-614-CAS-44479962
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 0 °C; 1.5 h, rt
1.2|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Tetrahydrofuran; 30 min, rt
1.3|Reagents: Diisopropylethylamine
Solvents: Tetrahydrofuran; 15 h, rt
Absolute stereochemistry shown,
Rotation (-)
Absolute stereochemistry shown,
Rotation (-)
Insights into Fast Amide Couplings in Aqueous Nanomicelles
By: Sharma, Sudripet; et al
Organic Process Research & Development (2021), 25(8), 1960-1965.
10.1021/acs.oprd.1c00203
```

---

## Reaction 31-614-CAS-44725294

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 1.0 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CCOc1cc(I)cc(COc2ccc(CCNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)C[C@H]3CC[C@@H](N)CC3)c3ccccc3)cc2)c1OCC(=O)O.Cl`
  - Products: `CCOc1cc(I)cc2c1OCC(=O)NC1CCC(CC1)CC(=O)NC(c1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NCCc1ccc(cc1)OC2`

**Reference:**
  - **Title:** Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen
  - **Authors:** Hekking, Koen F. W.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02206](https://doi.org/10.1021/acs.jmedchem.3c02206)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-44725294
1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 1 h, rt
Copyright © 2025 American Chemical Society (ACS). All Rights Reserved.
```

---

## Reaction 31-614-CAS-44725301

**Type:** Other

**Reagents:**
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 100%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)O.NCCc1ccc(OCc2ccccc2)cc1`
  - Products: `CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)NCCc1ccc(OCc2ccccc2)cc1`

**Reference:**
  - **Title:** Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen
  - **Authors:** Hekking, Koen F. W.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02206](https://doi.org/10.1021/acs.jmedchem.3c02206)

**Original Text:**
```
Steps: 1, Yield: 100%
CAS Reaction Number: 31-614-CAS-44725301
1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 1 h, 0 °C
Absolute stereochemistry shown
Absolute stereochemistry shown
Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils
By: Zhu, Di; et al
European Journal of Medicinal Chemistry (2023), 258, 115619.
10.1016/j.ejmech.2023.115619
```

---

## Reaction 31-614-CAS-44725302

**Type:** Other

**Reagents:**
  - Et3N (CAS: 121-44-8) - Role: BASE
  - HOBt (CAS: 2592-95-2) - Role: UNK (Registry: AMIDE_ADDITIVE)
  - EDC-HCl (CAS: 25952-53-8) - Role: UNK (Registry: ACTIVATOR)
  - 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 2.0 hours
  - Yield: 97%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)N[C@H]1CC[C@@H](CC(=O)O)CC1.Cl.N[C@H](C(=O)N[C@H](Cc1ccccc1)C(=O)NCCc1ccc(OCc2ccccc2)cc1)c1ccccc1`
  - Products: `CC(C)(C)OC(=O)N[C@H]1CC[C@@H](CC(=O)N[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)NCCc2ccc(OCc3ccccc3)cc2)c2ccccc2)CC1`

**Reference:**
  - **Title:** Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen
  - **Authors:** Hekking, Koen F. W.; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.3c02206](https://doi.org/10.1021/acs.jmedchem.3c02206)

**Original Text:**
```
Steps: 1, Yield: 97%
CAS Reaction Number: 31-614-CAS-44725302
1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride
Solvents: Dichloromethane; 2 h, 0 °C → rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
By: Behring, Lydia; et al
Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
10.1021/acs.jmedchem.2c01360
```

---

## Reaction 31-614-CAS-44938486

**Type:** Other

**Reagents:**
  - Thionyl chloride (CAS: 7719-09-7) - Role: BASE
  - DIPEA (CAS: 7087-68-5) - Role: WORKUP (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - MeOH (CAS: 67-56-1) - Role: SOLVENT
  - DMSO (CAS: 67-68-5) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 60.0°C
  - Time: 4.0 hours
  - Yield: 80%

**SMILES:**
  - Reactants: `CO.COC(=O)[C@@H](N)Cc1ccc(O)c(I)c1.CC(C)(C)OC(=O)NCCC(=O)O`
  - Products: `COC(=O)[C@H](Cc1ccc(O)c(I)c1)NC(=O)CCNC(=O)OC(C)(C)C`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria
  - **Authors:** Zhang, Yinyong; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(8), 6585-6609.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00018](https://doi.org/10.1021/acs.jmedchem.4c00018)

**Original Text:**
```
Steps: 1, Yield: 80%
CAS Reaction Number: 31-614-CAS-44938486
1.1|Reagents: Thionyl chloride
Solvents: Methanol; 0 °C; 2 h, 0 °C → 60 °C
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethyl sulfoxide; 2 h, rt
1.3|Reagents: Water; rt
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
By: Zhang, Rui; et al
European Journal of Medicinal Chemistry (2021), 211, 113004.
10.1016/j.ejmech.2020.113004
```

---

## Reaction 31-614-CAS-44938560

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - DCM (CAS: 75-09-2) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 1.0 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `Cl.N#CCN.C[C@@H]1NC(=O)[C@@H](N(C)C(=O)[C@H](CCNC(=O)OC(C)(C)C)NC(=O)OCc2ccccc2)c2ccc(OCCNC(=O)OC(C)(C)C)c(c2)-c2cc(ccc2OCCNC(=O)OC(C)(C)C)C[C@@H](C(=O)O)NC1=O`
  - Products: `C[C@@H]1NC(=O)[C@@H](N(C)C(=O)[C@H](CCNC(=O)OC(C)(C)C)NC(=O)OCc2ccccc2)c2ccc(OCCNC(=O)OC(C)(C)C)c(c2)-c2cc(ccc2OCCNC(=O)OC(C)(C)C)C[C@@H](C(=O)NCC#N)NC1=O`

**Reference:**
  - **Title:** Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria
  - **Authors:** Zhang, Yinyong; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(8), 6585-6609.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00018](https://doi.org/10.1021/acs.jmedchem.4c00018)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-44938560
1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide, Dichloromethane; 1 h, 0 °C
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists
By: Mhamane, Tukaram B.; et al
Bioorganic & Medicinal Chemistry (2023), 88-89, 117296.
10.1016/j.bmc.2023.117296
```

---

## Reaction 31-614-CAS-45117379

**Type:** Other

**Reagents:**
  - DIPEA (CAS: 7087-68-5) - Role: BASE
  - HBTU (CAS: 94790-37-1) - Role: WORKUP (Registry: ACTIVATOR)
  - Water (CAS: 7732-18-5) - Role: UNK (Registry: SOLVENT)
  - Diisopropylethylamine - Role: UNK

**Solvents:**
  - DMF (CAS: 68-12-2) - Role: SOLVENT

**Reaction Conditions:**
  - Temperature: 25.0°C
  - Time: 17.5 hours
  - Yield: 84%

**SMILES:**
  - Reactants: `CC(C)(C)OC(=O)NCC(=O)O.CN(C)c1ccc(/C=C/c2ccc(N)cc2)cc1`
  - Products: `CN(C)c1ccc(/C=C/c2ccc(NC(=O)CNC(=O)OC(C)(C)C)cc2)cc1`

**Reference:**
  - **Title:** Synthesis and bioactivity evaluation of a myelin-specific contrast agent for magnetic resonance imaging of myelination in central nervous system
  - **Authors:** Wei, Bin; et al
  - **Citation:** Bioorganic & Medicinal Chemistry (2023), 84, 117257.
  - **DOI:** [https://doi.org/10.1016/j.bmc.2023.117257](https://doi.org/10.1016/j.bmc.2023.117257)

**Original Text:**
```
Steps: 1, Yield: 84%
CAS Reaction Number: 31-614-CAS-45117379
1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide
Solvents: Dimethylformamide; 0.5 h, rt
1.2|overnight, rt
1.3|Reagents: Water
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
By: Zhang, Wen; et al
Bioorganic & Medicinal Chemistry (2021), 40, 116182.
10.1016/j.bmc.2021.116182
```

---

## Reaction 31-614-CAS-45941654

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.25 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CN(/N=C/c1ccc(Cl)cc1)C(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C.O=C(O)COc1ccc(Cl)cc1Cl`
  - Products: `CN(/N=C/c1ccc(Cl)cc1)C(=O)[C@H](Cc1ccccc1)NC(=O)COc1ccc(Cl)cc1Cl`

**Reference:**
  - **Title:** Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
  - **Authors:** Breidenbach, Julian; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00053](https://doi.org/10.1021/acs.jmedchem.4c00053)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-45941654
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt
1.4|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, Water; pH 12, rt
Absolute stereochemistry shown,
Rotation (+)
Absolute stereochemistry shown
Absolute stereochemistry shown,
Rotation (-)
Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability
By: Meta, Mergim; et al
ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.
10.1021/acsmedchemlett.4c00050
```

---

## Reaction 31-614-CAS-45941714

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.25 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CN(/N=C/c1ccc(Cl)cc1)C(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C`
  - Products: `CN(/N=C/c1ccc(Cl)cc1)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C`

**Reference:**
  - **Title:** Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
  - **Authors:** Breidenbach, Julian; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00053](https://doi.org/10.1021/acs.jmedchem.4c00053)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-45941714
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt
1.4|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, Water; pH 12, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-614-CAS-45941790

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Potassium bisulfate (CAS: 7646-93-7) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.25 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C`
  - Products: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C`

**Reference:**
  - **Title:** Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
  - **Authors:** Breidenbach, Julian; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00053](https://doi.org/10.1021/acs.jmedchem.4c00053)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-45941790
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt
1.4|Reagents: Potassium bisulfate
Solvents: Water; pH 1 - 2, rt
Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands
By: Andreasson, Maans; et al
Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.
10.1021/acs.jmedchem.3c02127
```

---

## Reaction 31-614-CAS-45941791

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.25 hours
  - Yield: 91%

**SMILES:**
  - Reactants: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccccc1F)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C`
  - Products: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccccc1F)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C`

**Reference:**
  - **Title:** Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
  - **Authors:** Breidenbach, Julian; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00053](https://doi.org/10.1021/acs.jmedchem.4c00053)

**Original Text:**
```
Steps: 1, Yield: 91%
CAS Reaction Number: 31-614-CAS-45941791
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt
1.4|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, Water; pH 12, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C
By: Zhu, Mei; et al
European Journal of Medicinal Chemistry (2022), 233, 114251.
10.1016/j.ejmech.2022.114251
```

---

## Reaction 31-614-CAS-45941792

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.25 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1cccc(Cl)c1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C`
  - Products: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1cccc(Cl)c1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C`

**Reference:**
  - **Title:** Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
  - **Authors:** Breidenbach, Julian; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00053](https://doi.org/10.1021/acs.jmedchem.4c00053)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-45941792
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt
1.4|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, Water; pH 12, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins
By: Behring, Lydia; et al
Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.
10.1021/acs.jmedchem.2c01360
```

---

## Reaction 31-614-CAS-45941797

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.25 hours
  - Yield: 95%

**SMILES:**
  - Reactants: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccc(F)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C`
  - Products: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C`

**Reference:**
  - **Title:** Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
  - **Authors:** Breidenbach, Julian; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00053](https://doi.org/10.1021/acs.jmedchem.4c00053)

**Original Text:**
```
Steps: 1, Yield: 95%
CAS Reaction Number: 31-614-CAS-45941797
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt
1.4|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, Water; pH 12, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
By: Breidenbach, Julian; et al
Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
10.1021/acs.jmedchem.4c00053
```

---

## Reaction 31-614-CAS-45941798

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.25 hours
  - Yield: 98%

**SMILES:**
  - Reactants: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccccc1Cl)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C`
  - Products: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccccc1Cl)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C`

**Reference:**
  - **Title:** Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
  - **Authors:** Breidenbach, Julian; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00053](https://doi.org/10.1021/acs.jmedchem.4c00053)

**Original Text:**
```
Steps: 1, Yield: 98%
CAS Reaction Number: 31-614-CAS-45941798
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt
1.4|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, Water; pH 12, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Identification of New Nitric Oxide-Donating Peptides with Dual Biofilm Eradication and Antibacterial Activities for Intervention of Device-Related Infections
By: Fei, Yue; et al
Journal of Medicinal Chemistry (2020), 63(17), 9127-9135.
10.1021/acs.jmedchem.9b01832
```

---

## Reaction 31-614-CAS-45941800

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.25 hours
  - Yield: 94%

**SMILES:**
  - Reactants: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C`
  - Products: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C`

**Reference:**
  - **Title:** Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
  - **Authors:** Breidenbach, Julian; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00053](https://doi.org/10.1021/acs.jmedchem.4c00053)

**Original Text:**
```
Steps: 1, Yield: 94%
CAS Reaction Number: 31-614-CAS-45941800
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt
1.4|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, Water; pH 12, rt
Absolute stereochemistry shown
Absolute stereochemistry shown
Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum
By: Teno, Naoki; et al
ACS Medicinal Chemistry Letters (2021), 12(3), 420-425.
10.1021/acsmedchemlett.0c00640
```

---

## Reaction 31-614-CAS-45941801

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.25 hours
  - Yield: 90%

**SMILES:**
  - Reactants: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1cccc(F)c1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C`
  - Products: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1cccc(F)c1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C`

**Reference:**
  - **Title:** Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
  - **Authors:** Breidenbach, Julian; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00053](https://doi.org/10.1021/acs.jmedchem.4c00053)

**Original Text:**
```
Steps: 1, Yield: 90%
CAS Reaction Number: 31-614-CAS-45941801
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt
1.4|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, Water; pH 12, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
By: Breidenbach, Julian; et al
Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
10.1021/acs.jmedchem.4c00053
```

---

## Reaction 31-614-CAS-45941810

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - NaHCO3 (CAS: 144-55-8) - Role: UNK (Registry: BASE)
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK
  - Sodium bicarbonate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.25 hours
  - Yield: 82%

**SMILES:**
  - Reactants: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1cccs1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C`
  - Products: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1cccs1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C`

**Reference:**
  - **Title:** Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
  - **Authors:** Breidenbach, Julian; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00053](https://doi.org/10.1021/acs.jmedchem.4c00053)

**Original Text:**
```
Steps: 1, Yield: 82%
CAS Reaction Number: 31-614-CAS-45941810
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt
1.4|Reagents: Sodium bicarbonate
Solvents: Dichloromethane, Water; pH 12, rt
Absolute stereochemistry shown
Double bond geometry shown
Absolute stereochemistry shown
Absolute stereochemistry shown
Double bond geometry shown
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
By: Breidenbach, Julian; et al
Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
10.1021/acs.jmedchem.4c00053
```

---

## Reaction 31-614-CAS-45941817

**Type:** Other

**Reagents:**
  - TFA (CAS: 76-05-1) - Role: BASE (Registry: SOLVENT)
  - DIPEA (CAS: 7087-68-5) - Role: UNK (Registry: BASE)
  - HATU (CAS: 148893-10-1) - Role: UNK (Registry: ACTIVATOR)
  - Potassium bisulfate (CAS: 7646-93-7) - Role: UNK
  - Diisopropylethylamine - Role: UNK
  - O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate - Role: UNK

**Solvents:**
  - DCM (CAS: 75-09-2) - Role: SOLVENT
  - DMF (CAS: 68-12-2) - Role: SOLVENT
  - Water (CAS: 7732-18-5) - Role: SOLVENT

**Reaction Conditions:**
  - Time: 18.25 hours
  - Yield: 99%

**SMILES:**
  - Reactants: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@@H](NC(=O)OC(C)(C)C)C1CCCCC1.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C`
  - Products: `CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C1CCCCC1`

**Reference:**
  - **Title:** Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
  - **Authors:** Breidenbach, Julian; et al
  - **Citation:** Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.
  - **DOI:** [https://doi.org/10.1021/acs.jmedchem.4c00053](https://doi.org/10.1021/acs.jmedchem.4c00053)

**Original Text:**
```
Steps: 1, Yield: 99%
CAS Reaction Number: 31-614-CAS-45941817
1.1|Reagents: Trifluoroacetic acid
Solvents: Dichloromethane; 2 h, rt
1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
Solvents: Dimethylformamide; 15 min, 0 °C
1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt
1.4|Reagents: Potassium bisulfate
Solvents: Water; pH 1 - 2, rt
Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents
By: Amblard, Franck; et al
Bioorganic & Medicinal Chemistry (2021), 31, 115952.
10.1016/j.bmc.2020.115952
```

---

